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Stroke is the largest cause of adult disability in the UK and stroke survivors 
commonly present with a partial or complete loss of movement. Physical 
therapy interventions as part of movement rehabilitation after stroke aim to 
facilitate a return to participation in activities of daily living. It has been proposed 
that the processes that underpin both movement recovery following stroke and 
motor learning are the same. By embedding physical therapies within a motor 
learning context it is possible that the effects of the therapy could be enhanced. 
Yet the application of motor learning principles within the field of movement 
rehabilitation after stroke is fragmented and supported by evidence of their 
application in studies with healthy volunteers. This thesis aims to carry out a 
systematic review of the evidence for the effectiveness of the application of 
motor learning principles in movement rehabilitation after stroke and to 
combine this with findings from a feasibility study of Functional Strength 
Training. These findings will be used to design a novel intervention embedding 
FST within a motor learning context. 
 
Organisation and synthesis of the systematic review was guided by the 
development of a motor learning framework. Interpretation of the findings from 
the review showed some evidence in favour of the application of motor learning 
principles. A phase II randomised controlled trial of FST to the upper limb and 
lower limb in people within six months and five years after stroke showed 
evidence of feasibility for both interventions but indicated efficacy of the upper 
limb intervention only (p=0.046).  
 
These findings were combined to inform the design and delivery of a novel 
intervention, testing for proof of concept for this intervention is now required.  
 
This thesis suggests an alternative approach to the development of physical 
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Stroke is defined as “a clinical syndrome, of presumed vascular origin, typified 
by rapidly developing signs of focal or global disturbance of cerebral functions 
lasting more than 24 hours or leading to death” (World Health Organisation, 
1978 cited in Intercollegiate Stroke Working Party, 2012 p.4). Stroke is the 
largest cause of adult disability in the United Kingdom (National Audit Office, 
2010); there are approximately 1.1 million people living in England, at any one 
time, who have had a stroke (Townsend et al., 2012) and. The disruption to the 
blood supply within the brain may occur as a result of a blockage to one of the 
major blood vessels, referred to as an ischaemic stroke, or as a bleed from 
these vessels, referred to as a haemorrhagic stroke (Department of Health, 
2005).The resulting damage to the brain may lead to a number of impairments 
such as difficulties with communication, cognition and movement. The most 
common impairment affecting movement following stroke is hemiplegia, which 
presents as weakness or complete loss of movement on one side of the body 
(contralateral to the site of the stroke within the brain) (Rathore, Hinn et al. 
2002).  
 
Stroke is conventionally classified according to the site and subsequent 
impairment of the lesion. One such classification, commonly referred to in both 
clinical and research environments, is the Bamford classification (Bamford and 
Sandercock, 1991). Patients diagnosed with a stroke fall within one of four 
subtypes,  
 Lacunar infarct (LACI) – patients presenting with a pure motor stroke, 
pure sensory stroke, sensori-motor stroke or ataxic hemiparesis. 
 Total anterior circulation infarct (TACI) – Patients presenting with of 
higher cerebral dysfunction (e.g. dysphasia, dyscalculia, visuospatial 
disorder); homonymous visual field defect; and ipsilateral motor and/or 
sensory deficit of at least two areas of the face, arm and leg. 
 Partial anterior circulation infarct (PACI) – Patients presenting with only 
two of the three components of the TACI syndrome. 
 Posterior circulation infarct (POCI) – Patients presenting with any of the 




sensory deficit; disorder of conjugate eye movement; ataxic hemiparesis 
or isolated homonymous visual field defect.                        
Bamford and Sandercock (1991) 
Physical therapy interventions are believed to contribute significantly to the 
movement recovery of people after stroke (Intercollegiate Stroke Working Party, 
2012).  The aims of therapy are to capitalise on natural movement recovery, 
maximise the patient’s return to functional activities and minimise secondary 
complications. Whilst there is general consensus about the overall aims of 
therapy the actual content has sometimes been described as a ‘black box’. The 
patient goes into the ‘box’, they participate in ‘therapy,’ and they emerge with 
improved movement control (Pomeroy and Tallis, 2000). There are a number 
of different ‘tools’ within the therapist’s ‘toolkit’ and each may be more or less 
effective depending on the presentation of each individual patient. To gain a 
better understanding of which therapeutic interventions, produce the best 
outcomes for the different movement impairments that can occur as a result of 
stroke, it is essential that we clearly define each intervention and investigate its 
efficacy and effectiveness. Physiological differences, underpinning recovery in 
the brain, also suggest that the same physical therapy intervention should be 
evaluated within populations of stroke survivors who are within both the acute 
and chronic period of recovery from stroke. Recovery within the so-called acute 
phase (up to six months after stroke) is underpinned by a rapid period of repair 
(Cramer, 2008). This is different to the processes that underpin later stages of 
recovery which have been likened to the usual physiological changes that occur 
within the brain in response to learning (Kleim and Jones, 2008).  
 
Loss of movement following stroke may be caused by a number of factors, 
however, reductions in muscle strength is widely considered to be one of the 
main causes of a loss of performance in functional activities such as walking 
and reaching for objects (Bohannon, 2007, Burke, 1988, Harris and Eng, 2007). 
Research evidence suggests that following stroke, strengthening interventions 
can increase muscle strength and may improve the stroke survivor’s ability to 





Functional Strength Training (FST) is a physiotherapy intervention, (a ‘tool’ 
within the ‘toolkit’), designed to increase the participant’s ability to produce 
voluntary muscle force throughout joint range, increase their ability to modulate 
force in muscles/muscle groups appropriate for the activity being trained and 
improve functional ability (Cooke et al., 2010b, Donaldson et al., 2009a). FST 
can be used to improve function in both the upper and lower limb. In order to 
achieve this, FST uses conventional strengthening techniques such as 
increased repetition and integrates them into functional activities such as 
standing up and sitting down (Cooke et al., 2010b, Donaldson et al., 2009a). 
Findings of early phase trials give evidence of feasibility for FST for both the 
upper and lower limb in people who are within 3 months of a stroke affecting 
the anterior circulation of the brain (Bale and Strand, 2008, Cooke et al., 2010b, 
Donaldson et al., 2009a). However, it is unclear whether the results of these 
trials can be generalised to people who are at least six months after stroke – 
the so-called chronic phase. It is important therefore to determine the feasibility 
of this intervention within this other population of stroke survivors.  
 
A body of work that coexists alongside the development of physical therapy 
interventions as part of movement rehabilitation after stroke is that of motor 
learning. There is a school of thought suggesting that the behavioural changes 
observed following movement rehabilitation is, in effect, a product of motor 
learning (Shmuelof et al., 2012), and certainly the concept of aligning motor 
learning to physiotherapy approaches within stroke rehabilitation is not new. 
The Movement Science approach (formerly the Motor Relearning Programme) 
(Carr and Shepherd, 2003) is underpinned by these principles and it is 
suggested that a number of current interventions, targeting movement recovery, 
are based on motor learning theories (Krakauer, 2006). Literature has identified 
motor learning principles in relation to mental practice, instructions, feedback, 
practice intensity, variability of practice and practice specificity (Magill, 2006).  
The application of these principles to physical therapy interventions after stroke 
has the potential to guide their delivery and arguably enhance their effects on 





Evidence in relation to the efficacy of these motor learning principles comes 
from studies that have included only healthy volunteers and there is limited 
evidence in relation to their use in studies including stroke survivors. The ability 
to engage in motor learning may be impaired in stroke survivors compared to 
that of healthy individuals, so it may not be appropriate to apply these principles 
in the same way (Hosp and Luft, 2011). There is a need therefore to synthesise 
the evidence for the use of all the motor learning principles and their relative 
effectiveness in promoting movement recovery after stroke.  
  
1.1 Development of thesis 
A number of years ago, as a clinical physiotherapist working in the field of 
movement rehabilitation following acquired brain injury, I attended a Movement 
Science course. Although previously aware of aspects of motor learning such 
as feedback and practice intensity I had at that time not used them consistently 
within my clinical practice. This course stimulated an interest in this area which 
has developed with my subsequent shift away from the clinical environment 
and into teaching and learning and research. As I became increasingly 
knowledgeable about this body of literature I became more aware of the 
limitations of directly applying research findings from healthy volunteers to 
physical therapy interventions targeting movement recovery after stroke.  I also 
perceived limitations in applying these principles to physical therapy 
interventions because of a lack of clarity and consensus around terminology. 
Despite this, it seemed that motor learning principles had the potential to guide 
delivery of physical therapy interventions and possibly enhance their effects on 
movement recovery after stroke.  
My on-going interest in this field of research and applied clinical practice 
coincided with an opportunity to expand work on a specific physical therapy 
intervention – Functional Strength Training (FST). The concurrent development 
of both these aspects of my work has led to the development of this thesis. This 
body of work reports on two studies, a systematic review evaluating the 
effectiveness of the application of motor learning principles to enhance 
movement recovery after stroke; a phase II randomised controlled trial 




recovery. The thesis seeks to use the findings from these studies to identify a 
novel intervention which will demonstrate how physical therapies can be 
informed by the application of motor learning principles. Such an approach 
could be used to enhance the delivery of movement rehabilitation after stroke. 
The design of both studies within this thesis has been underpinned by the 
conceptual framework published in the guidance document “Developing and 
evaluating complex interventions” (Craig et al., 2008). This framework 
describes a cyclical process where complex interventions can be piloted and 
subsequently tested for efficacy. The following chapter will first introduce the 
MRC framework for evaluating complex interventions (section 2.1) and briefly 
discuss why its application is appropriate as a means of guiding the 
development of the studies in this thesis. The chapter will then go on to 
separately identify the background literature which has led to the development 
of the following two research questions.  
Question 1:  
What is the effectiveness of motor learning principles applied to people after 
stroke in order to promote motor learning? 
 
Question 2: 
Is Functional Strength Training a feasible intervention for improving upper and 
lower limb recovery later after stroke? 
 
Subsequent chapters will identify the methods, results and interpretations from 
each of the studies. Finally, the findings from both studies will be combined to 
suggest a future intervention illustrating how physical therapy interventions can 






This chapter will address the background literature underpinning the 
development of both the systematic review and the trial of Functional Strength 
Training. Before reviewing the literature in these areas the first section will 
introduce the MRC framework for complex interventions. Evaluation of complex 
interventions prior to the publication of this guidance was problematic because 
the intervention had not been fully defined and developed (Campbell et al., 
2000). It is hoped therefore that by using this guidance to direct the 
development of a novel intervention described in this thesis that these problems 
can be avoided. Complex interventions are defined as such because they can 
be subject to a number of variables that may not be present in other types of 
intervention. These may include heterogeneous populations such as stroke 
survivors, the evaluation of individual behavioural responses and variability and 
little consensus for outcome measures (Campbell et al., 2000, Craig et al., 
2008). These factors are all present within the studies included in this thesis.  
 
2.1 MRC Framework for complex interventions 
 The MRC Framework for evaluating complex interventions was initially 
published in 2000, this publication served as the precursor to a refined 
framework published in 2008 which sought to address some of the criticisms 
that had subsequently arose following the implementation of the original 
document (Campbell et al., 2000).  The authors of the framework recognised 
the complexity inherent within some health care interventions and attempted to 
provide investigators with a framework that could guide the evaluation of these. 
Complex interventions were typically described as being an intervention with a 
number of interacting components however this definition did not preclude 
other aspects of complexity such as variability in a target population or the 
identification of a range of possible outcomes. The first document described a 
sequential series of investigations that enabled researchers to develop a 
complex intervention from a theoretical hypothesis through to a definitive trial 
and on to long term implementation (Campbell et al., 2000).  In the most recent 
framework this series of sequential steps has been developed into a cyclical 





Figure 1: Diagram describing the cyclical process for evaluating and describing complex interventions (Craig et 
al., 2008) 
 
The following paragraphs describe each of these steps (development, 
feasibility and piloting, evaluation and implementation) in more detail.  
 Development   
Craig et al. (2008) highlighted the importance of initially developing an 
intervention to the point where you can reasonably expect an effect; in 
order to do this it is necessary to identify the evidence base. They 
suggested that this is achieved through a systematic review or 
identification of one already in existence. Other aspects of this 
development phase include identifying and developing the appropriate 
theory and modelling the process and outcomes. 
 Assessing feasibility and piloting methods 
This stage is advocated in order to pre-empt issues that might arise in a 
definitive trial such as acceptability, likely retention and recruitment rates 
and sample size calculation (REF). 
 Evaluation 
Evaluation of a complex intervention subsequently needs to assess 
effectiveness. Craig et al. (2008) acknowledged the variety of study 
designs to choose from but recommended that randomisation should 
always be considered within these as a means of preventing selection 
bias. This stage of the framework is also used to understand and 




implementation. Cost effectiveness of the intervention should also be 
evaluated at this stage. 
 Implementation 
Implementation is achieved through publication in research journals but 
also provided in formats that are accessible to policy and decision 
makers. Successful implementation involves changing behaviour and 
research teams need to understand the barriers in order to overcome 
this. 
 
Monitoring of the success or not of the implementation of a complex 
intervention may lead to the identification of further work that needs to 
be carried out and thus the process may be cyclical as described in 
figure 1. Completion of each stage may also lead to aspects in the study 
design that require further refinement and thus there may be a need to 
revisit a previous stage in order to achieve this. This possibility is 
articulated by the presence of two way arrows in the diagram above. 
 
 
The following sections go on to discuss the background literature supporting 
the two studies which were intended to inform the development of a novel 
intervention. 
 
2.2 Motor Learning 
Motor learning has been defined as: 
“the acquisition of motor skills, the performance enhancement of learned 
or highly experienced motor skills, or the reacquisition of skills that are difficult 
to perform or cannot be performed because of injury, disease and the like.” 
(Magill, 2006 p.3). 
 
Motor learning has been assumed to take place if there has been a “relatively 
permanent” change in the performance of a movement in response to practice 
or increased experience of that movement (Magill, 2006, Shumway-Cook and 




motor skills are: consistency of performance, stability of performance in the 
face of disruption from internal factors (e.g. stress), sustained improvements in 
the performance seen over different periods of time and adaptability of 
performance to a variety of contexts (Magill, 2006). 
 
Rehabilitation of movement disorders following stroke is predicated on the 
assumption that stroke survivors need to relearn movement so that they can 
regain the ability to take part in functional activities (Carr and Shepherd, 2003). 
In the case of stroke rehabilitation this may mean teaching task specific 
compensatory strategies if there has not been sufficient return of muscle control 
or power. Alternatively, if there has been, strategies that promote recovery of 
normal motor control may be used (Kitago et al., 2013).  
 
It seems appropriate therefore to suggest that the underlying goal guiding both 
motor learning and movement rehabilitation following stroke is in effect the 
same; to produce a sustained and adaptable change in movement 
performance (Krakauer, 2006). Through motor learning the learner is moved 
from a state of little or no ability to perform, to a change in that performance 
through the practical application of motor learning principles. In movement 
rehabilitation after stroke the learner (stroke survivor) moves along the same 
continuum after taking part in ‘rehabilitation interventions’. Pioneering work by 
Carr and Shepherd has long recognised this link between movement recovery 
and motor learning and created the ‘Motor Relearning Programme’ (Carr and 
Shepherd, 1991). This has subsequently been developed into an approach 
now named ‘Movement Science’ (Carr and Shepherd, 2000). This project 
seeks to build on this work by examining the evidence for the effectiveness of 
the application of motor learning principles as part of movement rehabilitation 
after stroke.   
 
Despite the potential to inform the delivery of physical therapies, the application 
of motor learning theories by therapists working in the field of movement 
rehabilitation, appears to be limited. In an attempt to learn whether motor 
learning principles were being used to underpin walking interventions DePaul 




DePaul’s thesis and is yet to be published in a peer reviewed journal. Its 
findings are limited by the scientific rigour that peer review provides. However, 
they found little evidence of adherence to motor learning principles as part of 
walking training interventions after stroke. More detailed examination of the 
literature included in this narrative review revealed that whilst studies were not 
describing their interventions within the context of a motor learning construct, 
there was evidence of the inclusion of some motor learning principles such as 
feedback or practice specificity. It is possible that the authors of these studies 
included in this review had not recognised these as motor learning principles 
but simply methods for delivering the intervention. The description and use of 
motor learning principles within experimental studies needs to be clear so that 
the translation of findings from research studies to the clinical environment can 
be facilitated (Kleynen et al., 2013). 
 
Feedback, practice specificity and practice intensity appear to be the most 
commonly applied motor learning principles and have been the subject of both 
narrative and systematic reviews (Cooke et al., 2010a, French et al., 2010, 
Molier et al., 2010, Subramanian et al., 2010, and Veerbeek et al., 2011). Use 
of the other motor learning principles is less well documented. It is unclear why 
there has been a preference for the use of only one or two motor learning 
principles within individual studies as each has the potential to guide different 
aspects of the delivery of a physical therapy intervention. The development of 
a motor learning framework to contextualise the use of motor learning principles 
and their application to physical therapy interventions seems desirable. Such a 
framework would facilitate communication and possibly the uptake of those 
motor learning principles that have been less well applied. It could also provide 
a standardised structure to the development of motor learning theories as part 
of movement rehabilitation after stroke. 
 
The following section will explore the work surrounding the development of 





2.2.1 Overview of the development of motor learning principles 
Motor learning theorists have determined two types of learning believed to 
underpin the changes in motor performance; these are ‘implicit learning’ and 
‘explicit learning’ sometimes referred to as non-declarative or declarative 
(Shumway-Cook and Woollacott, 2007). In explicit learning there is a conscious 
intention to acquire a skill, whereas in implicit learning the act of acquiring the 
skill is unconscious (Shumway-Cook and Woollacott, 2007). The type of 
learning that underpins a change in motor performance is believed to be related 
to the complexity of the task that needs to be learnt (Halsband and Lange, 
2006). The learning of complex tasks is therefore generally believed to occur 
through the process of implicit learning because the ability to consciously recall 
every aspect of that task is not feasible (Halsband and Lange, 2006). Tasks 
that are likely to be the target of movement rehabilitation after stroke, such as 
walking, are generally held to be complex, and therefore it is the capacity for 
this type of learning that has been the focus of research in participants who 
have been diagnosed with a stroke (Boyd et al., 2009, Boyd et al., 2007, Boyd 
and Winstein, 2003, Boyd and Winstein, 2004b, Gomez-Beldarrain et al., 1998, 
Meehan et al., 2011, Orrell et al., 2007, Pohl et al., 2006, Pohl and Winstein, 
1999). This body of literature exploring whether stroke survivors can or cannot 
engage in implicit learning will be discussed in more detail later. This thesis is, 
however, based on the premise that it is this type of learning that will underpin 
the performance enhancement of the complex motor skills that are necessary 
for stroke survivors to regain the ability to take part in functional activities. 
 
Over the last one hundred years or so the identification of motor learning 
principles has been guided by motor learning theorists who have developed a 
set of principles which serve to promote changes in movement performance 
(Adams, 1987). A principle is defined as: 
“a general scientific theorem or law that has special applications across 
a wide field”  
(http://oxforddictionaries.com/definition/english/principle accessed 19.7.13) 
In motor learning therefore, a motor learning principle could be interpreted as 
a general rule that can be applied to the field of motor learning. Thus an 




learning, this interpretation appears to resound with current literature referring 
to the use of motor learning principles in stroke rehabilitation (Jonsdottir et al., 
2007, Piron et al., 2010) 
 
The following section will provide some background to the development of 
current motor learning principles by considering some of the theories that are 
prevalent within the published literature. Currently it seems that theorists tend 
to fall into two categories: those that adhere to a ‘cognitive camp’ and those 
who adhere to the ‘dynamical camp’ (Newell, 2003, Adams, 1987, Magill, 2006, 
McMorris, 2008, Shumway-Cook and Woollacott, 2007). 
 
Within the ‘cognitive camp’ lie those theorists who adhere to motor learning 
theories evolved from the Adam’s Closed Loop Theory (summarised in Adams, 
1987, Magill, 2006 and Shumway-Cook and Woollacott, 2007). This motor 
learning theory relies on sensory feedback derived from knowledge of the 
results of an initial movement. The body’s internal sensory mechanisms deliver 
information about the relative success or failure of the movement (knowledge 
of results), this feedback is interpreted and further movement is generated until 
the action is learnt. This theory emphasises the role of feedback and continued 
practice within motor learning. It does not however account for motor learning 
that has been seen to take place when there is no sensory feedback, such as 
in feedforward tasks like touch typing. Nor does it explain the adaptability of 
novel motor tasks to different contextual situations such as being able to play 
a piece of music on the cello when it has only been previously learnt on the 
violin (Shumway-Cook and Woollacott, 2007). Recognising the limitations of 
this theory Schmidt went on to develop the Schema Theory (Schmidt, 2003). 
Schmidt believed that new movements were created and learnt as ‘schema’. 
This referred to the creation of a generalised set of rules about the movement 
that could be applied within different contexts, such as the ability to play the 
same piece of music on two different instruments, something which was not 
addressed within the Closed Loop Theory. Schema were created in much the 
same way as the closed loop theory, i.e. in response to knowledge of results 
and sensory feedback, however they could be adapted to enable the learner to 




contextual constraints. Once the ‘new movement’ had been carried out then 
further adjustment based on the feedback mechanisms would serve to update 
the schema for different contextual situations. Schmidt (2003) suggested that 
learning the movement schema would be enhanced by physical practice under 
variable conditions. In support of the schema aspect of his theory Schmidt 
(2003) has referenced original work by Wadman et al. (1979). This study 
analysed the electromyographic (EMG) trace of arm movements in seven 
healthy males under three conditions; the first was analysis of the movement 
without any interference. The second and third analyses were conducted under 
changes of inertial load and mechanical blocking of the movement respectively. 
EMG traces of the movements shown on a graph, depicting the timing of activity 
within the main muscle groups (triceps and biceps), showed that the activity 
within the muscles remained largely the same despite any interference to the 
movement. Schmidt (2003) suggested that this was because of the presence 
of the generalised motor programme or schema which was programmed to act 
in a pre-defined way despite disruption.  
 
Support for the practice variability aspect of Schmidt’s theory lies within a 
concept referred to as ‘contextual interference’. This can be defined as: 
“the memory and performance disruption (i.e. interference) that results 
from performing multiple skills or variations of a skill within the context 
of practice” (Magill 2006, p.375). 
This concept was originally introduced by Battig and William (1972) and recent 
interpretation of this generally refers to changes in the practice schedule of the 
movement (Magill and Hall, 1990). Figure one shows an example of how this 
can be applied; different components of a movement task that need to be learnt 
have been labelled A to D. In the first example the practice schedule for these 
components is arranged in a random fashion, this design is described as one 
with ‘high contextual interference’. The second example shows a practice 
schedule that is referred to as a blocked or massed practice schedule and is 







Example of a random practice schedule with high contextual interference 
(A,B,C and D represent different components within one task) 
A C D B B D C A D A C B 
 
Example of a massed practice schedule with low contextual interference 
(A,B,C and D represent different components within one task) 
A A A B B B C C C D D D 
Figure 2: Example of massed and random practice schedules 
 
Schmidt (2003) contested that practice under random practice schedule 
conditions would lead to better retention of the movement task. In a study of 
healthy volunteers Shea and Morgan (1979) found statistically significantly 
increased retention and adaptability, as measured by reaction time, total time 
to complete the task (from the onset of the stimulus to task completion) and 
movement time, of a motor learning task following practice under random 
conditions compared to massed practice (P<0.05). This seemed to confirm 
Schmidt’s theory that random practice schedules enhanced motor learning. 
However, a more recent narrative review by Magill and Hall (1990) suggested 
that the practice schedule should be altered according to the skill variations 
required within the task. They proposed that where motor learning tasks 
required different motor programs, then randomly scheduled practice would be 
best, but where motor learning tasks involved modification of the same motor 
program, then a mixture of massed and then random practice schedules would 
be more appropriate. Empirical evidence supporting this is limited. 
 
A subsequent narrative review has also suggested that the type of practice 
schedule should vary according to the skill level of the learner. Brady (1998) 
suggested that novices and those with low skill levels would benefit more from 
a massed practice schedule than a random one. This hypothesis is largely 
based on the theoretical application of motor learning theorists; however, a 
study by Hebert et al. (1996) lends some support to this concept. In their study, 
comparing the effects of a tennis practice schedule with low or high contextual 




low skilled students who practiced under low contextual interference scored 
more highly than the matched group of low skilled students who practiced under 
high contextual interference (p<0.05). Conversely however, this study did not 
find a statistically significant effect of practice schedule for those students who 
were assessed as having a high skill level (p> 0.05). According to the 
hypothesis by Brady (1998) these students should have scored more highly 
after practice with high contextual interference. In order to challenge the more 
highly skilled players, the authors of this study had included complex 
components of the task within their practice sessions. They suggested this 
complexity may have impacted on the ability of the highly skilled players to 
show a statistically significant improvement regardless of practice schedules. 
Testing of the original hypothesis for the effects of both types of practice 
scheduling on novice and experienced learners is therefore still needed in order 
to either confirm or refute Brady’s theory. 
 
The importance of feedback as a means for promoting motor learning is also 
inherent within Schmidt’s Schema Theory (Schmidt, 2003). There are two types 
of feedback described within the literature, task-intrinsic feedback and 
augmented or extrinsic feedback (Magill, 2006). Schmidt’s Schema Theory 
(2003) refers to feedback derived from sensory systems within the body (e.g. 
auditory, visual, proprioceptive or tactile) that provide information about the 
delivery of the movement; this is known as task-intrinsic feedback. He also 
refers to ‘knowledge of results’, which is a form of augmented or extrinsic 
feedback. The term knowledge of results refers to the type of feedback 
obtained from information of the outcome of the movement, and comes from 
an external source to the individual undertaking the movement. The other form 
of extrinsic feedback, not referred to explicitly by Schmidt (2003), is knowledge 
of performance and this gives information about the movement characteristics. 
A recent study evaluating the effect of feedback versus no feedback on a 
complex movement task in a group of healthy individuals, found that the group 
of participants who received feedback performed significantly better than those 
who received no feedback (p<0.005) (Strandbygaard et al., 2013). The 
effectiveness of feedback in motor learning with healthy volunteers relies on 




perceptual systems. These results may therefore not be applicable to people 
who have impairments within any of these. 
 
Reflecting on his theory twenty seven years later Schmidt (2003) believed that 
whilst the Schema theory could offer many features to a new way of thinking it 
was lacking in a number of ways and he has subsequently called for a new 
theory to be developed. It is interesting to note, however, that despite this 
assertion, reference to Schmidt’s work still seems to dominate motor learning 
texts (Magill, 2006, McMorris, 2008, Shumway-Cook and Woollacott, 2007). 
 
An alternative ‘camp’ of motor learning theorists lies within those individuals 
who adhere to the ‘dynamical approach’. In this approach motor learning 
evolves in a dynamic way under the cooperation and interaction of various 
systems. This approach evolved in response to a need to explain temporal and 
spatial aspects of motor learning which were not accounted for in Schmidt’s 
theory. It refers to the evolution of movement patterns or learnt behaviours as 
‘attractors’ rather than schema which are perceived to be a more rigid 
representation of a movement pattern (Newell and Vaillancourt, 2001, Newell, 
1991). Practically, this theory offers the idea of stable coordination of 
movement through repeated practice, and the necessity of integrating many 
factors in order to learn movement (Newell et al., 2001, Shumway-Cook and 
Woollacott, 2007). It seems to differ from the Schema Theory in it’s concept of 
the development of a more fluid motor programme (attractor), which is more 
responsive to adaptation, than that proposed by schema. Thus this theory 
appears to be an evolution of the Schema Theory rather than something that 
directly contradicts it. In terms of the principles of motor learning this theory 
continues to support the need for feedback and practice variability identified 
within the Schema Theory.  
 
Theories relating to ‘how do we learn?’ are underpinned by theories about the 
stages of motor learning, and for this we are referred to the Fitts and Posner 
Three Stage Model and Gentile’s Two Stage Model (Magill, 2006, McMorris, 
2008, Shumway-Cook and Woollacott, 2007). Fitts and Posner referred to a 




through an associative stage and came finally to an autonomous stage (Magill, 
2006). Gentile’s two stage model referred more to the development of the 
movement goal, where the first stage was for the learner to develop a motor 
pattern which becomes refined through practice and interaction with the 
contextual aspects of the task. The later stages of the learning were then 
underpinned by the learner’s ability to adapt the task to new contexts and to 
show consistency in the task performance (Magill, 2006). Arguably, common 
to both were the need for instructions in the earlier stages of learning, and 
practice of the movement throughout the learning process.  
 
‘Instructions’ refer to the commands that the ‘teacher’ gives to the ‘learner’ prior 
to his or her practice of the motor task. Instructions can have either an internal 
or external focus; an external focus would be where attention is directed 
towards thinking about where an item is placed on a shelf, as opposed to an 
internal focus where the learner would be directed to think about how straight 
the elbow is whilst achieving that same task (Wulf, 2007). Evidence from 
studies evaluating either an internal or external focus of instructions on motor 
learning have consistently found that motor learning was better if the focus of 
the instructions is external (Wulf, 2007). But this evidence once again 
predominantly referred to learning in healthy volunteers. 
 
Gentile’s emphasis on interaction with the contextual aspects of the task is 
supported by another theorist and suggests a motor learning principle relating 
to specificity of practice. Thorndike (1914) cited by Magill (2006) proposed the 
‘identical elements theory’ which suggested that practice of a movement should 
involve the same or similar elements of the movement that needed to be learnt. 
Practice schedules that are contextually the same or similar to the desired task 
would enable better learning, in that transfer of learning to the actual situation 
would be more accurate. The concept of specificity of practice appears to 
conflict with the concept of variability of practice explored during the discussion 
of contextual interference. In order to discuss this further it is useful to 
remember how successful motor learning was originally defined at the start of 
this chapter. Requirements for successful learning were defined as consistency 




factors, sustained improvements in the performance seen over different 
periods of time and adaptability of performance to a variety of contexts (Magill, 
2006). It is likely that the motor learning principle relating to practice specificity 
refers to learning outcomes around consistency and sustainabilty and that that 
of contextual interference relates to adaptability. There seems to be a place 
therefore for motor learning principles referring to both concepts. The effect of 
practice specificity was explored by Pellecchia (2005) who compared the 
effects of a balance training task under  task specific conditions compared to 
non task specific and found a significant effect in favour of the task specific 
training (P<0.05).  In this study the task specific group practiced exactly the 
same task that was being measured as an outcome of the study. It would be 
difficult therefore to extrapolate conclusions about the adaptability of this task 
to different contexts. It may be interesting, in the future, to explore the effects 
of both practice variability and specificity and measure their relative affect on 
outcomes that represent both accuracy and adaptabiliy to see if each has a 
different effect depending on the outcome used. 
 
This overview of some of the theories surrounding motor learning supports a 
number of motor learning principles relating to the variability of physical practice, 
instructions, feedback and specificity (including context of the task, the objects 
involved within that task and the environment). Not explicit in this overview 
however, is the concept that practice can also be mental as well as physical 
(Shumway-Cook and Woollacott, 2007).  Mental practice is the cognitive act of 
performing or practicing a skill in the absence of actual movement (Magill, 2006, 
Shumway-Cook and Woollacott, 2007). A meta–analysis of the effects of 
mental practice in the field of sports skill acquisition has shown that mental 
practice alone is marginally better than performing no practice at all (effect size 
0.48, SD = 0.67) (Feltz and Landers, 1983). Although the evidence suggests 
that mental practice is not as effective as physical practice of the task, it may 
be useful as a means of promoting motor learning when the capacity for 
physical practice is limited (Hird et al., 1991).   
 
Thus far, this section has identified and defined a number of principles that 




development of interventions targeted at movement recovery following stroke, 
then arguably the potential to improve motor recovery and promote 
participation in activities of daily living may be enhanced. However, the body of 
evidence supporting the application of these motor learning principles has been 
developed and evaluated predominantly within healthy individuals who have an 
intact central nervous system (CNS). It is possible that stroke survivors by 
virtue of their diagnosis may be prevented from learning in the same way. Thus 
it should not be assumed that evidence supporting the application of motor 
learning principles in healthy participants can be directly transferred to stroke 
survivors  (Hosp and Luft, 2011).  
 
The followig section will review the evidence investigating whether or not stroke 
survivors are able to engage in implicit learning. 
 
2.2.2 Overview of the evidence for implicit learning following stroke 
Controlled trials investigating the ability to engage in implicit learning have 
evaluated whether stroke survivors have been as effective at learning an 
implicit motor task as a control group of healthy volunteers. Studies have shown 
that whilst learning did occur, stroke survivors were unable to learn as well as 
healthy volunteers, and that this was statistically significant (Winstein et al., 
(1999), P<0.001; Pohl et al. (1999), P<0.002; Boyd and Winstein (2004), 
P=0.003; Boyd et al. (2007), P<0.002); Vidoni and Boyd (2009), P=0.005). In 
these trials participants are commonly given a motor learning task such as a 
serial reaction time task, in which they are asked to respond to a series of lights 
by pressing a corresponding button when each light is lit. The sequence in 
which the series of lights are illuminated is repeated and can become implicitly 
learnt by the participant. Learning is demonstrated by a reduction in the time 
taken to complete the test sequences before and after the experiment (e.g. 
Boyd et al., 2007). Using a similar methodology, other studies have evaluated 
the accuracy of reaching the target rather than the time taken (e.g. Pohl and 
Winstein, 1999), thus learning is demonstrated by an improvement in the 




characteristic of movement performance and these studies have not evaluated 
elements such as stability and adaptability of the learnt task (Magill, 2006).  
 
Generalisability of the findings from the studies referred to above is limited by 
small sample sizes (Altman, 1990). Meta-analysis of the findings from these 
studies would be able to provide an effect size and estimate of statistical 
significance, this form of summary analysis might address this limitation 
(Borenstein et al., 2010). Participants included in these studies were all able to 
follow the instructions for completion of the task inherent within the study design 
(Boyd et al., 2007, Boyd and Winstein, 2004a, Gomez-Beldarrain et al., 1998, 
Orrell et al., 2007, Pohl and Winstein, 1999, Shin et al., 2005, Vidoni and Boyd, 
2009, Winstein et al., 1999). In order to do this, it implies that the participants 
had little or no cognitive impairment. 38% of stroke survivors have some 
cognitive impairment three months after stroke  (Patel et al., 2002) and this is 
likely to impact on implicit learning (Shumway-Cook and Woollacott, 2007). 
Studies evaluating the capacity for implicit motor learning in stroke survivors 
with cognitive impairments are therefore also required. 
 
Another limitation to these studies arises because of the decision to test implicit 
motor learning through reaction time tests or accuracy tests with the ipsilesional 
or unaffected arm. (Boyd et al., 2007, Boyd and Winstein, 2004a, Gomez-
Beldarrain et al., 1998, Orrell et al., 2007, Pohl and Winstein, 1999, Shin et al., 
2005, Vidoni and Boyd, 2009, Winstein et al., 1999). Following stroke the 
contralesional or affected arm may display movement impairments that could 
lead to a difficulty in carrying out a serial reaction time task. These impairments 
may lead to slower times on a reaction time test or inaccuracies in reaching a 
target. Assumptions may subsequently be made about the participant’s ability 
to learn, when the results may have occurred because of movement difficulties 
experienced as a consequence of the stroke. The decision to use the 
ipsilesional arm during both practice and outcome assessment avoids this 
confounder. Whilst this would seem appropriate as a means of evaluating the 
behavioural ability to learn a motor task, it is not appropriate as a means of 
investigating CNS activity during the learning of that task by a stroke survivor. 




contralateral structures of the CNS. Therefore neural activity within the 
damaged hemisphere, occurring in response to motor learning of the impaired 
limb, may manifest itself differently to learning involving the unaffected limb.  
 
There is little published work identifying CNS activity before and after an implicit 
motor learning task using the impaired limb following stroke (Hosp and Luft, 
2011). A small study by Meehan et al. (2001) attempted to identify the 
underlying CNS activity in response to a learning task in a small group of 
participants diagnosed with stroke (n=9) compared to that of healthy volunteers 
(n=9). Functional Magnetic Resonance Imaging (fMRI) was conducted during 
early practice of the task (day 1) (baseline), practice took place over days 2-6 
and then a second fMRI was taken at day 7 (retention).  
 
Behavioural tests indicated that both groups were able to learn the tracking 
task used in the study and fMRI revealed that during the early phase of learning 
both groups showed increased activity in the fronto-parietal regions as 
expected (notably dorsolateral prefrontal cortex (DLPFC) and premotor cortex). 
Activity in the DLPFC subsequently reduced during the second imaging 
session (day 7 – retention) for the group of healthy volunteers, demonstrating 
the need for less attentional resources as the activity became more familiar 
(learnt).  This shift away from activity in the DLPFC was not, however apparent 
when the participants diagnosed with stroke were scanned at retention. In 
contrast to the group of healthy volunteers, Meehan et al. (2011) found 
increased activity remained within both the dorsolateral pre frontal area and the 
pre motor cortex in the group of stroke survivors. This suggests that the 
participants diagnosed with a stroke required continued attention to the motor 
tasks even after behavioural assessment would suggest that the task had been 
learnt. This was a small study which included stroke survivors who were at least 
twelve months post onset, and therefore, the findings cannot be generalised to 
all individuals diagnosed with stroke. More research is required, but this study 
does suggest that there are differences in the physiological response to 
learning in stroke survivors that may not be apparent in healthy volunteers.  The 
continued assumption that physiological changes underpinning learning after 




may be inaccurate (Hosp and Luft, 2011). The potential for different 
physiological responses, together with the findings from the previously 
discussed behavioural studies of implicit learning, support the theory that motor 
learning principles may not be able to be applied to movement rehabilitation of 
stroke survivors in exactly the same way as for healthy volunteers. 
 
2.2.3 Application of motor learning principles to movement rehabilitation after 
stroke 
Section 2.1.1 has identified the theoretical background which supports the 
idenitification of motor learning principles in relation to mental practice, 
instructions, feedback, variability of physical practice and practice specificity. 
This theoretical stance has been supported by findings from studies which have 
applied these principles to motor learning in healthy volunteers. The findings 
from behavioural studies, and preliminary physiological studies, indicated that 
these may need to be applied differently in movement rehabilitation after stroke. 
The aim of this following section is to review the evidence for the application of 
these principles in movement rehabilitation with people who have been 
diagnosed with stroke.  
 
 Mental Practice 
Mental practice is the cognitive act of practicing or performing a motor skill in 
the absence of any physical action taking place (Barclay-Goddard et al., 2011, 
Garrison et al., 2010, Nilsen et al., 2010). The benefits obtained from mental 
practice are believed to be based on the findings that mental practice of an 
action activates the same CNS structures that are recruited during actual 
movement of the same action (Grezes and Decety, 2001). A Cochrane review 
of the effects of mental practice for treating upper limb deficits incurred as a 
result of stroke found a statistically significant effect in favour of mental practice 
plus physical practice versus physical practice alone (SMD 0.78, 95% CI 0.24-
1.31) (Barclay-Goddard et al., 2011). Interestingly, despite a good effect size 
and a small confidence interval, the authors of this review concluded that there 
was only some limited evidence in favour of mental practice combined with 
physical practice than physical practice alone. This rather conservative 




that was observed within the studies included in the meta-analysis, although 
they had tried to control for this in the analysis through the use of a random 
effects model rather than a fixed effect model (Borenstein et al., 2010). This 
review only referred to the effects of this intervention in the affected upper limb 
after stroke and findings may not apply to the recovery of lower limb function, 
however it did suggest that mental practice may be a useful adjunct to physical 
practice after stroke.  
 
The benefits of mental practice as a means of promoting motor learning in 
movement rehabilitation after stroke lie in the potential that it has to increase 
neural excitability in the motor execution areas, in a manner similar to the action 
actually being performed but without need for actual movement. Thus mental 
practice may have the potential to be useful as a means of promoting motor 
learning in those stroke survivors who have had little or no return of physical 
movement but who have capacity to perform mental practice of movement 
(Garrison et al., 2010, Sharma et al., 2009).  
 
Continued use of the term mental practice in this context may lead to some 
confusion, as it has been described in the literature as both an intervention 
used as part of movement therapy (Barclay-Goddard et al., 2011) and/or a 
motor learning principle (Magill, 2006). Therefore throughout this thesis the 
motor learning principle will be described as ‘priming’ and will be defined as: 
   
‘Interventions that are reported to have a motor learning effect because 
they increase neural excitability in the movement execution system’ 
  
The term mental practice will then be used to describe the therapeutic 
intervention. Precedent for the use of the term ‘priming ‘ to describe excitation 
within the movement execution system has already been established within the 
published literature, for example Stinear et al. (2007).  
 
Defining the motor learning principle in this way facilitates the identification and 
inclusion of other therapies which are also believed to be efficacious 




execution system. This would ensure that any subsequent reviews are 
inclusive of all therapies which are perceived to have the same motor learning 
effect. Examples of these therapies include action observation (Buccino et al., 
2001), passive movements (Matteis et al., 2003), transcutaneous electrical 
stimulation (Golaszewski et al., 1999), thermal stimulation (Gelnar et al., 1999) 
and mirror therapy (Michielsen et al., 2011). Synthesis of the evidence for these 
therapies within the context of a motor learning approach for stroke survivors 
has not been carried out but could provide a valuable insight into the role that 
they may have in promoting motor learning.  
 
 Instructions 
Instructions are given to the participant directing their attention to either an 
external or internal focus. Evidence from healthy volunteers has suggested that 
motor learning is more effective if the instructions are externally focussed (Wulf, 
2007). There is limited evidence evaluating the effect of instructions in stroke 
survivors, although a small study by Fasoli et al (2002) suggested the same 
outcome. Using a repeated-measures design, participants were randomly 
assigned to either an AB or BA sequence. Participants were asked to carry out 
the same reaching tasks under a set of instructions which had either an external 
or internal focus. Participants diagnosed with a stroke showed a statistically 
significant improvement in movement time (p=0.002) and peak velocity or 
speed (p=0.002) under the external focus condition. The generalisability of 
these findings is limited by the small sample size (n = 16), and inclusion criteria 
that stipulated that the participants had to be able to reach forward and grasp 
objects with the affected arm and show no evidence of comprehension 
impairments or apraxia (Fasoli et al., 2002a). Inclusion criteria such as these 
have the potential to exclude those individuals who have been more severely 
affected by the stroke; hence it is not readily applied to a broader population of 
stroke survivors. DePaul (2013) found that the use of motor learning principles 
was not always reported accurately. In light of this a more robust review of the 
literature is required to ensure that evidence underpinning the application of 






Feedback refers to information given to an individual about their performance, 
and which can be used as a basis for improvement (Magill, 2006). Feedback 
can be derived intrinsically or extrinsically. Intrinsic feedback is feedback 
provided through the body’s sensory systems during completion of the task. 
Extrinsic or augmented feedback is provided by an outside source and can 
therefore be manipulated in order to provide feedback relevant to knowledge 
of results or knowledge of performance  (Subramanian et al., 2010). Synthesis 
of the evidence for motor learning strategies after stroke has primarily focussed 
on the provision of extrinsic feedback (Glanz et al., 1995, Laver et al., 2011, 
Molier et al., 2010, Moreland and Thomson, 1994, Moreland et al., 1998, 
Subramanian et al., 2010, Woodford and Price, 2007). Feedback has been 
provided via electromyographic (EMG) biofeedback (Basmajian et al., 1982, 
Bradley et al., 1998, Wolf et al., 1980), balance platforms (Sackley and Lincoln, 
1997) and virtual reality environments using a variety of sensory, visual or 
auditory feedback methods (Adamovich et al., 2008, Boian et al., 2002, Broeren 
et al., 2006, Deutsch and Mirelman, 2007, Gourlay et al., 2000). 
 
Two reviews of extrinsic feedback have concluded that it may be of general 
benefit as a means of facilitating movement recovery following stroke (Molier 
et al., 2010, Subramanian et al., 2010). This assumption was based on a 
narrative synthesis of the included studies as the authors determined that 
heterogeneity prevented any form of meta-analysis. Meta-analysis would have 
provided a more rigorous means of assessing the findings and implications 
from the studies included in these reviews (Borenstein et al., 2010). These 
reviews were also confined to findings from studies that included upper limb 
function as an outcome, thus limiting their generalisability to lower limb 
outcomes such as walking. Woodford and Price (2009) appears to be the only 
review to date which has attempted to evaluate the effects of extrinsic feedback 
on lower limb functions such as walking. This review was however limited to 
one specific intervention, that of electromyographic (EMG) biofeedback and 
was similarly prevented from carrying out meta-analysis by virtue of the 




review of the effects of feedback including meta-analysis is warranted in order 
to determine more robust findings from the published studies to date. 
 
 Practice Intensity 
Engaging in physical practice was identified as an essential motor learning 
principle within all the motor learning theories reviewed at the commencement 
of this chapter. The quantification of the amount (dose) or intensity of physical 
practice necessary to promote motor learning after stroke remains however, 
undetermined (Cooke et al., 2010a, Veerbeek et al., 2011). Following stroke it 
is a widely held tenet by both researchers and clinicians that more practice is 
likely to result in better movement outcome (Kwakkel et al., 2006). The 
relationship between intensity of practice and movement outcome after stroke 
has been evaluated through two recent systematic reviews (Cooke et al., 2010a, 
Veerbeek et al., 2011). Both found limited support for the hypothesis that a 
higher dose of exercise-based therapy enhances motor recovery after stroke. 
However both reviews were limited by the heterogeneity of the included trials.  
There remains an ongoing need for well-designed trials that evaluate 
prospectively the intensity or dose of the same intervention (Cooke et al., 
2010a). Without this work to evaluate optimum dose of an intervention, 
subsequent trials may go on to incorrectly interpret a lack of efficacy. This is an 
interpretation which could occur because an insufficient amount/dose of the 
therapy was actually given. Until this work is carried out further synthesis of 
trials already published is unlikely to produce more definitive findings.  
 
The author of this present thesis extended the review initiated by Emma Cooke; 
the published paper has been attached as an appendix to this thesis as it adds 
to the body of knowledge surrounding the application of motor learning 
principles but would not have been appropriate for inclusion in this present 
thesis (appendix III). 
  
 Variability of Physical Practice 
Studies of healthy volunteers have suggested that motor learning is improved 




although this may depend on the skill level of the learner (Brady, 1998). A 
theoretical review by Brady (1998) suggested that those with low levels of skill 
may show greater improvements in motor learning from a less random or 
massed schedule.  
 
There is little work evaluating the effect of practice schedules in motor learning 
after stroke. Deprey (1999) published a single case report where random 
practice of a task led both to improved performance in the task and to effective 
transferability of the learnt skills. This report was based on a participant 
diagnosed with a stroke affecting the right parietal lobe; she had neglect and 
sensory problems affecting her left side and was also found to have severe 
cognitive problems. Although the task being taught was based around 
independence in walking, the problems that the participant experienced were 
not caused by motor impairments but were rather a product of her cognitive, 
perceptual and sensory impairments. Therefore results of this case report may 
be less relevant to improving motor impairment after stroke.  
 
Cauraugh et al. (2007) evaluated the effect of a random schedule of practice 
versus a massed schedule of practice in patients presenting with chronic 
hemiplegia. They found no evidence to suggest that one schedule was better 
than the other but this may have been because outcome measurement took 
place immediately after the training programme. One of the reported benefits 
of random practice schedules is improved retention of learning (consolidation) 
or adaptability of that learning (Shea and Morgan, 1979). A more robust way of 
measuring the effects of random practice schedules may have been to carry 
out follow up assessments some time after the intervention phase.  This may 
have provided a means of determining whether retention was better with one 
approach or the other. Outcome assessments could also have included a 
means of measuring adaptability of the learnt task by seeing whether it 
transferred to alternate environments. The findings from this study may also 
have been confounded by the presence of active muscle stimulation which was 
used to augment the movement practice. The muscle stimulation may have 





The evidence in favour of either a random or massed practice schedule as a 
means of promoting motor learning in stroke survivors is lacking. It is possible 
that there is other evidence evaluating this motor learning principle in stroke 
rehabilitation studies but that they may be ‘hidden’ behind key words that 
describe an intervention rather than the way in which that intervention was 
delivered.  A thorough, systematic search of the stroke rehabilitation literature, 
using key words that would encompass these studies, is required to determine 
if there are other relevant studies applying the principle of practice variability. 
 
 Practice Specificity 
Specificity of practice refers to the similarity between the task practice 
conditions and the final task that needs to be learnt. It can be related to the 
objects involved in the task practice, the task itself and/or the environment in 
which the practice takes place (Magill, 2006). This concept is already widely 
advocated within stroke rehabilitation (Langhorne et al., 2011). Aspects of this 
approach have been supported by a recent Cochrane review which evaluated 
the effects of task specific practice on functional outcomes measured by 
functional activity scales. Studies were included if the intervention involved 
practice of functional activities of the upper and/or lower limb. The review found 
statistically significant treatment effects for walking distance (standardised 
mean difference (SMD) 54.59 95% CI 17.5-91.68), walking speed (SMD 0.29 
95% CI 0.04-0.53) and sit to stand (standardised effect estimate 0.35 95% CI 
0.13-0.56). Results were however equivocal for upper limb interventions 
(French et al., 2010). Whilst this review did find statistically significant findings 
for the impact of the interventions on walking distance it is worth noting the 
large confidence interval for this analysis, which suggests a large degree of 
variability in the outcomes from these studies. This review was limited by the 
level of heterogeneity between the studies and this may have impacted on the 
findings particularly for the upper limb intervention studies. Further robust trials 
using the same outcome measures are needed before subsequent reviews of 
this aspect of practice specificity (task specific practice) are warranted. 
 
Practice specificity has not been limited to physical practice, as evidence from 




mental practice interventions such as observation to imitate. Buccino et al. 
(2001) found more regions of the CNS were activated during action observation 
of an individual reaching to grasp a cup, compared to action observation of the 
same individual mimicking a reach to grasp movement without the cup. 
Evidence of excitation in areas of the motor execution system suggests that 
these areas are active. Evidence of increased activity in more areas of the 
motor execution system is desirable in that it correlates more highly with 
activation that occurs in response to movement. Priming of as many areas as 
possible may be more beneficial in influencing motor recovery following stroke 
(Garrison et al., 2010, Sharma et al., 2009). The increased activity experienced 
in the object specific scenario suggests, therefore, that greater efficacy may 
result from practice that is more specific to the intended action in context as 
well as in terms of the actual movement. 
 
The manipulation of the environment through virtual reality, as another means 
of altering practice specificity after stroke, has also been documented (Laver et 
al., 2011).  A Cochrane review of studies evaluating the effects of virtual reality 
and interactive gaming on measures of upper limb, lower limb and global 
function after stroke concluded that virtual reality was a promising rehabilitation 
approach (moderate effect on arm function measures (SMD 0.53 95% CI 0.25 
to 0.81 based on seven studies with 205 participants) and larger effect on 
Activities of Daily Living measures (SMD 0.81 95% CI 0.39 to 1.22 based on 
three studies with 101 participants) (Laver et al., 2011). Virtual reality 
interventions in this study were diverse, in that they included studies where the 
participant interacted with a computer generated environment in both an 
immersive (as part of the environment) or non-immersive (gaming technology) 
situation. Some interventions were therefore designed to give extrinsic 
feedback about the accuracy of a specific reaching movement and therefore 
may not be facilitating motor learning via the principle of practice specificity.   
 
This section has highlighted some of the evidence underpinning the application 
of motor learning principles in movement rehabilitation after stroke. The 
subsequent critique has suggested the need for a more robust review of the 




aspects of ‘practice specificity’. Further reviews of the task specific aspect of 
‘practice specificity’ and ‘practice intensity’ were not indicated. 
 
The following section will discuss the development of a framework as indicated 
by the discussion in section 2.1.  
 
2.2.4 Developing a motor learning framework 
Section 2.1 suggested that the development of a framework could 
contextualise the application of motor learning principles in movement 
rehabilitation after stroke. Such a framework could facilitate clarity of definitions 
and provide a common template for use within both research and clinical 
practice. Within the framework, clearly defined motor learning principles could 
facilitate systematic synthesis of individual therapy interventions, with the same 
underlying theoretical construct. For example therapies described as 
‘observation to imitate’ and ‘thermal stimulation’ are reported to be efficacious 
because they increase neural excitability in the movement execution system, 
thus although different, both therapies could be seen to be applying the ‘priming’ 
motor learning principle. Similarly, studies which have used both biofeedback 
and balance performance monitors are applying the ‘feedback’ motor learning 
principle. Thus, in the emerging field of rehabilitation science where systematic 
synthesis of studies is limited because of heterogeneity, a motor learning 
framework may provide a means of grouping these studies under a common 
theoretical construct. Such categorisation may serve to decrease heterogeneity 
and facilitate systematic synthesis in order to provide robust evidence to 
support movement rehabilitation interventions after stroke (Shepperd et al., 
2009 and Gough et al., 2012). 
 
Motor learning principles per se are generally applied within the context of 
physical practice as a means of augmenting its effects (Magill, 2006). Stroke 
survivors who regain little or no movement may not benefit from motor learning 
principles that are usually applied to physical practice. Sub categorisation of 




rely on physical practice or not may also prove useful within the context of 
stroke rehabilitation.  
 
Figure two proposes a motor learning framework which includes the motor 
learning principles sub categorised according to whether there is evidence of 
their effectiveness in the absence of physical practice.  ‘Priming’ is the only 
motor learning principle within the no/little movement category. This decision 
was founded on the findings by Feltz and Landers (1983) who found an effect 
on motor learning of mental practice without physical practice.  No evidence of 
the same effect was found for the application of the other motor learning 
principles and therefore they have been categorised as ‘augmenting’. 
  
The framework has been shown in the context of its application to a physical 
therapy intervention. This linear representation of the motor learning principles 
is arguably too simplistic as practice specificity is likely to influence both the 
priming motor learning principle as well as physical practice, however, this 
framework does offer a starting point in trying to achieve some definition and 
structure to the application of these principles to physical therapies after stroke.  
 
Since the development of this framework DePaul et al. (2011) have published 
a study evaluating the effects of the ‘Motor Learning Walking Program’. This 
program embeds a treadmill training intervention within a motor learning 
framework. The framework and application proposed by DePaul et al. (2011) 
does not refer to the motor learning principles of mental practice or instructions 
and is supported by evidence from studies with healthy volunteers. It therefore 
seems less robust than the framework used in the present thesis in terms of its 







Figure 3: Motor learning framework 
 
2.2.5 Summary 
The use of motor learning principles within movement rehabilitation after stroke 
is becoming more evident, however, their application within this context has to 
a large extent been guided by evidence from studies in healthy volunteers. 
Studies investigating whether stroke survivors can engage in implicit learning, 
the type of learning that underpins complex motor skills, have shown that whilst 
they can learn, this learning is impaired compared to that of healthy participants. 
Thus it may not be appropriate to apply motor learning principles that have 
been investigated in healthy volunteers in the same way to stroke survivors. 
Systematic and quantitative synthesis of studies investigating how motor 
learning principles should be applied to motor learning after stroke is therefore 
required. A framework for contextualising the motor learning principles has 
been proposed. This facilitates clarity of definitions and provides structure to 
the application of these principles to interventions targeting movement recovery 




a motor learning framework may also serve to limit heterogeneity and thereby 
facilitate meta-analysis (Gough et al., 2012). Such a framework would allow for 
the grouping of disparate therapeutic interventions under motor learning 
themes identified by the motor learning principle that is being applied within the 
study. This would facilitate meta-analysis of studies comparing, for example, 
feedback derived through virtual reality and feedback from equipment such as 
balance performance monitors, as both interventions would be grouped under 
the ‘feedback’ principle.  
 
One aim of this thesis is to develop a novel intervention by embedding a 
physical therapy (Functional Strength Training) within a motor learning context. 
The following section will explore the background literature supporting 
Functional Strength Training. 
 
2.3 Functional Strength Training 
Muscle weakness affecting one side of the body is a common symptom of 
stroke, with strength training interventions recommended by the National 
Institute for Health and Care Excellence in their recent guidelines for stroke 
rehabilitation (NICE guidelines, 2013).  
 
Quantification of weakness during a static muscle contraction in both the 
affected upper limb and lower limb demonstrated that following stroke, muscle 
strength was statistically significantly impaired relative to the unaffected side 
(p<0.001) (Andrews and Bohannon, 2000). This loss of muscle strength is 
believed to contribute to the decreased levels of activity experienced by stroke 
survivors and consequently strengthening interventions have increased in 
popularity as part of movement rehabilitation after stroke (Ada et al., 2006). A 
systematic review of strengthening interventions, including non-exercise based 
trials using electrical stimulation and biofeedback, has revealed the potential 
for improvement in muscle strength in people following stroke. Muscle strength 
changes were measured in voluntary force production (p=0.001) (Ada et al., 
2006) and grip strength (p<0.001) (Harris and Eng, 2010). Arguably, of more 




statistically significant change in functional performance (p=0.002, (Ada et al., 
2006) and p=0.03, (Harris and Eng, 2010), although this has only tended to 
occur in the manoeuvres that were being trained and thus did not transfer to 
other functional activities  (Bohannon, 2007).  This finding, together with the 
assertion that muscle strength is only one among many factors influencing the 
production of movement, has led to the conclusion that strength training 
interventions need to incorporate task specific elements within their 
programmes (Bohannon, 2007, Harris and Eng, 2010).  
 
Functional Strength Training (FST) is an exercise-based intervention that 
combines conventional strength training techniques within a task specific 
context. The aims of FST are to improve muscle function such that the 
participant is able to take part in functional activities. The development of FST 
has emerged from early phase studies investigating both strength training 
interventions and task specific training. Patten et al. (2006) described a case 
study where one participant had received a combination strengthening and 
functional task practice programme called ‘hybrid therapy’. The participant was 
16 weeks post stroke so was arguably still within the subacute period of 
recovery. She received hybrid therapy for 75 minutes (35 minutes of resistance 
training and 40 minutes of functional practice) three times a week over six 
weeks aimed at improving strength and functional ability in the upper limb. The 
participant was reported to have been able to complete all training sessions 
and showed improvement in impairment and activity scores both immediately 
after the end of the intervention and at six months follow up. At this early stage 
of recovery this improvement could still be attributed to spontaneous recovery 
however the authors suggested that by completing this intensive post 
rehabilitation training that the participant had been motivated to sustain practice 
and continue to improve. The case study described by Patten et al. (2006) had 
no control phase and therefore the relative effects of the intervention as 
opposed to other factors such as spontaneous recovery were not detectable, 
however the intervention seemed well received by the participant and she 
tolerated the dose well. As described ‘Hybrid therapy’ offers both components 





Sullivan et al. (2006) described another case study using a similar methodology 
but this time targeting lower limb recovery (Sullivan et al., 2006). The participant 
was 15 months post stroke at the time of enrolment to the study and therefore 
findings were at less risk of being confounded by spontaneous recovery 
(Cramer, 2008). The intervention offered a strengthening component through 
a progressive increase in limb loading during treadmill walking and increased 
resistance during a static cycling task, thus combining the strengthening 
component with task specific practice. On admission to the study the participant 
was relatively high functioning (52/56 on the BBS). The participant tolerated the 
intensity of treatment (24 sessions; 4 one hour sessions over six weeks) and 
showed improvement in the clinical outcome measures (gait speed increased 
by 18% and the distance walked in the 6 minute walk test increased by 4%). 
The Berg Balance Score (BBS) however decreased immediately following 
treatment by 3. Any score on the BBS above 45 is generally accepted to mean 
that the participant has no balance impairment (Berg et al., 1992, Zwick et al., 
2000). A decrease by 3 in this case therefore is not likely to have any functional 
significance for the participant. At six months follow up the participant retained 
the improvements in walking speed. Although it is arguable whether these 
changes were also functionally significant to the participant as walking speed 
only increased by 0.09m/s. The intervention in this study necessitated use of 
equipment that would only be accessible in a clinical environment therefore 
delivery of this intervention would be limited to within a clinical setting. A 
qualitative study investigating barriers to exercise found that travel to and from 
the exercise location was one factor that inhibited participation in exercise 
programmes (Rimmer et al., 2008). The study by Sullivan et al. (2006) involved 
a single participant and therefore recruitment to the study was not an issue, 
however future studies aimed at determining feasibility and/or efficacy are likely 
to require a larger sample size. It may be useful therefore for future study 
designs to consider delivering the intervention using equipment that can be 
transported to home settings. This may facilitate recruitment to such a study as 
participants would not have to travel to take part. 
 
Early work investigating the task specific practice component of a functional 




study was to report on the findings from a case study which investigated the 
effects of a task specific physical therapy programme on lower limb recovery in 
one participant who was 38 months post stroke. The intervention took place in 
the participants own home. This study lacked the strengthening component and 
was delivered over a much greater period of time and with less frequency 
(twelve sessions every one to two weeks over a four month period, each 
session lasting between 60-75 minutes) than the previously described case 
studies. Following delivery of the intervention the participant showed an 
improvement in maximum ambulatory distance (increased by 200 feet) and the 
study indicated that a functional programme could be delivered successfully in 
a home environment. 
 
Teixeira-Salmela et al. (1999) carried out a randomised pre-test, post-test 
study with thirteeen participants who were at least nine months after stroke. 
The study was targeted at the lower limb with six participants receiving the 
intervention and seven assigned to the control group. Once again the 
intervention was not specifically described as functional strength training but 
the description of the intervention suggests that both a progressive 
strengthening component and a functional task practice component were 
present.  This study was delivered in an outpatient setting over ten weeks (three 
times a week for between 60 and 90 minutes). Following training walking speed 
increased by 31% (p=0.004) suggesting an effect of the intervention, although 
the absence of a power calculation for this study undermines this finding. A 
power calculation would indicate the sample size needed to determine whether 
the study had enough participants that the results once analysed could either 
support or refute the null hypothesis. Interpretation of the statistical significance 
is limited without a power calculation and it is unlikely that with such a small 
sample size that the findings from the study by Teixeira-Salmela et al. (1999) 
are robust (Altman 1990). The study authors also reported quality of life findings 
using the Nottingham Health profile. Improvements in this for those individuals 
who received the intervention also suggested that they found the intervention 
acceptable and perceived benefits greater than just improvements to their 
physical activity although this aspect of the study was also not powered 





Pilot work investigating strengthening and functional therapy programmes 
delivered to people later after stroke tentatively indicate that both these 
interventions were tolerated well by the participants. The studies described 
above have been predominantly carried out in people who are within the 
chronic phase of recovery from stroke. They suggest that people are able to 
tolerate an increased level of activity at later stages post stroke and that the 
potential for further recovery remains. The following paragraphs describe the 
trial-based literature that underpins functional strength training as an 
intervention that combines both strength training and task specific practice. 
 
To date three randomised controlled trials have reported findings evaluating 
the effects of FST in participants following stroke. Findings from the trials are 
summarised in Table two (Bale and Strand, 2008, Cooke et al., 2010b, 
Donaldson et al., 2009a). The following risk of bias table shows the 
methodological strengths and weaknesses of the three studies according to the 




















































































































































L U L L L L L 
Donaldson et al 
(2009) 
L L L L L L L 
Cooke et al 
(2010) 





Table 1: Table to show risk of bias from studies evaluating Functional Strength Training 
 
U Unclear 
L Low risk 




The study by Bale and Strand (2008) was judged to be ‘unclear’ with respect 
to allocation concealment, this was because insufficient information was given 
within the published article to judge whether there might have been a risk of 
selection bias caused by biased allocation to either of the interventions (Higgins 
and Green, 2011). Findings from this study therefore need to be interpreted 
within this context and could be less rigorous than those from the other two 
studies. The risk of bias assessment for all other aspects of the study by Bale 
and Strand (2008) were judged to be low, as were all aspects of the studies by 
Donaldson et al. (2009a) and Cooke et al. (2010b) respectively. This 
assessment suggests that with respects to methodological quality the findings 
from both Donaldson et al. (2009a) and Cooke et al. (2010b) can be judged to 
be rigorous and the effects of the interventions on the study outcomes relied 
upon (Higgins and Green, 2011).  
 
The trials conducted by Donaldson et al. (2009a) and Cooke et al. (2010b) 
compared three groups. These groups delivered conventional therapy (CPT), 
conventional therapy plus extra conventional therapy (CPT+CPT) and 
conventional therapy plus functional strength training (CPT+FST). The aim for 
this design was to provide an intervention group that would control for the 
potential confounder of dose or quantity of therapy received (CPT+CPT vs. 
CPT+FST). Findings summarised in Table 3 are the results from the CPT+CPT 
and CPT+FST groups. These results have been presented as they were the 
most comparable groups in terms of dose, thus findings from a comparison of 
these two groups were not confounded by the length of time that the 
intervention was received. 
 
Bale and Strand (2008) and Cooke et al. (2010b) have targeted lower limb 
recovery following stroke and Donaldson et al. (2009a) targeted upper limb 
recovery. All three studies included stroke survivors within the so-called 
subacute period after stroke. Mean time from stroke onset to inclusion in the 
study was similar in all three studies (between 25.6 and 32.4 days). Movement 
recovery following stroke over this period of time is underpinned by a period of 
spontaneous recovery (Cramer, 2008). This process is different to the 




(Kleim and Jones, 2008) therefore findings from these studies cannot be 
directly applied to people who are within the chronic phase of recovery from 
stroke (six months and beyond). 
 
Findings from the study by Bale and Strand (2008) showed a statistically 
significant improvement for the FST group in change in percentage body weight 
on both the affected and unaffected leg (although this was greater in the 
affected leg (p=0.001).  There were improvements in both the control and 
experimental groups for isometric muscle strength of the affected knee 
extensors (p=0.01), habitual gait speed (p>0.05) and maximum walking speed 
(p>0.05), suggesting no difference between the effects of either the control 
group intervention or the experimental group intervention (FST). There was 
however a statistically significant effect in favour of FST on isometric muscle 
strength of the affected knee flexors (p=0.02), which was not replicated by the 
control group (p=0.10). There is some limited evidence to suggest therefore 
that FST may lead to both improved weightbearing and an increase in isometric 
muscle force of the knee flexors on the affected leg, however this is a small 
study and therefore there is  potential for a Type II error. A type II error is the 
failure to reject a null hypothesis. Thus interpretation of these results might 
incorrectly suggest an effect for FST (Altman, 1990).  
 
This study showed little difference between the control and experimental group 
interventions for activities that could arguably be perceived to be more 
meaningful to the participant. Measures of walking speed showed equivocal 
changes for both groups (Bale and Strand, 2008). In order to determine 
whether FST can be more effective than usual care it may be appropriate to 
consider alternative outcome measures that reflect functional activities which 
are influenced by increased weight bearing on the affected side. At present 
there is little evidence from this study to support the use of FST instead of usual 
care as an intervention that could make a change to a participant’s ability to 







Table 2: Table to show the findings from the Functional Strength Training Studies
Study Participants Age (years, 
SD1)











Intervention Motor related outcome 
measures
Findings
Maximum weight bearing 
(% body weight)
Increase in weight bearing on affected side in 
CPT+FST group (p=0.001). Control group 
p=0.153
Isometric muscle strength 
(knee ext and flex) (torque 
Nm)
Increase in torque on affected knee extension in 
both groups (p=0.01). Increase in knee torque 
on affected knee flexion in CPT+FST group 
(p=0.02). Control group p=0.10
Habitual Gait Speed Improvement in both groups at p<0.05. Better in 
CPT+FST group
Maximum gait speed Improvement in both groups at p<0.05. Better in 
CPT+FST group
Motor Assessment Scale Not reported
Action Research Arm Test Improved score in both groups, Median change 
baseline to outcome - CPT+CPT 8.0 
(13.2):CPT+FST 19.5 (22.0). Difference between 
groups p=0.23
Nine hole peg test (pegs per 
second)
Improved score in both groups, Median change 
baseline to outcome (IQR2) - CPT+CPT 0.05 
(0.22):CPT+FST 0.11 (0.27). Difference between 
groups p=0.93
Hand grip force (N) Improved score in both groups, Change 
baseline to outcome (IQR2) - Median 10.5 
(40.25):CPT+FST 26.0 (44.0). Difference between 
groups p=0.52
Pinch Grip force (N) Improved score in both groups, Median change 
baseline to outcome (IQR2) - CPT+CPT 9.0 
(13.8):CPT+FST 19.0 (19.75). Difference groups 
p=0.60
Isometric elbow flexion 
force (N)
Improved score in both groups, Median change 
baseline to outcome (IQR2) - CPT+CPT 15.1 
(25.3):CPT+FST 32.5 (55.8). Difference between 
groups p=0.70
Isometric elbow extension 
force (N)
Improved score in both groups, Median change 
baseline to outcome (IQR2) - CPT+CPT 9.0 
(27.8):CPT+FST 13.5 (36.5). Difference between 
groups p=0.60
Walking speed (m/s) Improved score in both groups, Mean (SD1) - 
CPT+CPT 0.6 (0.5) (p=0.03):CPT+FST 0.4 
(0.4)(p=0.33) 
Knee flexion torque Greatest improvement in CPT+CPT group, 
Mean(SD1) - CPT+CPT 
34.0(23.1)(p=0.16):CPT+FST 25.4(20.3)(p=0.33)
Knee extension torque Greatest improvement in CPT+CPT group, 
Mean(SD1) - CPT+CPT 
45.3(35.9)(p=0.88):CPT+FST 35.9(28.5)(p=0.97)
Modified Rivermead Index Improved score in both groups. Mean (SD1) - 
CPT+CPT 36.6 (10.4)(p=0.73):CPT+FST 37.7 
(8.6)(p=0.45)
Symmetry step length % Greater improvement in CPT+CPT group, Mean 
(SD1) - CPT+CPT 13.5 (15.8)(p=0.46):CPT+FST 
51.5 (156.4)(p=0.24)
Symmetry step time % Greater improvement in CPT+CPT group, Mean 
(SD1) - CPT+CPT 18.8 (35.6)(p=0.48):CPT+FST 
32.4 (91.5)(p=0.90)
Walking speed of 0.8m/s Greater improvement in CPT+CPT group, 
CPT+CPT 11/31 (35%)(p=0.04):CPT+FST 7/35 
(20%)(p=0.42)
Donaldson et al 




Therapy with an emphasis 
on preparation and joint 
alignment via 'hands-on' 
sensory input. Activities 
l ike grasp and reach 
would use objects such as 
cones rather than cups. 
Right 6. Left 425.6 (15.5)73.3 (8.6)n = 10 Specific functional tasks 
using verbal prompting 
rather than sensory 
cueing. Systematic 
progression through 
increased repetition and 
resistance. Up to 60 
mins, 4 days a week for 6 
weeks.
Right 5, Left 521.7 (16.8)72.6 (12.5)n = 10
32.0 (18.5)64.9 (8.8)n = 10 CPT+FST to improve 
power of the lower l imb, 
50 minutes/day 5 
days/week for 4 weeks
Right 6, Left 249.4 (22.1)60.8 (13)n = 8Bale and Strand 
(2008) CPT+FST vs 
Training as usual for 
lower l imb
Control (CPT+CPT) group Functional Strength Training (CPT+FST) group
Cooke et al (2010) 




n = 35 67.5 (11.3) 32.4 (21.29) Right 13:            
Left 22
Included soft tissue 
mobilisation, facil itation 
of muscle activity, 
facil itation of coordinated 
multi joint movement, 
tactile and proprioceptive 
input, resistive exercise 
and functional retraining.
n = 36 71.2 (10.6) 33.9 (16.5) Right 12: Left 24 Specific functional tasks 
using verbal prompting 
rather than sensory 
cueing. Systematic 
progression through 
increased repetition and 
resistance through goal-
directed functional 
activity. Up to 60 mins, 4 
days a week for 6 weeks.
Training as usual, 
infleunced by Bobath 
concept, emphasis on 
decreased use of power to 
avoid associated 
reactions.





Cooke et al. (2010b) found improvements in all the outcome measures for the 
CPT+FST group when compared to the control group in the study (CPT) but 
these did not reach statistical significance. Comparison of the outcomes 
between the CPT and CPT+CPT group showed statistically significant findings 
for walking speed (p=0.03). The improvements in the other outcome measures 
for CPT+CPT were also greater than those of the CPT+FST group, although 
these did not reach statistical significance.  Findings from this study therefore 
suggest little effect of FST. Interpretation of the findings from this study need 
to be considered within the context of the study design, this was a phase II trial 
designed to evaluate feasibility of the intervention. A sample size calculated 
from the results of this trial estimated 660 participants would be required to 
determine effectiveness of the interventions. It would not be appropriate 
therefore to infer efficacy from a trial that included 109 participants (Cooke et 
al., 2010b). 
 
The authors of this study proposed a number of reasons for the improvements 
seen in the CPT+CPT group. Arguably the one that is most important for the 
design of future trials of FST, is the possibility that the conventional 
physiotherapy, provided in the study, had incorporated a more task specific 
focus and was therefore too similar to the CPT+FST group (Cooke et al., 
2010b).  The design of this study had tried to control for this confounder by the 
use of treatment protocols emphasising different aspects of movement 
rehabilitation, however these did incorporate functional training. Clear protocols 
detailing the content of CPT and FST are needed in future trials of FST to 
ensure that the therapy received by each group is sufficiently different.  
 
Trials of lower limb interventions may also need to consider the amount of ‘extra’ 
practice that patients receive outside of the research study. Simple transfers 
on and off the bed could be considered ‘functional practice’ and so the extra 
FST provided by Cooke et a.l (2010) could have been insufficient to provide 
further benefit.  
 
The study of FST for the upper limb suggested more positive findings in favour 




powered to detect statistically significant changes in the outcome measures; 
however, median change scores for the FST group were much larger than 
those for the CPT group suggesting some effect of FST.  The measures of 
functional ability at baseline for participants in the CPT+FST group were lower 
than those of the CPT+CPT group indicating that the participants in the 
CPT+FST group were more impaired. This difference caused the authors of 
this study to suggest that the change scores between the baseline and outcome 
measures for the CPT+FST group may have been better because these 
participants had more capacity for improvement (Donaldson et al., 2009a). This 
suggestion is at odds with studies that have found poor functional recovery on 
admission to stroke units to be an indicator of poor functional recovery following 
rehabilitation (Kwakkel et al., 1996). FST may therefore have proven highly 
effective in this group of participants, although this can only be speculation in 
light of the small sample size. As a precaution future trials of FST should 
consider severity of stroke as a potential confounder and control for this within 
the study design. 
 
The previous sections have summarised findings from FST studies to date. The 
evidence suggests that FST is a feasible intervention for both the affected 
upper limb and affected lower limb in people after stroke but that the findings 
from these trials are only relevant to stroke survivors within the first three 
months after stroke.   
 
Recovery in the acute phase of stroke is underpinned by a period of repair. 
Following the damage caused by stroke, the brain responds by clearing away 
debris and creating an environment for remodelling and synaptogenesis 
(Cramer, 2008, Kelley and Steward, 1997). This increase in activity is time 
dependent and decreases approximately six weeks after the onset of stroke, 
with most recovery from stroke reported to be within the first three months 
(Cramer, 2008). Recovery of functional activities over this period of time show 
rapid improvement (Partridge et al., 1987). The rapidity of functional gains 
subsequently decreases as time from onset increases, although significant 
changes to functional ability can still be made years after stroke onset (Murphy 





The processes that underpin later stage recovery from stroke are different from 
those occurring in the earlier stages (Kleim and Jones, 2008). Changes in 
functional ability later after stroke, are underpinned by the same physiological 
changes that occur within the healthy brain during learning (Kleim and Jones, 
2008, Nudo and Milliken, 1996, Taub et al., 2002). These processes include 
cortical reorganisation, such as the unmasking of existing pathways (Qu et al., 
1998) and sprouting of new dendrites (Allred and Jones, 2004), and they have 
been revealed through a variety of imaging techniques, including functional 
magnetic resonance imaging (fMRI), positron emission tomography (PET) and 
transcranial magnetic stimulation (TMS) (Buma et al., 2012). 
 
Despite the potential for on-going movement recovery later after stroke, 
movement impairments may persist. These impairments may lead to difficulties 
moving the affected arm or the affected leg which can in turn lead to poor levels 
of activity. Persistent inactivity may lead to physiological adaptation of the brain 
structures. A study involving stroke survivors within the chronic phase of 
recovery showed, poor motor function measured by the motor activity log 
paralleled decreased activation of central nervous system (CNS) structures 
involved in movement execution (Liepert et al., 2000). Thus, there is an opinion 
that physiological changes within the brain and body structures may further 
compound the disabling effects of the stroke (Taub, 2004).  Secondary 
adaptation in muscle leads to length associated changes and disuse, which in 
turn leads to alterations in both the active and passive properties of the muscle. 
This causes further negative impact on movement and function (Ng and 
Shepherd, 2000). These adaptations are unlikely to be present to the same 
degree within the early phases of recovery after stroke. Thus physical therapy 
interventions perceived to be efficacious or feasible over this period of recovery 
may not be effective in the chronic phase because they may not target these 
time dependent changes. 
 
There is a widely held belief that stroke survivors in the so-called chronic phase 
of recovery from stroke are perceived to have plateaued in terms of potential 




to the assumption that rehabilitation services delivered to people later after 
stroke would have little impact.  In a healthy population the capacity to learn, 
and thus the brain’s capacity to physiologically adapt and change, remains 
throughout life (Kleim and Jones, 2008), although it decreases with age 
(Sawaki et al., 2003). Therefore if the process for functional recovery from 
stroke, and the process underpinning learning are similar, then the concept of 
a motor recovery plateau may be caused by something other than the stroke 
survivor’s capacity to relearn and/or compensate for the movement 
impairments created as a consequence of stroke. 
 
It has been suggested that the perception of a motor recovery plateau may be 
driven by the healthcare environment rather than a true occurrence (Page et 
al., 2004). Stroke rehabilitation is often subject to restrictions in terms of time 
and resources and whilst acute services in the UK have seen considerable 
improvement since the advent of the National Stroke Strategy, rehabilitation 
services have not matched this (National Audit Office, 2010). It is possible that 
when stroke survivors stop making significant improvements in their recovery, 
access to services such as physiotherapy, declines and eventually stops. 
Stroke survivors are told that they have plateaued and are unlikely to make 
further progress (McKevitt et al., 2004). Believing this to be the case and 
without access to health professionals, it is highly possible that stroke survivors 
have little motivation to continue with exercise programmes that may continue 
to benefit them in terms of functional outcome. Thus the perception of a motor 
recovery plateau is reinforced. Overcoming a lack of motivation to exercise is 
one barrier faced by a research team that is looking to evaluate the 
effects/feasibility of exercise-based physiotherapy techniques in stroke 
survivors. Other factors which have been identified and which would also limit 
engagement in physical activity include: not knowing how to exercise, having a 
lack of energy as well as motivation, the perception that the exercise would not 
improve their condition and a lack of transportation to facilities (Rimmer et al,, 
2008). Physically stroke survivors, who have continued to experience 
impairments, may adopt a more sedentary lifestyle which is likely to impact on 
their overall cardiorespiratory fitness (Marsden et al., 2013). Therefore exercise 




need to be designed to incorporate the possibly greater potential for fatigue. 
Barriers to the participation in exercise groups outside of the home may also 
occur because of impairments related to communication difficulties. A survey 
found that those individuals with communication problems were more likely to 
need help with social participation than those individuals without a 
communication problem (p<0.001) (McKevitt et al. 2011). This survey included 
1251 participants who were within one to five years after stroke The findings 
from the survey have particular implications for the delivery of programs to 
stroke survivors where the incidence of communication problems is one third 
(Department of Health, 2007). 
 
The factors described above seem to have evolved as responses stroke 
survivors have made because of the long term impairments that are a 
consequence of stroke. The evaluation of exercise based physiotherapy 
techniques, such as Functional Strength Training, which have been developed 
with people in the early stage of recovery will need to consider the impact of 
these factors on the delivery and acceptability of the intervention, if it is to be 
successfully evaluated in people who are within the chronic phase of recovery 
from stroke.  
 
Despite these potential barriers research programmes involving exercise have 
been delivered to people in the chronic stage of stroke and have proven 
efficacious in terms of improving functional ability (Ferrarello et al., 2011). 
Stroke survivors who have participated in an exercise program have identified 
positive reasons for taking part in both aerobic and resistance training. Most 
commonly, these were “desire to improve overall health, improve functional 
abilities, enhance confidence, reduce musculoskeletal issues, and family 
support.” (Jurkiewicz et al., 2011 p. 280).  
  
Awareness of both the potential barriers and motivators to engaging in exercise 
programmes later after stroke may help researchers adapt the design of an 
intervention and its subsequent evaluation from that which has previously been 
tested in stroke survivors in the acute stage of recovery and within a hospital 




functional ability so that participants are able to discern what the potential 
benefits of taking part in the study may mean to them; they may need to ensure 
that the intervention is delivered in such a way that the participant is able to 
carry out the required activities; they may need to consider how to motivate the 
participant throughout the course of the study and they may need to consider 
the context of the study so that travel costs are avoided/costed into the study 
and participants are socially supported where appropriate (Rimmer et al., 2008). 
 
2.3.1 Overview 
Muscle weakness is common after stroke and is believed to contribute to the 
loss of function experienced by stroke survivors although strength training 
interventions may be effective in increasing muscle power. These interventions 
are likely to be most effective at increasing the stroke survivors ability to take 
part in activities of daily living, if they incorporate strength training principles 
within a task specific context. Functional Strength Training incorporates both 
these elements, and early phase trials have shown that FST is a feasible 
intervention for improving functional recovery in both the arm and the leg early 
after stroke. The differences in recovery processes observed in the brain 
between stroke survivors in the early and later stages after stroke, and the long 
term effects of disuse, indicate however that the efficacy of rehabilitation 
interventions evaluated in people within the acute phase of recovery may not 
necessarily be applicable to people later after stroke. There is a need therefore 
to determine whether FST is a feasible intervention for both the upper and lower 
limb in people in the chronic phase of recovery after stroke.  
The following section will consider the topic of intervention fidelity and how it 
might usefully inform the design and delivery of a feasibility study of FST to 
people later after stroke. 
 
2.3.2 Intervention Fidelity 
Intervention fidelity, a term which can also be used interchangeably with 
treatment fidelity refers to the methodological strategies used to enhance the 
reliability and validity of clinical interventions which are designed to effect a 




recovery from stroke may not have engaged in exercise for a prolonged period 
of time. In order for a study which is designed to test the feasibility of an 
exercise-based intervention such as FST to succeed, it is apparent that this 
behaviour will have to change.  
 
The concept of intervention fidelity appears to have been studied 
predominantly within psychological, social and behavioural research (Bellg et 
al., 2004, Gearing et al., 2011). In an early opinion paper on this topic Moncher 
and Prinz (1991: pp. 247) referred to treatment fidelity as being “two related, 
but distinct, issues”. These were:  
The degree to which the experimental interventions were implemented as 
intended and secondly that there was sufficient differentiation between the two 
experimental conditions such that the findings from the study could be 
attributed to the independent variable. 
 
It was reported that poor intervention fidelity could lead to unreproducible 
interventions, a decrease in statistical power and low uptake of potentially 
effective interventions (Moncher and Prinz, 1991). With this in mind a working 
party was subsequently created to examine the issues of intervention fidelity 
and to produce a set of guidelines for improving this in a particular group of 
studies examining the effectiveness of experimental interventions targeting 
change in health behaviours. The Behaviour Change Consortium (BCC) 
published best practice and recommendations for ensuring intervention fidelity 
(Bellg et al. 2004). In this the authors have addressed areas broader than the 
original definition of intervention fidelity posited by Moncher and Prinz (1991) 
and the working definition for intervention fidelity expanded to “the 
methodological strategies used to monitor and enhance the reliability and 
validity of behavioural interventions” (Borelli et al., 2005 pp852). However the 
underlying goal of improving study rigour remained the same.  
 
The BCC described five areas where intervention fidelity could be addressed. 
These are: 
- Design of study  




- Delivery of treatment 
- Receipt of treatment 
- Enactment of treatment skills’ (Bellg et al., 2004).  
 
These will be described below along with barriers and facilitators to each of 
these with examples from studies published in the field of long term conditions. 
There appears to be limited work published in this field specific to exercise and 
stroke and therefore the literature used has been expanded to include studies 
which have also evaluated the use of exercise in the management of other 
cardiovascular diseases.  
 Design of study: Methodological strategies aimed at ensuring 
intervention fidelity in this category are intended to ensure that the 
intervention has been appropriately identified (i.e. that there is sufficient 
theoretical and clinical underpinning), to avoid confounders such as the 
delivery of different ‘doses’ of each experimental intervention and strict 
adherence to the research protocol (Bellg et al., 2004).  
 
Defining and delivering an intervention consistently is important in 
research trials because of the need to be able to communicate it’s 
content to care providers if the results suggest that the intervention is 
effective. This can be particularly challenging in the evaluation and 
subsequent dissemination of complex interventions such as those 
designed to manage health behaviour change which may have several 
components and be delivered across different care settings (Spillane et 
al., 2007). The development of a robust treatment manual with clearly 
defined interventions may go some way to addressing this. 
 
Monitoring adherence to a research protocol and ensuring effective 
delivery of interventions that are self-directed such as engagement in an 
exercise programme may however prove particularly challenging. In 
their guidelines for best practice Bellg et al (2004) listed several 
strategies that could be incorporated into the study design which may 




research staff to ensure adherence to the protocol and the inclusion of 
methods for enabling participants a means of recording their 
engagement in the exercise programme. A review of intervention fidelity 
across exercise trials in participants with diabetes found that studies 
ensured adherence to the intended quantity of therapy by telephone 
calls, and motivational techniques such as goal setting (Avery et al., 
2012).  
 
Bellg et al. (2004) also suggested that studies could prevent 
implementation setbacks, such as lack of research staff to deliver the 
intervention by ensuring a pool of trained researchers. This of course 
carries its own challenges in that training of any extra staff needs to be 
maintained and monitored to ensure adherence to a protocol. Although 
this is likely to increase the costs of a study Henggeler et al. (1997) 
argued that these were minimal when compared to the expense incurred 
if ineffective treatments are declared effective because of poor 
intervention fidelity practices. 
The following area published in the guidelines specifically addresses 
training the intervention providers. The underlying goal for this area is 
also related to ensuring adherence to the research protocol. 
 
 Training providers; strategies within this category suggest standardising 
training, ensuring provider skill acquisition and maintaining provider 
skills throughout the study. 
  
Consistent training of the intervention providers is one method of 
attempting to improve adherence to a protocol. Particular barriers to this 
include lack of resource dedicated to this aspect of a study and poorly 
defined interventions. Studies may need to consider the costing 
implications for ensuring that intervention providers are trained and that 
this training is monitored and updated throughout the study. The quality 
of the training should be supported by treatment manuals which 
describe clearly defined interventions. Where this is not the case then 




the protocol. Such actions would threaten the rigour of the study findings 
(Bellg et al., 2004). 
 
In a study evaluating the effectiveness of a treadmill training programme 
with stroke survivors Resnick et al. (2011) identified that demonstrating 
intervention fidelity within this category was particularly challenging 
because of the high turnover of intervention providers. This had led to 
some discrepancies between the protocol and aspects of the 
intervention delivery. As the study progressed the research team had 
managed this by ensuring that there were regular reviews of treatment 
fidelity which enabled them to be able to reinforce prior training and pre-
empt further deviations.  
 
Borelli et al. (2005) developed a tool for assessing intervention fidelity 
and used this to evaluate the quality of treatment fidelity in 342 trials 
evaluating interventions targeted at health behaviour change. They 
found that only 22% of the included studies reported on the training 
strategies for the intervention providers. This review only reflects how 
well these studies have reported this aspect of intervention fidelity but 
does seem to indicate that further consideration may need to be given 
to the challenges researchers face in ensuring that intervention 
providers are suitably trained.  
 
 Delivery of treatment. This category was created to address aspects 
such as controlling for provider differences, ensuring adherence to 
treatment protocol and ensuring that control and intervention are 
sufficiently different and that there is no overlap between these if they 
are delivered by the same provider (Bellg et al. 2004).  
 
Where one provider is providing both experimental and control 
interventions then there is the potential for contamination of either 
intervention, this may be exacerbated if the provider has a particular bias, 
inadvertent or otherwise (Bellg et al., 2004). In the SPHERE project 




including exercise in people with  heart disease this aspect of 
intervention fidelity was managed through quality assurance visits by the 
research nurses, The study team also carried out randomly selected 
‘checks’ of the intervention delivery at different time points in the study 
(Spillane et al., 2007).  
 
 Receipt of treatment – Bellg et al. 2004 created this category to monitor 
whether studies were able to demonstrate that the participant 
understood the intervention and whether or not they were able to carry 
it out. 
 
Where studies rely on active participant engagement with cognitive 
strategies it is important that the research group determine that the 
participant understands what is involved and is able to carry out the task. 
Interventions such as mental imagery may involve the generation of 
static images, auditory recall, complex tasks or visual patterns and it 
may not always be possible for individuals to carry out these activities 
(Pearson et al., 2013). This may be particularly challenging if 
researchers are seeking to be inclusive in their sampling strategy. For 
example, following stroke, potential participants with cognitive problems 
may be unable to take part, thus biasing the sample. 
 
Studies aiming to deliver exercise such as that conducted by Resnick et 
al. (2011) need to ensure that the study population is capable of carrying 
out the required level of intensity and will remain motivated to do so. 
Resnick et al. (2011) evaluated the effects of treadmill training on 
cardiovascular fitness in stroke survivors who were within the chronic 
phase of recovery from the stroke. The threshold level of intensity (40% 
to 50% of the maximal heart rate reserve, 20 minutes continuous 
exercise, three times per week for six months) set by the study authors 
was arguably quite challenging for the participants who, as has 
previously been identified, may not have engaged in physical activity for 
some period of time. Inclusion criteria for this study therefore focussed 




less generalisable to the wider population (Altman, 1990). Strategies 
that were then used to facilitate ongoing engagement with the exercise 
were to deliver the intervention in an environment where the participants 
were socially engaged and able to motivate one another and to use 
verbal encouragement by the research staff. These strategies appeared 
to be effective as participants completed the desired number of exercise 
training sessions. 
 
 Enactment of treatment skills – this refers to the ability of the participant 
to be able to perform the skills/behaviours required by the research 
study to ‘real-life’ settings. An example of this described by Bellg et al. 
(2004) are the appropriate use of a cognitive strategy to prevent 
cigarette cravings. This category is distinct from adherence to the 
treatment protocol which would simply record whether or not the 
participant had engaged in the intervention not whether or not they had 
used it in the appropriate way. 
 
Interventions aimed at changing behaviours are generally deemed 
successful only if they can effect a change within ‘real-life’, therefore by 
addressing ‘enactment of treatment skills’ in the study design, study 
authors are prompted to assess whether participants use the 
experimental skills appropriately throughout the study. This is believed 
to give an indication of whether this will effect a change in their health 
behaviour once the study has stopped, a factor which can then be more 
accurately assessed if participants are subsequently followed up after 
completion of the intervention phase (Bellg et al., 2004). Adherence to 
exercise programmes declines following withdrawal of an exercise 
intervention (Jurkiewicz et al., 2011, Karingen et al., 2011). Arguably 
studies that address the concept of ‘enactment of treatment skills’ may 
find that long term adherence to the exercise programme following the 
end of the study may improve.  
 
Intervention fidelity refers to the strategies that have been developed for 




behaviour change are both reliable and robust (Moncher and Prinz, 1991; Bellg 
et al., 2004). This section has briefly reviewed some of the literature around 
intervention fidelity and the barriers and facilitators to its implementation. 
Arguably many of the aspects included in the guidelines developed by Bellg et 
al. (2004) could be considered to be best practice in research design and 
therefore should be inherent within individual study designs and protocols. 
However a review of intervention fidelity by Gearing et al. (2011) found that 
core components of fidelity such as study design, training providers and 
intervention receipt were still not being addressed sufficiently. Further reflection 
on the role of intervention fidelity strategies and their place within the design of 
the feasibility study described in this thesis will be discussed in chapter seven. 
 
2.3 Summary 
Therapies, such as Functional Strength Training, targeting late stage recovery 
of movement after stroke have the potential to increase an individual’s ability 
to engage in activities of daily living. These may be more effective if they are 
integrated into motor learning. Within the framework of developing complex 
interventions this thesis seeks to describe two studies, the results of which will 
inform the future development of a novel intervention.  The following chapter 






3.0 Statement of Aims 
There are approximately 1.1 million stroke survivors living in the United 
Kingdom (Townsend et al., 2012) and 76% of these people have movement 
impairments as a result of stroke (Intercollegiate Stroke Working Party, 2011). 
Physical therapy after stroke includes a number of interventions that aim to 
minimise the secondary effects of stroke and promote the return of movement 
so that the stroke survivor is able to take part in activities of daily living. This 
may be achieved by retraining movement so that individuals can return to 
activities in the same way that they had done before the stroke, or it may mean 
teaching compensatory strategies where this is not possible.  
 
The field of motor learning addresses the theories and principles that are 
believed to underpin skill acquisition. In chapter two it was suggested that the 
goal for both physical therapy interventions after stroke and motor learning are 
the same i.e. a change in movement performance. There is potential therefore 
to develop an intervention which combines both bodies of work, such an 
intervention may lead to enhanced movement recovery and a better return to 
activities of daily living. 
 
The application of motor learning principles to date has been largely based on 
the findings from studies in healthy volunteers, a systematic review of their 
application within movement recovery after stroke will provide evidence of their 
use with stroke survivors and therefore may be able to suggest more relevant 
methods of applying these.  
 
Muscle strength is widely considered to be one of the main causes of loss of 
performance in functional activities; interventions targeting this impairment are 
arguably therefore of great importance. Functional Strength Training is 
designed to increase muscle strength and increase participation in activities of 
daily living in stroke survivors. The work to develop this intervention was 
however restricted to people within the early phase of recovery from stroke. 
Physiological differences in response to early and late stage recovery from 




survivors may not be in the other. A feasibility study investigating the effects of 
Functional Strength Training in stroke survivors within the so-called chronic 
phase of recovery from stroke is therefore indicated. 
 
Subsequent development of a novel intervention from the results of both 
studies will show how Functional Strength Training can be delivered within a 
motor learning context. This could serve as an exemplar to inform the 
development of physical therapy interventions in the future. 
 
3.1 Aims: 
The aims of this thesis are to: 
 Aim 1: To systematically identify the relevant literature for inclusion in a 
literature review according to a motor learning framework. 
 Aim 2: To seek to quantify the findings from the review through meta-
analysis where appropriate. 
Objective 1: Establish the evidence for the effectiveness of the 
application of motor learning principles to promote motor learning 
after stroke. 
 Aim 3: To carry out a phase II randomised controlled trial to determine 
feasibility of a physical therapy intervention – Functional Strength 
Training for improving upper limb function and walking in people 
between six months and five years after stroke.  
Objective 2: Establish feasibility of Functional Strength Training 
for improving upper limb function and walking in people between 
six months and five years after stroke by determining likely rates 
of recruitment. 
Objective 3: Establish feasibility of Functional Strength Training 
for improving upper limb function and walking in people between 
six months and five years after stroke by testing procedures for 
acceptability including the choice of outcome measures and the 




Objective 4: Provide information for calculating a sample size for 
evaluation trials. 
 Aim 4: To present a novel intervention combining the results of the 
studies conducted fulfilling aims one and two in order to suggest how a 
motor learning framework could inform the delivery of physical therapy 
interventions as part of movement rehabilitation after stroke. 
 
This thesis will therefore aim to address the following research questions: 
Question 1:  
What is the effectiveness of motor learning principles applied to people after 
stroke in order to promote motor learning? 
 
Study 1: To systematically review the relevant literature and carry out meta-




Is Functional Strength Training a feasible intervention for improving upper and 
lower limb recovery later after stroke? 
 
Study 2: Functional Strength Training to improve upper limb function and 




Based on the findings from study one and study two how should physical 






4.0 What is the effectiveness of the application of motor learning 
principles applied to people after stroke in order to promote 




Chapter two identified the following motor learning principles, priming, 
instructions, feedback, practice intensity, variability of physical practice and 
practice specificity.  If these principles are applied to movement rehabilitation 
after stroke, they may have the potential to enhance physical recovery and 
promote the stroke survivor’s return to functional activity. However, motor 
learning in people following stroke has been shown to be impaired compared 
to healthy volunteers and thus it may not be possible to generalise findings 
from studies regarding motor learning principles with these participants to 
stroke survivors. Synthesis and quantification of the evidence for the 
application of these motor learning principles to people after stroke is lacking. 
The aim of this study is: 
 Aim 1: To systematically identify the relevant literature for inclusion in a 
literature review according to a motor learning framework. 
 Aim 2: To seek to quantify the findings from the review through meta-
analysis where appropriate. 
Objective 1: Establish the evidence for the effectiveness of the 
application of motor learning principles to promote motor learning 
after stroke. 
The following section will describe the design and subsequent methodology of 
a systematic review in order to answer the following research question:  
What is the effectiveness of motor learning principles applied to people after 








A systematic review provides a means by which evidence can be systematically 
identified and synthesised in order to provide an answer to a research question 
or to identify gaps within the current knowledge base (Higgins and Green, 
2011). As previously discussed, synthesis of the evidence identifying how 
motor learning principles should be applied to stroke survivors in order to 
promote motor learning and return to functional activity is lacking. A systematic 
review would therefore seem the most appropriate means of addressing this 
gap and providing an answer to the above research question. Due to the strict 
set of guidelines that are laid down Cochrane reviews are reported to be 
methodologically more robust and at less risk of bias than non-Cochrane 
reviews (Moher et al., 2007), therefore design of this review will be informed by 
the Cochrane methodology. 
 
4.3 Eligibility criteria 
The Cochrane methodology follows a process where criteria for the inclusion 
and exclusion of studies are pre specified. The intention behind this is to limit 
bias and ensure that the review process has been carried out rigorously 
(Higgins and Green, 2011). Where protocols stipulating the inclusion and 
exclusion criteria are not published before the review, then there is the potential 
for review authors to bias the findings (Moher et al., 2007). Eligibility criteria are 
guided by the research question and therefore for this study the following 
criteria have been defined: 
Participants: 
 Adults aged over eighteen years 
75% of stroke survivors are over the age of 35 (Intercollegiate Stroke 
Working Party, 2012). This criteria will ensure that the findings from this 
review are able to be generalised to a large proportion of stroke 
survivors. Physiologically there are also differences in the response to 
central nervous system damage in children compared to adults, which 
may prevent the application of motor learning principles in the same for 




 Diagnosed with stroke of either ischaemic or haemorrhagic origin, with 
no restriction from time since onset. 
In order to be as inclusive as possible the diagnosis of stroke included 
within the review was not restricted to either ischaemic or haemorrhagic 
origin. All periods of time since stroke were included, although as 
recovery processes early after stroke are different to those later after 
stroke (Kleim and Jones, 2008) it is possible that this distinction will need 
to be reflected on at some stage within the study findings. 
 Participants presenting with a motor impairment of either the affected 
upper limb or the affected lower limb 
The aim of the review is to consider the efficacy of motor learning 
strategies on movement recovery; therefore participants within the 
studies being considered for inclusion had to be diagnosed with a motor 
impairment as a consequence of stroke. Both upper and lower limb 
impairments were included as previous reviews have tended to focus on 
upper limb recovery (Molier et al., 2010, Moreland and Thomson, 1994, 
Subramanian et al., 2010). 
 
Interventions: 
 Randomised controlled trials (RCT) 
RCT are reported to be the ‘gold standard’ for measuring the efficacy of 
an intervention (Sim and Wright, 2000).  Therefore synthesis of the 
evidence derived from an RCT is arguably more robust than that derived 
from a study of potentially lesser quality. 
 Control and intervention groups needed to be identical except for the 
application of a motor learning principle. The findings from earlier 
reviews of the effects of intensity or dose of therapy have been limited 
by the inclusion of studies that have compared two different 
interventions at different doses (Kwakkel et al., 1997, Kwakkel et al., 
2004). Consequently changes in the outcome measures within each of 
these studies could not be attributed to the different amounts of therapy 
that the participants had received. To avoid the potential confounder of 




dependent variable (i.e. one likely to affect outcome) will be the effects 
of the motor learning principle.  
 No presence of electro-stimulation, robotics, orthotics or equipment that 
will supplement/support movement. Adjuncts to movement may 
confound the effects of the motor learning principle such as that 
experienced by Cauraugh et al. (2007).  
 Application of a motor learning principle 
Systematic reviews of complex interventions, such as the application of 
motor learning principles, are confounded by inherent difficulties. 
Interventions may have the same underlying aim but be described 
differently or inadequately within the published literature (Shepperd et 
al., 2009). One solution to this is categorisation, this helps limit 
heterogeneity by identifying the common aim within studies describing 
different interventions (Gough et al., 2012, Shepperd et al., 2009). The 
content of these categories were guided by the background chapter 
(chapter two) and the subsequent development of a motor learning 
framework displayed in figure two (section 2.1.4).  
 
Motor learning principles were categorised as either needing ‘no/little 
movement’ or ‘augmenting’ if they are usually applied to physical 
practice as described in the framework in section 2.1.4. Motor learning 
principles will include priming, instructions, feedback, variability of 
practice and practice specificity. It did not include practice intensity as 
the background chapter identified a recent, robust synthesis of this body 
of work (Cooke et al., 2010a, Veerbeek et al., 2011). It also did not 
include task specific practice as one component of practice specificity 
for the same reasons (French et al., 2010).  
 
Motor learning principles were therefore categorised as: 
Needing little or no return of movement 
 Priming - Interventions that are reported to be efficacious because they 






 Instructions – Commands given by the ‘teacher’ and can have either an 
internal or external focus. 
 Feedback – information given to a learner which can be used as a basis 
for performance improvement. 
 Variability of practice – Refers to the arrangement of the practice 
schedules which can be arranged in either a massed or random way. 
 Practice specificity – refers to the similarity between the task practice 
conditions and the final task that needs to be learnt.  
 
Outcomes: 
 Outcome measures in the impairment, activity or participation domains 
of the International Classification of Functioning, Disability and Health 
(ICF) (World Health Organisation, 2001), measuring movement or 
movement related outcomes. 
The focus of this review is on movement recovery therefore outcomes 
evaluating changes to cognitive, perceptual or sensory function were not 
included.  
 
4.4 Search Strategy 
In order to be as systematic and unbiased as possible it is important to design 
a search strategy that will identify as many relevant published studies 
appropriate to the research question as possible (Gough et al., 2012). 
Designing the search strategy includes identification of the appropriate 
databases as well as suitable key words with which to search. The search 
strategy needs to be sufficiently systematic for the prevention of bias, hence a 
robust search strategy should mean that another reviewer could complete the 
same process and get the same results (Gough et al., 2012). Developing the 
search strategy has been described as an evolving process and so a scoping 
exercise of the available literature was first carried out (Higgins and Green, 
2011). Higgins and Green (2011) recommend the need to strike a balance 
between a search strategy that is sensitive enough to identify all the relevant 




studies that are not. To assist with the identification of the search strategy two 
probe papers that were relevant to the research question were identified. If 
these papers were not found through a database search then that search 
strategy was discarded. Various permutations of key words identified by their 
relevance to the research question were used and a search strategy was 
subsequently developed. It became apparent as the process progressed that 
the key words used would need to incorporate a broad spectrum of movement 
therapy studies occurring during rehabilitation after stroke. This was because 
any attempt to define the search more precisely caused the loss of one or either 
of the probe papers.  
The following key words were subsequently developed: 
stroke, rehabilitation, motor, learn, feedback 
An example of the search strategy used in MEDLINE is shown in table three. It 
is important to note that searches designed for one database do not ‘translate’ 
to another (Higgins and Green, 2011), therefore use of facilities such as 
‘MetaLib’ which will search for key words across multiple databases were not 
appropriate. The search strategy was designed to be as inclusive as possible 
hence the use of the Boolean term ‘OR’ in step 9 of the search. 
 
Table 3: The electronic search used in MEDLINE 
 
1. exp Stroke/ 
2. rehabilitation/ or early ambulation/ or exercise therapy/ 
3. $rehabilitation.mp. 
4. Motor Skills/ 
5. motor.mp. 
6. learn$.mp. 
7. Feedback, Psychological/ 
8. Biofeedback, Psychology/ 
9. 2 or 3 or 4 or 5 or 6 or 7 or 8 




The following databases were searched from inception to December 2011: 
MEDLINE, EMBASE, AMED and CINAHL. Both EMBASE and MEDLINE index 
biomedical literature from peer-reviewed journals. EMBASE claims to contain 
all literature indexed by MEDLINE and over five million records more. However 
both databases were included following findings from a study by Minozzi et al. 
(2000) which suggested that differences in indexing by the respective 
databases may lead to a failure to identify relevant literature if only one 
database is searched. AMED and CINAHL both index literature specific to 
professions allied to medicine and nursing, and therefore may contain a 
significant amount of literature relevant to physical therapy interventions. 
Reference lists of included studies were also searched.  
 
4.5 Study Selection Process 
The Cochrane methodology for systematic reviews stipulates that at least two 
researchers should be involved in decisions relating to the inclusion or 
exclusion of studies. This ensures that the findings from the review are more 
rigorous as it addresses the potential for bias on behalf of either researcher. 
Reviews conducted by one researcher are open to criticism if there is a 
suspicion that a study may have been excluded erroneously because of a 
perceived bias on behalf of the author (Higgins and Green, 2011). The findings 
of a systematic review are generally considered to be robust because they can 
offer a summary analysis of all the relevant evidence for a given intervention 
(Gough et al., 2012). Excluding a study inappropriately may subsequently 
impact on the interpretation of the findings from a review (Higgins and Green, 
2011), for example the exclusion of a well-designed study showing a good 
effect of an intervention may lead to a summary analysis showing little or no 
effect. If clinical decisions are informed by such a review then there is the 
potential to cease delivery of an intervention that may be beneficial. 
 
The search strategy produces a list of possible studies; inclusion and exclusion 
criteria are subsequently applied to study titles, abstracts and then full papers 






In this review inclusion/exclusion criteria were applied to titles by the author 
only. This was a pragmatic decision which arose because of time constraints 
and the quantity of literature that was identified through the search strategy 
(see figure three). The author was very aware of the potential for bias at this 
stage of the study and attempted to be as rigorous as possible in her application 
of the inclusion criteria. The risk of bias however remained and the 
interpretation of this study may have been affected by inadvertently excluding 
a study that could have impacted on the subsequent findings. The implications 
of this have been explored in more detail later. 
 
The number of studies identified within each year from 1999-2011 have been 
presented in the form of a bar chart below (figure 7).  
 
Figure 4: Bar chart to show numbers of titles identified per year for 1999-2011 
 
As the search strategy used keywords referring to general concepts such as 
‘motor’ and ‘rehabilitation’ then this bar chart shows the rising popularity of 
rehabilitation literature over this period of time as well as the quantity of 

































All other stages of the study selection process were carried out by two 
researchers. The second researcher was a clinical colleague who had an 
interest in both the field of research and the methodology used. This person 
was not involved in the design of either the inclusion or the exclusion criteria 
so had no preconception of what they thought should be included or excluded. 
Their decisions were based solely on whether the papers fulfilled the inclusion 
criteria at each stage of the process and thus they were less likely to make 
biased decisions when applying these. If either researcher was unclear about 
the inclusion or exclusion of a paper then the default at each stage was to judge 
inclusion as ‘maybe’. In the case of dispute between the two reviewers, the 
opinion of a third reviewer was sought before a final decision was taken. 
 
4.6 Data Extraction 
 A copy of the data extraction form is included as appendix IV. The process of 
data extraction involves collating study characteristics and results relevant to 
the review question (Centre for Reviews and Dissemination, 2008). The data 
extraction form was based on examples obtained through the Cochrane 
Handbook for Systematic Reviews (Higgins and Green, 2011). The purpose of 
a systematic review is to collate all the relevant evidence for a given research 
question and to try and infer relationships between the given variables (Higgins 
et al., 2011). Sufficient data must be gathered to enable this to take place. It is 
also important to collect data related to the risk of bias of the included trials. If 
a causal relationship is to be inferred from the collection of data from numerous 
trials then the methodological quality of those trials has to be sufficient to 
ensure that those inferences are reliable (Higgins et al., 2011). This quality can 
be determined through the use of a numerical scale such as the PEDro scale 
(Verhagen et al., 1998), however these tools have been criticised for implying 
that the ‘weighting’ of different items related to quality are the same or have not 
been well justified (Higgins et al., 2011). Subsequently the Cochrane 
collaboration has developed a ‘risk of bias’ tool which evaluates items as either 
having a high, low or unclear risk of bias (Higgins et al., 2011). The criteria for 
judging risk of bias are listed in appendix V. The risk of bias tool assesses the 




implications for these biases on study rigour have been discussed in chapter 
five.  Selection bias is assessed by evaluating both the method for random 
sequence generation and allocation concealment. Studies are judged to be at 
low risk if they refer to random methods of allocation and have used adequate 
methods for concealing group allocation from study participants and personnel. 
Performance bias is assessed through the presence of blinding of participants 
and personnel to knowledge of the allocated intervention. Studies are judged 
to be at low risk if both participants and personnel are blinded to group 
allocation. In this category interpretation of the risk of bias assessment tool 
allows for the review author to take the decision as to whether or not blinding 
of participants or personnel would affect the outcome of that study. Blinding of 
both participants and personnel may be difficult to achieve in studies where 
there is an intervention which requires either the active engagement of the 
participant or the use of a device to elicit either a sensory or motor response in 
the participant. Even where there is the presence of a placebo, informed 
consent demands that the participant is fully informed of all the trial 
interventions, thus the participant will likely be aware of whether they are 
feeling/seeing something or not (MHRA, 2013). The decision was taken 
therefore to judge this item as high risk for all included studies.  
 
Detection bias is assessed by determining whether outcome assessors are 
aware of group allocation, studies are judged to be at low risk if they are blinded 
to this. Attrition bias is assessed through examination of the outcome data 
reported in the trial. Studies are judged to be at low risk if there is no missing 
outcome data or they have reported and accounted for missing data within the 
analysis (Higgins et al., 2011). 
 
The sections of the form referring to ‘selective reporting’ and ‘other bias’ were 
not used. Selective reporting refers to the potential for reporting bias due to 
selective outcome reporting, i.e. authors may only have reported results from 
the outcomes measures that showed an effect of the intervention. This can only 
be assessed accurately if the study protocol is present (Higgins and Green, 
2011). Only two studies within the present review had published protocols that 




the risk of bias therefore needs to be made within this context. Issues that have 
arisen that might have been included in ‘other bias’ will be discussed separately 
if it is felt that they impacted significantly on the interpretation and synthesis of 
this review. 
 
The results from these assessments will be presented in table form with an 
explanation of the implications for each of the findings. 
 
4.7 Synthesis of data 
The process of synthesis aims to transform the data from individual studies into 
a “connected whole” (Gough et al, 2012 p. 180) with the potential to produce 
new knowledge and inform practice (Gough et al., 2012). In order to do this the 
studies were synthesised in two categories according to the motor learning 
framework identified in section 2.1.4. Studies applying the priming motor 
learning principle were synthesised within the category of ‘no/little movement’ 
and the application of all other motor learning principles took place within the 
‘augmenting’ category. Each was then sub categorised according to whether 
the intervention was targeting the upper limb or the lower limb.  
 
4.8 Analysis of data 
Analysis of the findings from this review was conducted using Review Manager, 
Version 5 (REVMAN). Section 3.1. stated that one objective of the systematic 
review was to seek to quantify the findings, thus where this was possible, meta-
analysis of the results within the motor learning framework was undertaken in 
order to provide some quantification of the effect sizes of the studies. The 
purpose of a meta-analysis is to reflect the strength of the relationship between 
two variables by calculating the effect size (Borenstein et al., 2010). The data 
in each of the studies is likely to be presented using means and standard 
deviations, therefore the effect size was reported as the standardised mean 
difference (Borenstein et al., 2010). The inclusion criteria for this review led to 
the inclusion of studies that showed heterogeneity in respect of factors such as 
time since stroke, therefore the effect size was calculated using a random 




Where there was insufficient data for meta-analysis, i.e. only one study using 
any given outcome measure, data from the original study was presented. The 
alternative was to calculate an effect size for the individual study findings. Effect 
sizes make inferences about the effect of an intervention and are based on the 
differences between the mean outcome value of both the control and 
experimental groups divided by the standard deviation of the spread of all the 
outcome values across both groups. Thus they are reported to be a true 
measure of the effect of an intervention, whereas calculations identifying 
statistical significance make inferences about whether the outcome could have 
happened by chance (Coe, 2002). These calculations can be influenced by 
sample size and it is possible to have a statistically significant finding from a 
study which has a large sample size even though the effect of the intervention 
may be small (Altman, 1990). In light of this, calculation of effect sizes for 
individual studies seems intuitive; however the method for calculating an effect 
size requires the standard deviation of the spread of all the values across both 
control and experimental groups (Coe, 2002). Authors reporting the outcomes 
of their studies tend to provide a mean and standard deviation for each group 
and not for the whole sample. Standard deviations imputed into effect size 
calculations are therefore based on the standard deviation of one group or an 
average of the two groups. This can lead to inaccurate calculations of the effect 
size and may lead to a misleading interpretation of the findings (Coe, 2002). In 
order to avoid this, in the instance of only one study reporting an outcome 
measure, this review presented data derived from the original study. 
 
4.9 Interpretation of findings 
Figure four shows the PRISMA flow chart for this systematic review. This 
search strategy identified a large number of studies which should have ensured 
that the review process was sensitive enough to identify all relevant papers 
(Higgins and Green, 2011).  Managing this quantity of data did however have 
implications for the organisation of this review, in that only one person was able 
to include/exclude studies at title stage. This may have led to appropriate 
studies being excluded, something which may have impacted on the rigour of 





















































Titles identified through database 
searching 
(n = 22686) 
 
Duplicates removed 
(n = 8718) 
 
Records screened at title 
(n = 13968)  
 
Records screened at abstract 
(n = 796) 
 
Records excluded at title 
(n = 13172) 
 
Records screened at full text 
(n = 266) 
 
Records excluded at abstract 
(n = 530) 
 
Included studies 
(n = 32) 
 
Records included in risk of bias 
assessment (n = 25) 
 
Records included in quantitative synthesis  
(n = 16) 
 
Excluded studies (study did not have 
the potential to be entered into meta-
analysis) 
(n = 7) 
 
Studies not using ‘activity’ 
outcomes 




Thirty two studies were included in the review, authors were contacted where 
outcome data was presented in the form of graphs and would not have the 
potential to be entered into meta-analysis. As quantification of the findings from 
this review was one of the objectives listed in section 3.1 then studies that could 
not meet this criteria were excluded at this stage. Two authors responded to 
the request for numerical data, however seven did not. These studies were 




Study Reason for exclusion 
Basmajian et al (1982) Unable to enter outcome data in meta-analysis 
Bradley et al (1998) Unable to enter outcome data in meta-analysis 
Engardt and Knutsson 
(1994) 
Unable to enter outcome data in meta-analysis 
Geiger et al (2001) Unable to enter outcome data in meta-analysis 
Inglis et al (1984) Unable to enter outcome data in meta-analysis 
Saposnik (2010) Unable to enter outcome data in meta-analysis 
Shiavi et al (1979) Unable to enter outcome data in meta-analysis 
 
Table 4: Excluded studies 
 
Following removal of the excluded studies 25 trials remained within the review. 
These studies were all included in the risk of bias assessment, however, only 
sixteen were subsequently included in the meta-analysis. The reasons for this 
decision have been discussed later in this chapter. A description of each of the 










Tables five and six display the study characteristics for all the studies included 
in the risk of bias assessment. Table five shows all the studies evaluating the 
application of the ‘priming’ motor learning principle, which have been 
categorised as needing little or no return of movement. Table six shows the 
studies evaluating the other motor learning principles, which have 
subsequently been categorised as ‘augmenting’.    
 
Studies within both categories included participants who were relatively similar 
for age but showed a great degree of variability in terms of time since stroke 
onset, ranging from 0.28 months (Carmeli et al., 2011) after stroke to 73.2 
months (Yang et al., 2008).  
 
Studies included in this review have evaluated the application of priming, 
feedback and practice specificity motor learning principles. There were no 
studies evaluating the application of instructions or variability of practice.  
 
















 Number of 
participants 
Affected 
side - right No. of men Age mean (SD3)  Time since stroke onset/months (SD3) 
Study 
Motor Learning 
Principle Int1 Ctrl2 Int1 Ctrl2 Int1 Ctrl2 Int1 Ctrl2 Int1 Ctrl2 
Chen 2005 Priming 15 14 5 6 6 10 58.5(12.9) 59.6(12.0) 0.47(0.22) 0.41(0.22) 
Chen 2011 Priming 17 16 6 7 13 9 58.0 (11.5) 62.3 (11.3) 0.36(9.5-12.0) 0.36(9.3-14.0) 
Ertelt 2007 Priming 8 8 2 2 5 6 57.1(8.7) 55.4(10.8) 48.42(41.39) 23.83(11.87) 
Ietswaart 2011 Priming 39 31 17 16 23 22 69.3(10.8) 68.6(16.3) 2.70(1.80) 3.0(2.08) 
Lee 2011 Priming 13 11   6 4 60.7(7.5) 61.9(11.3) > 6 months 
Malouin 2008 Priming 5 3 5 2 3 3 61.3(7.2) 61.0(8.5) 28.8(21.6) 42(34.8) 
Ng 2007 Priming 21 20 7 10 16 17 58.4(7.1) 57.1(7.8) > 12 months 
Ng 2009 Priming 27 25 10 12 24 20 56.5(8.2) 56.9(8.6) 58.8(46.8) 51.6(45.6) 
Page 2000 Priming 8 8   16 men 63.4(4.0) mean 21.6 months 
Page 2001 Priming 8 5 2 2 6 4 64.4(9.7) 65.0(7.0) 5.88(3.44) 7.6(3.21) 
Page 2009 Priming 5 5 4 3 3 4 58.4(9.8) 6.4(9.0) 26.4(13.6) 30.6(11.4) 
Sutbeyaz 2007 Priming 20 20 6 7 10 13 62.7(9.7) 64.7(7.7) 3.5(1.3) 3.9(1.9) 
Wu 2010 Priming 12 11 5 4 4 5 59.9(11.4) 54.3(10.3) 10.0(7.3) 7.2(5.4) 
Yavuzer 2008 Priming 20 20 7 8 9 10 63.2(9.2) 63.3(9.5) 5.4(2.9) 5.5(2.5) 
Table 5: Characteristics of ‘priming’ studies needing no or little return of movement 
1. Int - intervention 
2. Ctrl - control 








side - right No. of men Age mean (SD3) Time since stroke/months (SD3) 
Study 
Motor Learning 
Principle Int1 Ctrl2 Int1 Ctrl2 Int1 Ctrl2 Int1 Ctrl2 Int1 Ctrl2 
Aruin 2003 Feedback 8 8   11 65.3 (3.4) 0.59(0.06) 
Carmeli 2011 Feedback 16 15 10 5 11 11 57.8 (8.9) 62.5 (5.0) 0.28 (0.25) 0.37(0.27) 
           
Crow 1989 Feedback 20 20 8 6 14 11 67.4(10.4) 68.1(9.5) 2-8 weeks post stroke 
           
da Silva 2011 Practice specificity 8 8 7 5 5 4 63.7(11.8) 58.8(11.4) 0.38(0.17) 0.50(0.16) 
Engardt 1994 
b 
Feedback 16 14 6 8 12 4 67 (6.05) 65 (8.46) 33.2(6.6) 34.3(5.8) 
Mirelman 
2010 
Feedback 9 9 no individual data but paper states that groups were 
matched 
>2 years 
Sackley 1997 Feedback 12 13 4 8 10 10 60.8(12.3) 67.9(9.2) 4.64(3.65) 4.34(4.45) 
Schauer 2003 Feedback 11 12 4 7   59.0(12.0) 61.0(12.0) 1.74 2.2 
Sungkarat 
2011 
Feedback 17 18 10 11 12 12 52.1(7.2) 53.8(11.2) 3.94(4.79) 4.7(5.8) 
Walker 2000 Feedback 16 16 7 7 12 8 65.4(13.8) 62.4(13.3) 1.34(0.64) 1.15(0.73) 
Yang 2008 Practice specificity 11 9 6 3 5 5 55.4(12.1) 60.9(9.3) 71.16(50.04) 73.2(123.84) 
 
Table 6: Characteristics of included studies in 'augmenting' category
1. Int - intervention 
2. Ctrl - control 






4.10 Risk of bias assessment 
A risk of bias assessment was carried out on each of the studies included in 
this review and the results of this are displayed in table seven.  
 Random Sequence generation: 
17 (68%) studies were assessed as low risk, 8 (32%) were assessed as 
unclear and there were no studies at high risk. 
 Allocation Concealment:  
11 (44%) studies were assessed as low risk, 14 (56%) were assessed 
as unclear and there were no studies at high risk. 
 Blinding of participants and personnel: 
25 (100%) studies were assessed as high risk. As previously discussed 
it is difficult  to blind participants to interventions which require active 
engagement in rehabilitation, therapies therefore whilst the studies were 
all assessed as high risk it was not felt that these results would adversely 
affect the interpretation of the findings from these trials.  
 Blinding of outcome assessment: 
16 (64%) studies were assessed as low risk, 8 (32%) were assessed as 
unclear and 1 (4%) study was at high risk. 
The only study that was judged to be at high risk was that of Walker et 
al (2000) who explicitly stated that the outcome assessor in their trial 
was aware of group allocation. The study authors perceived this to be 
acceptable because the outcome measures used were standardised, 
this they stated would prevent the assessor from entering inaccurate 
data. Clearly, despite the use of standardised measures there is still 
room for an individual who is aware of group allocation to knowingly 
enter incorrect data in order to bias the findings from the study in favour 
of one intervention or the other, therefore this study was judged to be at 
high risk of bias in this review. 
 Incomplete outcome data: 
25 (100%) studies were assessed as low risk. 
 
In summary only one study was found to have a high risk of bias in any of the 




All studies were judged to have a low risk of bias for ‘blinding of participants 
and personnel’ and ‘incomplete outcome data’ suggesting that the studies were 
not at risk of either performance bias or attrition bias. Between 32% and 56% 
of studies were judged to be ‘unclear’ for random sequence generation, 
allocation concealment and blinding of outcome assessment. This suggests 
that this information was either unavailable or that there was uncertainty of the 
risk of bias for these studies within these categories (Higgins and Green, 2011). 
40% (10) of studies were at low risk of bias for all categories. The implications 
of these findings have been discussed narratively together with the results of 
















































































































































Aruin 2003 U U H U L 
Carmeli 2011 L U H L L 
Chen 2005 L L H L L 
Chen 2011 L L H L L 
Crow 1989 L L H L L 
Da Silva 2011 U U H L L 
Engardt 1994 U U H U L 
Ertelt 2007 U U H U L 
Ietswaart 2011 L L H L L 
Lee 2011 L U H U L 
Malouin 2008 L U H L L 
Mirelman 2010 U U H U L 
Ng 2007 L L H L L 
Ng 2009 L L H L L 
Page 2000 U U H U L 
Page 2001 L L H U L 
Page 2009 L U H L L 
Sackley 1997 L U H L L 
Schauer 2003 U U H U L 
Sungkarat 2011 L L H L L 
Sutbeyaz 2007 L L H L L 
Walker 2000 L U H H L 
Wu 2010 U U H L L 
Yang 2008 L L H L L 












L Low risk 






4.11 Quantitative Synthesis 
Tables eight through to twelve summarise the individual results for each of the 
included studies. The intention was to carry out meta-analysis within these 
categories; however this synthesis of the study results revealed considerable 
heterogeneity in the outcome measures used (see tables thirteen and fourteen). 
Attempts at summary analysis using studies that have evaluated outcome with 
measures falling within the impairment domain of the ICF with those in the 
activity domain could lead to an accusation of comparing apples with oranges 
(Borenstein et al., 2010, Gough et al., 2012). By definition these domains 
measure different aspects of health and therefore the meta-analysis would not 
be comparing like with like. In order to avoid this outcome measures were 
mapped to their corresponding ICF domain. 
 
Table thirteen shows the range of measures that fall within the impairment 
domain across all the studies and table fourteen shows those that fall within 
the activity domain. Measures that have recorded global bodily function (i.e. not 















   Results at primary end point  








  median (IQR)1 median (IQR)1 between group change 
scores 
Chen 2011 Fugl Meyer LL                  14.0(10.5-15.5) 6(3.0-9.8) p<0.001* 
 Motor Assessment Score 16.0(12.5-18.5) 10.5(5.3-14.0) p=0.010 
 Postural assessment for stroke trunk control 5.0(3.5-7.0) 5.0(2.5-7.8) p>0.05 
 Berg Balance Scale 28.0(20.5-33.5) 15.5(9.3-23.5) p=0.007* 
 Functional Ambulation Categories 2.0(2.0-2.0) 1(1.0-1.0) p<0.001* 
 MRC Lower Extremity 6.0(4.0-7.0) 3(1.3-4.0) p<0.001* 
  mean (SD)2 mean (SD)2  
Lee 2011 Speed cm/s 55.6(17.7) 51.5(19.7) p>0.05 
 Cadence step/min 84.9(15.9) 74.3(20.3) p>0.05 
 step length cm 41.9(9.0) 42.8(8.7) p>0.05 
 stride length cm 77.2(13.5) 81.5(11.9) p>0.05 
 single limb support 25.4(6.3) 24.9(6.4) p>0.05 
 double limb support 38.0(9.3) 40.4(10.2) p>0.05 
Malouin 2008 Limb loading Rising  43.3(8.9) 43.4(4.0) p<0.03* 
 Limb loading Sitting 35.7(4.2) 41.9(1.9) p<0.03* 
Ng 2007 Composite spasticity scale 11.0(1.4) 11.2(1.7) p>0.05 
 isometric ankle dorsi-flexion 16.9(4.8) 14.7(6.2) p>0.05 
 isometric ankle plantar flexion 23.8(8.5) 20.3(16.0) p>0.05 
 Gait velocity cm/s 68.2(34.5) 57.7(29.8) p<0.01* 
Ng 2009 Gait velocity cm/s 66.6(32.5) 60.6(29.7) p<0.01* 
 6 Minute Walk Test 242.0(104.0) 206.7(97.2) p>0.01 
 Timed Up and Go 18.7(9.7) 26.2(21.7) p<0.01* 
Sutbeyaz 2007 Brunnstroms stages of motor recovery 3.5(0.8) 3.0(0.7) 
analysis based on mean 
change score over three time 
periods 
 Modified Ashworth Scale 2.0(2.3) 2.2(0.7) 
 Motor Functional Independence Measure 65.9(4.8) 61.7(14.6) 
 Functional Ambulation Categories 2.8(0.6) 2.9(0.7) 
 
Table 8: Reported outcomes for included studies evaluating interventions categorised as no/little movement 
1. IQR – interquartile range 
2. SD - standard deviation 















Study Outcomes Experimental Control  
  mean (SD)1 mean (SD)1 between group change 
scores 
Chen 2005 Brunnstrom stage 0.4(0.2) 0.2(0.1) p=0.005* 
 Modified Motor assessment scale 4.0(0.9) 2.4(0.8) p=0.001* 
 Grasping 0.8(1.2)  0.2(0.4) p=0.19 
 wrist flexion 5.4(5.4)  1.6(3.0) p=0.07 
 wrist extension 3.4(3.1) 0.7(1.5) p=0.01* 
Ertelt 2007 Frenchay Arm Test 4.4(0.5) 2.1(1.0) p=0.0005* 
 Wolf Motor Function Test 7.0(6.9) 17.0(19.0) p=0.0525 
Ietswaart 2011 Action Research Arm Test 31.5(20.7) 32.9(20.8) p=0.77 
 grip  force % of unaffected arm 38.2(36.1) 34.6(34.9) p=0.60 
 Timed manual dexterity 104.4(55.9) 95.7(57.6) p=0.98 
 Barthel 16.2(4.1) 16.8(3.8) p=0.38 
 Modified Functional Limitation  Profile 50.3(18.8) 55.4(15.8) p=0.98 
Page 2000 Fugl Meyer Upper Limb 30.0(4.1) 26.9(5.4) p<0.05* 
Page 2001 Fugl Meyer Upper Limb 43.0(10.1) 32.4(14.9) No   value 
 Action Research Arm Test 40.4(13.4) 25.0(11.7) No   value 
Page 2009 Action Research Arm Test 42.6(1.2) 43.5(1.5) analysis based on change score 
from follow up to baseline  Fugl Meyer Upper Limb 46.4(0.9) 48.8)1.31) 
Wu 2010 UE subscale STREAM2 10.0(5.3) 7.3(5.6) p<0.01* 
 Action Research Arm Test 24.8(20.8) 14.7(18.8) p<0.05* 
 Modified Ashworth Scale Elbow 1.7(0.9) 1.9(1.0) p>0.05 
 Modified Ashworth Scale Wrist 1.8(1.1) 2.0(1.3) p>0.05 
 LL subscale STREAM 11.0(5.3) 9.7(5.0) p>0.05 
 Barthel 17.4(2.6) 16.4(2.4) p>0.05 
Yavuzer 2008 Brunnstrom stages hand 3.5(1.3) 2.7(1.0) 
analysis based on change score 
from follow up to baseline 
 Modified Ashworth Scale 1.3(0.5) 1.6(0.6) 
 Self care Functional Independence Measure 28.9(10.0) 22.2(6.3) 
 Brunnstrom Upper Extremity 3.7(1.2) 2.8(0.9) 
Table 9: Reported outcomes for studies evaluating interventions categorised as little/no movement 
1. IQR – interquartile range 
2. STREAM – Stroke Rehabilitation Assessment of Movement  













Study Outcomes Experimental  Control   
  mean (SD)1 Within group change 
score 
mean (SD)1 Between group change score  
Aruin 2003 Step width 0.2(0.0)  0.1(0.0) <0.05*  
Engardt 1994 b Body weight distribution (BWD) 
standing up % 
47.8(6.7)  44.2(6.6) 
Analysis is based on follow up 
results 
 
 BWD sitting down % 47.9(5.3)  43.5(7.6)  
 Time to stand 3.1(1.0)  3.2(0.8)  
 Time to sit 3.5(0.9)  2.8(0.6)  





















 Hip range 32.7(11.3) P>0.05 32.3(13.6) P>0.05* 
 knee stance range 17.3(3.4) p=0.05 13.4(4.5) P>0.05 
 knee swing range 38.1(10.7) p=0.05 32.5(17.0) P>0.05 
 ankle range 20.9(8.1) p=0.05 18.3(7.1) p=0.05* 
 Onset of push off - time No data     
 Onset of push off - power No data     
Sackley 1997 Rivermead Motor Function 
Assessment 
17.0(2.9)  12.7(4.5) p<0.05*  
 Balance coefficient 0.0(0.0)  0.1(0.0) p<0.05*  
 Sway coefficient 0.0(0.0)  0.0(0.2) NS  
Schauer 2003 Gait velocity m/s 0.8(0.3)  0.8(0.4) p=0.008*  
 stride length cm 1.0(0.3)  1.0(0.3) p=0.009*  
 Gait cadence 47.2(7.8)  48.5(7.8) p=0.045*  
 Symmetry deviation 7.1(6.0)  8.4(9.7) p=0.008*  




Table 10: Reported outcomes for studies evaluating interventions categorised as augmenting (authors Aruin to Schauer) 
 
1. SD- standard deviation 















Study Outcomes Experimental Control  
  mean (SD)1  Mean (SD)1 Between group change score 
Sungkarat 2011 Gait speed cm/s 35.9(13.6)  26.3(8.5) p=0.02* 
 step length asymmetry ratio 0.4(0.1)  0.8(0.3) p=0.03* 
 single support time asymmetry 
ratio 
0.4(0.0)  0.5(0.0) p=0.03* 
 Berg Balance Scale 45.6(4.3)  41.8(7.3) p=0.001* 
 Timed Up and Go 22.3(10.4)  27.2(10.9) p=0.04* 
 Loading on paretic leg during 
stance % body weight 
45.5(4.8)  39.8(9.7) p=0.004* 
Walker 2000 postural sway eyes open 0.2(0.1)  0.3(0.3) 
analysis is based on mean 
scores achieved over three  
time periods 
 postural sway eyes closed 0.6(0.4)  0.5(0.5) 
 Berg Balance Scale 46.6(6.0)  48.8(6.2) 
 Gait speed (m/s) 0.6(0.3)  0.9(0.7) 
 Timed Up and Go 33.4(20.3)  21.3(12.8) 
Yang 2007 Walking speed m/s 0.9(0.3)  0.7(0.6) p=0.03* 
 Community Walk test 17.0(18.4)  20.6(20.0) p=0.04* 
 Walking ability questionnaire 58.4(9.3)  58.7(12.8) p=0.19 
 Activity specific  balance 
confidence 
87.4(6.8)  72.3(16.9) p=0.31 
 





1. SD- standard deviation 





   Results at primary end point  









  mean (SD)1 mean (SD) between group change scores 
Carmeli 2011 Box and Block 32.0(11.6) 31.4(16.1) p=0.015* 
 Fugl Meyer Upper Limb 56.6(6.6) 52.4(8.1) p=0.0417* 
 Tracking speed 2.8(1.3) 1.4(0.4) p=0.00049* 
 Tracking width 3.5(1.3) 6.7(1.6) p=0.000002* 
Crow 1989 Action Research Arm Test 21.3(22.8) 12.5(21.7) p=0.05* 
 Fugl Meyer Upper Limb 34.5(22.0) 22.9(21.1) p=0.02* 
da Silva 2011 Barthel 94.9(8.9) 88.0(17.8) p>0.05 
 Motricity Index 73.6(16.1) 60.2(20.0) p>0.05 
 Fugl Meyer Upper Limb 84.6(18.4) 66.9(22.9) p>0.05 
 Chedoke Arm and Hand Activity Inventory 90.2(17.0) 70.6(70.6) comparison of normalised improvement 
between groups P = 0.025 
 
 









1. SD- standard deviation 





 Needing little or no movement Augmenting 









Grasping Speed cm/s Nine hole peg test Ankle range 
Wrist flexion Cadence step/min Fugl Meyer Upper Limb Balance coefficient 
Wrist extension Step length cm Grip and pinch Body weight distribution standing up 
Modified Ashworth Scale Stride length cm Modified Ashworth scale BWD sitting down 
Modified Ashworth Scale Single limb support Tracking speed Heel on toe off distance 
Grip force % of unaffected arm Double limb support Tracking width Hip range 
Timed manual dexterity Composite spasticity scale  Knee stance range 
Fugl Meyer Upper  Limb Isometric ankle dorsiflexion  Knee swing range 
Upper Extremity subscale STREAM Isometric ankle plantarflexion  Limb loading 
Brunnstroms stages of motor recovery Lower Limb subscale STREAM  Loading on paretic leg during stance 
 Brunnstroms stages of motor recovery  Modified Ashworth scale 
   Onset of push off – power and time 
   Postural sway eyes closed 
   Postural sway eyes open 
   Single support time asymmetry ratio 
   Step length asymmetry ratio 
   Sway coefficient 
   Symmetry deviation 
   Time to sit 
   Time to stand 








 Needing little or no movement Augmenting 








Action Research Arm Test Functional Ambulation Categories Action Research Arm Test Berg Balance Scale 
Frenchay Arm Test 6 Minute Walk Test Arm Motor Ability Test Timed Up and Go 
Wolf Motor Function Test Timed Up and Go Box and Block Walking speed 
    
    
    
     


















Barthel  Rivermead Motor Function Assessment  
Motor and Self-care items of Functional Independence Measure Stroke Impact Score 
Modified Functional Limitation Profile Community Walk Test  
Modified Motor assessment scale    
   
    













Heterogeneity of measures within the impairment domain of the ICF limits the 
ability to carry out a coherent, quantitative summary analysis of the findings 
from the studies included in this review. There were however fewer measures 
across all the studies which fell within the activity domain. Outcome measures 
that fall within the activity domain of the ICF are likely to be more meaningful to 
participants than those that fall within the impairment domain (World Health 
Organisation, 2001). Evidence for the effectiveness of an applied motor 
learning principle which has been evaluated using activity domain measures 
may therefore be more relevant to the functional recovery of a participant. 
Findings from this review were also intended to inform the future delivery of 
Functional Strength Training as an exemplar of how motor learning principles 
can be applied to physical therapy interventions. The phase II trial of Functional 
Strength Training interventions evaluated outcome using only measures that 
fell within the activity domain, therefore parity across both studies would be 
facilitated if summary analysis of the review did the same. The decision was 
taken to carry out a quantitative summary analysis using the measures that fall 
within the activity domain, this resulted in sixteen studies (those using activity 







4.11.1 Meta-analysis and summary results 
The following tables show the different interventions included in this synthesis 
and their place within the motor learning framework proposed in chapter two. 
Lower Limb 
 Motor Learning 
Principle (MLP) 











Ng and Hui Chan (2007 
and 2009) 
 Mirror therapy Sutbeyaz et al (2007) 
    
Augmenting: 
 
Practice specificity Virtual reality  
 
Yang et al (2008) 
Feedback Music Schauer and Mauritz 
(2003)  
Feedback Insole shoe wedge 
 
Sungkarat et al (2011) 
Feedback Biofeedback device Walker et al (2000) 
Table 15: Summary of methods for applying motor learning principles to lower limb movement impairment  
Upper Limb 
 Motor Learning 
Principle (MLP) 
Method of applying 
MLP 
Study 
No or little 
movement: 
 




Ietswaart et al 
(2011) 
Priming Motor imagery 
 
Page  (2001) 
Priming Mental practice 
 
Page  (2009) 
Priming Thermal stimulation 
 
Wu et al (2010) 
Augmenting: 
 
Practice specificity Virtual reality Da Silva 









Crow et al (1989) 




4.11.1.1 Lower limb studies in no/little movement category 
Studies included within this category all applied the priming motor learning 
principle. Application of this principle was achieved through motor imagery (Lee 
et al., 2011), mirror therapy (Sutbeyaz et al., 2007) and transcutaneous 
electrical stimulation (Ng and Hui-Chan, 2007, Ng and Hui-Chan, 2009). This 
was set at a sensory threshold and therefore met the inclusion criteria because 
it did not provide movement or movement support. All three studies included in 
this meta-analysis included participants who were within the chronic phase of 
recovery from stroke (greater than six months (Lee et al., 2011); mean time 
from stroke 5.3 years and 4.6 years Ng and Hui-Chan (2007 and 2009). 
 
Meta-analysis was only possible for the findings from studies including walking 
speed as an outcome measure, this has been reported in table seventeen. To 
enable comparison all measurements were converted to metres per second. 
The results of the other outcome measures have been reported separately 
(table eighteen).          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
Meta-analysis of the separate study findings measuring a change in walking 
speed showed no effect of the intervention, although it was arguably close to 
statistical significance for a hypothesis tested at a significance level of 5%. 
(p=0.57).  
 
Other activity related outcome measures that have been used to evaluate the 
effects of the application of the priming motor learning principle to promote 
movement recovery in the lower limb were the Functional Ambulation 
Categories (FAC), the Six Minute Walk Test (6MWT) and the Timed Up and 
Go (TUG) (see table eighteen).  
 
Sutbeyaz et al (2007) applied this principle by evaluating mirror therapy 
combined with a conventional stroke rehabilitation programme versus a control 
group who were offered a sham therapy combined with the same conventional 
programme. All participants were within the first 3-6 months after stroke (mean 
3.7 months). Analysis of the findings from their study did not find a statistically 




study outcomes was based on a mean change score which was calculated over 
three time periods (pre-treatment, post treatment and follow up). Results of this 
study therefore do not show changes in response to the intervention as this 
was withdrawn between the post treatment and follow up measurement points.  
 
Ng and Hui-Chan (2009) included the 6MWT and TUG as part of their 
assessment battery as well as timed walking speed. They found statistically 
significant results for the improvement in the TUG (P<0.01) but not the 6MWT 
(p>0.01). Although both are a measure of mobility these two outcomes quantify 
different aspects of this function. The TUG includes rising from a chair and 
turning (Rockwood et al., 2000), whereas the 6MWT measures sustained 
walking ability (Butland et al., 1982). Differences in the effects of the same 
intervention on these outcome measures are therefore possible. 
 
Meta-analysis finds no evidence for the effects of applying a priming motor 
learning principle on walking speed (P=0.57) (Lee et al., 2011, Ng and Hui-
Chan, 2007, Ng and Hui-Chan, 2009) and summary analysis of the findings 
from the other studies in relation to the 6 minute walk test and the Functional 
Ambulation categories supports this interpretation. There is the possibility 
however, that there was some effect of the experimental intervention on 







Table 17: Summary results for walking speed in no/little movement category  
 
 
Study Outcomes Experimental Control  
    Mean (SD)1 Mean (SD)1 between group change scores 
Sutbeyaz 2007 Functional Ambulation Categories 65.9(4.8) 61.7(14.6) P=0.610 
Ng 2009 6 minute walk test 242.0(104.0) 206.7(97.2) p>0.01 
Ng 2009 Timed Up and Go 18.7(9.7) 26.2(21.7) p<0.01* 
 
 




 Experimental Control      
Study Mean  SD1 Total Mean SD1 Total  
SMD2 
(random) 25% CI3 75% CI3 Weight P 
Lee 2011 0.56 0.18 13 0.52 0.2 11 0.20 -0.60 1.01 20.4  
Ng 2007 0.68 0.35 21 0.58 0.3 20 0.30 -0.32 0.92 34.9  
Ng 2009 0.67 0.33 27 0.7 0.33 25 -0.09 -0.63 0.45 44.7  
Total   61   56 0.11 -0.26 0.47 100 0.57 
1.  SD- standard deviation 
2. SMD – standardised mean difference 
3. CI- confidence interval 




4.11.1.2 Upper limb studies in no/little movement category 
Studies included in this category evaluated the effects of the priming motor 
learning principle by a combined approach of motor imagery interventions 
(Ietswaart et al., 2011), motor imagery (Page, 2001), mental practice (Page et 
al., 2009) and action observation (Ertelt et al., 2007). 
 
Meta-analysis of the results from these studies was only possible for the Action 
Research Arm Test (table nineteen). This did not find an effect of the 
intervention at outcome (p=0.11).  
 
Table twenty shows the individual study findings from Ertelt et al (2007). This 
study evaluated the effects of a priming motor learning principle delivered via 
‘action observation’. Effects of the intervention were measured using the 
Frenchay Arm test (FAT) and the Wolf Motor Function Test (WMFT) The study 
authors found statistically significant results in favour of the experimental 
intervention when measuring change using the FAT (P=0.0005) but not the 
WMFT (P=0.0525), although arguably this is very close to statistical 
significance. The WMFT (Wolf et al., 2001) is reported to be a more robust 
measure of upper limb function in that it tests the ability to carry out more 
functional activities of the arm and measures more aspects of upper limb 
function including reaching, grip and prehensile movements. The FAT, whilst 
designed as an evaluative tool is brief and measures performance on five upper 
limb activities only (Heller et al., 1987). It has subsequently been described as 
being a better screening tool than an evaluative measure (Finch et al., 2002). 
The findings from the WMFT may therefore be more reliable as an indication 
of the effects of the experimental intervention in this study. This was a small 
study (n=16), which included only those participants within the chronic phase 
of recovery from stroke (mean 36.13 months) and therefore findings from this 
study may not be applicable to the wider population of stroke survivors. The 
small sample size may also have impacted on the study’s power to determine 
statistical significance. Underpowered studies are at risk of wrongly interpreting 









Table 19: Summary results for the Action Research Arm Test in no/little movement category 
 
Study Outcomes Experimental Control  
    Mean (SD)1 Mean (SD)1 between group change scores 
Ertelt 2007 Frenchay Arm Test 4.4(0.5) 2.1(1.0) p=0.0005* 
Ertelt 2007 Wolf Motor Function Test 7.0(6.9) 17.0(19.0) p=0.0525 
 
Table 20: Individual study findings for other upper limb outcome measures in no/little movement category 
 
 
 Experimental Control      
Study Mean  SD1 Total Mean SD1 Total  
SMD2 
(random) 25% CI3 75% CI3 Weight P 
Action Research Arm Test            
Ietswaart 2011 31.51 20.68 39 32.87 20.76 31 -0.06 -0.54 0.41 35.0  
Page 2001 40.4 13.4 8 25 11.7 5 1.12 -0.11 2.35 25.0  
Page 2009 42.6 1.2 5 36.4 1.1 5 4.86 1.86 7.87 9.4  
Wu 2010 24.8 20.8 12 14.7 18.8 11 0.49 -0.34 1.32 7.87  
Total   64   52 0.86 -0.20 1.93 100 0.11 
1.  SD- standard deviation 
2. SMD – standardised mean difference 
3. CI- confidence interval 




4.11.1.3 Lower limb studies in augmenting category 
Table 21 shows the meta-analysis of the studies that included interventions 
targeted at lower limb recovery following stroke which, for the purposes of this 
review, have been categorised as augmenting. Meta-analysis was possible for 
the Berg balance scale (BBS), the Timed up and go (TUG) and timed walking 
speed. 
 
Motor learning principles applied in this category included feedback which was 
achieved through musical motor feedback (Schauer and Mauritz, 2003), an 
insole shoe wedge which provided auditory feedback (Sungkarat et al., 2011) 
and visual feedback from a biofeedback device called the Balance Master 
(Walker et al., 2000). The effects of practice specificity were also evaluated 
through the medium of virtual reality (Yang et al., 2008).  
 
Participants included in the respective studies ranged in time from stroke onset. 
Schauer and Mauritz (2003) and Walker et al., both included participants within 
the first three months after stroke; Sungkarat et al (2011) included participants 
within the first six months and Yang et al (2008) included those within the 
chronic phase of recovery (mean times of 71.16 months and 73.2 months).  
 
All studies within this category contributed to the meta-analysis of the findings 
in relation to walking speed. The results of this found no statistically significant 
effect of the interventions (p=0.73). 
 
The meta-analysis for the BBS and the TUG included two studies by Sungkarat 
et al (2011) and Walker et al (2000) respectively. Both studies evaluated the 
effects of feedback. No effect was found for the intervention following meta-
analysis of both results from the BBS and the TUG (p=0.77 and 0.84 
respectively).  
 
In summary therefore, there appears to have been no statistically significant 




stroke when measured using walking speed (m/s) (p=0.73) , the Timed Up and 





 Experimental Control      
Study Mean  SD1 Total Mean SD1 Total  
SMD2 
(random) 25% CI3 75% CI3 Weight P 
Berg Balance Scale            
Sungkarat 2011 45.64 4.3 17 41.76 7.3 18 0.63 -0.05 1.31 50.3  
Walker 2000 46.6 6 16 48.8 6.2 16 -2.2 -0.35 0.35 49.7  
Total   33   34 0.14 -0.82 1.10 100 0.77 
Timed Up and Go            
Sungkarat 2011 22.26 10.4 17 27.17 10.9 18 -0.45 -1.12 0.22 50.6  
Walker 2000 33.4 20.3 16 21.3 12.8 16 0.70 -0.02 1.41 49.4  
Total   33   34 0.12 -1.01 1.24 100 0.84 
Timed Walking Speed m/s            
Schauer 2003 0.81 0.29 11 0.8 0.35 12 0.03 -0.79 0.85 23.8  
Sungkarat 2011 0.35 0.14 17 0.26 0.09 18 0.75 0.06 1.44 27.3  
Walker 2000 0.57 0.34 16 0.89 0.65 16 -0.60 -1.31 0.11 26.7  
Yang 2008 0.85 0.31 11 0.73 0.63 9 0.24 -0.65 1.12 22.2  
Total   55   55 -0.78 -1.9 0.45 100 0.73 
 
Table 21: Summary results for the Berg Balance Scale, the Timed Up and Go and Timed Walking Speed in augmenting category 
 
1.  SD- standard deviation 
2. SMD – standardised mean difference 
3. CI- confidence interval 




4.11.1.4 Upper limb studies in augmenting category 
Meta-analysis for upper limb studies defined within the category of augmenting 
was not possible because of the heterogeneity of outcome measures used. 
Individual results of the activity based outcomes were therefore presented for 
each of the studies (table 22).  Motor learning principles included in these 
studies and which have been categorised as augmenting are feedback 
(Carmeli et al., 2011, Crow et al., 1989) and practice specificity (da Silva 
Cameirao et al., 2011).  
 
Both studies by Carmeli et al (2010) and Crow et al (1989) evaluated the effects 
of feedback; in the study by Carmeli et al (2010) this was provided by a custom 
designed glove and in the study by Crow et al (1989) by EMG biofeedback. 
Participants within both studies were within the first three months after stroke. 
 
Carmeli et al (2010) found statistically significant results for the Box and Block 
(BBT) (p= 0.015). The study by Crow et al (1989) also found statistically 
significant results in favour of the intervention measured by the Action 
Research Arm Test (ARAT) (p= 0.04). These findings concur with those from a 
previous narrative review of the role of feedback in promoting motor learning in 
the upper limb following stroke (Subramanian et al., 2010). 
 
The final study included in this analysis of upper limb augmenting studies was 
that of da Silva Cameirao et al (2011). This study evaluated the application of 
practice specificity by changing the context in which practice of an upper limb 
movement task took place. This was achieved through the use of a virtual 
reality (VR) environment and the effects were measured using the Chedoke-
McMaster Stroke Assessment. Participants included in this study were within 
the first three months after stroke. This study attempted to control for both the 
movement practice that was part of the experimental intervention and the 
gaming experience that was inherent within the VR task. As such it had two 
control groups and so the results of both groups were pooled to provide data 
for the analysis. Statistically significant results were found in favour of the 





Synthesis of the findings for this category of motor learning was only supported 
by the interpretation of individual study findings and without benefit of meta-
analysis. All studies within this category showed a statistically significant effect 
of the interventions and therefore there is some evidence to support the use of 









Study Outcomes Experimental Control  
    Mean (SD)1 Mean (SD)1 between group change scores 
Carmeli 2011 Box and Block 32.0(11.6) 31.4(16.1) p=0.015* 
Crow 1989 Action Research Arm Test 21.3(22.8) 12.5(21.7) p=0.05* 












1.  SD- standard deviation 
2. SMD – standardised mean difference 
3. CI- confidence interval 




4.12 Discussion  
The purpose of a systematic review is to identify the evidence base for any 
given intervention by synthesising the findings from individual studies in order 
to establish a body of evidence. Individual studies evaluating many different 
interventions provide little evidence for changing practice because of the risks 
inherent in applying the findings from studies with relatively small sample sizes 
(Button et al., 2013). By defining interventions within a framework which has 
identified an underlying principle common to them all, it is possible to bring 
together a body of evidence which may provide an answer to the research 
question or identify relevant gaps (Higgins and Green, 2011). The aim of this 
review was to establish the evidence for the effectiveness of the application of 
motor learning principles to promote motor learning after stroke. The following 
sections have presented a summary discussion and critique of this review in 
the context of the objectives that were defined in chapter three. 
 Objective 1: To systematically identify the relevant literature for 
inclusion in a literature review according to a motor learning 
framework. 
The design of this systematic review was guided by the identification of motor 
learning principles and the subsequent development of a motor learning 
framework described in chapter two. The framework was developed following 
a review of the theoretical literature underpinning motor learning and provided 
definitions for each of the motor learning principles. Previous reviews of motor 
learning principles in movement rehabilitation after stroke may have failed to 
include all appropriate studies, because the application of these principles was 
not made explicit within the studies themselves. This may have occurred 
because of a lack of clarity around what constitutes a motor learning principle 
(DePaul, 2013). The development of definitions and a subsequent framework 
for motor learning within this thesis was intended to assist in identifying motor 
learning principles by defining the underlying theoretical construct for 
therapeutic interventions. Thus studies evaluating the effects of biofeedback by 
EMG and use of a device such as a Balance Performance Monitor could both 




may have facilitated the identification of studies that might not have otherwise 
been identified.  
 
The use of the term ‘priming’ to describe a motor learning principle facilitated 
the identification of studies which evaluated therapies such as ‘action 
observation’, ‘thermal stimulation’ and ‘mental imagery’. The decision to 
rename the motor learning principle ‘mental practice ‘ to ‘priming’ was made 
because of the potential for confusion which arose around the use of ‘mental 
practice’ as both a therapeutic intervention and the motor learning principle. 
Mental practice is believed to have a motor learning effect because of its action 
on the movement execution system in the brain (Grezes and Decety, 2001).  
Stinear and colleagues (2007) have used the term ‘priming’ to describe this 
action and therefore precedent for its use in this context had already been 
developed. The term ‘priming’ was therefore adopted to describe the motor 
learning principle. However, consensus around definition and descriptions in 
the terminology used within the context of motor learning has been cited as one 
reason for a lack of uptake of motor learning in movement rehabilitation after 
stroke (Kleynen et al., 2013). Discussion around the use of this term needs to 
be carried out in order to achieve a consensus of opinion around its use within 
the context of motor learning. 
 
As the systematic review progressed it became apparent that the motor 
learning framework developed in chapter two was not appropriate. Drawbacks 
in the framework’s design emerged because of the synthesis of the motor 
learning principles within the two categories of ‘no/little movement’ and 
‘augmenting’. Development of motor learning principles has been based on the 
assumption that physical practice of the motor task that needs to be learnt is 
possible (Magill, 2006, Shumway-Cook and Woollacott, 2007). This is not 
always the case following stroke, therefore the framework developed in this 
thesis  categorised motor learning principles according to whether there was 
evidence of their effectiveness in the absence of movement recovery or not. 
Only the ‘priming’ motor learning principle was categorised as ‘needing little or 
no movement’. This decision was supported by Feltz and Landers (1983) who 




this technique had not been accompanied by physical practice of the task. All 
other motor learning principles were categorised within the ‘augmenting’ 
category. Such categorisation of motor learning principles was subsequently 
judged to be inappropriate as motor learning principles related to instructions, 
practice specificity and practice intensity could be applied even when there is 
no movement recovery, i.e. they could be used to influence the delivery of 
therapies such as mental imagery.  
 
Synthesis of these motor learning principles within one category was also felt 
to be inappropriate. Whilst categorisation is one means of coping with 
heterogeneity in a meta-analysis (Shepperd et al., 2009), in this instance, this 
led to over-generalisation of the effects of each motor learning principle.  
 
In light of these reflections a revised framework has been designed and this 
will be presented and taken forward to inform the design of the novel 
intervention described in chapter six. 
 
Studies using electrostimulation or orthotics to either support or provide 
movement were excluded from this review. This decision had been determined 
by the findings from Cauraugh et al. (2007), where the effectiveness of the 
motor learning principle (variability of practice) may have been confounded by 
the presence of electrostimulation. Robotics and other external devices are 
however becoming established methods for delivering movement therapy after 
stroke (Langhorne et al., 2011) and so the decision to exclude them may have 
been inappropriate. The place for these interventions and the presence of 
electrostimulation and orthotics within a motor learning framework needs to be 
considered more carefully in future reviews. 
 
The systematic identification of literature relies on a robust search strategy 
(Centre for Reviews and Dissemination, 2008, Gough et al., 2012, Higgins and 
Green, 2011). In the present review, to ensure probe papers were not missed 
during the search process key words were kept deliberately inclusive. These 
incorporated a broad spectrum of movement therapy studies which facilitated 




the intervention within the context of motor learning. Previous reviews in this 
field have tended to rely on the use of key words that have been focussed on 
the motor learning principle: for example Subramanian et al. (2010) used the 
following key words in their systematic review of extrinsic feedback: 
‘cerebrovascular accident’, ‘stroke’, ‘upper limb’, ‘motor learning’, 
‘implicit and explicit feedback’, ‘extrinsic feedback’, ‘rehabilitation’, 
‘treatment’, and ‘brain damage’.  
Exact details of this search have not been given so it is not possible to draw 
any definitive conclusions about its rigour, however it was this author’s 
experience that early studies failed to use terms such as ‘feedback’ or ‘learning’ 
to describe the interventions. These studies may not have been identified as 
eligible for inclusion within the previous systematic reviews. The use of key 
words in the present study may have led to a more robust systematic review 
by including more studies that were appropriate to the research question.   
 
The design and subsequent use of the key words in the present review led to 
an initial identification of over 20 000 titles. Exclusion of studies at this stage 
was carried out only by the author of this thesis. Despite best attempts, it is 
possible that the author may have biased this review by inappropriately 
excluding a study at the titles stage. Cochrane methodology suggests that the 
inclusion and exclusion of studies should be carried out by at least two people, 
because this minimises the impact of bias on behalf of one or other of the 
reviewers. (Higgins and Green, 2011). The second researcher was not 
available for the inclusion/exclusion process at the title stage because she was 
a full-time clinician with little time at that point in the study to give to such a 
quantity of work. Future reviews could avoid this scenario by widening the 
review team so that workload would be more manageable.  
 
The search strategy employed in this review focussed on published studies that 
had been indexed in relevant databases. It is possible that despite best 
attempts at employing a rigorous search strategy, relevant studies may have 
been missed because of publication bias. It has been shown that studies with 
statistically significant results are more likely to be published than those with 




et al., 1991). To avoid excluding such studies from a systematic review Higgins 
and Green (2011) recommend searching so-called ‘grey literature’. The present 
study may be at risk of excluding appropriate studies, as searching databases 
of grey literature were not included in the search strategy. By searching other 
databases it is likely that the number of studies initially included in the present 
review would however have been greater. Section 4.4 discussed the need to 
design a search strategy that was sufficiently sensitive to identify all relevant 
papers but precise enough to avoid reading through those that weren’t. Despite 
the potential for missing relevant studies this author would not advocate 
increasing the number of databases, unless there is a way of increasing the 
specificity of the search strategy.  
 
This review was limited to those studies that were designed as randomised 
controlled trials (RCT). This follows general Cochrane methodology and is 
deemed to be one way of increasing the reliability and validity of the findings 
from a systematic review because of the rigour that is assigned to this type of 
research methodology (Centre for Reviews and Dissemination, 2008). It is of 
course to be expected that when searching as extensively as necessary for a 
systematic review that much literature will be discovered that, although not 
suitable for inclusion in the systematic review still forms part of the body of 
evidence for this topic. In this case many such studies were identified and have 
been reviewed in section 2.1.3.   
 
It has been suggested that a well designed RCT with complete blinding and 
appropriate analysis is likely to provide the “best possible evidence of 
effectiveness” (McKee et al., 1999 pp.314) however there may be occasions 
when randomisation is neither appropriate nor feasible (Black, 1996). 
Randomised controlled trials have been considered to be more robust because 
of the theory that alternative study designs such as cohort or case-control have 
led to overestimates in the effect size of an intervention. However a comparison 
of the findings of RCT and observational studies evaluating the same clinical 
subjects found that this wasn’t the case (Concato et al., 2000). Although this 
comparison was limited to a relatively small number of studies its findings 




randomised and non randomised studies which also found no evidence that 
either method consistently lead to larger estimates of effect size (McKee et al., 
1999).  
 
Systematic reviews of RCT exclude studies using alternative study designs. 
RCT are however one method of evaluating healthcare interventions, study 
authors may have opted for alternative study designs when faced with 
particular research questions (Black 1996). For example studies using case-
control series may be able to provide more information about the individual 
participant characteristics of people who respond to an experimental 
intervention. Including a timing element i.e. specifying the time point at which 
an intervention is delivered within this design would also be able to provide 
information about when, or at what stage in their recovery, a participant might 
respond (Bowling, 2000). Similarly dose-finding studies may have been able to 
provide information about the likely intensity that would be required for the 
experimental intervention to have an effect. It should be noted however that 
two reviews examining the intensity or dose of exercise therapies aimed at 
improving walking in people after stroke found a limited number of dose finding 
trials, suggesting that this type of study design is not readily used in 
rehabilitation therapies and therefore may not provide sufficient data for a 
systematic review (Cooke et al., 2010a, Veerbeek et al., 2011). This was 
discussed in more detail in section 2.1.3. Reviews including qualitative data 
either from mixed methods trials or qualitative studies may have been able to 
provide information about aspects of the intervention such as acceptability, 
context and variations in the effectiveness of the experimental intervention 
(Lewin et al., 2009). By including only RCT in the present systematic review it 
is possible that other relevant evidence may have been excluded. Whilst this 
work was reviewed in section 2.1.3 of the thesis its inclusion within the formal 
review may have been useful for the reasons discussed in the preceding 
paragraph. Future synthesis of this work may be able to include alternative 
forms of methodology although this will inherently limit the ability to synthesise 





Generalisability of the findings from this review is limited by the characteristics 
of the study participants, notably the time since onset of stroke. This ranged 
from very early after stroke (2-8 weeks post onset) to very late (>73.2 months). 
As has been previously discussed within the early chapters of this thesis the 
physiological processes underpinning recovery and learning over these two 
time periods are different (Kleim and Jones, 2008) and therefore the 
effectiveness of interventions within one period may not be generalisable to the 
other. Future reviews should consider stratifying subsequent findings according 
to time since stroke to avoid this confounder.  
 
 Objective 2: To seek to quantify the findings from the review 
through meta-analysis. 
Twenty five studies were initially included in this review; this resulted in a total 
of 47 outcome measures within the impairment domain of the ICF, 12 within 
the activity domain and 7 classified as ‘functional measures’. A systematic 
review of outcome measures in acute stroke trials found that in 51 trials there 
were  14 different measures of impairment, 11 different measures of activity, 1 
measure of “quality of life,” and 8 miscellaneous other measures (Duncan et 
al., 2000). The degree of heterogeneity seen in the present review is therefore 
not unusual. In an attempt to minimise heterogeneity studies were only included 
in the meta-analysis of the present review if they had measured outcome within 
the activity domain of the ICF. Despite this there was insufficient data to 
perform any meta-analysis on the upper limb interventions categorised as 
augmenting. Meta-analysis arguably provides a robust means of quantifying 
the effect of an intervention and therefore seems desirable (Borenstein et al., 
2010). Future reviews could consider ways in which impairment domain 
measures could be grouped together, assuming it is possible to define an 
aspect of measurement that is common to them all. Synthesis of future reviews 
would be strengthened however if consensus around the use of fewer outcome 
measures could be achieved. Table 23 provides a summary of the results from 






Table 23: Summary table of the results from the systematic review 
 
 









Action Research Arm Test 
P=0.11  
Not statistically significant effect 
Meta analysis: Ietswaart et al. (2011), 
Page et al. (2002), Page et al. (2009) 
and Wu et al. (2010) 
Action Research Arm Test 
P=0.05 
Statistically significant 
Single study findings: Crow et al. 
(1989) 
Frenchay Arm Test 
P=0.0005 
Statistically significant effect 
Single study findings: Ertelt et al. 
(2007) 
Box and Block 
P=0.015 
Statistically significant 
Single study findings: Carmeli et al. 
(2011) 
Wolf Motor Function Test 
P=0.0525 
Not statistically significant effect 
Single study findings: Ertelt et al. 
(2007) 




Single study findings: Da Silva  












Not statistically significant 
Meta analysis: Lee et al. (2011), Ng 
and Huichan (2007:2009) 
Berg  Balance Scale 
P=0.77 
Not statistically significant 
Meta analysis: Sungkarat et al. 




Not statistically significant 
Single study findings: Sutbeyaz et al. 
(2009). 
Timed Up and Go 
P=0.84 
Not statistically significant 
Meta analysis: Sungkarat et al. 
(2011), Walker et al. (2000). 
6 minute walk test  
P>0.01 
Not statistically significant 
Single study findings: Ng and 
Huichan (2009) 
Timed Walking Speed 
P=0.73 
Not statistically significant 
Meta analysis: Sungkarat et al. 
(2011), Yang et al. (2008),  Schauer 
and Mauritz (2003) Walker et al. 
(2000). 
Timed Up and Go  
P<0.01 
statistically significant 






Findings from the meta-analysis are discussed below within the categories in 
which they were analysed: 
 
No/little movement lower limb: 
 No statistically significant effects in favour of the experimental 
intervention for timed walking speed (p=0.57). Meta-analysis of findings 
from Lee et al. (2011) and Ng and HuiChan (2007 and 2009).  
 
 No statistically significant difference between the experimental and 
control groups for the Functional Ambulation Categories (p=0.610). 
Individual study findings from Sutbeyaz et al. (2007) 
 
 No statistically significant difference between the experimental and 
control groups for the Six Minute Walk Test (p>0.01). Individual study 
findings from Ng and Hui Chan (2009). 
 
 Statistically significant difference between the experimental and control 
groups for the Timed Up and Go (p<0.01). Individual study findings from 
Ng and Hui Chan (2009). 
Findings from the quantitative analysis of the lower limb studies evaluating 
interventions within the little/no movement category suggested some evidence 
for the effects of the application of the priming motor learning principle on 
mobility when measured by the timed up and go (TUG) (Ng and Hui-Chan, 
2009). This study applied this principle through the use of transcutaneous 
electrical nerve stimulation set to provide a sensory stimulus. Risk of bias 
assessment for this study was at low risk for all categories, which suggests that 
the relationship between the experimental intervention and the improvement in 
the TUG is reliable (Higgins and Green, 2011). Generalising these findings to 
all stroke survivors is however limited, as this study only included those 







No/little movement upper limb 
 No statistically significant effects in favour of the experimental 
intervention for the Action Research Arm Test (p=0.11). Meta-analysis 
of findings from Ietswaart et al. (2011), Wu et al. (2010), Page et al. 
(2009) and Page (2001). 
 
 No statistically significant difference between the experimental and 
control groups for the Wolf Motor Function Test (p=0.0525). Individual 
study findings from Ertelt et a.l (2007). 
 
 Statistically significant difference between the experimental and control 
groups for the Frenchay Arm Test (p=0.0005). Individual study findings 
from Ertelt et a.l (2007). 
Summary analysis of the studies targeting upper limb interventions in the 
liitle/no movement category found some evidence to support the application of 
the priming motor learning principle. This result was from only one study (Ertert 
et al, 2007) which applied this principle using a therapy called ‘action 
observation’. The only outcome measure to show statistically significant effects 
of the intervention was the Frenchay Arm Test (FAT). The study by Ertelt et al. 
(2007) was assessed as being at unclear risk of bias for random sequence 
generation, allocation concealment and blinding of outcome assessment, 
therefore these results may not be reliable (Higgins and Green, 2011).  
 
The design of the motor learning framework in this present review has led to 
the analysis of studies only evaluating the application of the priming motor 
learning principle, even though this was within the broader category of little/no 
movement. The inclusion of therapeutic interventions such as thermal 
stimulation and transcutaneous electrical nerve stimulation within a common 
category has not been carried out before thus there is no previous evidence 
with which to compare the findings from this present review.  If a consensus 
around the name and definition of this motor learning principle can be achieved 
then further synthesis including future studies that could be defined as applying 




this intervention. Synthesis within this context is likely to lead to the inclusion 
of a greater number of studies than systematic reviews of the individual 
therapies. Meta-analysis of the subsequent findings could therefore produce 
results that could be interpreted with more confidence if the studies were of 
good quality (Higgins and Green, 2011).  Such an interpretation may therefore 
make decisions about the effectiveness of this motor learning principle more 
robust. 
 
It is possible that in creating the ‘priming’ intervention the heterogeneity 
inherent within studies essentially evaluating different therapeutic interventions 
may have impacted on the meta-analysis. In order to address this, 
quantification of the heterogeneity could have been carried out and then this 
taken into account within the subsequent summary analysis (Borenstein et al., 
2010). Future reviews of this body of work will need to consider this within the 
analysis plan of the protocol. 
 
Augmenting lower limb 
 No statistically significant effects in favour of the experimental 
intervention for the Berg Balance Scale (p=0.77). Meta-analysis of 
findings from Sungkarat et al. (2011) and Walker et al. (2000). 
 
 No statistically significant effects in favour of the experimental 
intervention for the Timed Up and Go (p=0.84). Meta-analysis of findings 
from Sungkarat et al. (2011) and Walker et al. (2000). 
 
 No statistically significant effects in favour of the intervention for timed 
walking speed (p=0.73). Meta-analysis of findings from Sungkarat et al. 
(2011), Yang et al. (2008), Walker et al. (2000) and Schauer and Mauritz 
(2003). 
 






Walker et al. (2000) was the only study to be at high risk of bias in any category 
within the risk of bias assessment.  The authors of this study stipulated that 
bias was not present because the outcome assessors used standardised 
outcome measures. Whilst no weighting of the importance of any of the 
categories is given, lack of blinding of their outcome assessor creates the 
potential to falsify the study results. The inclusion of studies with a high risk of 
bias may lead to an unreliable interpretation of the overall findings of a review 
because the summary analysis has been founded on studies that were of poor 
methodological quality (Higgins and Green, 2011). The impact of this study on 
the summary analysis is unclear as risk of bias assessment has only been 
presented visually. An alternative means of managing the impact that these 
studies have on the synthesis of studies within a systematic review is via meta-
regression (Higgins and Green, 2011). Meta-regression can be incorporated 
into the meta-analysis and therefore provide a statistical means of reflecting 
the impact that these studies may have on the effect size (Higgins and Green, 
2011). Future reviews could consider this within the analysis plan in their 
protocol 
 
Analysed within the ‘augmenting’ category, studies included in the meta-
analysis of the Berg Balance Scale and the Timed Up and Go applied the 
feedback principle. Sungkarat et al. (2011) used an insole shoe wedge and 
Walker et al (2000) used a biofeedback device known as a Balance Master. 
Previous reviews of the effects of feedback in the lower limb have been limited 
to the application of feedback delivered via EMG and meta-analysis was not 
possible (Woodford and Price, 2007). This present review does not however 
support the general consensus that seems to be present within the literature, 
which is that feedback, particularly extrinsic feedback, is a useful adjunct to 
movement therapy after stroke. However, these reviews were based on the use 
of this principle to support upper limb movement recovery only and thus may 
not be applied to the recovery of lower limb movement (Subramanian et al., 
2010 and Molier et al., 2010). 
 
Use of the augmenting category meant that the effects of practice specificity 




present review to discern any specific effects of these motor learning principles. 
As stated previously the categorisation used in the present review may not be 
appropriate and future reviews of the application of each motor learning 
principle might be more useful.  
 
Augmenting upper limb 
 Statistically significant difference between the experimental and control 
groups for the Box and Block Test (p=0.015). Individual study findings 
from Carmeli et al. (2011). 
 
 Statistically significant difference between the experimental and control 
groups for the Action Research Arm Test (p=0.05). Individual study 
findings from Crow et al. (1989). 
 
 Statistically significant difference between the experimental and control 
groups for the Chedoke Arm and Hand Activity Inventory (p=0.025). 
Individual study findings from da Silva et al. (2011). 
 
Evidence in support of upper limb augmenting studies came from Crow et al. 
(1989), Carmeli et al. (2010) and da Silva Cameirao et al. (2011). Each study 
used a different outcome measure and all found statistically significant changes 
in upper limb activity measured by the Box and Block (p=0.015), the ARAT 
(p=0.05) and the Chedoke Arm and Hand Activity (p=0.025).  
 
Motor learning principles applied in this category were feedback and practice 
specificity. Feedback was applied through the use of a custom designed glove 
(Carmeli et al., 2011) and EMG biofeedback (Crow et al., 1989). These findings 
agree with both narrative reviews of the provision of extrinsic feedback 
(Subramanian et al., 2010 and Molier et al., 2010). Both reviews were 
prevented from meta-analysis due to the number of different outcome 
measures that had been used. These findings and those of the present study 
continue to support the need for a consensus on the use of common outcome 





Da Silva et al. (2011) evaluated the effects of practice specificity through a 
virtual reality environment. A review of the use of virtual reality has identified its 
potential for use in movement rehabilitation after stroke (moderate effect on 
arm function measures (SMD 0.53 95% CI 0.25-0.81), however this review did 
not discriminate between the underlying principles behind its use in the 
individual studies. Identifying this therapy within a motor learning framework 
would facilitate this.  
 
Carmeli et al. (2010) was at unclear risk of bias for allocation concealment and 
da Silva Cameirao et al. (2011) was assessed as unclear for both random 
sequence generation and allocation concealment. Although the impact of this 
risk of bias assessment is inherently ‘unclear’ these were small studies (n=31 
and n=16 respectively) and therefore the probability of these studies showing 
an effect that can be generalised to the wider stroke population is limited 
(Button et al., 2013). The study by Crow et al. (2010) was at low risk of bias 
suggesting that the findings from this study may be more reliable.  
 
Identification of motor learning principles within the category of augmenting 
was limited to just two applications (feedback and practice specificity).  There 
were no studies included in this review that evaluated the effects of the 
application of instructions or variability of practice. The absence of studies 
evaluating the application of these principles may be explained by the inclusion 
of randomised controlled trials only. The background chapter identified one 
study by Fasoli et al. (2002) which was designed using a repeated measures 
case series which evaluated the effects of ‘instructions’ and a single case study 
by Deprey (1999) evaluating the effect of ‘variability of practice’. Neither study 
would have been included in this review by virtue of their design. RCT are 
reported to be the gold standard (Sim, 2000) therefore the systematic synthesis 
of studies with this design are arguably most robust. There is an argument 
however that the design of a trial should be governed by the research question, 
consequently an RCT may not always be the most appropriate methodology 
(Sackett and Wennberg, 1997). The decision to exclude studies that are not 




all the evidence within that field of research. Future reviews may wish to 
consider including other study designs, although this could impact on the ability 
to conduct meta-analysis. 
 
4.13 Summary  
Thus far this study has systematically reviewed the relevant literature and 
carried out both a risk of bias assessment and summary analysis of the findings 
from studies evaluating interventions defined as either priming or augmenting 
within a motor learning framework.  
Twenty five studies were included and underwent a risk of bias assessment. 
Only ten (40%) studies were at low risk for all categories in the risk of bias 
assessment suggesting the potential for bias within the majority of studies 
included in this review. 
 
Owing to the heterogeneity of outcome measures used within the included 
studies, summary analysis of only those studies using outcomes within the 
activity domain of the ICF was carried out. 
 
Sixteen studies were subsequently included in the quantitative analysis of this 
review. Meta-analysis of the lower limb interventions categorised as little/no 
movement found no evidence for an effect of the intervention on walking speed. 
Findings from one study showed a statistically significant effect using the Timed 
Up and Go. The effectiveness of upper limb interventions within the same 
category were also not supported by meta-analysis of the findings of the Action 
Research Arm test, nor single study findings for the Wolf Motor Function test. 
Single study findings from the Frenchay Arm test were however, statistically 
significant for this category. Meta-analysis of the augmenting lower limb studies 
found no statistically significant effect for any outcome but individual study 
results for augmenting upper limb studies found statistically significant results 
for the Box and Block test, the Action research Arm test and the Chedoke Arm 





Interpretation of this review can only be made within the context of the 
definitions of the motor learning principles and the framework that has been 
used. Future work evaluating the evidence for each of the motor learning 
principles may be more appropriate as a means of informing future practice. 
 
In order to address second and third aims of this study, the following chapter 
will describe the design, methodology and results of the phase II trial 
investigating the effects of functional strength training on walking and upper 




5.0 Functional Strength Training to improve upper limb 
function and walking in people between six months and five 
years after stroke: A phase II trial (Question 2) 
 
5.1 Introduction 
Chapter three summarised findings from Functional Strength Training (FST) 
studies to date. The evidence suggests that FST is a feasible intervention for 
both the affected upper and lower limb in people after stroke but that the 
findings from these trials can only be applied to stroke survivors within the first 
three months after stroke.  
Designs of future trials need to incorporate clear protocols for the study 
interventions to ensure that they are sufficiently different  and randomisation 
will need to consider the impact of stroke severity as a potential confounder to 
ensure that groups are evenly matched for this factor. The aim of this study 
was: 
 
 To carry out a phase II randomised controlled trial to determine feasibility 
of a physical therapy intervention – Functional Strength Training for 
improving upper limb function and walking in people between six months 
and five years after stroke.  
Objective 2: Establish feasibility of Functional Strength Training 
for improving upper limb function and walking in people between 
six months and five years after stroke by determining likely rates 
of recruitment. 
Objective 3: Establish feasibility of Functional Strength Training 
for improving upper limb function and walking in people between 
six months and five years after stroke by testing procedures for 
acceptability including the choice of outcome measures and the 
pragmatics of delivering the interventions. 






The following sections describe the design, methods, results and interpretation 
of a phase II observer blinded randomised controlled trial to address the 
following research question. 
 
Is Functional Strength Training a feasible intervention for improving upper and 
lower limb recovery later after stroke? 
5.2. Design  
Research in health care is intended to answer the question of what the future 
practice for patients should be (Sim and Wright, 2000). The drive to achieve 
evidence based practice defined as:  
“the conscientious, explicit and judicious use of current best evidence in 
making decisions about the care of individual patients” (Sackett et al., 
1996) (p. 71)  
implies the need to engage with research in order to facilitate evidence based 
practice.  
 
Quantitative methodologies assume a positivist approach towards the 
gathering of knowledge  where theories are developed through a process of 
inductive reasoning (Bird, 1999). A hypothesis is deduced from these theories 
and this is tested against pre-determined criteria. Analysis of the results 
subsequently enables the researcher to either accept or refute this theory (Sim 
and Wright, 2000). 
 
Guidance from the Medical Research Council (MRC) (Craig et al. 2008) 
describes four key elements to the development of an evaluation process, 
these are: Development, Feasibility, Evaluation and Implementation. 
Development is defined as: 
1. Identifying the evidence base 
2. Identifying developing theory 





Chapter two identified both the theoretical construct for the development of 
Functional Strength Training as an intervention for improving movement after 
stroke (a strength training intervention incorporating task specific practice) and 
the current evidence base for this intervention in people who are within 3 
months of stroke (Bale and Strand, 2008, Cooke et al., 2010b, Donaldson et 
al., 2009a). These studies have provided information on the process for 
conducting future studies and identified potential outcome measures for 
evaluating efficacy in people early after stroke. Physiological differences in the 
recovery processes between people in the early stages of recovery and those 
in the later stages of recovery from stroke are underpinned by different 
processes (Kleim and Jones, 2008). Thus the feasibility of FST, established by 
the earlier trials, cannot be transferred to stroke survivors in the later stage of 
recovery. The subsequent step in the evaluation process for Functional 
Strength Training in people later after stroke is therefore ‘Feasibility’, this refers 
to the testing of procedures for acceptability, determining likely rates of 
recruitment and suggesting sample sizes for evaluation trials, this is carried out 
through a phase II trial (Craig et al., 2008). In essence the purpose of a phase 
II trial is arguably to decide whether there is merit in continuing to a phase II 
trial of the same intervention (Stallard, 2012).  
 
The research design needs to be guided by the type of question that is being 
asked (Sackett and Wennberg, 1997, Sim and Wright, 2000). The research 
question suggests a relationship between FST and functional recovery of the 
upper and lower limb in people later after stroke. Thus the variables that need 
to be investigated are FST and functional recovery in the upper and lower limb.  
 
Experimental study designs such as controlled trials are a way of evaluating 
the effectiveness of an intervention in a given population. They allow the 
researcher the opportunity to investigate the effects of an intervention against 
a comparator (Altman, 1990). Without the presence of a control group it 
becomes more difficult to attribute any changes in the outcome measures to 
the intervention. The typical design of a trial investigating the feasibility of FST 
relative to functional recovery of the upper and lower limb should have three 




need to offer the same amount of therapy time so that any results would not be 
attributed to a dose response relationship and be sufficiently different to FST 
to avoid comparing ‘like for like’. A three group design such as this would have 
carried considerable resource implications for the researcher, as it would have 
meant the provision of therapy to all three groups; previous trials of FST have 
been able to include a control group which has been provided for from within 
‘usual provision’ and has therefore not had to be supplied by the research team 
(Cooke et al., 2010b, Donaldson et al., 2009a). The researcher was also 
concerned about the ability to recruit sufficient numbers of participants to such 
a three group design, a belief that was underpinned by current recruitment 
problems to other trials that were being conducted at the time. It was decided 
therefore to design this study with two intervention groups (FST – upper limb 
and FST- lower limb), both groups would be matched for dose or amount of 
therapy and each could act as control for the other (see figure 4 for trial flow 
chart).  
 
There is some experimental evidence to suggest that strengthening the upper 
limb may have an effect on the lower limb, an effect possibly mediated by the 
presence of neuronal coupling between the upper and lower limbs during tasks 
such as walking (Dietz, 2002, Zehr et al., 2007). This effect was evidenced by 
an increase in EMG activity when the arms were used to passively move the 
legs through a cycling action (Huang and Ferris, 2004). Despite this, there are 
also some circumstances where the cross training effect was not evident; for 
example no cross training effect was seen if the lower limbs remained 
stationery during the same upper limb cycling action (Balter and Zehr, 2007). 
In light of a lack of clarity around the potential for a cross training effect between 
the upper and lower limbs, and the presence of clinical research that found  that 
stroke survivors who received upper limb therapy showed statistically 
significant improvements in upper limb function without improvements in the 
lower limb and vice versa (Kwakkel et al., 1999), the two group design 
described above was considered feasible.   
 
The design of a clinical trial needs to account for potential sources of bias 




results (Sim, 2000). Selection bias may occur where trial designs do not include 
a robust method of randomisation; random allocation to the intervention groups 
ensures that all participants are given equal chance of receiving one or other 
intervention (Altman, 1990). Randomisation has also been shown to improve 
the accuracy of the treatment effect, for example, Schultz et al (1995) found 
that non-randomised studies overestimated a treatment effect by 41%. This 
feasibility study of FST in people later after stroke was therefore designed to 
include randomisation.  
 
Finally, study design can also account for ‘observer bias’, i.e. the bias that 
arises when either participants or relevant study personnel know the group 
allocation (Sim, 2000). To avoid this source of bias individuals are ‘blinded’ to 
group allocation; trials are said to be ‘double-blinded’ when both participants 
and study personnel responsible for outcome measurement are unaware of 
group allocation and single-blinded when only one of these two groups of 
people are unaware. In this present study it would not be possible to ‘blind’ the 
participants to group allocation as they will be aware of whether they are 
receiving either the upper or lower limb intervention; therefore this study 
included single blinding of the outcome assessor. 
 
In summary the design of this study was determined by the previous work 
investigating Functional Strength Training and where this information fits within 
the framework provided by the Medical Research Council (Craig et al., 2008). 
It was also informed by the need to ensure a robust design which will avoid, 
where possible, sources of bias that may influence the treatment effect (Sim, 
2000). Therefore in order to determine the feasibility of Functional Strength 
Training for improving walking and upper limb function in people later after 
stroke this study was designed as a phase II observer blind randomised 
controlled trial with two intervention groups (FSTUL and FSTLL), each acting 



































Figure 6: Trial flow chart  
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The following section will discuss the process involved in undertaking this study 
in the following order: participant inclusion/exclusion criteria, sample size, 




All participants in this trial were: 
a) Adults aged 18+ years, six months to five years after a stroke.  
This study aimed to evaluate the feasibility of FST in adults within the 
‘chronic’ period of recovery after stroke, thus our inclusion criteria reflected 
this by including only those people who were between six months and five 
years after stroke.  
b) Diagnosed with either an infarct or haemorrhagic stroke in the territory 
of the anterior circulation. 
People who have been diagnosed with a stroke are a heterogeneous 
population and present with differing impairments (Bamford and 
Sandercock, 1991). To reduce the heterogeneity and thus the complexity 
previous trials have tried to define their population more specifically. One 
example of this is by using only participants who have been diagnosed with 
a stroke affecting the middle cerebral artery (Kwakkel et al., 1999). Findings 
from this study would therefore suggest an effect of the intervention for this 
group of stroke survivors only. Studies designed in this way have greater 
specificity but less generalisability. In everyday practice it is unlikely that a 
therapist will only manage a caseload of stroke survivors with a middle 
cerebral artery infarct. Thus there is a need to evaluate interventions as they 
would apply to ‘everyday practice’ (Haynes, 1999). This study aimed to be 
as inclusive as possible by including all stroke survivors with movement 
impairments that would respond to a strengthening programme. The 
anterior circulation supplies the motor cortex and a blockage or bleed in this 
area is likely to lead to these impairments. Conversely, the posterior 
circulation supplies the cerebellum, infarcts affecting this region lead to 
impairments such as ataxia (Cohen, 1999). There is no clinical evidence to 




and therefore it would not be appropriate to include them in this study 
(Cooke et al., 2010b, Donaldson et al., 2009a). Information pertaining to the 
site of the stroke was obtained during the recruitment process, when names 
and addresses of potential participants were obtained via the stroke 
database. As the study progressed recruitment methods were refined to 
include referrals from therapists, who were asked to suggest potential 
participants based on clinical signs and symptoms usually experienced 
following a stroke affecting the anterior circulation. Recruitment via this 
method meant that the research team did not have access to the medical 
records until informed consent was obtained, therefore participants were 
included if they presented with a hemiplegia but were not included if they 
had ataxia or other impairments associated with a posterior bleed.   
c) able to walk four steps with the continuous support from one person 
and/or assistive devices, but unable to step on and off a step 7.5cm high 
greater than fourteen times in fifteen seconds with either their affected 
or unaffected leg (the step test) (Hill et al., 1996). 
d) have sufficient voluntary activity in the paretic upper limb to move the 
paretic hand from a position on their lap to the table top in front of them, 
but unable to pick up four £1 coins individually from a table top and stack 
them evenly in a pile. 
Participants were randomised to receive either FST upper limb or FST lower 
limb. They needed to be able to have sufficient activity in their affected side 
to enable them to take part in repetitive, progressive functional practice, but 
not have made so much recovery that they would be unlikely to benefit from 
the intervention. The initial screening criteria, with respect to lower limb 
function, had included exclusion from the study on the basis of being able 
to walk up and down stairs one foot after the other. In practice this was 
difficult to assess because so few people had stairs, the study by Hill et al. 
(1996) found that the step test could distinguish between people who were 
independent walkers and those who could walk independently but still had 
substantial impairments as a result of stroke.  
Precedent for these inclusion criteria were determined by the previous 
studies of FST (Cooke et al., 2010b, Donaldson et al., 2009a). These 




with these clinical presentations. By limiting the inclusion of participants to 
those with specific clinical features it may be possible to gain some 
understanding of the effects of FST for the different severities of stroke 
symptoms as classified by the Action Research Arm Test and Functional 
Ambulation Categories. The inclusion of participants with a broader 
spectrum of symptoms in this relatively small study would lead to fewer 
numbers of participants within each category and therefore less potential 
for suggesting a causal relationship linked to severity. A finding which may 
prove useful for the design of future studies. 
 
e) Able to give informed consent and able to follow a 1-stage command 
with the non-paretic upper limb i.e. sufficient communication/orientation 
for the interventions in this trial.  
In order for participants to be able to fully participate in the exercise 
programme it is necessary for them to be able to follow commands. This 
inclusion criteria enables this study to be as inclusive as possible but 
exclusive of those who may not be able to gain any potential benefit of the 
intervention.  In order to include as many people with stroke who had 
communication difficulties the design of both Participant Information Sheets 
and consent forms were informed by the Department of Health (2009), 
Connect guidelines (Swinburn and Firenza, 2007) and liaison with a Speech 
and Language Therapist with expertise in working with people with aphasia. 
Specifically the study used the following strategies (Dalemans et al., 2009): 
 Key concepts were written in ‘bold’ text  
 Pictures were used to support the text  
 One to one information giving was achieved through a home visit 
 Carers were involved during the initial information giving event when 
the potential participant was happy for this to happen. 
In addition participants were not: 
f) diagnosed with a known pathology which excluded participation in the 
low intensity exercise training involved in functional strength training.    
g) receiving any physical therapy for their upper or lower limb. It was 




attributable to the intervention and not to any confounding factors such 
as different therapy that they may be receiving. 
 
5.3.2 Sample Size 
One purpose of a phase II trial is to determine sample sizes for future studies 
therefore the calculation of a sample size for the present study seems counter-
intuitive.  Despite this, it does not seem ethical to direct valuable resources to 
continue evaluation of an intervention where no effects of such have been 
detected (Stallard, 2012). Whilst the purpose of a phase II trial is to determine 
feasibility and it should be possible to obtain funding for a phase III trial based 
on its findings, funding bodies may be less likely to support the development of 
an intervention into phase III when there has been no evidence of efficacy at 
phase II. In order to provide some preliminary data regarding efficacy of the 
intervention a sample size calculation is required (Altman, 1990). Consensus 
over the methods for calculating sample sizes for phase II trials have not 
achieved and in the present study a formal power calculation was not possible 
because there was insufficient data of the effects of the intervention (Craig et 
al., 2008). It was estimated though that 26 participants per group would have 
90% power at 5% significance (2-tailed) to detect a change of 1 point on the 
Functional Ambulatory Category (FAC) (Holden et al., 1984) assuming a 
standard deviation (SD) of 1 and 5.7 points on the Action Research Arm Test 
(ARAT) (Yozbatiran et al., 2008) (minimal clinically important difference (van 
der Lee et al., 2001b)) assuming a SD of 5.7. A pragmatic decision was taken 
in respect of the minimal clinically important difference for the FAC, as this data 
is not available. The FAC is a 5 point scale which clearly defines advancing 
levels of functional gain and a change in 1 point on the scale indicates a 
clinically significant change in functional ability.  
 
To allow for an attrition rate of 10% (estimated from earlier trials) (Cooke et al., 







Approximately 800 people are discharged from the local acute hospital every 
year with a diagnosis of stroke. At the planning stage we anticipated recruiting 
two people per month. This figure was based on recruitment to previous FST 
trials (Cooke et al., 2010b, Donaldson et al., 2009a).  
 
A record of admissions following stroke, subsequent discharges and clinical 
information is maintained on a database at the NHS Trust in which the stroke 
unit is located. Potential participants were initially identified using this database. 
Anonymised data was sorted by the researcher in an attempt to target discrete 
geographical areas. The aim was to minimise travel expenses to and from 
participants’ homes. Once sorted the data was sent to the Stroke Research 
team at the acute hospital. As members of the clinical team they were able to 
interrogate the Patient Administration System (PAS) and ensure that those 
patients who had died were excluded from the recruitment strategy. 
Interpretation of the Data Protection Act (1998) stipulates that only members of 
the clinical team can access clinical data until the participant gives informed 
consent for this to be done by the research team. Once identified each potential 
participant was sent a recruitment letter (appendix VI) with an expression of 
interest form attached (appendix VII).  
 
If a potential participant was interested in taking part in the study they were 
asked to send the expression of interest form back, in the supplied stamped 
addressed envelope or to telephone the researcher directly. 
 
On receipt of an expression of interest from the potential participant the 
researcher contacted the participant by telephone and determined whether the 
individual would meet the inclusion criteria for mobility and arm movement. If 
this was likely then the researcher arranged a home visit. 
  
After four months it became apparent that the study was not meeting the 
intended recruitment rate. Two people had been recruited whilst the predicted 
target was eight; consequently, it became necessary to include additional 




recruitment factor in the ‘AMBULATE’ trial (Lloyd et al., 2010). This study was 
based in Australia but had a number of features in common with the current 
study: the study aimed to evaluate a physical therapy intervention and recruited 
from the same population of stroke survivors as the current study (stroke 
survivors between six months and five years after stroke and community-
dwelling). The decision was taken therefore to recruit via referrals from both the 
Stroke Early Supported Discharge team and from therapists employed 
providing healthcare services for stroke survivors. Other measures to improve 
the recruitment rate included securing funding from the Comprehensive Local 
Research Network for increased administration support in order to increase the 
number of invitation letters that were sent out. In an alternative exercise based 
trial where letters had also been the source of recruitment, 552 letters had to 
be sent to recruit 49 participants (Werner and Kessler, 1996) therefore it was 
anticipated that an increase in the number of letters sent would lead to better 
recruitment. 
 
Once participants had been identified the Research Therapist (RT) visited them 
at home to discuss the practicalities of taking part in the study, to ensure that 
they fulfilled the study inclusion criteria and to go through the Participant 
Information Sheet (PIS) (see appendix VIII). After a period of seven days, in 
which the potential participant was asked to reflect on the information provided, 
the RT telephoned the individual at home and established whether they were 
still interested in taking part in the study. If they were, then an appointment was 
made for the ‘blinded’ assessor to visit. At this visit the blinded assessor took 
informed consent and witnessed the signature of the participant on the consent 
form (see appendix IX). Once written informed consent had been obtained the 
participant completed the baseline outcome measures.  
 
As soon as confirmation of informed consent was obtained by the RT, a letter 
was sent to the participant’s GP to inform them of their patient’s wish to take 
part in the study. This was necessary to ensure that the participant was 





A summary of the study was attached to the GP letter so that they could make 
an informed decision about the medical suitability of their patient (see 
appendices X and XI). No reply within ten working days of the date of sending 
the letter implied medical suitability for the study. If there was no response from 
the GP the RT contacted the participant again in order to identify a start date 
for the study. If there was a response indicating medical unsuitability then the 
participant was informed and removed from the study at this time.  
Following completion of the baseline measures participants were able to be 
randomised to either FSTUL or FSTLL. 
 
5.3.4 Randomisation procedure 
As soon as baseline measures had been completed random group allocation 
to either FSTUL or FSTLL was determined by a telephone call to an 
independent automated system within the Norwich Clinical Trials Unit. The risk 
of selection bias could only be minimised if there was a robust method of group 
allocation (Altman, 1990). The use of an independent computer based system 
for generating the randomisation sequence ensures very little opportunities for 
biased allocation to either intervention group  and is therefore likely to avoid 
this risk of bias (Higgins and Green, 2011).  
 
The process of randomisation aims to ensure that the composition of the 
groups are comparable (Sim and Wright, 2000). In clinical trials with large 
sample sizes the influence of confounding variables is likely to be avoided by 
randomisation. Smaller studies, however, may need to use alternative methods 
in order to ensure that the groups are comparable. One method for ensuring 
comparability across groups is stratification; however this may not be 
appropriate where there are a number of factors that need to be taken into 
consideration (Pocock and Simon, 1975).  A previous study has identified 
severity of stroke to be a potential confounder in future trials of FST and 
recommended categorising severity of upper limb impairment into three groups 
according to the score achieved on the Action Research Arm Test (ARAT) 
(Donaldson et al., 2009a). This current study includes both an intervention for 




in both the arm and the leg. Modelling a measure of severity on that 
recommended by Donaldson et al (2009), lower limb severity could be 
categorised into three groups using the score obtained from the baseline 
measurement of the Functional Ambulation Categories (FAC). The following 
table demonstrates the combinations of severity that will therefore have to be 
taken into account within the randomisation process; UL and LL refer to upper 







UL mild/LL mild UL moderate/LL mild UL severe/LL mild 
UL mild/LL moderate UL moderate/ LL 
moderate 
UL severe/LL moderate 
UL mild/LL severe UL moderate/LL severe UL severe/LL severe 
 
Table 24: Combinations of severity that may occur 
An alternative method to stratification which is able to manage the allocation of 
groups according to multiple factors is minimisation (Altman, 1990, Scott et al., 
2002). Minimisation has been described as a “largely nonrandom” process 
(Scott et al., 2002 p. 663) which is based on an allocation sequence which may 
be predicted. This has the potential to create observer bias (Scott et al., 2002), 
however the number of variables available suggests that it would be unlikely 
for group allocation to be ‘worked out’.  
 
Minimisation of the baseline imbalance between treatment groups in this study 
was based on the Pocock and Simon’s range method (Pocock and Simon, 
1975). Severity of stroke was categorised using each participant’s baseline 
scores for the FAC and the ARAT.  The FAC is categorised as: mild, score 4+ 
(able to walk independently on level ground but needs help on stairs, slopes 
etc); moderate, score 3 (needs verbal supervision/stand-by help from one 
person); severe, score 2 of less (needs continuous/intermittent support of one 
person).  The ARAT is categorised as: mild, score 39-57 (57 = able to complete 
all items normally); moderate, score 20-38 (38 = able to complete all items 
albeit slowly/abnormally); severe, score 0-19 (19 = able to complete all items 
partially). 
 
5.3.5 Outcome measures 
Outcome measures need to be able to evaluate all possible changes that may 
occur as a result of an intervention (MRC framework, 2008). The choice of 
outcome measures for this trial was informed by a number of factors. This 
section will highlight these and then discuss how they have influenced the 





1. Evaluation which will show change relevant to the participant; the 
Cumberland Consensus Group (2009) identified a need to find therapies 
that show significant benefit to patients and carers. Without this, it is 
unlikely that clinical practice will change. The World Health Organisation 
devised the International Classification of Functioning, Disability and 
Health (ICF) (World Health Organisation, 2001). The ICF is a framework 
which enables the researcher to identify outcomes within the context of 
body functions or structure, activity and participation (see table 24). 
 
ICF Domain Definition 
Body 
function/structure 
Physiological functions of body systems and 
anatomical parts of the body. Impairments are 
problems in body function or structure. 
Activity The execution of a task or action by an 
individual. Activity limitations are difficulties an 
individual may have in executing activities. 
Participation Involvement in a life situation. Participation 
restrictions are problems an individual may 
experience in life situations. 
 
Table 25: Table to show definitions of each of the ICF domains 
 (http://www.who.int/classifications/icf/training/icfbeginnersguide.pdf accessed 
3.9.2012) 
The aim of the framework is to provide a view of health and disability which is 
not only from a ‘medical’ or ‘biological’ perspective. Using the framework it is 
possible to ‘map’ potential outcome measures to each of the domains (Salter 
et al, 2011 www.ebscr.com accessed 2012). Outcome measures that fall within 
the activity and participation domains are likely to be those that are most 
meaningful to a patient or carer. 
 
2. The choice of outcome measures needs to be informed by the intended goal 
of the study (Craig et al., 2008, Cumberland Consensus Working et al., 2009, 
Fitzpatrick et al., 1998). A range of measures may be appropriate in order to 
identify unintended consequences where possible and evaluate the breadth of 
potential outcomes (Craig, Dieppe et al. 2008). This study aims to determine 




in people at least six months after stroke.  The outcome measures therefore 
need to measure functional tasks that are likely to be improved by FST in both 
the upper and lower limb. This can be informed by the previous trials that have 
been carried out using FST. Consistency of outcome measures across 
rehabilitation trials is likely to facilitate future meta-analysis and synthesis of 
findings. 
 
This study aims to include participants who may have made little recovery, for 
example only able to walk a few steps with one person and a walking aid, to 
those who have made a relatively good recovery, able to walk outdoors 
independently with an aid. Attention needs to be paid to the floor and ceiling 
effects of potential outcome measures to ensure that clinically important 
functional gains in both these participant groups can be captured. 
 
3. Outcome measures need to be reliable, valid and responsive. Reliability 
refers to the ability of the measure to produce results that are consistent and 
that are able to differentiate between participants. This is most frequently 
measured by determining the internal consistency of the measure, the test-
retest reliability and the inter-rater reliability (Finch et al., 2002). An outcome 
measure that is judged to be valid is one that measures what it is supposed to 
measure; this has been determined by measuring face validity, content validity, 
construct validity and criterion validity (Finch et al., 2002). Finally 
responsiveness refers to the ability of an outcome measure to determine a 
‘clinically important difference’ (Finch et al., 2002).  
 
4. Outcome measures need to be suitable for the environment of the trial. This 
study was carried out in the community, generally within people’s own homes, 
therefore the outcome measures used need to be valid and able to be applied 
practically in this setting. Equipment to carry out the measures needs to be 
portable and simple to set up. Time to complete all the measures also needs 
to be considered, it would not be appropriate for a participant to become 






The following section will discuss each of the outcome measures used in this 
study in relation to these four factors. Factors one, two and four will be 
discussed under the heading of ‘suitability and ICF category’ and factor three 
will be discussed under the heading of ‘psychometric properties’. 
 
5.3.5.2 Primary Outcome Measures 
Action Research Arm test  
 Suitability of measure and ICF category 
The Action Research Arm Test (ARAT) is an observer rated scale for assessing 
both proximal and distal function of the upper limb. Precedent for its use within 
trials of FST has been set by Donaldson et al. (2009) and it has been found to 
be responsive to change in people diagnosed with chronic stroke (Van der Lee 
et al., 2001a). The ARAT was first described by Lyle (1981); it is divided into 
nineteen items of motor function of the upper limb, these are divided into four 
subscales evaluating grasp, grip, pinch and gross movement. Each test is given 
a score of 0 to 3, three being the highest score in each test, the total score for 
the ARAT is 57.  
 
The ARAT falls within the ‘activity’ domain of the ICF because it measures 
ability to carry out functional activities or tasks.  
 
The ARAT has been found to have a ‘floor’ effect in people in the acute phase 
after stroke (Hsueh and Hsieh, 2002a), although this finding was not 
substantiated by Nijland et al. (2010). Hsueh and Hsieh (2002) found that 51% 
of participants scored 0 whereas Nijland et al (2010) found that only 12.5% of 
participants scored below 2.85 (5% of the total score). Both trials were of similar 
size (n =48 (Hsueh and Hsieh, 2002b) and n = 40 (Nijland et al., 2010)). Nijland 
et al. (2010) did not report length of time from stroke in their study although 
participants were taken from rehabilitation centres. This may indicate that 
participants were in the sub-acute period after stroke suggesting that the floor 
effects demonstrated by the ARAT are less applicable at this time. This may be 
due to the fact that people have recovered sufficient movement to obtain a 
score. Investigation of this effect in people in the chronic phase after stroke has 





Pragmatically the ARAT can be used in the community setting and time taken 
to complete the test will vary depending on how much each participant can do. 
The test is based on a hierarchy; therefore those participants who are more 
able may take up to twenty minutes to complete the test (van der Lee et al., 
2001b). This would seem to be acceptable as it is those participants who are 
less able who are more likely to fatigue. 
 
 Psychometric properties 
Internal consistency i.e. the measurement of homogeneity of the items was 
established by Nijland et al. (2010). Measurement was carried out using 
Cronbach’s Coefficient Alpha, this was found to be excellent (α = 0.98). A 
coefficient this high might however suggest that whilst the measure has strong 
internal consistency there are some items within the scale that are redundant 
(Fitzpatrick et al., 1998). Test-retest reliability (Hsueh and Hsieh, 2002b) and 
inter-rater reliability (Yozbatiran et al., 2008) have been found to be excellent 
(ICC = 0.99). A standardised approach was established for completion of the 
ARAT by Yozbatiran et a.l (2008). 
 
Criterion validity of a measure can only be established if there is a ‘gold 
standard’ against which to measure it (Finch et al., 2002). To date this is not 
available for the ARAT, thus the alternative is to determine construct validity. 
This can be established by comparing the ARAT to alternative measures of 
upper limb function – convergent validity (Finch et al., 2002). Convergent 
validity was established in participants within the chronic phase of stroke. 
Excellent correlation was found between the ARAT and the arm section of the 
Fugl-Meyer (r = 0.94) (Yozbatiran et al., 2008). 
 
A minimally clinically important difference of 5.7 has been established for the 
ARAT (van der Lee et al., 2001b). A difference of 5.7 between baseline and 
outcome scores of the ARAT would therefore indicate a clinically important 





Functional Ambulation Categories  
 Suitability of measure and ICF category 
Regaining the ability to walk is very important to people diagnosed with stroke, 
and their carers’ (Bohannon et al., 1988). Consequently one of the aims for 
FST for the lower limb is to improve walking ability in people after stroke. 
Improvements in aspects of walking ability have already been suggested for 
FST in participants within the acute period after stroke (Bale and Strand, 2008, 
Cooke et al., 2010b). It follows then that one of the primary outcome measures 
for this trial needs to be a measure of walking ability. The Functional 
Ambulation Categories (FAC) (Holden et al., 1984) provide a measure of 
walking ability relative to the amount of assistance an individual requires. The 
categories of walking are numbered from zero to five and are hierarchical, with 
zero being a “non functional ambulator” to five being “a patient who can walk 
everywhere independently, including stairs” (Holden et al., 1984). The FAC are 
easy to administer in that they simply require observation of an individual’s 
ability to walk and assessment is consequently not restricted by the 
environment. The FAC lies within the activity domain of the ICF.  
 
Alternative lower limb outcome measures specific to walking in the previous 
trials of FST have focussed on walking speed (Bale and Strand, 2008, Cooke 
et al., 2010b). This is arguably less meaningful to a stroke survivor who is more 
likely to see the relevance of a scale which gives an indication of the level of 
assistance that they will require with their walking. Some walking speed 
measures are also dependent on a relatively large distance over which to 
complete the measure. The Six Minute Walk Test (6MWT) (Butland, Pang et 
al. 1982) requires a distance of thirty metres which is unlikely to be achievable 
in the community setting. The FAC is a common measure within rehabilitation 
trials for example the LEAPS trial which aims to evaluate so called ‘locomotor 
training’ and its effect on mobility post stroke (Duncan et al., 2007). Use of the 
measure in the current trial will continue to facilitate future synthesis and meta-
analyses. 
Floor and ceiling effects have not formally been reported for the FAC, although 




individuals who were able to walk in their homes to those able to ambulate in 
the community. There may be a ceiling effect for those individuals who are able 
walkers.  
 
The FAC is estimated to take between one and five minutes to complete 
(Marvin, 2011) indicating little burden to the research participant. 
 
 Psychometric properties 
No studies have reported on the internal consistency of the FAC. Test retest 
reliability and inter-rater reliability were tested by Merholz et al. (2007), both 
were found to be excellent (k = 0.950 and k = 0.905 respectively). No studies 
have reported on criterion or concurrent validity.  
 
Concurrent validity of the FAC has been established with alternative measures 
of walking ability. Merholz et al (2007) found that the FAC correlates 
significantly with walking velocity and the 6MWT (p=0.953, P<0.01 and p=0.949, 
P<0.01 respectively). 
 
Responsiveness to change was moderate to large as measured by the 
standard response time over a period of six months (Mehrholz et al., 2007). 
There are no studies to date identifying a minimally clinically important 
difference, although the hierarchical structure of the FAC suggests that an 
increase or decrease of one will have an impact on an individual’s need for 
assistance when walking. 
 
5.3.5.3 Secondary Outcome Measures 
Nine Hole Peg Test (NHPT)  
 Suitability and ICF category 
The NHPT is a measure of dexterity; the test involves removing nine pegs from 
a board and placing them in a box and then replacing them on the board as 
quickly as possible (Kellor et al., 1971). Normative data for adults completing 
the NHPT were established by Mathiowetz et al. (1985). It is recommended 
that the NHPT is completed with other measures of upper limb function in order 




the ARAT does include tasks for measuring dexterity, the addition of the NHPT 
will ensure that those participants with greater functional recovery are 
represented explicitly in the measurement battery. The NHPT lies within the 
‘activity’ domain of the ICF. 
 
The NHPT requires little equipment and is easily transported. Time taken to 
complete the test will vary depending on each participant’s functional ability. 
Normative values for healthy male adults indicate that one test will take 
approximately nineteen seconds (Mathiowetz et al., 1985) suggesting that the 
test is not likely to be too onerous for participants in this study. 
 
 Psychometric properties 
Intra-rater reliability has been established by Mathiowetz et al. (1985) who 
found excellent agreement (r = 0.69) for the right hand and adequate 
agreement for the left hand (r = 0.44) using a Pearson correlation in healthy 
individuals. Reliability values for this study were based on a wooden board for 
the holes and a wooden square with wooden pegs. This equipment has been 
reproduced for the current trial to avoid any confounding data arising from the 
use of different equipment. The same study established inter-rater reliability 
which showed excellent agreement for both right and left hand (r=0.97 and 
r=0.99 respectively) (Mathiowetz et al., 1985). 
 
Test-retest reliability was established in a population of individuals diagnosed 
with stroke (n = 62) (Chen et al., 2009). Using an Intra-class correlation (ICC), 
this study found ‘good’ agreement between the test-retest results. The ICC was 
similar for both the more affected and less affected arm (0.85 (CI: 0.71-0.92) 
and 0.89 (CI: 0.82-0.94) respectively).  
 
Criterion validity is not available; however concurrent validity was established 
for the NHPT correlated to the Box and Block test (BBT) and the ARAT. Using 
Spearman rank correlation coefficient, concurrent validity of the NHPT 
correlated with the BBT was good (p = -0.8, P<0.01) and moderate when 





A minimal clinically important difference has not been established for the NHPT, 
however Chen et al. (2009) calculated the ‘smallest real difference’ (SRD) or 
‘minimal detectable change’. This figure is the smallest change a participant 
can make that can be attributed to the intervention (Finch et al., 2002). Chen 
et al. (2009) identified an SRD of 32.8 seconds for the NHPT using the more 
affected arm; however this was only 6.2 seconds for the less affected arm. This 
discrepancy may have been caused by the smaller sample size in the more 
affected group. Only 44 participants were able to carry out the NHPT with their 
more affected arm compared to 62 using their less affected arm. The presence 
of spasticity may also have impacted on the high SRD; when the results of the 
more affected group were classified according to spasticity or no spasticity the 
SRDs were 67.5 seconds and 24.5 seconds respectively (Chen et al., 2009). 
Chen et al. (2009) re-emphasised the need to use the NHPT as part of a battery 
of upper limb measures. 
 
 Timed Up and Go 
 Suitability and ICF category 
The TUG (Podsiadlo and Richardson, 1991) is a timed measure of walking and 
balance. The participant is seated in a chair and on the ‘go’ signal is asked to 
get up, walk three metres, turn around and return to a seated position on the 
chair. The TUG falls within the activity domain of the ICF. The FAC may have 
a ceiling effect and therefore may not be sufficiently sensitive to identify those 
individuals who have made good functional recovery with respect to walking. 
Conversely the TUG may have a large floor effect; Rockwood et al. (2000) 
found that 29.3% of participants were unable to complete the TUG. Therefore 
the use of both the FAC and the TUG should ensure that participants across 
all spectrums of functional recovery will be reflected in the outcome measures 
chosen for walking.  
 
The TUG requires little equipment and a distance of three metres over which 
to walk is feasible within a community setting. The use of the TUG has been 
established in other strength training trials, most recently Hill et al (2012), 




Time taken to complete the test is approximately one to two minutes and 
therefore is not expected to be onerous to the participant (Zeltzer and Zaino, 
2008). 
 
 Psychometric properties 
Test-retest reliability was established by Flansbjer et al. (2005) and Ng and 
Hui-Chan (2005) in individuals diagnosed with chronic stroke. Both studies 
found excellent agreement between the two values (ICC: 0.96 and 0.95 
respectively). Inter-rater and intra-rater reliability for the TUG has been 
established as excellent (ICC of 0.99) (Podsiadlo and Richardson, 1991). 
People included within this study were diagnosed with a variety of impairments 
including stroke, however this was not found to correlate with the TUG score.  
 
Criterion validity has not been established but concurrent validity of the TUG 
was established against other gait parameters including the six minute walk 
test (p = -0.960, P<0.01) (Ng and Hui-Chan, 2005) and ICC of -0.92 (Flansbjer 
et al., 2005). 
 
As for the NHPT, a minimally clinically important change has not been 
suggested for the TUG; however the SRD has been identified as 23% 
(Flansbjer et al., 2005) indicating that the TUG can detect small changes in 
participant performance. 
 
Modified Rivermead Mobility Index  
 Suitability and ICF category 
The two previous outcome measures relate specifically to the activity of walking, 
it is likely FST will have an effect on other functional activities involving the 
lower limb. The MRMI is developed from the Rivermead Mobility Index (RMI) 
(Forlander and Bohannon, 1999) and measures a range of mobility related 
activities such as rolling over in bed and sitting to standing. The MRMI extends 
the scoring system of the RMI in order to provide a better description of the 
difficulties experienced by individuals diagnosed with stroke (Lennon and 




when tested on individuals up to 180 days after stroke (Hsueh and Hsieh, 
2002a). Coincidentally the original version of the RMI showed significant floor 
effects (Hsueh and Hsieh, 2002a) indicating that the changes to the scoring 
system pioneered by Lennon and Johnson (2000) made the test more sensitive 
for people with significant motor impairment after stroke.  
 
Internal consistency for the MRMI was calculated using Cronbach’s alpha, 
which was found to be high (α = 0.949), the reader is referred back to comments 
made in the ARAT section concerning scores that are found to be this high. 
 
The MRMI requires no special equipment and was reported to take three to five 
minutes to complete (Figueiraedo, 2008).  
 
 Psychometric Properties 
Test-retest reliability of the MRMI was carried out using a paired t-test, Lennon 
and Johnson (2000) found no significant difference between the two values (t 
= 0.732; p = 0.47). Inter-rater reliability was found to be excellent in studies by 
both Lennon and Johnson (2000), (ICC: 0.98, P<0.001) and Hsueh and Hsieh 
(2003), (ICC 0.95 (95% CI 0.90 – 0.97)). Intra-rater data for this measure does 
not appear to be available. 
 
Concurrent validity was established for the MRMI against the mobility subscale 
of the Stroke Rehabilitation Assessment of Movement measure (STREAM) 
(Daley et al., 1997) and the Motor Assessment Scale (MAS) (Carr et al., 1985). 
Scoring on items differed by a mean of 7% (SD 4.8%), which equated to a 
difference of three points on the MRMI; this was felt to be acceptable (Lennon 
and Johnson, 2000). The MAS is a well-known measure of motor function after 
stroke, however items on the scale are not restricted to mobility items but 
include ‘upper arm function’, ‘hand movements’ and ‘advanced hand activities’ 
(Lennon and Johnson, 2000). The MRMI appears to have been used more 
frequently in rehabilitation trials than the STREAM, which would suggest that 
for the purposes of future comparisons between trials, the MRMI remains the 





A minimally clinically important change has not been established for the MRMI. 
The standardised response mean was found to be moderate for assessing 
change before ninety days after stroke, however was low for those participants 
within the 90-180 day period after stroke (Hsueh and Hsieh, 2002a). To date 
the responsiveness of the MRMI in participants diagnosed with chronic stroke 
has not been carried out therefore it would be inappropriate to exclude its use 
for the current trial on this basis. 
 
5.3.6 Adverse Reactions 
According to Good Clinical Practice guidelines an adverse reaction is defined 
as: 
“All untoward and unintended responses to an investigational 
medicinal product related to any dose administered” 
(http://www.crncc.nihr.ac.uk/workforce_development/learning_and_de
velopment/gcp/gcp_resource/gcp_glossary accessed 8.2.13) 
 
 Reporting of adverse reactions is specifically defined for CTIMP (Clinical Trial 
Involving Medicinal Products) trials. The present study would be classified as 
a non CTIMP, however Good Clinical Practice guidelines with respect to the 
reporting of adverse reactions remain the same, because the reporting of 
adverse reactions is essential for maintaining patient safety (MHRA, 2013). 
Previous studies of FST revealed no adverse reactions from either the upper 
or lower limb interventions (Cooke et al., 2010b, Donaldson et al., 2009a). 
However, it is possible, that as this study is recruiting from people later after 
stroke, the increased activity that is associated with this intervention may have 
an impact which did not occur in people early after stroke.  
Participants who were within the chronic period of recovery from stroke, by 
virtue of their physical impairments, may not have engaged in exercise for 
some time.  This study aimed to deliver FST to people four times a week for up 
to sixty minutes each time, this may be a considerable increase in the amount 
of exercise that some participants had engaged in. It is possible therefore that 
some participants may experience joint pain or muscle soreness. Pain or 




physiological damage, however pain that persists may be an indication that 
damage has occurred. Adverse reactions for this study were therefore defined 
as the reporting or exhibiting of pain over four consecutive days. If such pain 
occurred then the participant was withdrawn from their allocated treatment but 
included in the measurement battery according to the intention to treat principle, 
which will be discussed later.  
 
5.3.7 Procedure for delivering interventions 
The first visit with each of the participants identified the specific activities that 
they felt were difficult as a result of their stroke. The Research Therapist (RT) 
identified which muscle groups appeared to be most affected and established 
therapy goals with the participant. Involving the participant in the goal-setting 
process aims to ensure that the intervention has relevancy for the participant 
which may improve motivation (Sugavanam et al., 2012). The intervention was 
targeted to the specific impairments and level of recovery experienced by each 
participant.  
 
Participants undertook a six week programme, four days a week for up to sixty 
minutes a day of either FST for the upper limb (FSTUL) or FST for the lower 
limb (FSTLL).  
 
In the absence of definitive data from robust rehabilitation trials of people within 
the chronic phase after stroke, intensity or dose of the intervention in the current 
study was informed by previous trials of FST (Cooke et al., 2010b, Donaldson 
et al., 2009a). 
 
It was anticipated that participants could become fatigued during the 
intervention; this presented itself as an increasing difficulty in performing the 
activities and reported feelings of tiredness. When this happened the therapist 
initially offered motivational encouragement and then changed tasks so the 
focus of the activity was biased toward a different muscle group. Finally the 
participant was offered a rest period until either one hour of therapy had been 




with the rest of the session for that day. Field diaries were completed recording 
the time spent in either intervention activity or rest within the sixty minute period. 
 
Standardised treatment schedules were used (as developed for and used in 
the earlier trials of FST) (see appendices XII and XIII) to record the content of 
the FST intervention (Cooke et al., 2010b, Donaldson et al., 2009b, Donaldson 
et al., 2009a, Pomeroy et al., 2005).   
 
As this trial intervention was carried out by different therapists over the time 
that it ran, adherence to the intervention was monitored by the RT. Training for 
each new therapist who participated in the study took place before they 
commenced any interventions. During the study, the RT monitored how and 
what therapy was recorded in both the field notes and the treatment schedules. 








 Functional strength training for the lower limb (FSTLL) 
FST for the Lower Limb (FSTLL) focused on functional activities involving the 
lower limbs, whole or component parts of the movement were practiced.  
 
Activities included: 
 Getting on and off the floor 
 Sitting to standing 
 Stepping on and off a block 
 Going up and down stairs 
 Dynamic balance exercises such as standing on one leg 
 
Progression was informed by the Oxford programme (Zinovieff, 1951, Trew and 
Everett, 2005) (see table below). This provided a framework for advancing the 
strengthening programme. Ten repetition maximum (10RM) refers to the load 
an individual can lift ten times before the muscle starts to fatigue (this is usually 
indicated when the muscle starts to ‘quiver’) (Hollis, 1989). This was 
ascertained by the therapist who was delivering the intervention. In practice as 
the objects used to create loading were often functional items such as bottles, 
or functional tasks such as sit to stand, the therapist judged when the 
participant was easily able to achieve ten repetitions (10 REPS) and would then 
increase the load or the difficulty of the task so that the strengthening 
programme was progressed. 
Oxford Programme (Trew and Everett, 2005: pp. 119) 
10 REPS at 10RM 
OR 
10 REPS at 10RM 
Then reduced by 
5kg for 10sets 
10REPS at ¾ 10RM 
10 REPS at ½ 10RM 
REPS – Repetition 
RM – Repetition Maximum 
 
Table 26: The Oxford Programme for muscle strengthening 
Increased resistance was given through the use of ankle weights and 
resistance bands or increasing the task difficulty e.g. increasing the height of 





In order to illustrate how one participant would have progressed through a 
programme of FST, field notes kept over a period of one week for a participant 






 Functional strength training for the upper limb (FSTUL) 
FSTUL is based on the key elements of normal upper limb function, i.e. moving 
the hand into a position and then using it to manipulate objects.  The focus is 
on: improving the power of shoulder/elbow muscles to enable appropriate 
placing of the hand; improving the production of appropriate force in arm and 
hand muscles to achieve the specific grasp; and specific interventions for the 
wrist and finger muscles to maximise ability to manipulate objects.  Whole or 
component parts of the movement were practiced.  
 
Activities included: 
 Reaching for a jug and then pouring water from it 
 Picking up a jar and unscrewing the lid 
 Reaching down to the floor 
 Placing pegs on a clothes line 
 
Progression was again informed by the Oxford programme (Zinovieff, 1951, 
Trew and Everett, 2005) (see table above). Greater resistance was given by 
increasing the effects of gravity e.g. reaching across a table using a duster was 
progressed to reaching toward a cup without allowing the arm to rest on the 
table; auto assisted activities such as reaching to the floor using a stick were 
progressed to use of the affected arm without assistance; objects to be lifted 
were made heavier e.g. by increasing the amount of water in the jug. 
 
5.3.9 Ethics 
In the United Kingdom the Research Governance Framework (DH, 2005) lays 
out the guidelines which all research within the healthcare environment must 
comply with and this system is managed by relevant departments within the 
host NHS site. Ethical approval was granted by the Cambridgeshire 2 Research 
Ethics Committee (ref: 09 H0308 147). The trial is registered on the Current 
Controlled Trials database (ISRCTN71632550). For a copy of the ethics form 
please see appendix XV. 
All other aspects of the study conformed to guidelines laid out by Good Clinical 




by Physiotherapists or Occupational Therapists registered with the Health 
Professions Council. Data was anonymised and stored in a lockable cabinet to 
comply with the Data Protection Act (Government, 1998). 
 
5.3.10 Analysis 
Analysis of the data obtained from this study was carried out using Stata® 
version 9. Descriptive data was plotted on a histogram to determine whether it 
was normally distributed, if this was the case then the results were displayed 
using mean and standard deviation,  if not, then median and interquartile range 
were used. If the distribution of the data is skewed then it is more appropriate 
to use median and interquartile range to summarise the distribution of the data 
(Sim, 2000). 
 
An intention to treat analysis was used to control for the potential for attrition 
bias, which may occur when participants within a study who drop out or are 
withdrawn are discounted from the final analysis. Bias may occur if all these 
participants are from one group or are all those for whom the experimental 
intervention is not working, this may lead to a Type I error or a false positive. 
An intention to treat analysis therefore, refers to an analysis where data from 
each participant is analysed according to the group they were allocated to 
following the randomisation process, regardless of whether they leave the 
study or move to a different intervention group (Sim, 2000). 
 
A regression model was used to complete the statistical analysis of the 
difference between the outcome measures of the two groups. The use of 
minimisation introduces variables that need to be taken into account within the 
analysis model used and therefore regression models are deemed to be most 
appropriate for this (Scott et al., 2002). The process of minimisation reportedly 
leads to a correlation between the intervention groups because it forces the two 
groups to be similar for everything (apart from the effect of the experimental 
intervention). In effect this ‘matches’ the participants in each group preventing 
the participants from being ‘independent’, this matching needs to be taken into 
account in the analysis (Kahan and Morris, 2012). In  simulated analyses of 




adjust for the stratification or minimisation process led “to biased standard 
errors, overly wide 95% confidence intervals, type I errors rates that were too 
low and a reduction in power”.  Thus data derived from the ARAT and the RMI 
were analysed using a rank based analysis of covariance (RANCOVA). Neither 
of these measures are defined as interval ratio and therefore do not meet the 
criteria for an analysis based on parametric methods. Parametric methods are 
deemed to be more sensitive than non-parametric and would therefore be the 
preferred method of analysis. However in order to undertake parametric 
analysis the data must meet certain criteria, including being interval ratio and 
with a normal distribution (Sim, 2000).  Data derived from the NHPT and the 
TUG were plotted on a histogram, as this is interval ratio, if this data is normally 
distributed then it was analysed using an ANCOVA, if it did meet this criteria 
then a RANCOVA was used for this data also. The results of the FAC were 
analysed using a proportional odds ratio; this is recommended as being the 
most appropriate method for an ordinal scale such as the FAC, where the 
difference between each of the levels is not equal (Scott et al., 1997). 
 
5.3.11 Summary 
The previous sections described the justification for the design and methods of 
a phase II trial intended to answer the following research question: 
“Is Functional Strength Training a feasible intervention for improving upper and 
lower limb recovery later after stroke?”  
 
Following recruitment participants were randomly allocated to one of two 
treatment groups (FSTUL or FSTLL). Baseline measures were recorded by an 
assessor blinded to group allocation before the start of the intervention phase. 
Participants received either FSTUL or FSTLL four times a week, for up to sixty 
minutes each time, for six weeks. Following completion of the intervention 
phase (outcome) and six weeks after the end of the intervention phase (follow 
up) outcome measures were repeated by the blinded assessor. Primary 
outcome measures for this study were the Action Research Arm Test (ARAT) 
and the Functional Ambulation Categroies (FAC); secondary outcome 




and the Modified Rivermead Mobility Index (MRMI). Analysis comparing the 
outcomes of the two groups at both outcome and follow up was undertaken. 
 
5.4. Results 
The previous section described the methods used to carry out a phase II trial 
investigating the feasibility of Functional Strength Training to improve walking 
and upper limb function later after stroke. This chapter will describe the results 
for this study, focussing initially on participant characteristics, recruitment and 
then the results for the primary outcome measures and secondary outcome 
measures. 
 
5.4.1 Participant characteristics 
Fifty two people were recruited to this trial from across Norfolk. Table 26 
describes the participant characteristics for each group. 27 people were 
randomised to the upper limb treatment group and 25 were randomised to the 
lower limb treatment group. 
Characteristics Upper limb (n = 27) Lower limb (n = 
25) 
Age/years (median, IQR) 70 (60-76) 74 (61-79) 
Right hemiplegia 15 12 
Time from onset to 
randomisation / days 
(median,  IQR) 
520 (337-1306) 562 (428-1029) 
Male 18 17 
Baseline ARAT score 
(median, IQR) 
13 (3-25) 10(3-23) 
Baseline FAC score 
(median, IQR) 
2 (1-4) 2 (1-4) 
 
Table 27: Baseline characteristics of the participants 
Median scores and interquartile ranges (IQR) have been given for age, time 
from onset to randomisation, baseline ARAT score and baseline FAC score 
because the range of values for each of these were not normally distributed. 
When data is skewed a median value gives a better representation of the 
central score for that range of data (Altman, 1990). Both groups were matched 




matched but showed a wide range of values. Within the total sample, time from 
onset to randomisation had a median of 562 days (approximately 1.5 years) 
and an IQR of 372 days to 1077 days (approximately one to three years). 
Participants presented with similar ARAT and FAC scores at baseline between 
the groups. 
 
Participants were initially screened for diagnosis of a stroke affecting the 
anterior circulation, however when recruitment strategies moved to include 
people referred by local therapists it was not always possible to obtain this data. 
Recruitment was therefore based on a clinical examination of the potential 
participant, following consent and inclusion in the study it was possible to obtain 
this information retrospectively. Figure six demonstrates the proportion of 
people included in the study within each classification according to Bamford 
and Sandercock (1991). The highest proportion of participants fell within the 
PACI and LACI classification which corresponds with the original data 
described by Bamford and Sandercock (1991). 
 
 
Figure 7: Proportion of participants diagnosed with each stroke classification according to Bam ford and 
Sandercock (1991) 
 
Donaldson et al (2009) suggested that severity of stroke may be a confounding 









Minimisation was therefore used to stratify for this according to the baseline 
scores for the FAC and ARAT. The following table shows the distribution of 








Mild  Moderate Severe Total 
Mild 2 5 13 21 
Moderate 0 2 1 3 
Severe 1 9 18 28 
Total 3 17 32 52 
 
Table 28: Disutribution of severity across the total sample of participants 
Table 27 shows that compared with lower limb impairment there were a high 
proportion of people included in the study who presented with severe upper 
limb impairment (61%). Severity for the lower limb was distributed more evenly 
between the mild and severe groups (25% and 33% respectively). Participant 
numbers for ‘mild’ in the ARAT and ‘Moderate’ for the FAC are small and are 
unlikely to impact on the analysis, therefore for the purposes of this study the 
mild and moderate groups for both the FAC and the ARAT were combined. 




Figure seven shows the consort diagram for this study. In total 1127 potentially 
suitable participants were screened for inclusion in the study. This included 
those participants who were identified from the stroke database, therapist or 
were self-referred. 805 people were subsequently excluded because they had 
died or did not meet the inclusion criteria. This resulted in a total of 52 
participants who were randomised to either FSTUL or FSTLL. Following 
randomisation 27 participants were allocated to the upper limb group and 25 
participants were allocated to the lower limb group.  
 
Delays to the start of the recruitment period were incurred because of research 
governance procedures. Ethical approval for this present study was granted in 
September but Research and Governance approval was not granted until the 



















































Assessed for eligibility 
(n=1127) 
Excluded (n=1075) 
   Not meeting inclusion criteria 
(n=805) 
 Did not respond to letters (n=270) 
   Declined informed consent (n=0) 
Analysed (n=23) 
 Unable to complete measures to protocol 
(n=1) 
 Unwell for outcome measures (n=1) 
 Unable to contact (n=1) 
 Away when follow-up measures due (n=1) 
Analysed (n=24) 
 Unable to complete measures to 
protocol (n=1) 
 Unwell for outcome measures (n=1) 
 Unable to contact (n=1) 
Allocated to FSTUL (n=27) 
 Received allocated intervention 
(n=27) 
 Did not receive allocated 
intervention (n=0) 
Analysed (n= 20) 
 Unwell for outcome measures 
(n= 3) 
 Unavailable (n=2) 
 
Allocated to FSTLL (n=25) 
 Received allocated intervention (n=23) 
 Did not receive allocated intervention (n=2):  
 declined assigned group allocation n=1 
 too unwell to start intervention n=1 
Analysed (n=21) 
 Unwell for follow-up measures 
(n=2) 










5.4.3 Recruitment strategies 
Recruitment was initially predicted to be at the rate of two participants per 
month, figure eight shows the predicted rate of recruitment against the actual 
rate of recruitment, which was lower than expected.  
 
 
Figure 9: Predicted recruitment against actual recruitment 
 
The initial recruitment strategy was to send letters to people who had been 
diagnosed with a stroke and who had been admitted to the local acute hospital. 
434 first letters were sent, these achieved a 31% response rate, 269 second 
letters were then sent to non-responders and these achieved an 11% response 
rate.   
 
Figure eight illustrates the poor rate of recruitment seen at the start of the study 
when the only recruitment strategy was via letters. Once recruitment strategies 
opened up to include therapist referral there was a rise in the rate of recruitment. 
Table 28 shows the proportion of people who were recruited to the study via 
the different methods used. Referral by therapist was clearly the most 






































































27% 69% 2% 2% 
 
Table 29: Proportion of participants recruited through each strategy 
 
5.4.4 Attrition 
Following randomisation one participant withdrew because he did not receive 
the group allocation that he wanted. Two people withdrew from the lower limb 
group before the intervention was completed; both because of illness not 
associated with the trial and one person withdrew from the upper limb group 
because they no longer wished to take part in the study. All participants were 
entered into the outcome and follow up assessments on an intention to treat 
basis. One participant allocated to FSTUL was subsequently removed from the 
analysis because baseline measures had not taken place as per the protocol. 
 
5.4.5 Treatment received 
The study set out to deliver sixty minutes of FST for either the upper or lower 
limb for four days a week for six weeks this equates to a target of 24 hours of 
FST per participant. 
 
The mean time spent on FST per participant in the lower limb group was 14 
hours with a standard deviation of 5.7; the mean time spent on FST in the upper 
limb group was 15.9 hours with a standard deviation of 5.2. Table 29 below 
shows the total intervention time delivered by group. As this data was not 
normally distributed a non-parametric analysis using the Mann-Whitney was 
used to determine whether there was any difference between the groups with 
respect to time. This revealed no significant difference between the groups (z 







 Upper limb 
group (n = 27) 
Lower limb 
group (n = 25) 
Total 
Total intervention time 
delivered (hours) 
430.15 351.92 782.07 
Intervention time as a 
% of total intended 
time 
66.4% 58.7% 62.7% 
 
Table 30: Total amount of FST delivered to each group 
 
One of the aims of this phase II study was to determine whether it would be 
feasible to deliver FST to people in their homes four days a week for six weeks 
later after stroke. Figure five demonstrates why sessions were not delivered by 
group. The highest proportion of cancelled sessions was because of participant 
















































Analysis was carried out as per an intention to treat. Missing data was not 
imputed for the purposes of analysis except for the Modified Rivermead Mobility 
Index, this decision was based on the advice of a statistician  
5.4.6.1 Primary outcome measures: Action Research Arm Test 
The following table displays the median scores for the Action Research Arm 
Test (ARAT) for each group at baseline, outcome and follow up. 
 
 
Table 31: Median and IQR of the ARAT for each of the groups at baseline, outcome and follow up 
 
The median score for the ARAT for the lower limb group remains relatively 
unchanged between baseline, outcome and follow up. The score for the upper 
limb group however increases between baseline and outcome by 8.5 points 
and remains at the higher score at follow up. Van der Lee et al (2001) identified 
a change score of 5.7 on the ARAT to be the minimal clinically important 
difference (MCID). Clearly the upper limb group have exceeded that MCID. 
 
The ARAT cannot be classified as interval/ratio and therefore a non-parametric 
ANCOVA was carried out to determine whether there was a statistically 
significant relationship between the ARAT score at outcome and group 
allocation. This regression model was used to account for the minimisation 
procedure which stratified for severity, it found a statistically significant 
relationship between group allocation and outcome on the ARAT, t=2.06 
(p=0.046). There was no statistically significant relationship found for the ARAT 
score at follow up, t=1.96 (p=0.057). 
Group  Baseline Outcome Follow up 
Lower 
limb 
N 25 20 21 
 Median 
(IQR) 
10 (3-23) 9 (3.5-20.5) 11 (5-21) 
Upper 
limb 
N 26 24 23 
 Median 
(IQR) 





5.4.6.2 Primary outcome measures: Functional Ambulation Categories 
Table 31 displays the score for each of the groups for the Functional 
Ambulation Categories (FAC) at baseline, outcome and follow up.  
 
Group  Baseline Outcome Follow up 
Lower limb N 25 20 21 
 Median (IQR) 2 (1-4) 2 (1-4) 2 (1-4) 
Upper limb N 26 24 23 
 Median (IQR) 2 (1-4) 4 (2-4) 4 (1-4) 
 
Table 32: FAC score at baseline, outcome and follow up 
 
Median scores for the FAC remain unchanged between baseline, outcome and 
follow up for the lower limb group; however there is an improvement in the 
upper limb group, which shows an increase in the FAC score of 2. The MCID 
has not been formally identified for the FAC however the broad categorisation 
of this scale suggests clear differences in walking ability between categories. 
This suggests therefore that those people who received the upper limb 
intervention this group also could have improved in walking ability. 
 
Statistical analysis of the FAC scores was to be undertaken using a 
proportional odds ratio, however the table below indicates that there were 
insufficient numbers within each group for this to prove useful. Consequently 
the five groups (-2 to +2) which identify the difference between baseline and 
outcome score were combined to create two groups (0 and 1), a difference of 
-2 to 0 was recoded as 0 and a difference of 1 to 2 was recoded as 1. This 







 Number of people in 
Lower limb group with 
change score 
Number of people in 
Upper limb group 









































-2 0 1 1 
-1 1 0 1 
 0 17 18 35 
 1 1 2 3 
 2 1 3 4 
Table 33: Difference between outcome and baseline FAC score for both groups 
 
Logistic regression revealed no statistically significant relationship between 
group allocation and FAC score at outcome (z=1.19, p=0.235). The same 
process was carried out for the follow up FAC score which also identified that 
there was no statistically significant relationship between score at follow up and 
group allocation (z=0.56, p=0.573). 
 
5.4.6.2 Secondary outcome measures: Nine Hole Peg Test 
According to the protocol for the Nine Hole Peg Test (NHPT) only one 
participant was actually able to complete this outcome measure. That 
participant’s score at baseline was 44 seconds and at outcome 38 seconds and 
they had received the upper limb intervention. The use of outcome measures 
in this study will be discussed later. 
 
5.4.6.3 Secondary outcome measures: Timed Up and Go 
Table 33 shows the median and IQR for the Timed Up and Go (TUG) for 
baseline, outcome and follow up for both groups.  
 
Group  Baseline Outcome Follow up 
Lower 
limb 


























Rockwood et al (2000) reported a potential floor effect for the TUG with 29.3% 
of participants being unable to complete this test. This study found that only 
11.5% of participants were unable to complete the TUG at baseline. 
 
Median and IQR for the TUG have been used as the data was not normally 
distributed, table 33 shows that there is little difference between baseline, 
outcome and follow up for the lower limb group, however the upper limb group 
showed an improvement of 11 .33 seconds  at outcome although this difference 
decreased at follow up.  
 
Analysis of these data was carried out using the non-parametric version of the 
ANCOVA, although the TUG is interval ratio data it was not normally distributed, 
therefore the data does not meet the criteria for carrying out an ANCOVA. 
Regression analysis found a statistically significant relationship between group 
allocation and TUG at outcome (t=-2.19, p=0.035), but not at follow up (t=1.01, 
p=0.319). 
 
5.4.6.4 Secondary outcome measures: Modified Rivermead Mobility Index 
Completion of the Modified Rivermead Mobility Index (MRMI) was in some 
cases limited by the environmental constraints within people’s homes, the final 
two items were particularly difficult to complete (timed ten metre walk and 
stairs); only ten people were able to complete the timed ten metre walk at 
baseline. The MRMI score is a total of all the scores for each of the items, there 
is a difficulty therefore in comparing total scores for one participant whose 
environment allowed for the completion of all eight items to another participant 
whose environment only allowed them to complete six. One option for the 
purposes of analysis was to calculate a total score based on the first six items 
only, this however did not allow for missing data when environmental 
constraints had prevented measurement of other items. Following advice from 
a statistician the decision was taken therefore to impute data for those items 
that had missing scores because of environmental constraints; where there 
was missing data an average of the available scores for each participant was 
calculated and this value was imputed. Table 34 shows the median scores for 





Group  Baseline Outcome Follow up 
Lower limb N 25 20 21 
 Median 
(IQR) 
35(33-38) 34(32.5-38) 37(34-39) 
Upper limb N 25 23 19 
 Median 
(IQR) 
36(32-38) 37(32-39) 37(34-39) 
Table 35: Median MRMI scores at baseline, outcome and follow up for each group 
 
A non-parametric RANCOVA was carried out to determine whether there was 
any statistically significant relationship at both outcome and follow up for the 
MRMI, neither analysis was statistically significant (t=0.39, P=0.698 and t=0.39, 
p=0.70). 
 
5.4.7 Adverse reactions 
There were no adverse reactions reported in the present study. 
 
5.4.8 Summary of findings 
Fifty two people were recruited to this study, of these 27 were allocated to 
FSTUL and 25 were allocated to FSTLL, 44 participants were subsequently 
included in an intention to treat analysis at outcome (n=24 to FSTUL and n=20 
to FSTLL) and follow up (n=23 to FSTUL and n=21 to FSTLL). Results from 
the study found a statistically significant increase in ARAT score in favour of 
the intervention at outcome (p=0.046), suggesting a positive relationship 
between FSTUL and clinically significant improvements in upper limb function 
in participants who were between six months and five years after stroke . The 
same finding was not observed at follow up (p=0.057). There was no 
statistically significant effect in favour of FSTLL measured by the FAC at 
outcome (p=0.235) or follow up (p=0.573) suggesting that FSTLL has no effect 
on walking function in stroke survivors who were between six months and five 
years after stroke. 
 
Only one person was able to complete the NHPT and therefore analysis for this 




TUG at outcome (p=0.035) but not at follow up (p=0.319), although the number 
of people able to complete this measure was low compared to the number of 
participants included in the analysis of the primary outcome measures (n=39 
compared to n=44). Interestingly the improvement in the TUG was found in the 
group receiving FSTUL and not FSTLL. 
 
Finally, no statistically significant results were found in favour of either group 
when measuring change using the MRMI at either outcome (p=0.698) or follow 
up (p=0.70).  
 
5.5. Discussion 
The aim of this study was: 
 To carry out a phase II randomised controlled trial to determine feasibility 
of a physical therapy intervention – Functional Strength Training for 
improving upper limb function and walking in people between six months 
and five years after stroke.  
Objective 2: Establish feasibility of Functional Strength Training 
for improving upper limb function and walking in people between 
six months and five years after stroke by determining likely rates 
of recruitment. 
Objective 3: Establish feasibility of Functional Strength Training 
for improving upper limb function and walking in people between 
six months and five years after stroke by testing procedures for 
acceptability including the choice of outcome measures and the 
pragmatics of delivering the interventions. 
Objective 4: Provide information for calculating a sample size for 
evaluation trials. 
 
In this section the findings from this phase II study will be discussed, including 




trials. is section will go on to discuss the extent to which this present study has 
or has not achieved these aims.  
5.5.1 Determining likely rate of recruitment 
The present study aimed to recruit two participants a month over an 
approximate period of 28 months in order to achieve a total sample size of 58 
people. This section will discuss the recruitment strategies used throughout the 
trial in order to make recommendations for future trials of FST. This section will 
also discuss the implications for future trials in relation to attrition and the 
impact of the decision to include participants following a clinical assessment to 
determine site of stroke (as described in section 5.3.3.)  
5.5.1.1 Recruitment 
This present study successfully recruited 52 out of a planned 58 participants 
over a two and a half year period. Recruitment strategies did, however, have 
to be refined over the period of the study.  
 
Examination of the overall recruitment strategy showed that less than 5% of 
those participants screened for inclusion were recruited to the study. On further 
analysis of the relative success of each of the strategies however it seems that 
the least successful method used in the present study was recruitment via 
letters. The initial recruitment strategy was to send out letters to stroke 
survivors listed on a clinical database held at the local hospital. Over one 
thousand letters were sent out and yet this method yielded only fourteen 
participants. If all respondents to the letter had been able to be included in the 
study then this strategy would have yielded 135 participants; The response to 
the letters suggested that this method of informing people of the study was 
relatively successful; however there was a problem in converting an expression 
of interest communicated via the letter into recruitment to the study.  The 
reasons for refusing to participate in the study were not systematically sought 
during the progress of this study and initiating further contact once individuals 
had refused to participate was not within the ethical constraints of the study. 
However some responders had volunteered their reasons for refusal when they 
returned the expression of interest form. A number of these responses 




did not meet the description of the inclusion criteria of “a significant impairment 
in both the arm and leg following stroke” they met the inclusion criteria for either 
arm or leg but not both. The impact of this inclusion criteria on this feasibility 
study will be discussed again later in this section but, in the context of 
recruitment, if future studies continue to model themselves on the present study 
then they may have to consider recruiting over longer periods of time or over a 
greater geographical area in order to achieve the desired sample size. 
Alternatively it may be useful for future studies to consider broadening the 
inclusion criteria to reflect individuals with either greater or lesser severity in 
both the arm and the leg. Although this would impact on the specificity of the 
findings from any future study it would be more in keeping with the design of a 
pragmatic trial. Broader inclusion criteria would arguably reflect more ‘everyday 
practice’ (Haynes, 1999). 
 
As well as potential issues around the inclusion criteria the feasibility study 
design required a high level of commitment from the participants over the six 
week period and this may have been off putting for some people, however this 
‘worry’ may have been offset by delivering the intervention within people’s own 
homes. A systematic review of barriers to participation in randomised controlled 
trials identified that some patients may refuse because of concern over 
additional procedures and appointments and travel and travel costs (Ross et 
al., 1999). Data relating to the current study does however need to be sought 
systematically as at this moment the reasons for refusing to participate can be 
only speculative. Future trials of FST may benefit from adding something to the 
‘expression of interest’ form that would enable them to systematically collect 
sufficient information on an individual’s reasons for refusing to take part in a 
study. 
 
Once it became clear that the recruitment strategy initially proposed was 
unsuccessful an additional strategy was included into the study. This strategy 
allowed direct referral to the study by therapists involved in the rehabilitation 
and management of stroke survivors. Following the integration of therapist 
referrals into the recruitment strategy for the present study, the rate of 




to be the most successful; recruiting 69% of the total number of participants. 
There appears to be little work evaluating recruitment to rehabilitation trials that 
are specifically targeted at interventions related to stroke (Lloyd et al., 2010). 
Therapist referrals were however reported to be a successful recruitment 
strategy in the ‘AMBULATE’ trial (Lloyd et al., 2010). This study recruited via 
advertisements and referral from therapists who were involved in the 
rehabilitation of stroke survivors. Whilst this method of recruitment was the 
most successful it may not have produced a study population that is 
representative of the population of stroke survivors who are within the chronic 
phase of recovery from stroke. Access to health professionals involved in 
stroke rehabilitation in the UK is limited in the later stages of recovery (National 
Audit Office, 2010). A recruitment strategy therefore that only involves therapist 
referral may not access stroke survivors who no longer receive their input. 
Conversely an individual, who continues to receive treatment, may feel ‘obliged’ 
to participate in a study which is being supported by a therapist to whom they 
are grateful for any recovery they have achieved following the stroke. 
 
Future trials of FST based in the community should consider including therapist 
referrals as part of the recruitment strategy, although effort should also be 
made to identify those stroke survivors who are not accessing those services.  
 
Alternative recruitment strategies that have been shown to increase the rate of 
recruitment in randomised controlled trials could also be considered. These 
include monetary incentives, which may or may not be feasible depending on 
the budget for running the study; and telephone reminders or follow-ups 
(Mapstone et al., 2007). The use of telephone calls as a follow up to the letters 
was identified as a recruitment strategy in the original ethics application for the 
current study.  This was however rejected by the ethics committee, who felt 
that at this point, the researcher should accept the refusal to return either of the 
two ‘expression of interest’ forms that had been sent to them, as a clear 
indication of a wish not to take part in the study.  
 
Findings from the present study suggest that a recruitment rate of 2 participants 




of 28 months. To allow for the potential for difficulties in recruiting to future 
studies however, a recruitment rate of 3 participants per 2 months may prove 
more achievable.   
 
5.5.1.2 Retention and Attrition 
Following the previous studies of FST, sample size calculations for the present 
study were based on an expected attrition rate of 10% (Cooke et al., 2010b, 
Donaldson et al., 2009a). Results from this study indicated a similar attrition 
rate of 12%.  
 
One participant left the study after randomisation but before taking part in the 
intervention, because he did not receive the group allocation that he wanted. It 
was the researcher’s perception during the design of this study that two 
intervention groups would prevent attrition based on group allocation, because 
‘something is better than nothing’. This may not the case however, and 
therefore future studies of FST do not need to be constrained by this two group 
design, especially in light of the potential for a cross training effect from the 
FSTUL group to lower limb function. 
 
A second participant who was allocated to the upper limb group was removed 
from the analysis as closer examination of the baseline measures revealed that 
he had been unable to complete the ARAT per protocol. This occurred because 
of environmental constraints and therefore the decision was taken to remove 
him from the analysis, this can be avoided in future trials by ensuring that all 
the equipment needed to carry out the outcome measures is  available to the 
outcome assessor, including a table that can be transported between 
participants’ homes at the beginning of the study.  
 
A further two participants were lost to outcome from the upper limb group and 
four participants from the lower limb group. One participant was unable to be 
contacted despite visits to the address where the intervention had taken place, 
and follow up telephone calls. Contact was discontinued when it was clear that 




participants who were lost to outcome and follow up were not available because 
of ill health unrelated to the trial.  
 
The attrition rate for this present study was estimated at 10% based on the 
information obtained from previous trials of FST (Donaldson et al, 2009 and 
Cooke et al, 2010). Forty four out of a potential forty nine participants completed 
both baseline and outcome measures in the present study indicating the same 
attrition rate (10%). Comparison of attrition rates between the previous and 
current trials of FST are limited by the differences in both the time from stroke 
and the setting in which the trials take place (acute hospital setting versus 
people’s homes). Comparator studies using both the same or similar 
interventions within the same time frame after stroke and in the same setting 
are limited; however an attrition rate of 10% for future trials of FST seems to be 
reasonable based on current findings and published protocols for other trials 
investigating the effects of exercise based interventions on motor recovery in 
stroke survivors, even though study populations differ in their time from stroke 
onset (e.g. Askim et al (2012) estimates an attrition of 15 %, Logan et al (2012), 
20% and Pomeroy et al (2012), 10%). 
 
5.5.1.3 Changes to recruitment processes 
Initial inclusion criteria stipulated only those stroke survivors who were 
diagnosed with a stroke affecting the anterior circulation. Following the 
amendment to include referrals from therapists it was not possible for the 
researcher to access the clinical information necessary to determine whether 
an individual met this inclusion criteria before they had been given and signed 
the ‘Informed consent form’. This would have necessitated the researcher 
having access to clinical records which was not possible within the context of 
Good Clinical Practice (MHRA, 2013) and the ethical consent obtained prior to 
the start of the study. Decisions as to whether or not to include potential 
participants were therefore based on their clinical presentation. This 
subsequently resulted in the inclusion of participants who were subsequently 





The decision to restrict inclusion to those stroke survivors diagnosed with a 
stroke affecting the anterior circulation was based on the premise that FST was 
likely to be most effective in this group of individuals. One of the ‘movement’ 
consequences of a stroke affecting the anterior circulation is a loss of muscle 
power to the opposite side of the body affected by the stroke, this results in a 
so-called hemiplegia (Cohen, 1999).  A stroke affecting the posterior circulation 
can also present with muscle weakness but this may be confounded by the 
presence of ataxia or problems with coordination of the movement (Cohen, 
1999). Evidence has been published in favour of the effects of strength training 
on muscle weakness after stroke (Ada et al., 2006); however evidence in favour 
of any specific physical therapy intervention is less well defined in the presence 
of ataxia (Stoykov et al., 2005). 
 
In order to obtain the information required to determine whether the stroke had 
affected the anterior circulation, potential participants would have had to have 
given informed consent to the study before the researcher could have acquired 
the information. It was deemed inappropriate to ask individuals who were very 
keen to take part in the study to undergo the visits that were necessary for 
screening and participant information, and the subsequent wait before informed 
consent was taken, before they could be told whether they were allowed to take 
part in the study or not. Logistically, this would also have impacted on the costs 
of the study as baseline measures were taken just after informed consent was 
gained. For the participants where inclusion was unclear, a further visit to carry 
out the baseline measures would have been required following the receipt of 
informed consent, once it was established that the participant could be included 
in the study. 
 
Where clinical information relating to the site of the stroke was unavailable at 
the point of recruitment, individuals referred to the study by therapists were 
included if their clinical presentation was the same as that usually found in 
people following a stroke affecting the anterior circulation, i.e. the presence of 
hemiplegia but with no signs of ataxia. Assessment of treatment suitability 
based on clinical signs and symptoms may reflect circumstances found in 




not have access to scans and detailed medical notes prior to seeing  their 
patients. In order to ensure generalisability of findings to the clinical setting the 
design of a trial should take into account ‘real clinical practice’ (Roland and 
Torgerson, 1998), therefore inclusion criteria based on clinical presentation 
may be more appropriate for a study based in this type of setting.  
 
The inclusion of participants with a specific lesion location, even that as general 
as a stroke affecting the anterior circulation, may inform decisions such as 
which stroke survivors may respond to which therapy (Kwakkel et al., 1999). A 
study that includes stroke survivors without specifying aspects of lesion 
location may therefore be criticised for lacking specificity. There are however, 
clear examples where well categorised therapy has been associated with 
clinical presentation rather than diagnostic information such as lesion location. 
One example of this is Constraint Induced Movement therapy (CIMT), which 
showed statistically significant improvements in upper limb performance 
measured by the Wolf Motor Function Test (P<0.001) compared to usual care 
in a group of stroke survivors who had a specific clinical presentation of 
movement ability (Wolf et al., 2006).  
 
Further work needs to be carried out in order to identify which stroke survivors 
are likely to respond most effectively to FST, but this work could feasibly focus 
on aspects of clinical presentation such as range of available movement or the 
quantification of muscle paresis rather than lesion location. Study designs other 
than RCT may facilitate the process of identification of individual characteristics. 
Studies using single case experimental designs for example facilitate more 
detailed analysis of which patient characteristics may be associated with 
clinical changes caused by the effect of the intervention, albeit on an individual 
level (Bowling 2000). Further pilot work investigating who may or may not 
respond to FST may prove effective before moving on to further evaluative trials 





5.5.2 Testing procedures for acceptability 
This section will discuss the findings from this present study in terms of key 
aspects of the study design including the choice of outcome measures and 
the pragmatics of delivering the interventions. 
 
5.5.2.1 Study Design 
The present study was designed with two intervention groups – FSTUL and 
FSTLL. This decision was based on the premise that there was not expected 
to be a cross training effect between the upper and lower limb groups. The 
findings derived from the TUG, described above, could however suggest that 
this may not be the case for the upper limb intervention. This interpretation 
should be made cautiously however as this outcome only reflected a change in 
the participants who were able to complete the test. Nevertheless it is worth 
considering this information in light of the need to inform the design of a future 
trial, especially as this initial decision was based on conflicting findings.  
 
The case for the two group design used in this study was based on findings 
from a published clinical trial which did not show inter-limb coupling in response 
to therapy (Kwakkel et al., 2002) and some experimental evidence that did 
(Dietz, 2002, Zehr et al., 2007). It has been suggested that strengthening the 
upper limb would have an effect on the lower limb because of the presence of 
neuronal coupling in tasks such as walking (Zehr et al., 2007) and there is also 
evidence to suggest that arm training can improve oxygen delivery to the lower 
limbs which was associated with improved walking speeds  (Tew et al., 2009). 
The TUG is arguably a timed test of aspects of mobility; therefore these 
mechanisms may explain the statistically significant changes to the TUG in the 
FSTUL group. Future studies will need to take this finding into account but it is 
possible that a two group study design where FSTUL acts as the control for 
FSTLL may not be appropriate. 
 
Forty eight out of a possible fifty one participants who received the intervention 
fell within the moderate to severe groups for upper limb function categorised 
by the ARAT. Findings from the present study therefore may not generalise to 




affecting upper limb recovery, Coupar et al. (2012) found that less lower limb 
impairment was moderately associated with better upper limb recovery (odds 
ratio 11.83, 95% CI 6.53-21.43). It may be that the design of this study i.e. two 
intervention groups requiring participants to be impaired in both the upper and 
lower limb has led to the inclusion of a higher proportion of participants who are 
by default more severely affected than the previous study, where participants 
could be included with only an upper limb deficit and not both upper and lower 
limb. In order to ensure that the study population is representative of all 
categories of upper limb severity a study design which does not necessitate the 
presence of an impairment in both the upper limb and the lower limb may be 
more appropriate. 
 
5.5.2.2 Outcome measures 
The outcome measures for this study were chosen because they fulfilled 
certain requirements; they fell within the activity domain of the ICF, indicating 
that the findings are likely to be more meaningful to the participant (World 
Health Organisation, 2002). The outcome measures reflected the functional 
tasks that were targeted by the intervention, they have been shown to be 
reliable, valid and responsive but they were not all appropriate for use within 
the community setting.  Findings from the present trial in relation to some of 
these factors will now be discussed in order to provide information relating to 
their usefulness within future trials. 
 
Measures of upper limb function 
The Action Research Arm Test (ARAT) (Yozbatiran et al., 2008) appeared to 
meet all the requirements for the present study and was able to detect change 
in the movement performance of those participants receiving FSTUL enrolled 
in the present study. This would suggest that the ARAT has the capacity to 
evaluate change in motor performance of the upper limb following FST. This 
measure does fall within the activity domain of the ICF and therefore the 
assumption is that it should measure functional change that is meaningful to 
the participant (World Health Organisation, 2002), however future studies may 
wish to consider a mixed methods approach in order to determine if this is in 





The only unforeseen circumstance which affected the use of this outcome 
measure was the lack of a suitable table in participant’s homes; this was solved 
very quickly by the purchase of a suitable, portable table. Future studies using 
the ARAT in the community setting need to consider purchasing a table prior 
to its use. 
 
The nine hole peg test (NHPT) (Kellor et al., 1971) proved to be of little use in 
evaluating change in movement performance within the present study. This 
measure was chosen because of its perceived ability to be able to distinguish 
a change in function for those people with less severe paresis in their affected 
arm, however only one person was able to complete the NHPT as per the 
protocol. It is possible that the use of this outcome was affected by the severity 
profile of the participants within this study i.e. there were more participants with 
moderate to severe impairment than those with mild. Previous studies 
suggested that the NHPT was a useful outcome for measuring dexterity in 
future studies (Donaldson et al., 2009a) however if the study population of 
participants is likely to predominantly include participants with severe upper 
limb impairments, then global measures of upper limb function that incorporate 
measures of dexterity such as the ARAT may be sufficient to measure change. 
 
Measures of lower limb function  
The Functional Ambulation Categories (FAC) (Holden, 1984) was reported to 
be easy to administer and seemed to have the capacity to show change in the 
walking ability of participants within the present study. This outcome measure 
should therefore be considered for use in future studies. 
 
Findings from the Timed Up and Go (TUG) (Podsiadlo and Richardson, 1991) 
were inconclusive because the number of people who were able to successfully 
complete the measure at baseline was too small (n = 39); one participant was 
unable to complete because of a lack of space and the other five were unable 
to physically manage the task. Participants in the FSTLL group were classified 
across all categories of severity therefore an outcome measure that is only 





The Modified Rivermead Mobility Index (MRMI) (Forlander and Bohannon, 
1999 and Lennon and Johnson, 2000) was chosen to reflect changes in 
mobility related activities other than walking. This measure proved to be difficult 
to complete in the community setting because of the environmental constraints 
incurred using this measure in people’s homes. At baseline only eight out of 
the 52 participants were able to obtain a score for the ten metre walk and only 
fourteen were able to complete the stairs item. The previous study of FST had 
completed this measure in a hospital setting and therefore had had sufficient 
space to lay out a ten metre length over which participants could walk; similarly 
they also had access to a set of stairs (Cooke et al., 2010b). Findings from the 
present study indicate that the MRMI is not a useful outcome measure for use 
within the community setting, where measurement will predominantly be taking 
place in people’s homes. Alternatives to this measure, which were discussed 
earlier in section 4.3.5, were the Motor Assessment Scale (MAS) (Carr et al., 
1985), which also relies on a distance of 10m and a rail to hold on to and the 
Stroke Rehabilitation Assessment of Movement measure  (STREAM) (Daley et 
al., 1997), which similarly needs at least three steps and a distance of ten 
metres. Future studies of FST targeted at the lower limb may need to consider 
whether it would be more appropriate for participants to attend accessible 
venues, such as a GP surgery, for the measurement sessions so that 
environment is not a constraint to accurate and complete records of the 
outcome measures chosen for the study. The cost implications of such a plan 
would need to be considered, however this would avoid the loss of potentially 
significant data. 
 
Impairment or activity measure? 
The present study opted to evaluate changes in functional activity in both upper 
limb and lower limb using measures that fell within the activity domain of the 
ICF. The reasons for this reflected a wish to evaluate a change in movement 
performance that would be more meaningful to the participant than if the 
measurement tool fell within the impairment domain. Barak and Duncan (2006) 
observed however that the link between the impairment experienced as a result 




FAC. This is because functional scales may be influenced by factors other than 
the one being directly targeted by the intervention. For example, a participant’s 
lower limb muscle strength may be seen to improve throughout the course of 
an interventional study such as the present trial, but a lack of confidence may 
mean that this improvement does not enable that individual to walk more 
independently. Thus by choosing only functional measures that sit within the 
activity domain of the ICF a study may neglect to show a significant effect of 
the intervention.  Future studies of FST may wish to consider the inclusion of 
an outcome measure that sits within the impairment domain as well as one that 
sits within the activity domain of the ICF.  
 
5.5.2.3 Delivering the interventions 
This study was designed to deliver FSTUL and FSTLL to people who were 
within 6 months to five years after a stroke, in their own homes. The intention 
was to deliver the interventions for up to sixty minutes at a time over a period 
of four days a week for six weeks. This section will discuss the pragmatics of 
delivering FSTUL and FSTLL within the context of this study and the 
information gained from this experience that can usefully inform future studies. 
 
Geographical location 
The delivery of this intervention to people later after stroke, in their homes, 
involved considerable travel throughout a widespread geographical area. The 
original intention for the running of this trial had been to target the intervention 
at defined geographical areas. Entries to the stroke database were grouped 
according to postcode so that when responses were received intervention visits 
could be grouped together in order to minimise the travel distance. As 
previously discussed the response rate to letters generated so few participants 
that this strategy was not effective. Subsequently included participants could 
be based in any part of Norfolk and over the course of the study this resulted 
in the therapists having to carry out long journeys between individuals. This 
reduced the number of participants that could be seen in any given day and 
also carried cost implications in terms of reimbursing travel expenses. When 
recruitment opened up to include therapist referral geographical spread 




would tend to refer a number of people ‘en bloc’.  Future trials of FST delivered 
in the same way as the present trial may need to consider the time and cost 
implications of delivering an intervention over a potentially widespread 
geographical area; alternatively they may need to reflect on a recruitment 
strategy that could avoid this consequence. 
 
Future research could also be focussed on the feasibility and acceptability of 
delivering FST by alternative methods than those used in the present trial, this 
might include for example, delivering FST to a group of people within a local 
community setting. Group exercise schemes such as circuit classes have been 
found to be as or more effective than individual therapy sessions when 
delivering conventional care targeted at improving walking in people who were 
within the first six months since stroke onset (no statistically significant 
difference between the two groups in the mobility domain of the stroke impact 
scale (p = 0.943) and statistically significant difference in favour of the 
intervention group for gait speed (p < 0.001), with the conclusion being that 
circuit classes could effectively replace usual physiotherapy in the outpatient 
setting (van de Port et al., 2007). 
 
Delivering FST to a group of people might prevent so much travel on behalf of 
the therapist delivering the intervention, and may prove more cost effective in 
that one therapist would be able to deliver the intervention to more than one 
individual at a time. Feasibility of delivering FST in a group setting has not been 
established and therefore further work evaluating the effects of FST in a group 
setting is warranted. 
 
Intensity of intervention 
This study set out to deliver FST to individuals in their homes for one hour a 
day over four days per week for six weeks. This equates to an intended delivery 
time of 24 hours of FST per participant. Analysis of the amount of FST delivered 
during the study revealed no statistically significant difference between the two 
groups and participants received on average 15.94 hours of FST over the 
period of the study. The reasons for being unable to deliver the prescribed 




behalf of the participant (see figure nine). Interestingly participant cancellation 
in the lower limb group was double that of the upper limb group; one can only 
speculate on the reasons for this but it is possible that participants in the lower 
limb group found the intervention more physically demanding than participants 
in the upper limb group. Whilst the lower limb intervention is not intended to 
increase cardiovascular effort, the nature of some of the strengthening 
exercises, such as sit to stand, may have proved more tiring for participants 
within this group compared to those in the FSTUL group. In order to investigate 
this in more detail future studies of FST could include a qualitative aspect that 
would generate a better idea of the acceptability of FST particularly for the 
lower limb in people later after stroke.  
 
Findings from this study in terms of the discrepancy between intended delivery 
time for an intervention and actual time correlate with other rehabilitation trials 
such as the EXCITE trial (Wolf et al, 2007). Intervention time was intended to 
be delivered for up to 84 hours per participant but was actually delivered from 
between 20.9 hours to 60.5 hours. More recently the study by Cooke et al 
(2010b), where FST was intended to be delivered for 24 hours but was only 
delivered for an average of 14.8 (SD 4.3) hours. Evidence in favour of 
appropriate doses for exercise-based therapies is limited by the lack of dose 
finding studies (Cooke et al, 2010b); however the results from the present study 
indicate that it may be possible to see an effect from FST, targeted at the upper 
limb specifically in less time than that intended for the current study (mean time 
for FSTUL was on average 17.2 hours per participant compared to the intended 
24 hours). A prospective dose finding study would however be necessary to 
determine the optimal dose for this intervention.  
 
Intervention time was also lost due to therapist sickness and statutory holidays. 
Over the period of two and a half years, loss of therapy time for these reasons 
is to be expected, and funded studies need to try and plan for these 
eventualities if they have to be completed within a discrete time period. One of 
the strategies highlighted by Bellg et al. (2004) in their position paper on 
intervention fidelity in health behaviour change studies was planning for 




increased costs associated with managing these would outweigh the costs of 
implementing an ineffective treatment because it had not been rigorously 
tested. Information gained in the course of this study will inform funding 
applications for future trials of FST 
 
Governance procedures 
This section will discuss the impact that the delays associated with governance 
procedures for research trials had on this present study. Ethical approval was 
granted in September but subsequent Research and Governance approval 
was delayed by a further three months. Delays incurred as a result of the 
administration of these guidelines is not unique to this study; Elwyn et al (2005) 
reported a median delay of 61 days (95% CI 51-81 days) in gaining research 
governance approval over twenty sites, the total delay for gaining approval for 
all the sites was 150 days (103 days for research governance approval and 47 
days for ethics). Further correspondence by Galbraith et al (2006 p.238) has 
stated that researchers are becoming put off by the “idiosyncratic R&D 
departments”. Delays incurred as a result of Research and Development 
approval also has cost implications. Al Sahi Salman and colleagues (2007) 
created a measure called the ‘number not treated’ (NNT). This was the number 
of participants that could have been randomised to each of the studies included 
in their review over the period of time that the study coordinators were waiting 
for Research and Development approval. By multiplying the NNT by an 
approximate per capita cost the total cost that could be attributed to the delays 
found in their study was £53,743. They compared this to the cost that would be 
incurred if Research and Development processes could be reduced to a delay 
of four weeks, which they felt could be perceived to be acceptable. Costs 
incurred over this shorter period of time equalled £37,700 for the same studies, 
a saving of £16,000 to the funders. Since these studies were carried out the 
Department of Health (2006) has published a document called “Best Research 
for Best Health”, one of the goals for this strategy is to “strengthen and 
streamline systems for research management and governance”. Despite this, 
the delays incurred by the present study (conducted from 2009) still suggest 
that work needs to be completed in order to reduce delays to the possibly more 




presented by Thompson and France (2010) whose trial was conducted at a 
similar time, where Trust approval took 97 days. They have concluded that this 
and other delays incurred as a result of delayed governance procedures across 
the multiple sites have led to recruitment problems and believe that the 
scientific integrity of their study has been compromised as a result. Interestingly 
their trial required working with the governance procedures in Scotland, which 
they reported to be easier (approval was granted in 44 days within the 
appropriate department), which seems to indicate that it is possible for the 
process in England to be more efficient. 
 
 
5.5.4 Sample Size 
Finally, phase II trials are designed to provide information that will allow the 
calculation of a sample size for future evaluative trials (Craig et al., 2008). In 
light of the potential for a cross training effect from FSTUL to lower limb function, 
sample size calculations for individual trials evaluating FSTUL and FSTLL 
separately have been calculated. 
 
Based on the findings from the present trial a two group evaluative study of 
FSTUL versus a placebo in people within six months and five years after stroke 
would require 208 participants (104 per group). This sample size would have 
80% power at 5% significance (2-tailed) to show a 5.7 point change on the 
ARAT (minimal clinically important difference (MCID) (van der Lee et al., 
2001b)) assuming the standard deviation of 14.66 found in this study. In order 
to account for an attrition rate of 10%, also determined from the present trial, 
this study would need to recruit 228 participants. 
 
Again, based on the findings from the present study a two group evaluative 
study of FSTLL versus a placebo in people within six months and five years 
after stroke would require 68 participants (34 per group).  This sample size 
would have 80% power at 5% significance (2-tailed) to show a 1 point change 
on the FAC assuming the standard deviation of 1.47 found in this study. An 





5.5.5 Clinical Findings 
As previously highlighted in section 5.3.2 phase II trials are not designed to 
determine efficacy of an intervention, however future evaluations of 
interventions that have shown no effect are unlikely to result in being taken 
forward into phase III trials (Stallard, 2012). Consequently whilst a formal power 
calculation was not possible a sample size for the present study was carried 
out. It was estimated that a sample size of 52 would have 90% power at 5% 
significance to detect a change in 1 point on the FAC and 5.7 points on the 
ARAT. As the present study met this sample size it is possible to gain some 
estimate of the clinical effect of  the interventions in this study. The finding of a 
statistically significant increase in ARAT score in favour of FST for the upper 
limb group at outcome (21.5 (10.5-29.0); p=0.046), and the absence of a 
statistically significant change of the FAC for the FST lower limb group (2 (1-4); 
p=0.235) suggests therefore that there may be some evidence for the efficacy 
for FSTUL on motor function recovery of the upper limb late after stroke. It is 
important to note however that these results were not maintained at follow up 
and thus the intervention was seemingly only effective in the short term. This 
will be discussed in more detail later in this section. 
 
The findings from the present study correspond with the results from the 
earlier study of FSTUL in people early after stroke, where clinically significant 
changes were also found in favour of the upper limb intervention (Donaldson 
et al., 2009a). One may cautiously suggest therefore, that there is some 
preliminary evidence that FST is effective as an intervention for improving 
motor function recovery in the upper limb both early and later after stroke. 
This hypothesis would however need to be tested further in a subsequent 
adequately powered definitive trial. 
 
The earlier studies of FSTLL showed conflicting results; Bale and Strand (2008) 
found in favour of FSTLL for both habitual walking speed (p<0.05) and 
maximum gait speed (p<0.05). Comparison between this and the present study 
is however limited because of a difference in the choice of outcome measures. 
Findings from the previous lower limb study by Cooke et al (2010b) however, 




present study and that of Cooke et al (2010b) could lead to the hypothesis that 
FSTLL has little or no effect on motor function recovery either early or late after 
stroke. This interpretation should be made cautiously however, as neither study 
was based on a formal power calculation from previous data, and therefore 
may not have been sufficiently powered to detect a change in the FAC which 
could either refute or support the efficacy of FSTLL. Similarities between the 
findings in the present study and that of Cooke et al., (2010b) may also be 
reflective of the fact that aspects of this study design were informed 
predominantly by the earlier work. Inclusion criteria for both were similar but 
the other study investigating the effects of FST on lower limb recovery by Bale 
and Strand (2008) seemingly included a much broader population of stroke 
survivors. Inclusion criteria for the study by Bale and Strand (2008) included all 
participants who were assessed to have reduced muscle strength in their 
affected leg. This present study applied more rigorous criteria and excluded 
those who were able to step on and off a block greater than fourteen times in 
fifteen seconds. The aim for this selectivity was to ensure that participants 
would be sufficiently able to take part in a strength training programme but not 
be so able that they would gain little benefit from the intervention. This premise 
may however have been incorrect as the study by Bale and Strand (2008) 
showed the capacity for further recovery despite the fact that they presumably 
included participants who were less severely affected. Arguably this capacity 
for further recovery may have been greater as the participants were earlier after 
stroke. Although in an earlier described case study a participant who received 
strength training and task specific practice and had already made a good 
recovery was still able to show further improvement despite being fifteen 
months post stroke (Sullivan et al., 2006). Baseline characteristics of the 
severity of participants in the Bale and Strand (2008) study were not provided 
so it is not possible to determine whether they did indeed include participants 
that were functionally better than those included in the present study. As 
discussed previously further work needs to be done to identify individual 
characteristics for those participants who either do or don’t respond to FST and 





Lack of a statistically significant finding in favour of FSTLL could also be 
attributed to other factors, for example Cooke et al (2010b) identified that the 
dose for FSTLL may not have been sufficient within their study to effect a 
change in lower limb function. Only approximately 60% of the intended dose 
for FSTLL was delivered in both that and the present study (table 29) which 
equated to a mean of 14.8 hours per participant in the study by Cooke et al 
(2010b) and 14.5 hours in the present study. It is possible therefore that FSTLL 
was not delivered in sufficient dose to effect a change in lower limb function. 
The pragmatics of attempting to deliver the intended dose of FST will be 
discussed later. 
 
A further reason for the findings in favour of FSTUL but not FSTLL could also 
be attributed to the current clinical context in which rehabilitation is taking place. 
It is possible that current clinical practice offers little therapy to improve upper 
limb function. Donaldson et al (2009a) recorded an average of 2.81 hours of 
upper limb therapy over a period of six weeks for those participants receiving 
only conventional physiotherapy. This contrasts with Cooke et al. (2010b) who 
recorded an average of 9.2 hours over the same period of time for those 
participants also receiving conventional physiotherapy but this time targeted at 
the lower limb. It may be therefore, that as rehabilitation interventions seem to 
be targeted predominantly at the lower limb early after stroke, there is more 
capacity for clinically significant changes in upper limb function, when 
additional experimental therapy for the upper and lower limb are delivered in 
the same intensity over the same period of time. Further research comparing 
FSTUL to an upper limb placebo in a matched group of participants later after 
stroke would be necessary to determine whether this was in fact the case.  
 
An alternative hypothesis which would account for the findings from the present 
study would be to suggest that the upper limb recovers more slowly than the 
lower limb and that the results of the present trial were simply the product of 
late stage spontaneous recovery.  Findings from this study would not support 
this as the ARAT score for the FSTLL group did not increase which would be 
the expected scenario if late stage spontaneous recovery were occurring. This 




lower limb have been shown to occur over similar time scales (Duncan et al., 
1994). In addition a recent systematic review has highlighted the capacity for 
lower limb recovery late after stroke following physiotherapy interventions 




Interpretation of the findings from the secondary outcome measures was 
equivocal except for the findings from the Timed Up and Go (TUG). 
Measurement using the TUG found a statistically significant effect in favour of 
the upper limb intervention at outcome (19.17 (15.83-33.58); p=0.035), 
although this calculation was based on a relatively small number of participants 
(n=39 of 52). One should be cautious therefore about assigning importance to 
this finding because an inappropriately small sample size may lead to the risk 
of a Type I error; a Type I error being a false positive (Altman, 1999). Despite 
this, this result was unexpected as the TUG is a measure of mobility and 
therefore any changes in this outcome measure were expected within the 
FSTLL group, as they were receiving an intervention that would have been 
expected to improve mobility measures. This finding was discussed earlier as 
it pertains to the testing of procedures. 
 
Finally, this study found no statistically significant effect of either intervention at 
follow up for any of the outcome measures. This suggests that any effects that 
were observed in the outcome measures were not maintained once the 
intervention phase had ended; ideally this would not have been the case as 
one of the aims of movement rehabilitation after stroke would be to promote 
motor learning and therefore effect a longer term change in functional activity. 
There are a number of things that could be explored in future studies that might 
help to enhance the uptake of the activities that were learnt during the 
intervention phase.  
 
One of the factors highlighted in the earlier discussion of intervention fidelity 
was ‘enactment’. This referred to the incorporation of components that tested 




of the trial into everyday life (Bellg et al., 2004). Strategies for doing this 
included assessment with a questionnaire and self-monitoring using practice 
logs (Bellg et al., 2004 and Carpenter et al., 2013).  Self-monitoring of practice 
through a diary could have been incorporated into the present study and 
checked each time the therapist visited. The concept of practice however would 
need to be explicitly stated as one expectation of participation in the study. By 
ensuring enactment it is possible that the participant will be more able to 
maintain and use the skills taught as part of the intervention study.  
 
In a study measuring adherence to a home-based exercise programme in 
people later after stroke Jurkiewicz et al. (2011) found that individuals were 
more likely to carry out exercises at home if they were also taking part in a 
structured exercise programme requiring attendance at another venue. 
Graduation from the exercise group resulted in less adherence with the home-
based programme. It is possible that FST could be delivered over a longer 
period of time with greater intensity at the beginning of the programme which 
is then gradually decreased. This might place greater responsibility on the 
participant to carry out their own exercises, whilst ensuring that the therapist is 
able to monitor the self-practice, possibly leading to better self-efficacy and 
empowerment. Interestingly in a RCT which compared two intervention groups 
– one receiving supervised exercises and the other unsupervised with written 
and verbal instructions, both groups made gains in the clinical outcomes but 
there was no difference between the groups at either six months or one year 
after the end of the intervention (p>0.05), suggesting that self-directed practice 
can be effective. The authors speculated however that as participants were 
aware of the follow up time points that this degree of ‘long arm’ supervision may 
have maintained their motivation to continue with the exercises (Olney et al., 
2006).  
 
One of the main issues identified within the literature is in relation to non-
adherence with home exercises in a group of elderly participants six months 
post stroke was the lack of understanding on behalf of the participant regarding 
their responsibility in the rehabilitation process (Karingen et al., 2011). Goal 




recommended in relevant guidelines (e.g. RCP and NICE). Although initial goal 
setting was carried out with participants in this present study, the discussion 
centred on what they hoped to achieve following receipt of the intervention, and 
long term aims were not explicitly discussed. Future studies could reflect on 
this and facilitate discussion around longer term goals. 
 
The incorporation of explicit behavioural techniques that might enhance 
motivation and ongoing adherence could also be considered. The role of the 
therapist in motivating the participant is likely to have been an important aspect 
of the present study. Once this was withdrawn then the participants’ ability to 
remain motivated in carrying out the exercises could have lessened. Current 
research has explored the use of technology as an adjunct to home based 
therapy in order to promote motivation and facilitate monitoring of practice. 
Early phase clinical trials have proved feasible but have yet to be tested in a 
definitive study (Pang et al. 2006).  
 
A recent systematic review revealed that group exercise classes were also 
reported to be motivating, although as access, transport and cost were 
identified as environmental barriers and embarrassment as a personal barrier 
then this type of intervention would need to be carefully investigated first 
(Nicholson et al., 2013). 
 
Finally it is possible that the dose or intensity of FST delivered in this study was 
insufficient to effect long term change. Dose finding studies need to be carried 
out with a particular emphasis on long term follow up. The aim of this study was 
to consider the feasibility of a study design investigating a well-defined physical 
therapy intervention – FST. Effects of the intervention that carry over into the 
long term are clearly desirable but were not evidenced within the present study 
design. The previous paragraphs have offered some reflection for this lack of 





5.5 Summary  
The present study aimed to assess the feasibility of delivering FST to people in 
the chronic stage of recovery from stroke. Delivering a trial of both FSTUL and 
FSTLL in people’s homes was feasible. The amount of travel impacted on the 
cost of the study and the number of people who could receive an intervention 
in any one day. Future studies based in community settings will need to 
consider the impact of travel on both the time taken to complete the study and 
the costs involved. Alternatively other methods for delivering the intervention, 
such as via groups, could also be explored 
 
The initial recruitment strategy via letters of invitation proved to be unsuccessful 
at meeting the target recruitment rate of two participants per month, therefore 
the study’s strategy widened to include direct referral from therapists working 
within stroke services. This proved to be the most successful means of 
recruiting participants to this present study, with 69% of participants being 
recruited via this route. Future studies within the community setting should 
consider including therapist referrals as part of their recruitment strategy and 
whilst the present study found the recruitment rate of two participants a month 
may be achievable three participants per two months may be more realistic. 
 
The present study included two intervention groups (FSTUL and FSTLL), 
where each group was intended to act as control for the other. A statistically 
significant finding for the TUG in the FSTUL group suggests the potential for a 
cross training effect of FSTUL on lower limb function made possible by the 
presence of neuronal coupling. In order to evaluate the effects of FSTLL on 
lower limb function, future trials should include a comparator that targets the 
lower limb, so that confounding results induced by the effects of neuronal 
coupling will not affect the outcome of the study. 
 
The effects of FSTUL were determined using the ARAT and the NHPT, whilst 
the ARAT appears to be a suitable measure for future trials; future use of the 




that the NHPT may not be useful in detecting change in a population of stroke 
survivors who present with a severe impairment of their upper limb.  
 
The effects of FSTLL were determined using the FAC, the TUG and the MRMI. 
It appears that the TUG may have been more sensitive than the FAC although 
there were a number of people that were unable to complete this measure at 
baseline. Future trials of FSTLL where lower limb impairment ranges from mild 
to severe will need to consider a choice of outcome measures that are capable 
of showing change in both these groups of participants. The MRMI was found 
to be an ineffective outcome measure for use within the community setting 
because of the environmental constraints that limited measurement of the final 
two items on this scale. A more acceptable alternative for measuring lower limb 
function other than walking will need to be used in future trials conducted in the 
same setting. 
 
The intervention seemed to be acceptable to the participants in the present 
study however this would need to be investigated in future studies; a qualitative 
component would have facilitated discussion of this aspect of the study.  
 
Based on findings from the present trial future studies evaluating FSTUL versus 
a placebo should aim to recruit 228 participants and studies evaluating FSTLL 
versus a placebo should aim to recruit 74 participants. These calculations are 
based on measuring change in upper limb function using the ARAT and lower 
limb function using the FAC. 
 
The purpose of this phase II trial was not to investigate clinical efficacy, 
however results from this and previous studies suggest that FSTUL might be 
an efficacious intervention for improving upper limb function both early and late 
after stroke. This hypothesis requires testing in a subsequent trial. In this study 
findings in response to FSTLL were equivocal; however this may have been 
because of inadequate power to detect a change in lower limb function 
measured using the FAC. It is also possible that FSTLL was delivered in too 
small a dose for it to have been effective. Future studies could include dose 




useful to consider the specific clinical characteristics that would respond to 
these interventions, so that FST can be targeted at those who are most likely 





6.0 Secondary analysis 
This chapter describes the secondary analysis of the results from the phase II 
study of functional strength training in the upper limb and the lower limb. The 
intention for this chapter was to determine whether there was any information 
that could be derived from the study that might contribute to the discussion 
around it’s feasibility. The implications of any findings will be discussed in the 
following chapter (seven). Secondary analysis of the upper limb group will first 
be presented followed by the analysis of the lower limb group. In both cases 
analysis will focus on the primary outcome measures, further analysis of the 
secondary outcome measures is limited because of the quantity of missing data 
for all of these. 
6.1 Secondary analysis of upper limb group 
The following box plot shows the Action Research Arm Test (ARAT) scores for 
each group at baseline, outcome and follow up. As expected from the main 
analysis discussed in chapter five, participants who received the upper limb 
intervention have shown a positive change in the ARAT score indicating some 
effect of FST-UL, although this effect was reduced by the follow up 
measurement time point.  
 




The following analysis will investigate the individual participant responses to 
FST-UL by examining their respective scores at each of the time points above. 




Figure 12: Line graph showing individual scores for each participant at three time points 
 
Figure eleven shows the individual responses to FST-UL, participants who 
were found to have a change score on the ARAT between outcome and 
baseline or follow up and outcome of greater or less than 5.7 were then 
extracted and a second chart was created. A change score of 5.7 was deemed 
to be clinically significant (van der Lee et al., 2001b) thus the individual 
characteristics of participants showing a change score of greater or less than 





























Figure 13: Line graph showing baseline, outcome and follow up scores for participants with a change score 
greater than or equal to 5.7 
In order to determine whether there were any particular characteristics that 
might be associated with either a positive or negative change on the ARAT 
score at outcome the following table lists each of these participants and the 
individual variables that were collected as part of the main study. The first 
participant listed was the only individual with an ARAT score which decreased 
by greater than or equal to 5.7 points. All other individuals in this sample 
showed a clinically significant improvement and have been displayed in 
ascending order of change score on the ARAT.  
Participant FEST134 became ill during the study and therefore was not able to 
fully take part (he received only 26% of the intended dose of the intervention), 
this may have accounted for his deterioration in the ARAT score at outcome. 
FEST106 made the most improvement in the ARAT score at outcome and went 
on to improve at follow up and yet it appears that he received the least amount 
of FST-UL of those participants displayed in the table below (excluding 
FEST134). 50% of the participants who showed a clinically significant change 
at outcome deteriorated at follow up, although only one participant decreased 
by greater than 5.7. This participant was the only participant to receive the 
intervention at the day centre she attended three times a week; she lived alone 





















It appears from this table that there this little to guide future studies in terms of 
individual participant characteristics collected as part of this study for those 
who did or did not respond to FST-UL.  
The following analyses will go on to investigate whether there is any correlation 
between the change scores on the ARAT at outcome and follow up and the 
total sample of participants who received the upper limb intervention and the 
variables that were collected as part of the main trial. As shown in the table 
above these variables are: therapy time, age, side of stroke, male/female, time 
since stroke and severity of stroke. The relatively small number of participants 
in this study is likely to prevent any definite conclusions being made about the 
presence of a relationship or not between the variables. But they may be able 

























FEST134 -9 1 80 6.4 PACS Right 371 Severe Male 
FEST152 6 0 87 10.9 PACS Left 1125 Severe Male 
FEST128 8 -2 76 17.1 POCS Left 1220 Moderate Female 
FEST142 11 2 71 14.0 TACS Right 987 Severe Male 
FEST102 12 -2 67 43.5 PACS Right 1170 Severe Female 
FEST108 12 2 70 45.9 LACS Right 1350 Mild Male 
FEST123 14 -7 78 12.0 LACS Left 1040 Severe Female 
FEST138 17 -3 36 6.7 POCS Left 1020 Severe Male 
FEST106 23 5 60 48.3 LACS Right 970 Severe Male 
 





6.1.1 Analysis of correlation between baseline and outcome difference for the 
ARAT and therapy time. 
 
 
Figure 14: Scatter plot to show correlation between therapy time and change score of the ARAT at outcome 
This scatterplot shows the relationship between the change score at outcome 
for the ARAT and the amount of therapy time that each participant received for 
each of the intervention groups and also for the total sample. The graphs show 
the possibility of some correlation between the amount of therapy received and 
greater change scores for the ARAT in the upper limb group, however this 
relationship is not statistically significant (p=0.11). As previously mentioned the 
lack of a statistically significant relationship is not unexpected given the small 
sample size, future studies may however wish to consider the potential for a 






6.1.2 Analysis of changes occurring between baseline and outcome for the ARAT 
and age of the participant. 
The scatterplots below show no relationship between age and the change in 
ARAT score at outcome for either group. Participants spanned a wide age 
range with arguably some clusters of participants around 50-60 years and 70-
80 years.  
 
 
Figure 15: Scatter plot to show correlation between age in years and change score of the ARAT at outcome. 
 
In this study, age was found to correlate significantly with the baseline ARAT 
score (p=0.01). Figure 13 shows this relationship which indicates that as age 
increased so did the baseline ARAT score, suggesting  that older participants 
were more severely affected by the stroke with respect to upper limb activity 















6.1.3 Analysis of changes occurring between baseline and outcome for the ARAT 
and the side of the hemiplegia for each participant. 
The histogram below shows the relationship between the change in ARAT 
score at outcome and the side of hemiplegia in the upper limb group. and then 
the lower limb group. There doesn’t appear to be a relationship between these 
two variables, there appears to be similar proportions of participants with both 
right and left sided hemiplegia who have achieved similar outcomes measured 




Figure 17: Histogram showing relationship between side of hemiplegia and change in the ARAT score at 






Figure 18: Histogram showing the relationship between the side of hemiplegia and change in the ARAT score 




6.1.4 Analysis of changes occurring between baseline and outcome for the ARAT 
and gender of each participant. 
 
The following histogram shows the relationship between the gender of the 
participant and the change in ARAT score at outcome. As for the previous 
charts these seem to show little correlation between these two variables. 
 
Figure 19: Histogram to show relationship between the gender of the participant and the change in ARAT 






Figure 20: Histogram to show relationship between the gender of the participant and the change in ARAT at 













6.1.5 Analysis of changes occurring between the baseline and outcome for the 
ARAT and time since stroke onset. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
 
Figure 21: Scatterplot of change in ARAT score at outcome and time between stroke onset and recruitment to 
the study 
This scatter plot shows the time between stroke onset and recruitment to the 
study plotted against the change score in the ARAT at outcome. None of the 










6.1.6 Analysis of changes occurring between the baseline and outcome for the 
ARAT and severity. 
In order to determine whether there is any relationship between the severity of 
the stroke and the change in ARAT score at outcome, the change score has 
been plotted against the baseline ARAT score. Higher scores on the ARAT 
indicate the participant has been mildly affected by the stroke in terms of upper 
limb recovery and lower scores indicate increased severity. 
 
Figure 22: Scatterplot to show relationship between change in ARAT at outcome and ARAT score at baseline 
 
These plots appear to show no relationship between the change in ARAT at 
outcome and the baseline ARAT score as an indicator of severity. For the 
purposes of the study the ARAT was classified as mild (39-57), moderate (20-
38) and severe (0-19). The following plot shows the change in ARAT score at 





Figure 23: Scatterplot to show relationship between Change in ARAT at outcome and severity as categorised 
by the baseline ARAT score 
 
This plot seems to suggest that those participants who have been more 
severely affected by the stroke in terms of upper limb function have shown 
greater changes on the ARAT at outcome. Six out of the eight participants with 
a clinically significant change on the ARAT at outcome were also categorised 
as severe, suggesting that there may be some correlation between these 
categories and changes on the ARAT. This will be discussed in the following 
chapter. 
6.2 Follow up 
Figure 11 indicates no change at follow up, secondary analysis was carried out 
for each of the variables as for the results at outcome. There was nothing to 
note from these analyses. Subsequent plots and graphs have been included in 




6.3 Secondary analysis of lower limb group 
The following analysis will consider the relationships between the changes 
incurred by the lower limb group following FST-LL. The box plot below shows 
the range of scores obtained by each group at baseline, outcome and follow up 
for the Functional Ambulation Categories (FAC). This plot shows no change in 
the FAC for the group receiving the lower limb intervention at either outcome 
or follow up. The change in lower limb function measured by the FAC seen in 
the upper limb group has been discussed in chapter five.  
Once again further analysis of the potential for a relationship between the 
variables and any change in outcome in the lower limb group will focus on the 
primary outcome measure as there was insufficient data from the secondary 
outcome measures. 
 
Figure 24: Box plot of FAC scores at baseline, outcome and follow up 
 
The following plots show the individual responses to FST-LL. Any participant 
who increased or decreased their score by 1 (clinically significant difference) at 




individual characteristics for those who responded well or badly to the 
intervention. These plots are shown below. 
 
 
Figure 25: Line graph showing baseline, outcome and follow up FAC score for all participants in the lower limb 
group 
 
Figure 26: Scatterplot showing participants who showed a clinically significant increase or decrease in the FAC 












































The following table shows the characteristics collected as part of the main study 
for each of the participants in the plot shown above. FEST127 was the only 
participant to show a drop in the FAC score at the outcome measurement time 
point although this was reversed at follow up. There appears to be nothing of 
noteto suggest why this participant responded in this way. He was a relatively 
young gentleman who lived with his partner and who received 75% of the 
intervention. FEST139 made the most improvement in the lower limb group at 
outcome (2 points on the FAC). Again there appears to be little of note in the 
characteristics that were collected as part of this study that would suggest any 
reason for this. This lady lived alone in a bungalow but received only 52% of 
the intervention. She missed two of the appointment dates because of ill health 
but was only able to tolerate a mean of 32 minutes of FST-LL per session 
although this increased incrementally as the study progressed.  
FEST122 showed the greatest drop in FAC score at follow up, however this 
was likely to be due to factors unrelated to the study. Following the study the 
gentleman was diagnosed with an infected hip replacement which would have 




































FEST127 -1 1 50 10.7 TACS Right 1080 Severe Male 
FEST135 0 1 63 21.7 POCS Left 856 Severe Male 
FEST122 0 -2 51 14.9 PACS Right 445 Severe Male 
FEST136 0 1 49 18.7 PACS Right 917 Severe Male 
FEST149 1 -1 79 6.2 PACS Right 752 Moderate Male 
FEST139 2 0 62 14.3 TACS Left 704 Severe Female 




The following analyses will go on to investigate whether there is any correlation 
between the change scores on the FAC at outcome and the total sample of 
participants who received the lower limb intervention and the variables that 
were collected as part of the main trial. Once again these variables are: therapy 
time, age, side of stroke, male/female, time since stroke and severity of stroke. 
The analysis will not be repeated for the follow up scores as there was no 
change for the total sample between outcome and follow up (see figure 21). 
This analysis is likely to be limited by the finding that the majority of participants 
within the lower limb group experienced no effect of FST-LL. Therefore it is 
unlikely to provide any further information than that that’s has been determined 
from the individual participant descriptions above. 
 
6.3.1 Analysis of correlation between baseline and outcome difference for the FAC 
and therapy time. 
The following scatterplot plots the difference between the outcome and 
baseline FAC score against the intervention time. The plot shows no correlation 
but the outliers and analysis of individual participants described above show a 






Figure 27: Scatterplot to show correlation between therapy time and change score on the FAC at outcome 








These graphs suggest no correlation between age and change score at 
outcome for the FAC. 
Age was subsequently plotted against the baseline FAC score to see if there 
was any relationship between age and severity of stroke as measured by the 
FAC. 
 
Figure 29: Scatterplot to show relationship between age and the baseline FAC score 
This plot suggests that age was negatively correlated with the baseline FAC 
score suggesting that older participants were more likely to present with a 
severe lower limb impairment compared to younger participants. This 
relationship was statistically significant (p=0.01). 
6.3.3 Analysis of correlation between baseline and outcome difference for the FAC 
and the side of the hemiplegia. 
The following histogram shows more variance in the change scores at outcome 
for the FAC in those participants with a left sided hemiplegia in the lower limb 
group but in light of the low numbers of participants this is unlikely to be 






Figure 30: Histogram showing the relationship between the side of hemiplegia and change in the FAC score at 
outcome for the lower limb group 
 
Figure 31: Histogram showing the relationship between the side of hemiplegia and change in the FAC score for 




6.3.4 Analysis of the correlation between the baseline and outcome difference for 
the FAC and gender difference 
 
The following histograms show the relationship between the gender of the 
participant and the change score in the FAC at outcome. As for the graphs 
displayed above there appears little of note for future studies.  
 
Figure 32: Histogram to show the relationship between the gender of the participant and the change in the 





Figure 33: Histogram to show the relationship between the gender of the participant and change in the FAC at 
outcome for the upper limb group 
 
6.3.5 Analysis of the changes occurring between the baseline and outcome score 
of the FAC and time since stroke onset 
 
The scatterplot below shows no relationship between the change scores in 





Figure 34: Scatterplot of change in FAC score at outcome and time between stroke onset and recruitment 
 
 
6.3.6 Analysis of the changes occurring between the baseline and outcome score 
of the FAC and severity 
 
The change score in the FAC between baseline and outcome has been 
plotted against the baseline score of the FAC to see if there is any correlation 





Figure 35: Scatterplot to show relationship between change in FAC at outcome and FAC score at baseline 
 
Severity according to the FAC was categorised in the following way: a score of 
4+ indicates mild, 3 indicates moderate and less than or equal to 2 indicates 
severe. The following plot shows the change score of the FAC at outcome 
plotted against these categories. The plot does not show a relationship 









Figure 36: Scatterplot to show relationship between the change in FAC at outcome and severity as categorised 
by the baseline FAC score 
 
6.4 Follow up 
Figure 21 indicates no change at follow up, secondary analysis was carried 
out for each of the variables as for the results at outcome. There was nothing 
to note from these analyses. Subsequent plots and graphs have been 















The aim for this chapter is to reflect on the findings from both the systematic 
review and the feasibility study presented earlier in order to consider the final 
aim stated in chapter three. 
Aim 4: To present a novel intervention combining the results of the studies 
conducted fulfilling aims one, two and three in order to suggest how a motor 
learning framework could inform the delivery of physical therapy 
interventions as part of movement rehabilitation after stroke. 
 
The MRC Framework for developing and evaluating complex interventions 
described in chapter two has been used throughout the thesis to underpin the 
conceptual development of both the systematic review and the phase II study.  
This current chapter goes on to present a novel intervention which has evolved 
from the findings of the two previously described studies. Reflection on these 
studies and the secondary analysis presented in chapter six as well as the other 
literature that has been incorporated within this thesis suggests several ways 
in which this novel intervention could be designed and developed. The MRC 
Framework illustrated by the diagram presented in section 2.1 shows a cyclical 
process with arrows indicating a two way relationship between ‘feasibility and 
piloting’ and ‘development’ (Craig et al., 2008).  Thus within the context of the 
framework it would be desirable to return to the ‘development’ stage in order to 
refine both design and delivery of the novel intervention.  
 
Discussion of the findings from both the systematic review and the phase II 
study have identified further consideration could be given to developing 
broader aspects of the novel intervention in terms of motor learning principles, 
the identification of characteristics for people who respond most to the 
intervention and dose of the intervention. Aspects of study design that could be 
further refined include the incorporation of different methods of delivery such 




setting and follow up strategies after the end of the intervention phase to 
improve adherence. 
 
This chapter will present a summary and key findings from both studies as 
discussed in chapters four and five and embed these findings into the 
presentation of the novel intervention. Further potential steps to develop both 
the intervention and future study designs will then be discussed. 
 
7.2 Summary from Systematic Review  
A review of the background literature supporting the development of motor 
learning principles identified principles of mental practice, instructions, 
feedback, practice intensity, variability of physical practice and practice 
specificity. Mental practice of an action is believed to increase excitation within 
the movement execution system of the brain, in a manner that is similar to the 
action being performed. This increase in CNS activity has been referred to as 
priming (Stinear et al., 2008). The motor learning principle ‘mental practice’, 
was therefore renamed ‘priming’. Thus the following definitions for each of the 
motor learning principles were established: 
Priming - Interventions that are reported to have a motor learning effect 
because they increase neural excitability in the movement execution system. 
Instructions – given to the participant directing their attention to either an 
external or internal focus.  
Feedback - refers to information given to an individual about their performance, 
and which can be used as a basis for improvement. 
Practice Intensity – refers to the amount of practice required to achieve learning. 
Variability of practice – refers to the scheduling of practice, which can be 
blocked or random. 
Practice specificity – refers to the similarity between the task practice conditions 
and the final task that needs to be learnt. 
 
Stroke survivors may not recover sufficient movement to take part in physical 
practice, therefore the motor learning principles were subsequently grouped 




was ‘little/no movement’ recovery or whether they would be used to ‘augment’ 
the physical practice.  
 
Evidence suggesting that stroke survivors may not be able to engage in implicit 
learning in the same way as individuals without a CNS lesion was discussed. 
This established a need to identify the effectiveness of the application of motor 
learning principles with stroke survivors. The narrative review of the published 
literature in this field revealed that robust systematic reviews existed for the 
application of intensity of practice and aspects of practice specificity i.e. task 
specific practice. These were therefore not included within the subsequent 
systematic review for this thesis. The application of feedback had also been 
investigated, however, there were limitations in this body of work, therefore this 
was included within the present review.  
 
Twenty five studies were subsequently included. Closer examination of these 
studies revealed considerable heterogeneity of outcome measures within the 
impairment domain of the ICF. In order to provide summary findings from this 
review therefore, the decision was taken to exclude studies that had not 
evaluated outcome using a measure within the activity domain. Sixteen studies 
were subsequently taken forward into the summary analysis and where more 
than one study had used an outcome measure meta-analysis was carried out.  
 
Table 23 in chapter four provides a summary of the findings from the systematic 
review. Individual studies showed statistically significant results in favour of the 
experimental intervention for the application of motor learning principles within 
the no/little movement/lower limb category for the Timed Up and Go (p>0.01 
Ng and Hui-Chan, 2009) and in the no/little movement/upper limb category for 
the Frenchay Arm Test (p=0.0005 Ertelt et al., 2007). Where more than one 
study used the same outcome measure meta-analysis was carried out.  The 
meta-analysis results for both these categories for timed walking speed and the 
Action Research Arm Test  were not statistically significant (Timed walking 
speed, p=0.57 and Action Research Arm Test, p=0.11). The only motor 




therefore these results represent the effects of the application of this motor 
learning principle only.  
 
Meta-analysis of three outcomes in the augmenting/lower limb category found 
no effect of the motor learning principles included in this category (Berg 
Balance Scale, p=0.77; Timed Up and Go, p=0.84 and timed walking speed, 
p=0.73). Results of the augmenting/upper limb category were derived from 
three individual study findings as meta-analysis was not possible, these studies 
all showed a statistically significant result in favour of the experimental 
intervention. (Box and Block Test, p=0.015 (Carmeli et al., 2011); Action 
Research Arm Test, p=0.05 (Crow et al., 1989) and Chedoke Arm and hand 
Inventory, p=0.025 (da Silva et al., 2011). Interpretation of findings from the 
augmenting/lower limb category reflected the effects of different motor learning 
principles (practice specificity and feedback). The inclusion of more than one 
motor learning principle within a category for the purposes of meta-analysis 
was criticised in chapter four as it prevented any ability to discern an effect of 
either motor learning principle. A recommendation for reviews in the future to 
avoid such categorisations was therefore made. 
 
The systematic review limited the inclusion of studies to only those which were 
designed as RCTs. It was intended that this inclusion criteria would increase 
the validity and reliability of any subsequent findings of the review. In light of 
the lack of RCTs within this field of rehabilitation however further reflection was 
given to this decision. Alternative study designs may offer different insights into 
understanding alternative aspects of the application of motor learning principles 
(Black, 1996). Thus their inclusion within the formal review may have proven 
useful. It is worth noting though that the extensive literature search that was 
undertaken as part of the systematic review identified a number of studies 
which did not meet the inclusion criteria but were reviewed as part of the 
background chapter for this thesis. This body of work has also been used to 
inform the development of the novel intervention discussed later on in this 





The paucity of empirical evidence surrounding the application of motor learning 
principles in physical rehabilitation of movement impairments following stroke 
would suggest that further work needs to be carried out before moving forward. 
However their application to clinical practice is already established through the 
work of pioneers such as Carr and Shepherd (2003). Further pilot/evaluative 
work does need to be continued into the application of each of the motor 
learning principles, but as was proposed in chapter two of this thesis, the use 
of a framework could help to reduce the heterogeneity currently observed within 
both research and clinical practices and provide a common method of 
communication. The framework presented below (see figure 37) has been 
modified from that used in the systematic review because that framework 
included the categorisation of the motor learning principles into the two 
categories of ‘no/little movement’ and ‘augmenting’. During the discussion of 
the findings of the systematic review this categorisation was deemed 
inappropriate because motor learning principles related to instructions, practice 
specificity and practice intensity could be applied to a physical therapy 











The following section summarises the findings from the feasibility study of FST 
in people later after stroke. 
 
7.3 Summary from Functional Strength Training Trial 
Muscle weakness is a common symptom of stroke, therefore strength training 
interventions are recommended as part of therapies targeting movement 
recovery following stroke (NICE guidelines, 2013). Functional Strength Training 
is designed to increase muscle strength and subsequently increase an 
individual’s ability to participate in activities of daily living. Previous work 
designed to investigate the feasibility of delivering FST was limited to stroke 
survivors who were within the first three months after stroke. Physiological 
differences underpinning the recovery processes in the early and chronic 
phase of recovery may mean that the impact of FST is different in people within 
these different time phases of recovery. Delivery of FST to people in their own 
homes as opposed to a hospital setting may also affect the feasibility of 
studying this intervention in this group of stroke survivors. A phase II trial was 
therefore carried out to investigate the feasibility of conducting a study which 
delivers FST to improve upper limb and lower limb activity in people who were 
between six months and five years after stroke. The following provides a brief 
summary of the findings, the implications and further discussion of these has 
been given in section 5.4. 
 
Delivering the intervention to people in their own homes had resource 
implications in terms of both time and cost. The initial recruitment strategy had 
to be expanded to include therapist referral as well as via the original plan for 
invitation by letter. By expanding the recruitment strategy the study was 
however able to achieve its’ target of two participants per month. Inclusion 
criteria were altered to include those individuals who presented with the clinical 
features of an anterior circulation stroke rather than relying on imaging 
information only. This change reflected the need to assess participants for 




access imaging information at the time of screening. This resulted in the 
inclusion of some individuals with a posterior circulation stroke. 
 
Findings from the study suggested that two intervention groups (FSTUL and 
FSTLL) each acting as the comparator for the other may not be suitable for 
future studies because of the potential for a cross training effect. This was 
noted because participants receiving the upper limb intervention made 
improvements in the lower limb measures. These findings should be 
interpreted cautiously as the number of participants able to complete the 
outcome measure were small and therefore may not be generalisable. Despite 
this a more appropriate comparator for FST to the lower limb would be 
desirable as the control group intervention in future investigative studies. 
 
The intention had been to deliver the intervention for up to 24 hours per 
participant however this did not prove possible because of cancellations by 
both the research team and the participants. On average each participant 
received 15.94 hours of the intervention. Arguably speaking some cancellation 
is to be expected when attempting to deliver such an intense intervention 
however methods for managing sickness or leave on behalf of the research 
team could be planned for prior to study start up. Future studies may also 
benefit from systematically investigating reasons for participant cancellation so 
that where possible these could also be addressed. 
 
The clinical findings from the study suggested an effect for FSTUL for the ARAT 
(p=0.046) but not FSTLL for the FAC (P=0.573) and there was no effect from 
either intervention at follow up. Reasons for this have been explored in more 
detail in chapter five however it is possible that neither intervention was 
delivered at a dose sufficient to achieve any long term effects. It is also possible 
that the participants were not able to transfer the functional activities that they 
were practising within the intervention phase into ‘real-life’.  
 
The following section will go on to discuss the development of the ‘novel’ 
intervention by incorporating findings from the formal studies presented in this 




7.4 Developing  FST within a motor learning framework 
It was the intention of this chapter to present a novel intervention which had 
been developed from the findings of both the systematic review and the phase 
II study in order to fulfil the final aim of this thesis. However in light of the 
reflections made following both studies it is likely that further development work 
is required before proceeding to the identification of a definitive intervention 
and subsequent evaluation.  The following sections reflect on the findings from 
the systematic review and phase II study in order to suggest future 
developmental steps that relate firstly to a novel intervention and secondly to 
future study designs. 
 
7.4.1 Development of novel/refined intervention 
Priming-observation to imitate, mental practice 
and/or mental imagery
Instructions – Externally focussed instructions, 
activity focussed on placing object
Feedback – extrinsic forms of feedback 
incorporated into practice
Practice Intensity – exact dose currently 
unknown 
Variability of practice – Alter the scheduling of 
practice so that task can be practiced in 
different environments or with different objects
Practice Specificity – Task specific practice in 












The diagram above illustrates how Functional Strength Training could be 
refined to incorporate motor learning principles. The description for each of 
these is given below. 
 Priming (evidence from present systematic review) 
The participant will be asked to engage in interventions that apply the 
priming motor learning principle, this could include observation to imitate, 
mental practice and mental imagery as some examples.  
 Instructions (Fasoli et al., 2002b) 
The instructions for the physical practice of the task will incorporate an 
external focus. In the drinking scenario the participant will be asked to 
take the cup to their mouth and not to focus on the position of the arm. 
 Feedback (evidence from this systematic review) 
Extrinsic forms of feedback incorporated within the physical practice. 
 Practice intensity (Cooke et al., 2010a, Veerbeek et al., 2011) 
Exact dose is currently unknown. 
 Practice variability (Cauraugh et al., 2007, Deprey, 1999) 
In the drinking scenario this could be applied by changing the type of 
cup that the participant drinks with or changing the environment where 
the activity is practiced. Random scheduling of the practice would be 
applied. 
 Practice specificity 
This refers to the similarity between the task practice conditions and the 
final task that needs to be learnt. Task specificity as one application of 
this principle is an integral part of functional strength training and is 
strongly advocated in movement rehabilitation therapies after stroke 
(Langhorne et al., 2010). The functional activity that will be focussed on 
will therefore be identified before commencing any of the experimental 
intervention (goal setting). The environment can also form another 
aspect of practice specificity with practice taking place in context specific 
environments (evidence from present systematic review). 
As identified in chapter four synthesis of the findings from the systematic review 
was limited because of a lack of robust clinical trials investigating the 




stroke. Development of this new/refined intervention was therefore made using 
evidence gained from the literature included in both the systematic review and 
the narrative review of literature described in section 2.1.3. A critique to this 
approach is given in chapter 8, in the following sections developmental work 
relating to the intervention will be described. 
7.4.1.1 Proposals for future developmental work of the novel/refined 
intervention 
- Participant characteristics 
Reflection on the inclusion criteria for the phase II study investigating FST in 
section 5.5 led to the suggestion that further work needs to be carried out in 
order to investigate which participants would respond most effectively to FST. 
Secondary analysis of the findings from the study revealed no relationship 
between any of the participant characteristics that were collected and change 
in the outcome measures for either the FST upper limb or lower limb 
intervention, although this outcome was to be expected in light of the relatively 
small numbers of participants within this study. A review of the individual 
studies included as part of the systematic review similarly revealed no apparent 
relationship between data collected on participant characteristics and response 
or not to the application of the motor learning principles.   
 
Future development of FSTML therefore could include investigations to 
determine whether any participant characteristic (either aspects of behavioural 
clinical presentation or clinical presentation based on lesion location) could 
indicate relative responsiveness to FSTML. Studies using single case 
methodology may be a good way of identifying the characteristics that could be 
entered into an algorithm as a means of predicting response to the intervention, 
as this particular methodology lends itself to detailed analysis based on a 
sample of n=1 (Bowling 2000).  An algorithm using a profile with both clinical 
and imaging features has already been proposed by Stinear (2010) for 
predicting the recovery of motor function after stroke; therefore this approach 





Other characteristics that could be explored may be best determined through 
qualitative methodology.  Previous qualitative studies looking at the use of 
exercise in people after stroke identified that personal aspects such as lack of 
motivation and lack of energy inhibited uptake of exercise (Rimmer at al., 2008) 
but that a desire to improve functional abilities and reduce musculoskeletal 
problems could motivate people to take part (Jurkiewicz et al., 2011). The 
inclusion of a qualitative component into any future study of FSTML may help 
to provide key personal characteristics that would suggest participants were 
more likely to respond to the intervention or identify characteristics that the 
future development of the intervention would need to overcome in order to gain 
participation. The interpretation of these findings would however have to be 
made cautiously as presumably the participants’ willingness to take part in the 
study in the first place indicates some personal motivation toward exercise. It 
would also be useful to explore reasons for non-participation in any study of 
FSTML. 
 
- Dose of FSTML 
The phase II study of FSTUL and FSTLL aimed to deliver the interventions for 
sixty minutes a day over four days a week for six weeks. In the absence of 
robust data from studies with people in the chronic phase of recovery this dose 
of FST was informed by the previous trials of FST (Cooke et al., 2010b, 
Donaldson et al., 2009a). This has been discussed in greater detail in section 
5.5. with the conclusion being that a prospective dose finding trial would be 
desirable. Subsequent secondary analysis of the study findings did suggest the 
possibility of a dose response relationship for the FSTUL group which supports 
the premise that further investigation of this aspect of FSTML is warranted.  
 
Confounders within previous studies that have tried to determine dose have 
tested the study intervention against a placebo or another intervention and 
therefore have not compared different doses of the same experimental 
intervention (Cooke et al., 2010a, Veerbeek et al., 2011). Designs which may 
be more suitable could test FSTML in different doses and measure the point at 
which an effect plateaus, one example of this is seen in the dose finding trial 




30 minutes, 60 minutes and 120 minutes (Hunter at al. 2011). This model has 
been repeated in a more recent study by Han et al. (2013) who investigated 
the relative effects of either 1 hour, 2 hours or 3 hours of an upper limb 
rehabilitation programme. Despite an attempt to control for dose, interpretation 
of the findings from these studies may still be confounded by differing views on 
what factors constitute dose. For example, it is unclear whether one hour of 
practice refers to an hour of repetitions of the same movement which, from a 
pragmatic point of view would seem difficult to sustain from both the point of 
view of muscle fatigue and/or participant motivation, or whether this refers to 
an intervention which incorporates all upper limb movement regardless of 
repletion or body region. The convention applied in the phase II study of FST 
presented in this thesis was to record time spent carrying out the intervention 
irrespective of whether this time was spent focussing on wrist and hand 
movements, shoulder movements or both. Until consensus can be reached the 
interpretation of the results from dose findings trials need to be supported by 
the publication of clear protocols identifying how dose has been applied within 
each study.  
 
Findings from the feasibility study of FST presented in this thesis found no 
evidence of continuing effect of the intervention at follow up and changes that 
occurred at outcome following FSTUL were not sustained. Early phase studies 
of strengthening interventions suggested that there is the potential for a ‘carry-
over’ effect of the intervention at least six months after the end of the 
intervention phase (Patten et al. 2006 and Sullivan et al. 2006). Both Patten et 
al. (2006) and Sullivan et al. (2006) suggested that the longer term effects of 
the intervention were the result of the intensive training programmes.  
 
Prospective dose findings studies of FSTML also need to include an 
investigation into the relative effects of the varying doses of the intervention at 
time points following the end of the intervention phase. This will determine 
whether dose could influence the possibility of sustained effects for FSTML. 
 
The previous sections have described how the novel/refined intervention 




review and the phase II study of FST suggest further work needs to be carried 
out to understand who might or might not respond to FSTML and the need for 
prospective dose finding trials. The following sections will consider how future 
studies could be designed. 
7.4.1.2 Proposals for future development of the study design 
As discussed earlier one of the findings from the phase II study of FST was the 
absence of data suggesting that the participants had any lasting effects of the 
intervention six weeks after delivery of the intervention had ceased. Further 
investigation into the effects of different doses of FSTML was suggested as 
one means of determining whether effects could be sustained in the longer 
term. However if the increased dose of FSTML was delivered as per the phase 
II study of FST there would be continued reliance on the presence of a therapist 
to deliver the intervention. Domain two of the NHS outcomes framework 
emphasises the need to help people with long term conditions such as stroke 
to live as independently as possible. (NHS England, 2014). The continued 
development of an intervention that leads to dependency on a healthcare 
practitioner therefore seems counterintuitive. Thus the design of a future study 
delivering FSTML could include methods for reducing the reliance on a 
therapist.  
Strategies suggested in section 5.5.5 that have emerged from the literature 
around the application of motor learning principles, and that might enable 
participants to engage with FSTML without the presence of a therapist, were 
through the use of adjuncts such as virtual reality (VR). Virtual reality has the 
potential to offer a learning environment which is more enjoyable, task and 
environment specific and is able to provide feedback on performance 
characteristics (Laver et al. 2011).  The systematic review presented in this 
thesis identified three studies that had used VR as a method for applying motor 
learning principles (Yang et al., 2008, Mirelman, 2010 and Da Silva Cameirao 
et al., 2011). The studies by Yang et al. (2008) and Da Silva Cameirao et al. 
(2011) used VR to facilitate practice specificity and the study conducted by 
Mirelman (2010) used it to apply feedback. Each of these studies described the 
presence of research personnel during the delivery of the intervention via VR 




enabling independent practice. The interventions were however successfully 
delivered by a VR system and resulted in little attrition suggesting that the 
participants were engaged with the activities and motivated to take part. One 
method for facilitating independent practice and a reduced reliance on the 
presence of a therapist which has emerged alongside the use of VR is the 
concept of tele-rehabilitation. Tele-rehabilitation involves the use of remote 
conferencing facilities with virtual reality systems to provide training to people 
in their home without the presence of a therapist or healthcare professional on 
site (Holden et al., 2007). Tele-rehabilitation can be used to deliver many 
aspects of stroke care such as nursing interventions as well as exercise 
programmes and a systematic review of these has reported high levels of 
satisfaction with interventions delivered in this way (Johansson and Wild, 2011).  
 
Piron et al. (2009) investigated the effects of a tele-rehabilitation programme 
for delivering an upper limb rehabilitation programme at home compared to 
traditional physical therapy in a small group of stroke survivors (n=36). The 
experimental intervention was delivered via a VR system which could be 
monitored by the therapist through a videoconferencing tool. The VR system 
was able to provide application of the motor learning principles ‘feedback’ and 
‘instructions’ and enabled the participant to practice five virtual tasks. There 
was no difference between the descriptive characteristics of the groups at the 
beginning of the study and both groups received equal amounts of the 
intervention. At the end of the intervention phase both groups had made 
improvements in the Fugl-Meyer upper extremity test (p<0.05) although these 
improvements were greater in the experimental intervention group (mean 
change of 5.1 compared to 2.2). Follow up measurements were taken one 
month after the end of the intervention, results were not statistically significant 
and graphic representation of the findings did suggest a downward trajectory 
although this was inconclusive as no further follow up measures were taken. 
The Fugl-Meyer used in the study by Prion et al. (2009) is a measure of 
impairment and therefore does not indicate transfer to function (Van der Lee et 
al., 2001a). This study was also relatively small and there was no evidence of 
a power calculation therefore findings may not be robust or generalisable 




be as effective at delivering exercises to people after stroke as traditional 
therapy. Future development needs to investigate how best to use this method 
of rehabilitation for facilitating sustained recovery and also transfer to functional 
activities.  
 
FSTML delivered via tele-rehabilitation may be able to provide methods for 
‘long arm supervision’, enhanced motivation and remote contact with therapy 
staff which could prevent the need for intense face to face delivery and possibly 
facilitate adherence to the exercise regime. Thus the development of FSTML 
within this model of delivery may be a useful developmental step as part of 
future study designs. 
 
Another method for delivery of FSTML that could be explored would be via 
groups. Group exercises have been shown to be as effective in delivering 
exercises to people after stroke as one to one physical therapy (van de Port et 
al., 2007) and participants have reported that exercises in a group setting were 
enjoyable because of the social interaction (Pang et al., 2006). Olney et al. 
(2006) investigated the relative effects of either supervised exercises in a group 
setting or unsupervised exercises, participants in both groups showed 
statistically significant improvements in some outcome measures one year 
after the completion of the supervised intervention (e.g. six minute walking test: 
supervised group (0.09+/-0.02 p<0.001), unsupervised group (0.05+/-0.02 
P<0.05)), suggesting some clinical benefit of either intervention however the 
results were better for the supervised group (Olney et al., 2006). Therefore it 
may be useful to consider whether FSTML could feasibly be delivered in a 
group setting and then investigating how this form of delivery would compare 
to ‘one-to-one’. It is possible that the costs of delivering FSTML in a group 
format may be less than one-to-one however as some stroke survivors have 
indicated that travel may be a barrier to participation in exercise programmes 
(Rimmer et al., 2008) the venue for this research study would need to be 
carefully considered. 
 
Assuming FSTML has the potential to be an effective intervention then one 




the end of the intervention phase would lead to improved results at follow up. 
Chapter two discussed some of the barriers to this in people who are within the 
chronic phase of recovery from stroke. Overcoming some of these barriers 
such as reduced levels of activity is likely to require a change in behaviour. A 
review of the literature surrounding intervention fidelity in chapter two identified 
how certain strategies could be incorporated into a study design to promote 
behaviour change. Strategies aimed at ‘enactment of the treatment skills’ relate 
to the transference of the skills learnt within the research study to ‘real-life’ 
settings (Bellg et al., 2004). Presumably if this can be achieved then it is 
possible that the participants will be able to perceive the ‘real-life’ effect of the 
intervention and therefore be motivated to continue with the exercise 
programme.  
 
One way of achieving this could be through the process of goal-setting. The 
active engagement of stroke survivors in the rehabilitation process through 
goal-setting is identified as key within recent guideline and standards 
documents (RCP, 2012; NICE, 2013). In this case goal setting would facilitate 
the identification of relevant task specific exercises which could subsequently 
be incorporated into the FSTML programme. As well as helping to identify 
contextually relevant activities the process of goal setting is believed to 
empower the individual, something which has been identified as a factor in 
increasing adherence to physiotherapy home exercises (Karingen et al., 2011).  
 
Empowerment per se was believed to be the most important factor affecting 
adherence to exercise programmes (Karingen et al., 2011). As well as goal-
setting another factor that was identified as influencing empowerment was the 
awareness that the individual would be followed-up (Karingen et al., 2011). A 
strategy which Olney et al. (2006) also identified as a reason for continued 
engagement in an exercise programme.  A feature such as telephone contact 
for ‘long-arm follow up’ could be incorporated into future studies investigating 
FSTML, alternatively the use of ‘homework diaries’ or log books which are 
regularly reviewed by the research team may also improve the uptake of the 
exercise programme. Log books recording engagement with the intervention 




reliability of the information obtained from them was not reported (Ng and Hui-
Chan 2007; 2009). It is difficult to determine from these studies therefore 
whether these would be effective in ensuring continued engagement as part of 
future studies of FSTML. 
 
7.5 Summary 
The intention for this chapter was to demonstrate how both studies within this 
thesis, could lead to the development of a physiotherapy intervention that would 
aim to improve functional activity after stroke. This intervention incorporated 
the findings from both studies to produce a potential design for a future study 
evaluating FST with applied motor learning principles (FSTML).  Findings from 
both studies in this thesis indicated further developmental work was required . 
Therefore suggestions have been made for studies that would investigate who 
would respond most effectively to FSTML, how much FSTML should be 
delivered to effect a change in functional performance and methods for altering 
the delivery of FSTML so that functional changes are sustained in the longer 
term. 
 
The following chapter will discuss and critique the approach to the development 




8.0 Discussion  
Seventy six per cent of stroke survivors are left with movement impairments 
following stroke (Intercollegiate Stroke Working Party, 2011). Physical therapy 
interventions after stroke aim to eliminate or minimise the effects of these 
impairments so that people can return to activities of daily living. This thesis 
has presented a novel approach to the development of a physical therapy 
intervention by combining the findings from a feasibility study of Functional 
Strength Training with that of a systematic review evaluating the effectiveness 
of motor learning principles used as part of movement rehabilitation after stroke. 
Physical therapy interventions created within this context may enhance motor 
learning and facilitate a better return to movement and activities of daily living. 
Interpretation and discussion of the individual study findings have been 
reported separately within the context of the studies themselves. This chapter 
will discuss and critique development of this novel intervention. 
 
Support for the concept of developing a physical therapy intervention within a 
motor learning context lies within the theoretical stance that recovery of 
movement following stroke is a form of motor learning (Carr and Shepherd, 
2003). This interpretation has been supported by neuroscientists who have 
used experimental findings to conclude that current physical therapy 
interventions are founded within a motor learning construct (Krakauer, 2006). 
It has also been supported by findings from imaging studies that have shown 
that the physiological changes that underpin both motor learning and 
movement recovery from stroke are the same (Kleim and Jones, 2008, Nudo 
and Milliken, 1996, Taub et al., 2002).  
 
The concept of aligning motor learning with movement recovery after stroke is 
not new as evidenced within the Motor Relearning Programme (subsequently 
renamed a Movement Science Approach) (Carr and Shepherd, 2003). Despite 
this the uptake of motor learning principles in movement rehabilitation after 
stroke has been fragmented (DePaul, 2013). There is evidence of the 
application of aspects of practice specificity i.e. task specific practice which is 




al., 2011), and the application of both feedback and practice intensity have 
been the subject of systematic reviews (Molier et al., 2010, Subramanian et al., 
2010, Veerbeek et al., 2011). There is limited evidence however of the 
application of the other motor learning principles identified in this thesis as 
priming, instructions and environmental aspects of practice specificity.  
 
Kleynen and colleagues (2013) have suggested that one reason for the limited 
uptake of motor learning principles in movement rehabilitation after stroke, 
observed by DePaul et al. (2011) may be because of a lack of consensus 
around terminology. The intervention developed in chapter seven of this thesis 
(FSTML) has embedded a physical therapy intervention within a motor learning 
framework. The motor learning principles described in this present framework 
were identified within the context of their theoretical development. This work 
has led to clear definitions for each of these although it is important to note that 
these were the result of the author’s interpretation of this body of work only, so 
would still not represent a consensus of opinion.  
 
The greatest potential for failing to achieve consensus arguably lies in the 
decision to rename the motor learning principle ‘mental practice’ to ‘priming’. 
The action underpinning the effectiveness of mental practice as a motor 
learning principle was an increase in excitation within the movement execution 
system on the CNS. Precedent for the use of the word ‘priming’ to describe this 
type of activity had already been established in the literature. This term was not 
used however within the context of motor learning, but rather to describe a state 
in which the brain may be more responsive to rehabilitation therapies (Stinear 
et al., 2008). Continued use of this term within either context may not 
necessarily be exclusive, but as previously discussed a lack of consensus 
around terminology has been cited as one reason for the poor uptake of motor 
learning principles, therefore an agreed ‘term’ and definition of this motor 
learning principle would be advantageous for the future development of 
physical therapies within this framework (Kleynen et al., 2013). Work related to 
this is currently being undertaken by Kleynen and colleagues through a Delphi 
study (Kleynen et al., 2013), but the theoretical foundation that underpins the 





Subsequent application of the motor learning principles in this framework was 
informed by evidence from studies which evaluated their effectiveness in 
movement recovery following stroke. In light of the potential differences that 
stroke survivors may have in engaging in motor learning compared to that of 
healthy individuals, this is advantageous as the framework can arguably be 
more effectively generalised to physical therapies designed to improve 
movement recovery after stroke. This is in contrast to the framework designed 
by DePaul et al (2011), which has used evidence from studies with healthy 
volunteers to direct the application of some of the motor learning principles in 
their framework.  
 
Application of the framework presented in chapter six may be limited by both 
the changes that were made to the existing framework and inadequacies that 
are inherent within the studies that have been used to support the motor 
learning principles.  
 
Chapter seven presented a revised framework of motor learning principles, 
which had been developed through a critique of the framework used to 
underpin the systematic review. The existing framework had synthesised the 
evidence relating to ‘practice specificity’ and ‘feedback’ within one category. 
For the purposes of the intervention presented in chapter six, meta-analysis 
was not viable because of the heterogeneity present within the outcome 
measures, so it was possible to extrapolate findings from the individual studies 
to inform the delivery of the motor learning principles. If the intervention had 
been targeted at lower limb movement recovery however this could not have 
been achieved as meta-analysis had combined the findings from studies 
evaluating both interventions. Until synthesis of the evidence supporting the 
application of the individual motor learning principles has been achieved 
transferability of the revised framework in chapter seven may be more 
appropriately limited to integration with physical therapies targeting upper limb 





The evidence that has been used to guide the application of the motor learning 
principle to FST&ML have been critiqued within sections of this thesis, whether 
this is evidence that has been derived from the present systematic review 
(chapter four) or discussed in the background chapter (chapter two). The 
weaknesses that have been identified within each of these studies therefore 
compromise the integrity of the present framework. However, until new 
evidence emerges in support of the application of the motor learning principles, 
the design of this framework reflects the available knowledge to date. It is likely 
that as more robust evidence is published this framework will evolve.    
 
8.1 Summary 
If motor learning and motor recovery from stroke are effectively the same then 
it seems appropriate that physical therapy interventions targeting movement 
recovery after stroke should be informed by motor learning principles. This 
thesis has sought to present a novel approach to developing physical therapy 
interventions by establishing feasibility of one such intervention and then 





















This thesis set out to address the following aims: 
The aims of this thesis are to: 
 Aim 1: To systematically identify the relevant literature for inclusion in a 
literature review according to a motor learning framework. 
 Aim 2: To seek to quantify the findings from the review through meta-
analysis where appropriate. 
Objective 1: Establish the evidence for the effectiveness of the 
application of motor learning principles to promote motor learning 
after stroke. 
 Aim 3: To carry out a phase II randomised controlled trial to determine 
feasibility of a physical therapy intervention – Functional Strength 
Training for improving upper limb function and walking in people 
between six months and five years after stroke.  
Objective 2: Establish feasibility of Functional Strength Training 
for improving upper limb function and walking in people between 
six months and five years after stroke by determining likely rates 
of recruitment. 
Objective 3: Establish feasibility of Functional Strength Training 
for improving upper limb function and walking in people between 
six months and five years after stroke by testing procedures for 
acceptability including the choice of outcome measures and the 
pragmatics of delivering the interventions. 
Objective 4: Provide information for calculating a sample size for 
evaluation trials. 
 Aim 4: To present a novel intervention combining the results of the 
studies conducted fulfilling aims one and two in order to suggest how a 
motor learning framework could inform the delivery of physical therapy 





Aim 1 and 2:  
A systematic review of the effectiveness of the application of motor learning 
principles applied to people after stroke to promote motor learning was 
conducted within the context of a motor learning framework that had been 
developed through a review of the theoretical literature. Interpretation of the 
findings from the review offered some support for the effects of the application 
of motor learning principles as part of movement rehabilitation after stroke. 
Although summary analysis was limited by heterogeneity of the outcome 
measures used in the individual studies. Findings about the effects of ‘practice 
specificity’ and ‘feedback’ were difficult to extrapolate because of the 
categorisation used within the design of the motor learning framework. Future 
reviews of the motor learning principles should avoid any categorisation and 
evaluate the evidence for each of the motor learning principles separately.  
 
Aim 3: 
A phase II randomised controlled trial of Functional Strength Training in people 
between six months and five years after stroke proved that both Functional 
Strength Training for the upper limb and Functional Strength Training for the 
lower limb were feasible. Although not inherent within the aims of a phase II 
study, the results suggested some initial evidence of efficacy for the upper limb 
intervention but not the lower limb. However this interpretation needs to be 
tested in an appropriately powered definitive trial. The findings from the present 
study suggested the possibility of a cross training effect between the two 
intervention groups therefore future trials should avoid this design and include 




The findings from both the systematic review and the phase II trial were 
combined to suggest a future intervention that might enhance movement 
recovery of stroke survivors within the chronic phase of recovery from stroke. 
Proof of concept and feasibility of this intervention (Functional Strength 





The underlying goal behind both motor learning and physical therapy 
interventions targeting movement recovery after stroke is inherently the same. 
Thus, by embedding physical therapies within a motor learning context it may 
be possible to enhance their effects. This thesis has aimed to present a novel 
intervention developed within this approach; this work was supported by a 
robust investigation of the relevant literature evaluating the application of motor 
learning principles as part of movement rehabilitation after stroke. The findings 
from this work were then added to the findings from a study of a physical 
therapy intervention. Thus feasibility of this intervention was established before 
developing it within the motor learning context, future work is now required to 
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Abstract 1 
Objective:  Functional Strength Training (FST) might enhance recovery after stroke.  The aim was to 2 
evaluate the efficacy of FST for enhancing upper and lower limb motor function at least six months 3 
after stroke. 4 
Design: Randomised, observer-blind trial.  Measures were undertaken before randomisation (baseline), 5 
after six weeks intervention (outcome) and six weeks thereafter (follow-up). 6 
Setting: Participants’ own homes.   7 
Participants: Participants (n = 52) were six months to five years post-stroke with difficulty using their 8 
paretic upper (UL) and lower limbs (LL)  9 
Interventions: Participants were randomised to  FST-UL or FST-LL by an independent randomisation 10 
service with allocation concealed from the research team until after baseline.  Interventions were 11 
delivered for up to four days each week for six weeks.   12 
Main outcome measures: Primary outcomes were Action Research Arm Test (ARAT) and Functional 13 
Ambulation Categories (FAC).  ARAT analysis ranked individuals and compared mean rank, based on 14 
a regression model, between the two groups using the non-parametric bootstrap.  Analysis of FAC 15 
used the proportional odds model.    16 
Results: ARAT scores were significantly lower in the FST-LL group at outcome (14.2, 22.9, p=0.042) 17 
and follow-up (15.6, 20.3, p=0.019).  There was no difference in FAC scores between groups at 18 
outcome (p=0.654) or follow-up (p=0.925).  The proportional odds assumption for FAC was tested and 19 
no reason was found to reject the fit of the model (outcome: p=0.964); follow-up: p=0.821). 20 
Conclusion: This early-phase trial found that FST could improve motor function of the upper but not 21 
lower limb between 6 months and 5 years after stroke.  22 
Keywords: Stroke; rehabilitation; walking; upper extremity; physical therapy; exercise; functional 23 
strength training 24 
Abbreviations: FST: Functional Strength Training; UL: upper limb; LL: lower limb; ARAT: Action 25 
Research Arm Test; FAC: Functional Ambulation Categories. 26 
*Manuscript without author identifiers
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 27 
List of abbreviations:  28 
FST: Functional Strength Training 29 
UL: upper limb 30 
LL: lower limb 31 
ARAT: Action Research Arm Test 32 
FAC: Functional Ambulation Categories 33 
MRMI: Modified Rivermead Mobility Index 34 
TUG: Timed Up and Go Test 35 
9HPT: Nine Hole Peg Test 36 
IQR: interquartile range 37 
LACS: lacunar anterior circulation stroke 38 
PACS: partial anterior circulation stroke 39 
TACS: total anterior circulation stroke 40 
POCS: posterior circulation stroke  41 
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Introduction 42 
People often experience permanent disability after stroke which impacts adversely on everyday life.  43 
This is an unsatisfactory outcome which could be ameliorated by the provision of task-specific re-44 
training of everyday function
1
.    Participation in functional re-training, however, requires the 45 
production of sufficient voluntary activation of paretic muscle to attain the muscle strength thresholds 46 
required for everyday activity
2
.  Potential way forward is suggested by early phase evidence that 47 
Functional Strength Training (FST), for people up to three months after stroke, could enhance upper 48 
limb (UL) recovery although it might provide little advantage for the lower limb (LL)
4
, except for 49 
habitual gait speed 
5
.   It is not known if these findings are applicable to people who are six months or 50 
more after stroke.   51 
 52 
Most spontaneous recovery occurs during the first three months after stroke
6
.   People who are six 53 
months or more post-ictus are often considered have “plateaued”.  However, further motor recovery in 54 
the chronic phase after stroke does occur
7
.   Consequently, people who are at least six months after 55 
stroke could gain further motor recovery in response to FST.  Benefit might not be restricted to people 56 
in the sub-acute phase after stroke.  57 
 58 
The emergent hypothesis is that people who are six months or more after stroke gain better motor 59 
function in response to FST.  The first step in testing this hypothesis is presented in this article which 60 
reports a single-centre pragmatic randomised controlled trial.  This early-phase trial is congruent with 61 
(a) the UK Medical Research Council framework for trials of complex interventions
8 
and (b) 62 
recognition that advances in stroke rehabilitation will emerge from progressive staging of trials
9
.   The 63 
aims of the early phase trial reported here were: 64 
 To determine whether FST for upper and lower limb can enhance motor function in people who are 65 
6 months to 5 years after stroke and therefore should be evaluated in a subsequent definitive trial: 66 
 To estimate the sample size and recruitment rate for a subsequent definitive clinical trial. 67 




A summary of the methods is given here.  A full description is given in the published protocol 
10
.   70 
Design, setting, randomization and ethics  71 
A two-group, randomised, observer-blind, early phase trial based in participants’ own homes.  The 72 
assessor who conducted the measurement battery at baseline, outcome and follow-up time-points 73 
remained blinded to participants’ group allocation throughout the trial.   Participants were recruited 74 
from: (a) the discharge database of one acute stroke service; (b) the 6-month post-stroke clinic of the 75 
same stroke service; and (c) therapist referral.  After providing informed consent participants 76 
undertook the measurement battery (baseline).  An independent randomisation service, who concealed 77 
group allocation until contacted by a researcher, then used the baseline Functional Ambulation 78 
Category (FAC)
11
 and Action Research Arm Test (ARAT)
12 
scores to minimise any imbalance in 79 
allocation of participants to either FST-UL or FST-LL.  In this trial the FAC was categorised as: mild, 80 
score 4+ (walk independently on level ground but requires assistance with stairs, slopes etc); moderate, 81 
score 3 (requires the verbal supervision and/or stand-by help of one person); severe, score 2 or less (the 82 
continuous or intermittent assistance of one person is needed).  The ARAT was split into categories of: 83 
mild, score 39-57 (when 57 indicates normal completion of all items); moderate, score 20-38 (38 = 84 
able to complete all items but either slowly or abnormally); severe, score 0-19 (when 19 indicates the 85 
ability to complete all items in part).   The design of allocation of participants to either to FST-UL or 86 
FST-LL was used to minimise the potential confounder of one group receiving(a)  less therapy than the 87 
other and (b) an inactive therapy
10
.  Although there could be a clinical expectation of a cross-training 88 
effect between the upper and lower limbs this is not supported by clinical research evidence
10
.  89 
 90 
A research therapist provided participants with their allocated intervention for up to one hour a day, 91 
four days a week for six weeks.  On completion of the intervention phase participants undertook the 92 
measures (outcome) and 6 weeks thereafter (follow-up) (Fig 1).    93 
5 |  P a g e
 
 94 
Ethical approval was granted by a local Research Ethics Committee (ref: 09 H0308 147).  The Current 95 
Controlled Trials registration ID was ISRCTN71632550. 96 
 97 
Study Population and sample size 98 
Study criteria were  similar to those in our earlier studies
3,4
: 99 
 aged 18+ years between 6 months to 5 years after a stroke (infarct or haemorrhage)  in the anterior 100 
circulation (anterior or middle cerebral artery); 101 
 able to walk four steps with support from one person and/or an assistive device, but in 15 seconds 102 
unable to step on and off a 7.5cm high block, with either leg, more than 14 times (Step test
13
); 103 
 able to move the paretic hand from lap to table surface, but unable to pick up £1 coins individually  104 
and stack four in an even pile; 105 
 able to follow a 1-stage command with the non-paretic upper limb; 106 
 no known pathology contraindicating participation in FST;    107 
 not participating in formal upper or lower limb physical therapy. 108 
 109 
A power calculation estimated that 26 participants per group would have 90% power at 5% 110 
significance (2-tailed) to detect a change of: (a) 1 point on the FAC
11
 with the assumption that the  111 
standard deviation (SD) would be 1;  and (b) 5.7 points on the ARAT
12,
 with the assumption that the  112 
SD would be 5.7 
14
.   The authors were unable to find published data to inform the choice of the 113 
clinical important difference for the FAC.  Choice of 1 FAC point was therefore based on the clinical 114 
experience that the broad categories reflect walking recovery milestones for stroke survivors. 115 
 116 
Functional Strength Training 117 
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FST provided in the present study has been previously described therapist
3,4,10
.  In essence FST 118 
involves repetitive progressive resistive exercise during goal-directed functional activity
3,4,10
.  119 
Examples of exercises used in this trial include variations of: 120 
 reaching, picking up a jug containing water  and pouring contents into a container; 121 
 picking up a container and removing the screw lid; 122 
 reaching down to a foot and then using both hands to lace up a shoe; 123 
 picking up and then moving everyday objects of various weights and size  to position them in a 124 
different locations of diverse heights. 125 
FST-LL exercises included: 126 
 Standing up and sitting down; 127 
 Ascending and descending stairs and/or using a block for step up/step down exercise; 128 
 Practice of balance activity including one-leg standing; 129 
 Walking whilst avoiding and/or stepping over obstacles. 130 
Activities were progressed systematically, increasing the amount of resistance and number of 131 
repetitions.   Resistance was varied using external resistance bands/weights and also increasing task 132 
difficulty through strategies such as decreasing seat height for sit/stand activities and 133 
increasing/decreasing the requirement for hand grip span.   If participants became fatigued, presenting 134 
as increasing difficulty in performing the activities, the therapist initially changed activities or offered 135 
a rest period until either one-hour of therapy was completed or it became apparent that the participant 136 
was unable to continue with the intervention that day. 137 
 138 
Outcomes 139 
At six months or more after stroke the changes of interest are largely those that make a difference to 140 
how people are able to use their more affected limbs for functional activity.   Primary outcomes were 141 
therefore the FAC
11
 for lower limb function, and the ARAT
12
 for upper limb function.   Secondary 142 
outcomes were the Modified Rivermead Mobility Index (MRMI)
15   
and the Timed Up and Go Test 143 




to assess mobility  (lower limb function)  and Nine Hole Peg Test (9HPT)
17
 to assess hand 144 




Statistical analysis  149 
First, a full-case analysis was performed in which all individuals with outcome data were included 150 
according to the assigned treatment group. Second, an intention-to-treat analysis with all individuals 151 
included was conducted by imputing the values for those missing. The method for imputing the 152 
missing data was iteratively chained equations with all outcome measures included, prognostic 153 
baseline factors and treatment group.  154 
 155 
ARAT was analysed by ranking each individual and comparing the mean rank, based on a regression 156 
model with the minimisation variables included, between the two groups using the non-parametric 157 
bootstrap.  FAC categories were compared using the proportional odds model with group and 158 
minimisation variables included. The proportional odds model assumption was tested. FAC categories 159 
were further categorised to ensure that sufficient numbers were included in each category; the 160 
classification was 0-1, 2-3 and 4-5. The MRMI was compared between groups by bootstrapping the 161 
difference in the mean rank based on a regression model with the minimisation variables included. The 162 
TUG was analysed by firstly comparing those individuals who could complete the task and then by 163 
comparing the time using a log-transformed linear regression model including group and the 164 
minimisation variables. Data for the 9HPT was analysed by comparing the number of people in each 165 
group who could complete all 9 pegs in 50 seconds on at least one of three attempts. 166 
 167 
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To estimate the parameters needed for a formal sample size calculation for a subsequent pragmatic 168 
trial the variation in outcome measure was estimated from the primary analysis and the recruitment 169 
and attrition rates predicted from those in this trial.  170 
 171 
The analysis was undertaken according to the predefined statistical analysis plan, agreed with the Trial 172 
Steering Committee prior to the un-blinding of the data.  This led to using different specific statistical 173 
tests as were specified in the protocol 174 
 175 
Results 176 
Recruitment, attrition and characteristics of participants 177 
The CONSORT flowchart gives details of screening, recruitment and attrition during this early phase 178 
trial (Fig 1).   In brief, 1,127 stroke surviors were assessed for eligibility and 1,075 were excluded.  179 
The remaining 52 provided informed consent.  Twenty-seven participants were allocated to FST-UL 180 
with all receiving their allocated intervention  and 25 to FST-LL with 23 receiving their allocated 181 
intervention.  Attrition rates were 11% and 15% for FST-UL and 20% and 16%  FST-LL at outcome 182 
and  follow-up respectively.  183 
 184 
Table 1 provides participants’ characteristics.  In summary, participatns were a mean of 24.4 months 185 
after stroke with a mean age of 68.3 years.  The median scores for ARAT and FAC were 15.7 (total 186 
possible is 57)  and 2.5 (total possible is 5) respectively.  All characteristics were balanced across the 187 
two groups except for stroke classification.  The FST-UL group had a higher percentage of people with 188 
a partial anterior circulation stroke and the FST- LL had a higher percentage of people classified as 189 
having a lacunar stoke or posterior circulatory stroke (see fidelity section).  190 
 191 
Fidelity to trial protocol 192 
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All participants received intervention as allocated except one participant who withdrew from the FST-193 
LL group as he wanted FST-UL.  The content of FST-UL and FST-LL was consistent with the 194 
protocol (Table 2) and the amount of therapy was essentially the same in the two groups (Table 3).  195 
For the participants recruited via referral from therapists it was not possible to access the clinical 196 
neuroimaging information in a timely way to confirm stroke location.  Inclusion or otherwise was, 197 
therefore, based on clinical presentation.   This resulted in the inclusion of four participants who were 198 
subsequently identified to have a stroke affecting the posterior circulation (Table 1).    199 
 200 
Adverse reactions 201 
No adverse reactions were experienced by any participant in this trial. 202 
 203 
Efficacy of Functional Strength Training  204 
Table 4 displays the results for the primary and secondary outcomes.   There was a significant 205 
difference in the ARAT scores (primary outcome) between the groups with the lower limb group 206 
having a lower score at both outcome (p=0.042) and follow-up (p=0.019).   There was no difference in 207 
the FAC scores between the groups at either outcome (p=0.654) or follow-up (p=0.925).   The 208 
proportional odds assumption for FAC was tested and no reason was identified to reject the fit of the 209 
model (outcome: p=0.964; follow-up: p=0.821).  The only secondary outcome to show a significant 210 
difference was the TUG at outcome (p=0.047) with the lower-limb group completing the test in a 211 
shorter time. However, that analysis only includes individuals who were able to complete the TUG and 212 
fewer individuals in the lower-limb group could complete this.  213 
The results of the imputed data, in terms of the effect sizes and significance levels, are similar to those 214 
of the observed and are therefore not presented.  215 
 216 
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 Using actual standard deviation data from ARAT and FAC scores from this trial and the drop-out rate, 217 
the estimated sample size to provide 90% power at 5% significance for a subsequent multi-centre trial 218 
is 150 participants per group to detect a 5.7 unit change in ARAT and 57 per group to detect a 1.0 unit 219 
change in FAC.   220 
 221 
Discussion 222 
This trial found that FST provided to people between six months and five years after stroke improved 223 
motor function of the upper limb but not the lower limb immediately after a six-week period of therapy 224 
and that these results were maintained at follow-up six weeks thereafter.  Safety and feasibility of 225 
providing FST to people late after stroke in their own homes has been demonstrated.  Furthermore the 226 
results add to evidence which questions the notion of a recovery “plateau” for upper limb function six 227 
months or more after stroke
7
.   The sample size for a subsequent definitive pragmatic trial is estimated, 228 
based on actual data from this trial, as 150 participants per group. 229 
 230 
The present findings of benefit from FST-UL but not FST-LL are similar to those of earlier 231 
randomised trials with participants within three months of stroke 
3,4
.  Combining this evidence is, 232 
however, inadvisable because of the different populations of stroke survivors sampled.  Interpretation 233 
of the present findings also needs to consider that the differences found in earlier trials were not 234 
statistically significant 
3,4
 and that a related intervention called task-orientated progressive resistance 235 
strength training enhanced lower limb motor function in people at least one year after stroke
18
.  It is 236 
possible therefore that earlier observational finding of benefit for FST-LL early after stroke
5 
could be 237 
replicated in the so-called chronic stroke population.   Arguing against this possibility is that the 238 
randomisation procedures used in the present trial avoid deficiencies of earlier studies namely: risk of 239 
randomisation bias
5,
 and comparison with a no-intervention condition
18
.   240 
 241 
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Another strong design aspect of the present trial is avoidance of the potential confounder of comparing 242 
experimental treatment to no treatment or to a conventional treatment of lower dose
19
.  Participants 243 
were randomised to equal doses of either FST-LL or FST-UL.  Although the amount of therapy 244 
delivered was smaller than planned, the present trial shows that the positive result for the upper limb is 245 
unlikely to have been confounded by intensity of therapy as the lower limb group received essentially 246 
the same amount (Table 3).   247 
 248 
It is possible, however, that improvement potential differs between the upper limb and lower limb 249 
irrespective of the amount of therapy.   The baseline data (Table 1) show that the median (IQR) ARAT 250 
scores were 16.7 (13.5) and 14.8 (12.9) for the upper limb and lower limb groups respectively. The 251 
total possible ARAT score is 57 so the percentage of total score for the upper limb group was 29% and 252 
for the lower limb group was 26%.  Whereas 44% of all randomized participants had a baseline FAC 253 
score of 3 or more of the highest possible score of 5.  This possible difference in improvement 254 
potential could be greater in the upper limb as: (a) there is a tendency for rehabilitation to focus on 255 
lower limb rather than upper limb function
20
; (b) the lower limb is used during everyday activity such 256 
as moving in and out of a chair; and (c) stroke survivors may exhibit a learned non-use for the upper 257 
limb.  The present results could therefore have been influenced by differences between the upper and 258 
lower limbs in potential for improvement in the so-called chronic phase after stroke.  259 
 260 
The recruitment rate of 5% to the present trial was lower than the 9% and 10% of the two earlier trials 261 
of FST
3,4
.  The present trial recruited people who were living at home a mean of  two years after stroke 262 




days after stroke.   263 
As these studies
3,4  
used face-to-face recruitment methods whereas we contacted most people via a 264 
letter
10
 this suggests that recruitment to a subsequent trial might be higher if face-to-face screening 265 
could be conducted 266 
 267 
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A potential disadvantage of randomising participants to either FST-UL or FST-LL was the clinical 268 
expectation of a cross-training effect between the upper and lower limbs mediated by inter-limb 269 
coupling mechanisms.   Some experimental evidence supports this possibility
22,23 
and some does 270 
not
24,25
.   More pertinent is that clinical research data indicate that stroke survivors who receive upper 271 
limb therapy may improve upper limb function but not lower limb and vice versa
25
.  The results of the 272 
present trial also question the clinical expectation of a cross-training effect between the upper and 273 
lower limbs.   Randomisation to either FST-LL or FST-UL in a subsequent multi-centre definitive trial 274 
is justified. 275 
 276 
Study Limitations 277 
A challenge encountered during the present trial was to ensure timely access by research therapists to 278 
neuroimaging data held in the hospital hosting the acute stroke unit.   This challenge arose when 279 
participants were recruited through referral from community-based therapists who did not have access 280 
to neuroimaging data or detailed medical notes.  As this was a pragmatic trial the process adopted was 281 
that used in clinical community practice whereby therapists make assessments based mainly on 282 
behavioural clinical presentation.  This procedure resulted in the inclusion of four participants who 283 
were subsequently found to have stroke in the posterior not anterior circulation territory.  However, 284 
this protocol deviation has arguably increased the applicability of these findings to clinical practice.  285 
From a pragmatic viewpoint, and learning from the experience of conducting the present trial, it seems 286 
sensible to recommend that any subsequent trials of FST in community settings should recruit 287 
participants using study criteria that can be replicated in clinical practice
27
 whilst also then obtaining 288 
the neuroimaging data required for detailed characterisation.    289 
 290 
Conclusions 291 
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In summary, a subsequent multicentre trial of  FST-UL and FST-LL upper and lower limb function of 292 
people 6 months to five years after stroke is justified and informed by the results of the present first-293 
ever trial.  The findings of this present trial erode the notion of a recovery plateau after stroke.  294 
14 |  P a g e
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Fig 1.  Trial Flowchart  
(FST-UL = functional strength training for the upper limb;  
FST-LL = functional strength training for the lower limb) 
 
 
Assessed for eligibility (n=1127) 
Excluded (n=1075) 
   Not meeting inclusion criteria (n=805) 
 Did not respond to letters (n=270) 
   Declined informed consent (n=0) 
Analysed (n=23) 
 Unable to complete measures to protocol (n=1) 
 Unwell for outcome measures (n=1) 
 Unable to contact (n=1) 
 Away when follow-up measures due (n=1) 
Analysed (n=24) 
 Unable to complete measures to protocol (n=1) 
 Unwell for outcome measures (n=1) 
 Unable to contact (n=1) 
 
Allocated to FST-UL (n=27) 
 Received allocated intervention (n=27) 
 Did not receive allocated intervention (n=0) 
Analysed (n= 20) 
 Unwell for outcome measures (n= 3) 
 Did not take part in the intervention (n=2) 
 
Allocated to FST-LL (n=25) 
 Received allocated intervention (n=23) 
 Did not receive allocated intervention (n=2):  
o declined assigned group allocation n=1; 
o too unwell to start intervention n=1) 
Analysed (n=21) 
 Unwell for follow-up measures (n=2) 












Table 1.  Baseline characteristics of all randomized participants 
 FST-UL 
 (n = 27) 
FST-LL 
 (n = 25) 
Age in years * 67.6 (12.9) 69.0 (13.7) 
Months since stroke * 24.4 (16.6) 24.4 (13.7) 
Gender 
#
   
 Male  18 (66.7) 17 (68.0) 
 Female 9 (33.3) 8 (32.0) 
Hemiside #   
 Right 15 (55.6) 12 (48.0) 
 left 12 (44.4) 13 (52.0) 
Stroke classification 
#
   
 LACS 6 (22.2) 9 (36.0) 
 PACS 12 (44.5) 9 (36.0) 
 TACS 3 (11.1) 6 (24.0) 
 POCS 3 (11.1) 1 (4.0) 
 haemorrhage 3 (11.1) 0 (0) 
Action Research Arm Test 
+ 16.7 (13.5) 14.8 (12.9) 
Able to complete Nine Hole Peg Test 
# 1 (3.9) 0 (0) 
Functional Ambulation Categories 
# 
  
0 3 (11.1) 2 (8.0) 
1 4 (14.8) 5 (20.0) 
2 8 (29.6) 7 (28.0) 
3 1 (3.7) 2 (8.0) 
4 11 (40.7) 9 (36.0) 
5 0 0 
Modified Rivermead Mobility Index 
+ 26.8 (3.4) 26.1 (4.4) 
Timed Up and Go Test * 42.3 (31.5) 49.3 (36.8) 
 
* = mean (standard deviation);  
#
 = number of participants (%);  
+
  = median (interquartile 
range);  ST-UL = Functional Strength Training for Upper Limb; FST-LL = Functional Strength 
Training for Lower Limb; LACS = lacunar anterior circulation stroke; PACS = partial anterior 







Table 2.  Content of Functional Strength Training for participants who completed both baseline 
and outcome measures: percentage of total therapy time 
 
  Group allocation 
  FST-UL FST-LL 
FST-UL provided   
Functional movement training – upper limb 54.5 0 
Focus primarily on resistance during function 26.0 0 
Facilitation upper limb activity from another body part 8.7 0 
Focus on cueing 5.6 0 
Gravity-neutral repetitive movement 5.2 0 
FST-LL provided   
Functional movement training – lower limb 0 67.8 
Focus primarily on resistance during function 0 13.8 
Performance of specific movement patterns 0 10.9 









Table 3.  Functional Strength Training for participants who completed both baseline and 
outcome measures: time-duration and reasons for “missed” intervention 
 
  Allocated group 
 FST-UL FST-LL 
Hours of FST-UL for 24 participants   
 Total delivered 410.2  
 Total planned 576.0  
 Percentage of planned that was delivered 71.3%  
 Mean delivered per participant 17.1  
Hours of FST-LL for 19 participants   
 Total delivered  325.7 
 Total planned  504.0 
 Percentage of planned that was delivered  64.6 % 
 Mean delivered per participant  17.1 
Reasons for “missed” intervention  (% of planned time)   
 Participant unwell 2.8 % 2.4 % 
 Participant cancelled 5.4 % 7.5 % 
 Therapist unavailable 2.8 % 3.6 % 
 Annual leave/bank holiday 0.7 % 1.1 % 
 Data unavailable 0 % 0.8 % 







Table 4.  Outcome scores over time for both groups  
 Outcome Follow-up 





FST-UL FST-LL Effect size p-value 
 N Mean (SD)/ 
N (%) 
N Mean (SD)/ 
N(%) 
N Mean  (SD)/  
N(%) 
N Mean (SD)/ 
N(%) 
 



























































































19 26.4 (2.0) 
-3.2 
(-10.0,3.7)* 









19 47.1 (35.0) 
1.61 
(1.01,2.59) 























9HPT – ability to 
complete2 
24 1 (4.2) 17 0 (0.00) NA 1.0003 23 1 (4.4) 0 0(0.00) NA 1.0003 
 
+ = p-value for difference between treatment groups * = mean difference in rank;  # = common odds ratio for a one unit increase;  ARAT = Action Research Arm Test;  
FAC = Functional Ambulation Categories; TUG = Time Up and Go Test; 9HPT = ( Hole Peg Test;  1 the average of those times taken to complete the task;  2 the ability to 
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The FeSTivaLS trial protocol: A randomized evaluation
of the efficacy of functional strength training on
enhancing walking and upper limb function later
post stroke
Kathryn Mares1*, Jane Cross1, Allan Clark2, Garry R. Barton2, Fiona Poland1,
Marie-Luce O’Driscoll3, Martin J. Watson1, Kate McGlashan4, Phyo K. Myint2 and
Valerie M. Pomeroy1
Rationale Functional Strength Training may enhance motor
function of people who are more than six months post
stroke.
Aims to evaluate the clinical efficacy of enhancing upper
and lower limb motor function with FST to explore partici-
pants’ views (expectations and experiences) of FST, and
to determine what cost-effectiveness data to collect in a
subsequent Phase III trial.
Design Randomized, observer-blind trial with embedded
qualitative investigation of participants’ views of FST (n = 6,
purposive sampling).
Study Participants (n = 58), six months to five years after
stroke with difficulty using their paretic upper (UL) and
lower limbs (LL) for everyday functional activity. All will be
randomized to either FST-UL or FST-LL delivered in their own
homes for fours days each week for six weeks. FST involves
repetitive progressive resisted exercise during goal directed
functional activities. The therapist’s main input is to provide
verbal prompting and feedback.
Outcomes Measures will be undertaken before randomiza-
tion (baseline), after the six-week intervention (outcome)
and six weeks thereafter (follow-up). Primary outcomes for
clinical efficacy will be the Functional Ambulation Categories
(FAC) and the Action Research Arm Test (ARAT). Clinical effi-
cacy analysis will use the proportional odds model for FAC
and a Mann-Whitney test for ARAT. Participants’ views of
FST will be explored at baseline and outcome through audio-
taped, semi-structured, narrative approach, interviews. The
analytic process for interviews will sort transcribed data
thematically and seek categories to inform conceptualiza-
tion (theory-building). A purpose-designed cost question-
naire will identify what cost resource items are likely to be
affected by FST.
Key words: exercise, physical therapy, rehabilitation, stroke,
upper extremity, walking
Introduction
Many stroke survivors are left with permanent disability. To
improve current rehabilitation outcomes the rehabilitation
therapy provided might need to be task-specific re-training of
functional activity (1). A prerequisite for participation in such
repetitive functional re-training is the ability to produce suf-
ficient voluntary activation of paretic muscle to achieve the
muscle strength threshold required (2). Indeed, decreased
muscle strength may contribute more to loss of functional
activity than impaired dexterity, muscle tone, sensation or
pain (3). A systematic review suggests that there is capacity for
improvement in muscle strength (4). This may not, however,
translate into improvements in functional activity unless
the strengthening program incorporates that activity (2).
Findings of early phase trials of Functional Strength Training
(FST) offers evidence of efficacy in people who are within 3
months of stroke (5,6) but it is unclear as to whether these
results can be generalized to people who are at least 6 months
after stroke.
There are potential clinical differences between the sub-
acute and chronic phase populations as spontaneous recovery
Correspondence: Kathryn Mares*, School of Allied Health Professions,
University of East Anglia, Queen’s Building, Norwich Research Park,
Norwich, NR4 7TJ, UK.
E-mail: k.mares@uea.ac.uk
1School of Allied Health Professions, University of East Anglia,
Norwich, UK
2Norwich Medical School, University of East Anglia, Norwich, UK
3Faculty of Health and Social Science, University of Bedfordshire,
Luton, UK
4Colman Centre for Specialist Rehabilitation Services, Colman Hospital,
Norwich, UK
Conflict of interest: None.
DOI: 10.1111/j.1747-4949.2012.00778.x
Protocol
© 2012 The Authors.
International Journal of Stroke © 2012 World Stroke Organization
Vol ••, February 2012, ••–•• 1
occurs mainly in the first three months after stroke (7). Stroke
survivors in the chronic phase have often been perceived
to have ‘plateaued’ in terms of potential for further motor
improvement. This assumption is being questioned as many
stroke survivors continue to show substantial motor improve-
ment late after stroke because of continued spontaneous
recovery and/or rehabilitation interventions (8). It is possible,
therefore, that participation in FST after stroke will result in
better motor function. However, participation in FST requires
stroke survivors to commit time and energy. This commit-
ment has been found early after stroke (5,6) when both physi-
otherapy and the recovery that can be achieved is valued (8).
In the chronic phase, people may cease or reduce ongoing
activity (9), even though further motor improvement is
possible (7,10).
Aims
The hypothesis is that providing FST to people who are at least
6 months after stroke will improve motor function and ability
to perform everyday functional activities. The first steps
toward testing this hypothesis in a definitive clinical trial are:
• to find whether there is sufficient efficacy to justify a subse-
quent trial of FST for upper and lower limb motor recovery in
people between 6 months and 5 years after stroke
• to explore participants’ expectations and experiences of
undertaking FST in their own homes
• to estimate the probable recruitment rate to a subsequent
clinical trial
• to estimate the sample size required for a subsequent defini-
tive clinical trial (considering effect size, attrition rate and
response variation), and
• to determine what cost-effectiveness data should be col-
lected in a subsequent clinical trial.
This trial adheres to the UK Medical Research Council
guidance for evaluation of complex interventions (11) and the
need for progressive staging of pilot studies of motor inter-
ventions in stroke rehabilitation (12).
Methods
Ethics, design and setting
Ethical approval was granted by the Cambridgeshire 2
Research Ethics Committee (ref: 09 H0308 147). The trial
is registered on the Current Controlled Trials database
(ISRCTN71632550).
This is a two-group, randomized, observer-blind, trial with
an embedded qualitative investigation of participants’ expec-
tations and experiences of undertaking FST in their own
homes (Fig. 1).
The design of this trial considers the potential confounder
of comparing experimental treatment to no treatment or to a
conventional treatment of lower dose (13) by randomizing
participants to equal doses of either FST for the lower limb
(FST-LL) or the upper limb (FST-UL). This strategy increases
value for money above that provided by an alternative design
of a three-group trial, where one group receives either no
treatment or, preferably, a placebo. If a placebo were used for
FST, it would need to match therapy time, therapist attention
and appear to have potential for improving functional ability
despite evidence of no effect. Devising such a credible placebo
is challenging, if not impossible, because even passive move-
ments and observing a picture of another person’s action
have excitatory effects on the motor execution system (14).
Therefore, the present trial has been designed with two inter-
vention groups (FST-LL and FST-UL). Each group will act as
the control for the other.
Allocation of participants to either FST-UL or FST-LL
could, however, create a difficulty, as there is a clinical expec-
tation of a cross-training effect. Some experimental evidence
supports this clinical expectation of cross-training between
the upper and lower limbs during functional tasks (15–17).
Although, this effect was absent in lower limbs when they were
kept motionless during rhythmic upper limb cycling (18).
Furthermore, cross training may be inhibited when the rela-
tionship between the upper and lower limb movement is
not functionally related (19). In summary, there are inter-limb
coupling neuronal mechanisms, but it is unclear from experi-
mental evidence whether or not a cross-training effect may
or may not occur during either FST-LL or FST-UL. We have
therefore used clinical research findings that stroke survivors
who received upper limb therapy statistically improved upper
limb but not lower limb and vice versa (20). All participants in
this trial will therefore undertake both upper and lower limb
measures irrespective of group allocation. In the unexpected
event of both groups showing statistically important improve-
ment in the upper and lower limbs, i.e. a cross-training effect
is found, then this strategy will not be used in subsequent
trials. The two-group design, however, is suitable for initial
evaluation of efficacy as spontaneous motor recovery is not
expected at this time-point after stroke and clinical research
evidence indicates no cross-training effect between upper and
lower limb therapy (20).
Procedure (Fig. 1)
After providing informed consent all participants will under-
take the clinical efficacy and cost-effectiveness measurement
battery (baseline) conducted by an assessor who is blinded to
group allocation throughout the trial. Those participants who
have given additional informed consent for participation
in the embedded qualitative investigation will undertake a
semi-structured interview (A) with a qualitative researcher.
This interview is conducted before the participant is aware of
their group allocation. Following baseline measures, partici-
pants are randomized to either FST-UL or FST-LL and receive
their allocated intervention for 1 hour each day, 4 days a week
for 6 weeks. On completion of the intervention phase of the
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trial all participants will undertake the clinical efficacy and
cost-effectiveness measurement battery (outcome) conducted
by the blinded assessor. Those participants involved in the
embedded qualitative investigation will subsequently under-
take another semi-structured interview (B) with a qualitative
researcher. Six weeks after the last of the 24 intervention ses-
sions, all of the participants will undertake the clinical efficacy
and cost-effectiveness measurement battery (follow-up) con-
ducted by the blinded assessor.
Study population
All participants in this trial will:
• be adults aged 18+ years, 6 months to 5 years after a stroke
in the territory of the anterior or middle cerebral artery
(infarct or hemorrhage)
• be able to walk four steps with continuous support from
one person and/or assistive devices, but unable to step on and
off a 7·5 cm high block more than 14 times in 15 s with either
their paretic or non-paretic leg [Step test (21)]
• have sufficient voluntary activity in the paretic upper limb
to move the paretic hand from position on lap to table top in
front, but unable to pick up four £1 coins individually from a
tabletop and stack them evenly in a pile
• be able to follow a one-stage command with the non-paretic
upper limb, i.e. sufficient communication/orientation to par-
ticipate in FST
• not have a known pathology which excludes participation
in the low intensity exercise training involved in functional
strength training, and
• not be receiving formal therapy for their upper or lower
limb.
Screen, recruit and informed consent 
Baseline measures – blinded 
Outcome measures – blinded 
6 weeks after start of intervention 
Semi-structured interview A 
Randomization 
Upper Limb Functional Strength Training 
1 hour per day, 4 days a week for 6 weeks 
Lower Limb Functional Strength Training 
1 hour per day, 4 days a week for 6 weeks 
Semi-structured interview B 
At outcome 
Follow-up measures – blinded 
1 weeks after start of intervention 
Fig. 1 Flowchart to illustrate trial design.
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Sample size
Clinical efficacy and cost-effectiveness
This study will provide data for a power calculation for a
subsequent definitive trial. A formal power calculation is not
yet possible but we estimate that 26 participants per group
would have 90% power at 5% significance (two-tailed) to
detect a change of 1 point on the Functional Ambulation
Categories (FAC) (22) assuming a standard deviation (SD) of
1 and 5·7 points on the Action Research Arm Test (ARAT) (23)
assuming a SD of 5·7. To allow for an attrition rate of 10%
(estimated from our earlier studies) we will recruit 58 stroke
survivors.
Participants’ expectations and experiences of
undertaking FST
We will use purposive selection to identify six of the partici-
pants recruited to the trial. Sample selection aims to maximize
diversity in participants’ characteristics to increase the validity
and transferability of research findings to other settings. The
sample will include:
• people taking part in FST-UL and FST-LL
• men and women
• people of ages crossing the age range of the main sample,
and
• people of varying levels of functional independence (meas-
ured in terms of mild,moderate or severe UL or LL disability).
Recruitment (Fig. 2)
Potential participants will be recruited from three sources:
• A clinical database of people discharged from the acute
stroke service. A clinical teammember will check the names of
discharged stroke survivors against other hospital records to
remove the names of those who have since died. The remain-
ing potential participants will be sent a letter providing infor-
mation about the trial with a reply slip and stamped addressed
envelope (recruitment letter). Potential participants will be
asked to return the reply slip to the research team to indicate
whether or not they would be interested in taking part in the
trial. If this reply slip is not returned within 2 weeks, then one
follow-up letter will be sent.
• The 6-month follow-up clinic for all stroke survivors. The
Stroke Specialist Nurse will give recruitment letters to all those
people likely to meet the trial criteria. If an individual is inter-
ested in taking part, they will send the reply slip to the research
team.
• Therapy staff will be informed about the trial by the
research team and by posters. They will give recruitment
letters to all patients likely to meet the inclusion criteria. If
individuals are interested in taking part they will return the
reply slip to the research team.
Following receipt of a reply slip, the research team will
arrange a home visit to complete screening and to provide a
Participant Information Sheet. Those interested in taking part
in the trial will receive a phone call to confirm this at least 1
week after the date of the home visit. This ensures sufficient
time to consider the implications of taking part in the trial.
During this time, the potential participant’s general practi-
tioner is contacted to confirm that for that individual there is
no medical reason precluding performing exercises. Written
informed consent is obtained by the blinded assessor carrying
out the baseline measures.
Randomization
Group allocation to either FST-UL or FST-LL will be deter-
mined by telephone call to an independent automated
system within the Norwich Clinical Trials Unit. Minimiza-
tion of baseline imbalance between treatment groups will be
based on the Pocock and Simon’s range method and used to
determine the allocation for each participant by Functional
Ambulation category (FAC) (22) and Action Research Arm
Test (ARAT) (23). The FAC is categorized as: mild, score
4 + (able to walk independently on level ground but needs
help on stairs, slopes etc); moderate, score 3 (needs verbal
supervision/stand-by help from one person); severe, score 2
or less (needs continuous/intermittent support of one
person). The ARAT is categorized as: mild, score 39–57
(57 = able to complete all items normally); moderate, score
20–38 (38 = able to complete all items albeit slowly/
abnormally); severe, score 0–19 (19 = able to complete all
items partially).
Service user involvement
This protocol was reviewed by the Norfolk Stroke Service
Patients Forum who said they had no concerns. They wel-
comed the idea of therapy delivered at home and felt that
the amount proposed was acceptable and achievable. They
expressed a preference for choosing whether they worked on
their arm or leg, but reported that if this choice was not
available, this would not stop them from being a participant.
Ongoing user involvement is provided by the Patient and
Public Involvement in Research Group (PPIRES: norfolk-
healthresearch.nhs.uk) in the design of information sheets
for potential participants. The content and structure of the
semi-structured interviews are also informed by Connect
guidelines to support participation of people with aphasia.
Interventions
The research therapists will provide FST to participants for
either their paretic upper or lower limb, according to group
allocation, for an hour a day, 4 days a week for 6 weeks. This
intensity of therapy is planned because repetition of activity
may be important for outcome and can be tolerated by people
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late post stroke (24). There is a possibility, however, that par-
ticipants could become fatigued so sessions will be paced to
give sufficient rest periods.
FST involves repetitive progressive resistive exercise during
goal-directed functional activity with the therapist: directing
participants’ attention to the activity being performed;
providing verbal prompting to enhance performance; and
providing appropriate verbal feedback to enhance knowledge
of performance (5,6). FST is designed to increase ability to
produce voluntary muscle force throughout joint range,
increase ability to modulate force in muscles/muscle groups
appropriate for the activity being trained and improve func-
tional ability (5,6). The first session will identify the specific
activities particularly affected by muscle weakness, thus FST
will be individually adapted to each participant. Activities are
progressed systematically, increasing the amount of resistance
and number of repetitions. Resistance can be varied using
external resistance bands/weights and also increasing task dif-
ficulty through strategies such as decreasing seat height for
sit/stand activities and increasing/decreasing the requirement
for hand grip span. If participants become fatigued, presenting
as increasing difficulty in performing the activities, the thera-
pist will initially change activities or offer a rest period until
either 1 hour of therapy has been completed or it becomes
apparent that the participant is unable to continue with the
intervention that day.
Standardized treatment schedules will be used to record the
amount and type of intervention provided. This approach has
Excluded 
• refused consent n = 
Excluded 
• refused consent n =
• unsuitable
Provided informed consent  
and recruited as participants in this trial 
n =  
Given information sheet in clinic 
n = : 
Screened by Research Therapist 
n = : 
Excluded 
• unsuitable n =  
Excluded 
• not interested n =  
• unsuitable n =  
Excluded
• not interested n =
• unsuitable n =
• no reply n =
Screened by Research Therapist  
n = : 
Identification of potential participants 
From discharge database 
by member of clinical team 
n =  
Other referrals e.g. from ESD clinic 
or therapist referral 
n =  
Research Nurse check PAS 
for recorded deaths 
Excluded 
• died n =
Stroke survivors sent letter with 
brief details of trial 
self-selection criteria 
n = : 
Non-responders  
sent 2nd letter 
n = : 
Fig. 2 Flowchart to illustrate participant recruitment process.
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been used in earlier trials (5,6). This recording should provide
sufficient description of therapy to enable replication of
findings and implementation into clinical practice (25).
As this trial intervention is likely to be carried out by
different therapists over the time that it will run, adherence
to the intervention will be monitored by the lead research
therapist. Training for each new therapist who participates in
the study will take place before they start any interventions.
During the trial, the lead research therapist will monitor how
and what therapy is recorded and will also visit all partici-
pants at least once during their intervention phase to ensure
consistency.
Functional strength training for the lower limb (FST-LL)
FST-LL will focus on functional activities involving the lower
limbs. Exercises may include variations of:
• standing up and sitting down
• stepping on and off a block
• going up and down stairs
• balance exercises such as standing on one leg, and
• obstacle negotiation.
Functional strength training for the upper limb (FST-UL)
FST-UL is based on the key elements of normal upper limb
function, i.e. moving the hand into a position and then using
it to manipulate objects. The focus is on: improving the power
of shoulder/elbow muscles to enable appropriate placing of
the hand; improving the production of appropriate force in
arm and hand muscles to achieve the specific grasp; and spe-
cific interventions for the wrist and finger muscles to maxi-
mize ability to manipulate objects. Exercises may include:
• reaching for a jug and then pouring water from it
• picking up a jar and unscrewing the lid
• reaching to the foot to lace up a shoe using both hands, and





These will be the Functional Ambulation Categories (FAC)
(22) for lower limb function and the Action Research Arm Test
(ARAT) (23) for upper limb function.
Secondary outcomes
Clinical efficacy
For lower limb function we will use the Modified Rivermead
Mobility Index (26) and the Timed Up and Go Test (27). The
Nine Hole Peg Test (28) will be used for upper limb function.
Participants’ expectations and experiences of
undertaking FST
The subset of six purposively sampled participants will each
be interviewed in their homes at baseline and outcome (Fig. 1)
by a researcher with expertise in qualitative methodology.
Any of this subset of participants withdrawing from the study
will still be interviewed at outcome if this is appropriate and
they agree. These interviews use a semi-structured format
and a narrative approach (29,30). All will be audio recorded.
Interview guides (Table 1) will ask participants to share their
experiences and views. These will elicit rich detailed data by
actively and sensitively probing issues identified during the
interviews as having particular importance for the participant.
This longer-term approach will facilitate respondents to
convey their own story of their stroke experiences, including
participation in FST, and to raise issues they see as pertinent,
independently of the researcher’s initial questions, while still
enabling collection of some pre-set broad categories of infor-
mation across all participants.
Adverse event monitoring
Adverse events are not expected but there is a small possibility
of an overuse syndrome resulting in limb pain. This will be
considered to have occurred if a participant reports or exhibits
limb pain (behavioral signs) to the Research Physiotherapist
on four consecutive treatment days. If pain occurs then par-
ticipants will be withdrawn from their allocated treatment but
included in the measurement battery according to the inten-
tion to treat principle.
Cost effectiveness
For costs, we will seek to identify what resource items should
be monitored in a future study as likely to be affected by FST
and those items about which we are most uncertain. These will
be monitored using a purpose-designed cost questionnaire.
For effectiveness, we will seek to test the suitability of using the
EuroQuol EQ-5D (31) in subsequent trials by using baseline
and follow-up data to estimate the validity and responsiveness
(32) of the EQ-5D in stroke survivors. Finally, the information
on the costs and effects will be used to give an indication of
the likely cost-effectiveness of FST, the level of uncertainty
associated with these estimates, and to conduct a value-of-
information analysis to provide an indication of the expected
value of future research (33). Both the cost questionnaire and
the EQ-5D will also be carried out at baseline, outcome and at
follow-up by the same assessor who carries out the clinical
outcome measures (Fig. 1).
Data monitoring body
Because this is an early phase trial a formal Data Monitoring
Committee will not be convened. This function will be pro-
vided by the Trial Management Group.
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Analysis
Clinical efficacy
In accordance with the intention-to-treat principle all partici-
pants will be analyzed according to the group to which they
were randomly allocated. Statistical analysis will use a Mann-
Whitney test for ARAT, Modified Rivermead Mobility Index,
Timed Up and Go and the Nine Hole Peg Test, although if
imbalance occurs at baseline, a rank-based analysis of covari-
ance will be used. FAC will be analyzed using the proportional
odds model. Secondary analyses will focus on a per-protocol
analysis and the analysis of the secondary outcome measures.
Adverse events will be recorded and using a Poisson regression
model a comparison of the event rate will be carried out. The
main aim of the analysis is to estimate the parameters, which
will be needed for a formal sample size calculation for a sub-
sequent Phase III trial. To inform subsequent trials the varia-
tion in outcome measure will be estimated from the primary
analysis and the recruitment and drop-outs rates predicted
from those in this trial. Statistical analyses will be carried out
using Stata. The analysis will also estimate recruitment and
attrition rates to inform subsequent trials (aims 3 and 4).
Cost effectiveness
A model will be constructed in order to estimate both the
mean overall cost and mean overall effect of i) FST-LL and ii)
FST-UL, compared to no provision of FST (assuming that
outcomes without FST provision would have been the same as
at baseline). In both cases, if either FST or no FST were shown
to be less costly and more effective then this would suggest
that it ‘dominates’ the other, and represents a cost-effective
use of scarce resources. Alternatively, the incremental cost-
effectiveness ratio (ICER) associated with FST will be esti-
mated and assessed in relation to a range of cost-effectiveness
thresholds, e.g. a threshold of £20 000 to £30 000 per QALY is
recommended by NICE (34) in order to estimate the likely
cost-effectiveness of the intervention. The associated level of
uncertainty will also be characterized by estimating the cost-
effectiveness acceptability curve (CEAC).Value of information
analysis will also be used to estimate the value of further
research (32). Finally, sensitivity analysis will also be under-
taken to assess the robustness of conclusions to changes in key
assumptions.
Participants’ expectations and experiences of
undertaking FST
All audio-recorded interview data will be transcribed verba-
tim and analyzed using a framework analytic approach, which
will elucidate participants’ expectations and experiences of
undertaking FST. Analysis may be additionally supported by
the use of appropriate software such as NVivo 9. This will
be used to build more fully conceptualized understandings
of experience-based reasons for possible differences in
Table 1 Interview schedules
Interview 1 (Baseline) to capture participants’ own stories of their lives before their stroke, at the time of stroke, their post-stroke experience of
managing their condition and initial expectations of rehabilitation. This will help contextualise views and expectations of rehabilitation generally
and FST specifically.
Indicative questions (all to be probed)
Introduction and checks on convenience and continued willingness to be interviewed
1. Could you please tell me something about your life before you had your stroke?
2. Could you please tell me a bit about your life just before you had your stroke?
3. Can you please tell me what happened when you had your stroke?
4. What about any things done to help you manage things for yourself after the stroke while you were in hospital?
5. Can you tell me about your thoughts about your recovery and things done to help you recover?
6. What kinds of things do you hope to get from the FST that you are taking part in for this research?
7. Can you tell me a bit about any home or family arrangements which help you to get on with your life since you had your stroke?
8. Is there anything else you would like to tell me about your experience of managing your recovery since your stroke?
Interview 2 (Outcome) to access participants’ subsequent experiences of taking part in FST, to further contextualise and collect data on their views
on the acceptability of FST delivered in a community setting, in relation to specific features of FST.
Indicative questions (all to be probed)
Introduction to say this is to find out how the participant found the FST and about life since last interviewed; checks on convenience and
continued willingness to be interviewed
1. Could you please tell me what has been happening in your life since the last time we met?
2. What was it like taking part in the FST exercise?
3. Is there anything you have enjoyed about taking part, and if so, please tell me about it. What was it? Why did you enjoy it?
4. Is there anything you have not liked about taking part, and if so, can you tell me about it? What was it? Why didn’t you like it?
5. Are there any ways in which you think it has helped you?
6. Are there any ways in which you feel your life may have changed since taking part in FST?
7. How do you feel about keeping up any of the exercises yourself?
8. How do you feel about the idea of now going on to get other referrals/treatments for yourself?
9. Is there anything else you would like to tell me about your experience of FST?
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acceptability of the interventions for different participants and
to highlight potential challenges to researchers’ assumptions
about what may be acceptable and feasible.
The analytic process will sort the data thematically and seek
categories to inform conceptualization (theory-building).
Such conceptualization will be developed iteratively, so as to
emerge from the beginning of the interview data collection
process and be completed within the timescale indicated for
the wider project. The qualitative analytical approach will
draw on narrative analysis approaches to identify meaningful
categories and structures in participants’ stories. It will
combine ‘top down’ scrutiny of the data (seeking views about
acceptability of specific features of FST and specific aspects of
delivery of the program in the community) and ‘bottom up’
scrutiny of the data (seeking and charting categories, concepts
and themes which emerge from the narratives presented,
about participants’ approach to and engagement in the
program). It is expected that initial analysis will guide the
development of questions in Interview 2. The longitudinal
analysis will help establish links between reasons, interactions,
experiences and potentially changing views of respondents in
relation to the FST program and its acceptability to them. Such
findings can be used to inform options in developing the
intervention intended to follow this study.
Summary
This mixed methods protocol describes an early phase trial
designed primarily to evaluate whether delivery of FST is
acceptable to people living in the community who are at least
6 months after stroke and whether there is sufficient evidence
of clinical efficacy to justify a subsequent definitive clinical
trial. This trial is congruent with the need to undertake
progressive evaluation of stroke rehabilitation therapies to
enhance the design of Phase III trials (12,13).
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Background:To determine the strength of current evidence for provision of a higher dose of the same 
types of exercise-based therapy to enhance motor recovery after stroke.  
Methods:  An electronic search of: MEDLINE, EMBASE, CINHAL, AMED, and CENTRAL was 
undertaken.  Two independent reviewers selected studies using predetermined inclusion criteria: 
randomised or quasi randomised controlled trials with or without blinding of assessors; adults, 18+ 
years, with a clinical diagnosis of stroke; experimental and control group interventions identical except 
for dose; exercise-based interventions investigated; and outcome measures of motor impairment, 
movement control or functional activity. Two reviewers independently extracted outcome and follow-up 
data.  Effect sizes and 95% confidence intervals were interpreted with reference to risk of bias in 
included studies.   
Results: 9 papers reporting 7 studies were included.    The risk of bias was assessed as low 
predominantly. Intensity of the control intervention ranged from a mean of 9 to 28 hours. Experimental 
groups received between 14 and 92 hours of therapy. The included studies were heterogeneous with 
respect to types of therapy, outcome measures and time-points for outcome and follow-up. 
Consequently, most effect sizes relate to one study only. Single study effect sizes suggest a trend for 
better recovery with increased dose at the end of therapy but this trend was less evident at follow-up  
Meta-analysis was possible at outcome for: hand-grip strength, -10.1 [-19.1,-1.2]; Action Research Arm 
Test (ARAT), 0.1 [-5.7,6.0]; and comfortable walking speed, 0.3 [0.1,0.5].  At follow-up, between 12 and 
26 weeks after start of therapy, meta-analysis findings were: Motricity Arm, 10.7 [1.7,19.8]; ARAT, 2.2 [-
6.0,10.4]; Rivermead Mobility, 1.0 [-0.6, 2.5]; and comfortable walking speed, 0.2 [0.0,0.4].  
Conclusions: Current evidence provides some, but limited, support for the hypothesis that a higher 
dose of the same type of exercised–based therapy enhances motor recovery after stroke. Prospective 
dose-finding studies are required. 
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BACKGROUND 
Exercise-based therapy is known to enhance motor recovery after stroke but the most appropriate 
amount, i.e. the dose, of therapy is unknown.  There is strong clinical opinion that if higher doses of 
exercise-based therapy could be provided then motor outcome would be improved.   
 
The possibility of a dose-response relationship between exercise-based therapy and motor recovery is 
supported by the findings of several systematic reviews [1-5] .  However, some of the included trials in 
all of the published systematic reviews were not designed primarily to evaluate different doses of the 
same therapy.  Rather, they were designed to evaluate either different types of therapy, augmentation 
of one therapy with another or even the effects of a therapy compared with no treatment.  
Consequently, the results of these systematic reviews are confounded by examination of different types 
as well as different intensities of therapies.  Differentiation of the effects of different types and different 
intensities of exercise-based therapies is required. 
 
In contrast to widely-held clinical opinion and conclusions of systematic reviews an increased dose of 
constraint-induced movement therapy (CIMT) resulted in a worse outcome than either a smaller dose of 
CMIT or a smaller dose of conventional therapy [6].    This unexpected finding echoes those from 
animal model studies which indicate that a high usage of a paretic forelimb early after experimental 
stroke is associated with a poorer motor outcome and an increase in size of the brain lesion [7-9] if it is 
provided early after stroke [10].  It is possible, therefore, that high doses of exercise-based therapy 
could be detrimental for motor recovery after stroke.  This is not the only possibility, however, as 
experimental animal model studies indicate that more activity, provided in enriched environments, 
enhances motor recovery more than a standard housing environment [11]..  In addition, preliminary 
investigation suggests the existence of a moderate relationship (r = 0.45, p<0.01) between the number 
of repetitions of an exercise and improvement  in motor function[12] and post-hoc analysis of three 
separate research studies  of the same therapy suggests greater benefit for a higher dose [13].   
 
Whether an increased dose of exercise-based therapy is beneficial, detrimental or makes no difference 
to motor recovery after stroke needs to be elucidated.   Well designed studies of different doses of the 
same therapy at different times after stroke in well characterised groups of stroke survivors are 
required.  Before undertaking such studies it will be beneficial to update and refine published systematic 
reviews to ensure that current evidence informs their design.  This paper reports a systematic review 
and meta-analysis designed to determine the strength of current evidence for providing a higher 




The design of this systematic review followed recommendations of the Cochane Collaboration.  The 
review protocol was not published prior to this report other than as part of a PhD thesis [14]. 
 
Search strategy  
The following databases were searched electronically; US National Library of Medicine Database 
(MEDLINE); European Medical Database (EMBASE); Cumulative Index to Nursing and Allied Health 
Literature (CINHAL); Allied and Complementary Medicine Database (AMED); and Cochrane Central 
Register of Controlled Trials (CENTRAL).  An example of the search strategy used is given in Box 1.  
The initial search was conducted to cover the time period from induction of the databases to November 
2008 and this was updated in a subsequent search to include the period up to October 2009.  The 
updated search (December 2008 to October 2009) did not include CINHAL because the host had 
changed from OVID. A decision was made not to update the CINHAL search because records identified 
through it in the initial search were also found in other databases.    
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Reference lists of all articles reporting included trials were searched for any extra possibly relevant 
records.  If any records were identified from the hand searching of reference lists and they came from 
journals not included on the CENTRAL data base, the contents pages of those journals were hand 
searched. A hand search of our own private databases of references was also undertaken. In addition 
authors of included articles were contacted for any unpublished data.   
 
Criteria for inclusion of trials 
Types of trial  
Randomised or quasi randomised controlled trials with or without blinding of assessors;  
Types of participants 
Adults, aged over 18 years, with a clinical diagnosis of stroke 
Types of interventions   
• Experimental and control group interventions identical except for dose.  Therapy dose can be 
described in terms of time spent in therapy and/or of effort expended [15].  Description of time 
includes: minutes per session; sessions per day/week; and number of days/weeks [15].  Description 
of effort can be made in terms of the work or power required to perform an exercise for example, 
resistance training and the amount of weight used [15].  For this systematic review dose refers to the 
total time spent in exercise-based therapy.  
• Interventions investigated were exercise-based (no electrostimulation, splinting or orthotics) to 
facilitate muscle activity or functional ability; 
Types of outcome measures 
• Measure of motor impairment – muscle function e.g. Motricity Index, muscle tone, joint range of 
motion; 
• Measures of motor impairment – movement control e.g. co-ordination, dexterity, reaction time; 
• Measure of motor activity  e.g. Modified Rivermead Mobility Index, Action Research Arm Test, 
Functional Ambulation Categories, 9 Hole Peg Test.  
 
Trial selection. 
The identification of relevant trials was undertaken by two reviewers independently using the pre-set 
inclusion criteria set out on a predesigned form.  Reviewers assessed the record titles and categorised 
each  as ‘definitely relevant’, ‘possibly relevant’ or ‘definitely irrelevant’.  Any title that both reviewers 
ranked ‘definitely irrelevant’ was excluded.  The reviewers repeated the categorisation process for 
abstracts and full papers in turn.  They did not use the category ‘possibly relevant for the full papers.  
Any disagreements between the reviewers were resolved through referral to full papers and discussion.   
Trials reported in full papers which were categorised as ‘definitely irrelevant’ by both reviewers were 
excluded and reasons documented.  Trials which both reviewers categorised as ‘definitely relevant’ 
were classified as included trials for evaluation in this systematic review. 
 
Assessment of risk of bias 
Assessment of the risk of bias in included trials was undertaken by two reviewers independently for 
design features using the tool developed by the Cochrane Collaboration [16].  Any disagreements 
between reviewers were resolved by discussion, referral to full papers and contact with authors for 
clarification where necessary.  A risk of bias plot was produced for the review using categories of low, 
unclear or high risk.   
 
Data Extraction 
Data extraction was undertaken by two reviewers independently using a predesigned form. Any 
disagreements were resolved by discussion and referral to the original full papers.  Trial authors were 
contacted to clarify results when this was necessary and possible.  Data was extracted on: 
• Trial design, sample size and attrition; 
• Participant  characteristics’ e.g. age, gender, site of lesion, stroke classification; 
• Type of interventions;  
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• Dose of interventions (sum of treatment hours); 
• Measures made at outcome (end of intervention period) and follow-up time-points in terms of 
average scores for trial groups. 
 
Statistical analysis of outcome and follow-up data  
Analysis was undertaken, where possible, on an intention- to-treat basis.  Trials were not excluded if 
data was unavailable for subjects who did not complete all the outcome measures. Data analysis was 
undertaken using the Cochrane statistical package RevMan 4.2.   
 
Effect sizes were calculated as odds ratios (OR) and 95% confidence interval (CI) for dichotomous 
outcomes and as weighted mean differences (WMD and 95% CI) for continuous outcomes.  WMDs 
were determined initially using a Fixed Effect Model.  Where two or more trials had used the same 
outcome measure, however, and if there was evidence of heterogeneity, the WMDs were estimated 
from a Random Effects Model.   Where it was not possible to combine and compare the outcome 
measures reported in different trials, then statistical results were described and tabulated individually. 
Sub-groups were formed by each follow-up time point.  No overall analysis was done since this would 
involve combining subgroups based on the same individuals and could bias the results.  
 
Synthesis and interpretation  
The results of the statistical analysis were interpreted with reference to the risk of bias in trials, and 
comparability of participants, types of interventions and dose of interventions. 
 
RESULTS 
Full details of the number of records screened and studies included in this review are given in Figure 1.  
In summary, 940 potentially relevant records were screened and 31 potentially relevant records were 
identified.  Twenty-two records did not meet the inclusion criteria and are listed in Table 1 alongside the 
reasons for their omission from this review.  The remaining nine records were articles reporting seven 
studies (three articles reported different aspects of the same study [17-19].  Therefore nine articles 
reporting seven studies have been included in this review [17-25] (Fig 1). 
 
Study designs 
Of the 7 included studies three used a multi-centre, observer-blind randomised controlled design.  The 
remaining four studies used a single-centre, observer-blind randomised controlled design (Table 2) 
 
Participants 
The seven studies included 680 participants (range 20-189) who completed baseline measurements 
(Table 2).  One trial provided additional therapy from a qualified therapist and an assistant, but only the 
subjects treated by the qualified therapist are included in this review to ensure comparability with the 
other studies [21].  The mean age of participants in the seven studies ranged from 65.9 years [17-19] to 
76.5 years [22] and time since stroke on admission to studies ranged from a median of 5 days [23] to a 
mean of 35 days [25](Table 2).  Full details of participant characteristics are provided in Table 2. 
 
Interventions 
Four of the studies described the intervention as a ‘normal movement‘ (Bobath) approach [20-23], two 
studies investigated conventional physical therapy as used in the UK [24,25] and one  study based the 
intervention on an eclectic approach involving task specific training regime following stroke [17-19]  
(Table 3).  The dose of the exercise-based intervention was described in terms of intensity (minutes per 
day), frequency (times per week), duration (number of weeks).  From this the total dose was calculated.  
The dose of the control intervention was not provided in two studies [21,22].  The dose of the control 
intervention in the remaining five studies ranged from a mean of 9.2 hours [25]  to 27.5 hours [17-19].   
The mean dose received by the experimental groups (control plus extra) ranged  from  13.8 hours [24] D 
to 91.8 hours [17-19].  Details are provided in Table 3.   
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Assessment of potential bias 
The results of the assessment of potential bias are presented in Table 4.  In summary, the majority of 
design elements for included studies were assessed as likely to present a low risk of bias.  The 
exceptions were: 
1. The blinding procedure used in one study [23] was assessed as presenting a potential high risk of 
bias because in the discussion section of the paper it is stated that clinical therapists were not blind 
to treatment allocation and therefore gave more uni-disciplinary treatment to those participants who 
were receiving less therapy in the trial. 
2. Allocation concealment procedures used in two studies [17-19, 21]were unclear as there were no 
specific statements about this aspect of randomisation procedure e.g. use of sealed opaque 
envelopes 
3. Incomplete outcome data is possibly present in two studies [21,22] but this is unclear from 
information presented in the papers.  In one trial [21] it was reported that a number of participants 
died yet there was no reference to the process used for analysis for drop outs.  Indeed the results 
tables suggest that all participants were included in the outcome analysis. One trial [22] provided no 
reasons for withdrawals and no methods for dealing with participants who withdrew before 
measurement time-points. 
4. One trial appeared to report outcomes selectively [22].  Specifically step-time ratio was included in 
list of outcomes to be measured yet was not reported in the results section.  Also sit-to-stand time, 
timed walk and functional reach were not measured at baseline yet there was no explanation as to 
why these were omitted. 
 
Outcomes 
Extraction of data for one study [17-19] was undertaken considering its 3-group design of placebo, extra 
arm therapy and extra leg therapy and that all participants undertook all measures.  In this present 
review we considered that the placebo group would act as a control for both experimental groups but 
that data extracted for the arm group would be that specific to the upper limb and data extracted for the 
leg group would be that specific to the lower limb.  Consequently data analysed in this present review 
does not include upper limb measures reported for the leg group and vice versa.  Two other studies 
also used a 3-group design [24,25]  to compare different types and different doses of physical therapy.  
The data extracted from these for this review consists of that for the groups receiving the routine 
amount and extra amount of conventional physical therapy.   
 
The time-points for outcome measures were mostly comparable as they were made between 4 and 6 
weeks after the start of therapy except for one study where treatment was provided for 20 weeks [17-
19] (Table 3)   At follow-up 1 there was more variety between studies with time-points ranging from 12 
to 26 weeks after the start of treatment and also 3 months after stroke (Table 3).  Follow-up 2 time-
points were either 6 months after start of treatment, 52 weeks after start of treatment or 6 months after 
stroke (Table 3) 
 
1. Motor impairment – muscle function (Table 5) 
Heterogeneity between studies in use of specific measures limited meta-analysis.  At outcome there 
was a trend towards benefit for a higher dose of therapy but effect sizes for 5 of the 10 comparisons 
were not statistically significant.  Significant effect sizes found for individual comparisons were:  
Motricity Index Leg score, 23.0 [10.0,35.9]; Motricity Index Arm score, 24.1 [9.2,33.1]; knee 
extension torque, 17.5 [1.1,33.9], knee flexion torque, 15.0 [3.7,26.3];  and hand grip strength, -11.0 
[-20.2,-1.8].   Meta-analysis was only possible for hand grip force/strength (2 studies) and this found 
a benefit for the standard dose of therapy, -10.1 [-19.1,1.2]. 
 
At follow-up 1 the trend toward benefit for a higher dose of therapy remained but only two of the 
seven individual effects sizes were significant.  These were both from the same study [17-19] 
Motricity Index Leg score, 41.0 [27.7,54.3]; and  Motricity Index Arm score, 17.5 [2.3,32.7].  Meta-
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analysis was only possible for  Motricity Index Arm score (two studies) and the effect size was 10.7 
[1.7,19.8].,   
 
No significant differences were found between the two doses of therapy at follow-up 2 (three 
studies). Meta-analysis was not possible. 
 
2. Motor impairment – movement control (Table 6) 
All of the outcome measures were made at 5 or 6 weeks after the start of therapy but heterogeneity 
in measures used between studies prevented meta-analysis.    Effect sizes were insignificant for all 
individual comparisons and no trends were discernable in the data. 
 
3. Functional activity (Table 7) 
At outcome, data from one trial relating to Rivermead Mobility Index was omitted because only 3 of 
35 participants in the extra therapy group appear to have been included in the outcome data 
compared to all participants in the control group [21].  Therefore values provided may not have been 
representative of the entire group. Meta-analysis was undertaken for Action Research Arm Test (3 
studies) and comfortable walking speed (2 studies) with effect sizes of 0.1 (-5.7,6.0] and 0.3 
[0.1,0.5] respectively. For other measures, the individual study comparisons found a trend towards a 
better outcome with higher dose for most comparisons but this was weaker than for motor 
impairment- muscle function.  Significance was only found in individual study comparisons in favour 
of extra therapy for: ability to walk at 0.8m/sec or more with an odds ratio of 3.9 [1.1,13.9] and 
maximal walking speed effect size, 0.4 [0.1,0.7].  A significant benefit for standard dose therapy was 
found for one individual study comparison for the Rivermead Gross Function score with effect size -
2.0 [-3.4,-0.6].   
 
At follow-up-1 meta-analysis was undertaken for Action Research Arm Test (2 studies), Rivermead 
Mobility Score (2 studies) and comfortable walking speed (2 studies) with non-significant effect sizes 
of 2.2 [-6.0,10.4], 1.0 [-0.6,2.5] and 0.2 [-0.1,0.4] respectively. For other measures the significant 
effect sizes from individual studies were: Rivermead Arm score, -2.0 [-3.7,-0.3]; 5 metre walk time, -
13.6 [-26.2,-1.0]; Functional Ambulation Categories, 1.0 [0.2,1.8]; and ability to walk at 0.8 m/sec or 
more, 2.8 [0.8,10.6]. 
 
The follow-up-2 meta-analysis (3 studies) found a significant benefit for standard dose therapy for 
ARAT, subtotal of -6.4 [-12.8,0.00].  A significant benefit in favour of standard dose therapy was also 
found from an individual study in respect of the Rivermead Arm score with an effect size of -2.00 [-
4.0,-0.1].  The benefit for higher dose therapy was, however, maintained for Functional Ambulation 
Category, 1.0 [0.4,1.6].   
 
DISCUSSION  
Unlike the findings of earlier meta-analyses this present systematic review is not confounded by the 
inclusion of primary studies which compared both different types as well as intensities of exercise-
based therapy.  Consequently the present findings refine and also update the results of earlier 
systematic reviews and meta-analyses.   Essentially, some, but limited, support is provided for the 
hypothesis that a higher dose of exercise-based therapy enhances motor recovery after stroke.  There 
are some indications from the present meta-analysis for benefit from a higher dose for: comfortable 
walking speed; maximum walking speed; and upper limb muscle function. Meta-analysis was, however, 
limited by heterogeneity between studies in the measures used and therefore most estimates of effect 
size were derived from single studies.  Those single study sample estimates that were statistically 
significant were mostly in favour of a higher dose of therapy.  In contrast, there are also some 
indications from meta-analysis for benefit from a standard dose for hand grip force/strength and upper 
limb functional ability. Consideration of the mostly low risk of bias within included studies provides 
assurance for these findings.    
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The more stringent inclusion criteria for studies in this present review resulted in a smaller number of 
included studies than in previous reviews.  For example, the  meta-analysis undertaken by Kwakkel and 
colleagues [3] included 20 RCTs involving 2686 patients.  The systematic review reported here also 
differs from earlier ones because it did not combine different outcome measures in the same analysis.    
We were concerned to avoid undertaking analyses of sets of heterogeneous measures in a single 
meta-analysis.   
 
An earlier systematic review concluded that a 16-hour difference in treatment time between 
experimental and control groups provided in the first 6 months after stroke is needed to obtain 
significant differences in activities of daily living” [3].   Investigation of the data reported here for a 
potential dose-response relationship is limited by the relatively small number of comparisons that can 
be included in a meta-analysis because of the variation in measures used in included studies.  
However, visual inspection of outcome time-point data (Tables 5, 6 and 7) and data on dose (Table 3) 
suggests a trend for better outcome with higher dose.  The highest doses, however, were of task-
specific interventions [17-19] whereas the smaller doses consisted of UK conventional physical therapy 
[24,25].  This difference could have influenced the results of the present review.  It is also possible that 
differences in effect sizes between studies could be due to differences in underlying standard care.  The 
study by Kwakkel and colleagues [17-19] was conducted in the Netherlands whereas the other four 
studies took place in the United Kingdom.  This could have influenced the results of the present review 
because there may be important differences in underlying routine care between centres and countries 
[26].  There may also be differences in standard therapy over time [27].  Therefore the differences in 
clinical setting for studies may also be influential on outcome.  Consequently, this present review which 
restricted included studies to those investigating different doses of the same therapy to avoid the 
confound of different types of therapy  may itself be confounded by the inclusion of different types as 
well as different intensities of therapy.  Essentially this systematic review highlights the need for 
prospective dose-ranging studies of specific interventions before undertaking efficacy studies. 
  
None of the doses investigated in included studies emerged from preliminary dose-finding studies.  The 
same observation emerged from in a systematic review and meta-analysis of electrostimulation [28].  
Indeed dose-finding has not featured prominently as a precursor to stroke rehabilitation trials [29,30]  
Without precursor dose-finding studies it is possible that the studies included in this review investigated 
sub-optimal doses of exercise-based therapies. The case for prospective dose-finding studies as 
precursors to Phase II and phase III trials of rehabilitation has been made already [29,30].  
Nevertheless, we are aware of only one study designed to investigate the relative efficacy of three or 
more doses of the same rehabilitation therapy [31].  Dose-finding has not featured prominently as a 
precursor to phase II and phase III trials of rehabilitation therapies.  
 
It is possible that the present review may be influenced by a publication bias as the literature search 
excluded studies written in a language other than English.  A strong publication bias is, however, 
unlikely to be present the studies included in this present review were also included in previous meta-
analyses.  In addition, authors of included studies were contacted for any unpublished data.   
 
CONCLUSIONS  
To the best of our knowledge the present systematic review of the effects of dose of therapy is the first 
to control for the potential confounder of different types of intervention.  It has refined and updated 
knowledge of the effects on motor recovery of the provision of an increased dose of exercise-based 
therapy after stroke.  The findings indicate that there is limited empirical evidence to inform clinical 
decisions on how much exercise-based therapy is needed to enhance motor recovery after stroke. 
Further systematic reviews are unlikely to resolve this clinical uncertainty because of the heterogeneity 
between exercise-based therapies in included studies and the apparent lack of dose-finding studies 
undertaken as precursors to robust clinical trials.  The results of the present systematic review therefore 
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indicate a need to undertake dose-finding studies of specific exercise-based interventions as precursors 
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Box 1.  Search strategy for electronic databases 
1. exp Stroke/ 
2. stroke.mp.  
3. cerebrovascular diseas$.mp.  
4. cerebral vascular diseas$.mp. 
5. cerebral vascular accident$.mp.  
6. cerebrovascular accident$.mp.  
7. (hemipleg$ or hemipar$).mp.  
8. 6 or 4 or 1 or 3 or 7 or 2 or 5 
9. exp Physical Therapy Modalities/ 
10. physiotherapy.mp.  
11. physical therapy.mp.  
12. 11 or 10 or 9 
13. randomized controlled trial.pt. 
14. controlled clinical trial.pt. 
15. randomised controlled trials.sh. 
16. random allocation.sh. 
17. double-blind method.sh. 
18. single-blind method.sh. 
19. 18 or 16 or 13 or 17 or 12 or 15 or 14 
20. clinical trial.pt. 
21. exp Clinical Trial/ 
22. ((singl$ or doubl$ or treb$ or trip$) adj25 (blind$ or 
mask$)).ti,ab. 




27. research design.sh. 
28. 27 or 25 or 21 or 26 or 20 or 22 or 24 or 23 
29. comparative study.sh. 
30. exp Evaluation Studies/ 
31. follow up studies.sh. 
32. (contro$ or prospectiv$ or volunteer$).ti,ab. 
33. 32 or 30 or 31 or 29 
34. 33 or 28 or 19 
35. exercis$.mp.  
36. exercis$.sh. 
37. exp Exercise/ 
38. functional strength train$.mp.  
39. activities of daily living.mp.  
40. neuro facilitation.mp.  
41. bobath therap$.mp. 
42. motor relearn$.mp.  
43. rehabilitation.mp.  
44. rehabilitation.sh. 
45. exp Rehabilitation/ 
46. restoration of function$.mp.  
47. 35 or 39 or 40 or 36 or 41 or 38 or 42 or 46 or 45 
or 37 or 43 or 44 
48. intensit$.mp.  
49. intensit$.sh. 
50. frequenc$.sh. 
51. frequenc$.mp.  
52. duration.mp.  
53. duration.sh. 
54. dose.mp.  
55. dosage.mp.  
56. amount.mp.  
57. quantit$.mp.  
58. how much.mp.  
59. dos$.mp.  
60. dosing.mp.  
61. doses.mp.  
62. amounts.mp. 
63. 63. 50 or 53 or 57 or 61 or 51 or 58 or 48 or 59 or 
52 or 60 or 56 or 49 or 62 or 54 or 55 
64. 64. 8 and 63 and 34 and 12 and 47 
 
Abbreviations 
mp=title, original title, abstract, name of substance word, subject heading word 
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Table 1.  Excluded Studies  
Study  Reason for Exclusion 
Ada 2006 Not a randomised controlled trial. 
Barreca 2004 Treatment interventions between control and experimental group differed in content. 
Dromerick 2009 Interventions included different time periods for wearing of mitt (not an exercise 
based intervention) and different doses of shaping, therefore, unable to determine 
which aspect of this intervention would contribute to functional outcomes. 
Duncan 2003 Treatment interventions between control and experimental group differed in content. 
Fang 2003 Control group received no intervention, therefore study investigated effects of 
physiotherapy rather than an increased intensity of physiotherapy. 
Feys 1998 Investigated the effects of an intervention not intensity. 
Fisher 2001 Not a randomised controlled trial. 
Green 2002 Investigated the effect of an intervention in a specific setting not intensity. 
Kuys 2008 Not a randomised controlled trial. 
Kwakkel 2002 Examination of a subgroup of the original trial (Kwakkel 1999). 
Moreland 2003 Progressive resisted exercise - not the definition of intensity used in this review. 
Nugent 1994 Not a controlled or randomised controlled trial. 
Page 2004 Investigated the effect of an intervention not intensity. 
Richards1993 Treatment interventions between control and experimental group differed in content. 
Richards 2008 Not a randomised controlled trial. 
Sivenius 1985 Extra therapy incorporated components of physical, occupational and speech 
therapy.  It was not possible to isolate the effects of exercise-based therapy. 
Slade 2002 Therapy analysed included physical, perceptual and cognitive, washing and 
dressing, daily living activities, group treatment, joint treatment and splinting and this 
was analysed as ‘a package’.   It was not possible to isolate the effects of exercise-
based therapy. 
Smith 1981 No specific treatment techniques described. Intensive therapy involved multi 
disciplinary treatment and therefore difficult to isolate the effects of exercise-based 
therapy.  Control group also given extra treatment if deemed necessary. 
Sunderland 1992 Treatment interventions between control and experimental group differed in content.  
The experimental group also included EMG biofeedback. 
Wade 1992 Subjects received physiotherapy immediately or after three months delay, therefore 
effectively the first half of a crossover study – physiotherapy versus no treatment.  
Therefore not different intensities of the same physiotherapy treatment. 
Werner 2002 Treatment interventions between control and experimental group differed in content. 
Wolf 2007 Not a randomised controlled trial. 
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Table 2.  Included studies design, participants and attrition 
Participants Study Design 






Mean (SD) time  
after stroke (days) 
Attrition 
(cumulative) 
      
Control 


















7 by 6 weeks 
21 by 6 
weeks 
3 by 6 
weeks 









10 (5M) 10 (5 M) 72.7 
(14.5) 
73.0 (8.6) 5 right 4 right All anterior circulation 
stroke 
 
13.4 (4.4) 25.6 
(15.5) 
2 by 6 weeks 
7 by 12 
weeks 
0 by 6 
weeks 








35 (17 M) 35 (24 M) 67 (10) 68 (11) 15 right 15 right TACI    =   
7 
PACI    = 
18 
LACI    =   
8 
POCI    =   
1 
unsure =  
1 
TACI    =   
6 
PACI    = 
15 
LACI    = 
10 
POCI    =   
2 
unsure =  
2 
 
25 days  
(range 6-71) 
0 by 4 weeks 
1 by 3 
months 
1 by 6 
months 
1 by  4 
weeks 
3 by 3 
months 
















38 right 47 right TACI = 7 
PACI = 
29 
LACI = 13 
POCI = 0 
unsure = 
46 
TACI   =    
9 
PACI   =  
31 
LACI   =  
11 




1-5 weeks after 
stroke 
5 by 5 weeks 
11 by 3 
months 
14 by 6 
months 
7 by 5 
weeks 
10 by 3 
months 
13 by 6 
months 












TACI   = 
19 
PACI   = 
11 
LACI   =   
3 








4 by 20 
weeks 
4 by 26 
weeks 









37 (14 M) 
Leg group 







TACI = 25 
PACI =   
9 
LACI =   3 
POCI = 0 
unsure =0 Leg group TACI   = 
17 
PACI   = 
13 
LACI   = 1 






3 by 20 
weeks 
3 by 26 
weeks 
4 by 52 
weeks Leg group 5 by 20 
weeks 
5 by 26 
weeks 
6 by 52 
weeks 






(52 M)   
No data provided in 
paper 
No data provided in 
paper 
4 by 6 weeks 
11 by 6 
months 
2 by 6 
weeks 
















35 right 34 right TACI   = 
13 
PACI   = 
17 
LACI   = 
29 




TACI   =  
8 
PACI   = 
17 
LACI   = 
34 
POCI   = 
3 
unsure =0 
Median of 5 days 
after stroke 
10 by 3 
months 
13 by 6 
months 
8 by 3 
months 
14 by 6 
months 
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Table 3.  Included studies interventions, intensity and outcome measures 
Study Intervention Intensity -  mean 
hours delivered 
(SD) 
Measurement  time points Outcome measures 
 Control Extra Control Extra Baseline Outcome Follow-up 1 Follow-up 2   
Cooke 
2009 
Conventional physical therapy 













  Extra from  
research staff 
      
 Walking speed 
 Ability to walk at 0.8 m/s or more 
 Modified Rivermead Mobility Index 
 Knee flexion peak torque 
 Knee extension peak torque 
Donalds
on 2009 
Conventional physical therapy 













  Extra from  
research staff 
      
 Action Research Arm Test 
 9 hole peg test 
 Hand grip force 
 Pinch grip force 
 Elbow flexion force – isometric 
 Elbow extension force - isometric 
GAPS 
2004 
Treatment broadly based on 
‘normal movement’ (Bobath 

















6 months after 
start treatment 
 Rivermead Mobility Index 
 Motricty Index 
 
Treatment based on the 























6 months after 
start treatment 
 
 Rivermead Arm Assessment 
 Action Research Arm Test 
 Rivermead Motor Assess – gross 
function 
 10-hole Peg Teat 
 Maximum grip strength 
Routine arm & leg training 
using evidenced-based 










after start  
treatment 









 Leg group 
Leg training 










    
Arm group 
 Action Research Arm Test 
 Frenchay Activities Index 
 
Leg group 
 Comfortable walking speed 
 Maximum walking speed 




Bobath method of treatment 
from usual staff 
No data 
 
No data  Pre-
intervention 
After 6 weeks 
of intervention 
6 months 
after start  
treatment 
NA  Functional reach 
 5-metre timed walk 
 Timed sit-to-stand 
Rodgers 
2003 
Normal movement approach 
(Bobath) within meaningful 
activity and task analysis from 
17.4 24.9 Pre-
intervention 
None 3 months 
after stroke 
6 months after 
stroke 
 Action Research Arm Test 
 Upper Limb Motricity Index 
 Frenchay Arm Test 
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usual staff 
* calculated using minutes/day data 20 weeks each with 5 treatment days 
$
  calculated using median 30 days with 0.58 hours a day for control and 0.83 hours a day for extra
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Sequence generation        
Allocation concealment 
       
Blinding (participants, personnel and assessors)        
Incomplete outcome data 
       
Selective outcome reporting 
       
Other sources of bias 
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Table 5  motor impairment – muscle function 
Time-point Study Measure used Augmented therapy Standard therapy Mean difference 
   Number 
subjects 
Mean (SD) Number 
subjects 




        
 4 weeks after start therapy GAPS Motricity arm + leg 33 119.0 (46.0) 34 111.0 (45.0) 8.0 [-13.8,29.8] 
 20 weeks after start therapy Kwakkel Motricity leg 26 68.2 (25.8) 34 45.2 (24.8) 23.0 [10.0,35.9] 
 20 weeks after start therapy Kwakkel Motricity arm 29 53.1 (32.0) 34 28.9 (28.5) 24.2 [9.2,33.1] 
 6 weeks after start therapy Donaldson Hand grip force 10 71.9 (49.5) 8 64.8 (39.3) 7.1 [-34.0,48.1] 
 5 weeks after start therapy Lincoln Hand grip strength 87 0 (25.19) 90 11.0 (36.3) -11.0 [-20.2,-1.8] 
  Subtotal – hand grip force/strength 97  98  -10.1 [-19.1,-1.2] 
 6 weeks after start therapy Donaldson Pinch grip force 10 31.5 (23.1) 8 24.5 (19.7) 7.0 [-12.8,26.8] 
 6 weeks after start therapy Donaldson Elbow extend force 10 64.5 (44.6) 8 68.6 (39.6) -4.1 [-43.1,34.8] 
 6 weeks after start therapy Donaldson Elbow flexion force 10 76.1 (58.7) 8 75.0 (38.7) 1.1 [-44.1,46.3] 
 6 weeks after start therapy Cooke Knee extend torque 26 45.3  (33.2) 25 27.8  (26.3) 17.5a [1.1, 33.9] 
 6 weeks after start therapy Cooke Knee flexion torque 26 34.0  (23.1) 25 19.0  (17.8) 15.0a [3.7, 26.3] 
Follow-up 1 
        
 3 months after start therapy GAPS Motricity arm + leg 32 130.0 (44.0) 33 120.0 (42.0) 10.0 [-10.9,30.9] 
 26 weeks after start therapy Kwakkel Motricity leg 26 68.2 (25.3) 34 27.2 (26.8) 41.0 [27.7,54.3] 
 26 weeks after start therapy Kwakkel Motricity arm 29 48.6 (31.1) 34 31.1 (30.1) 17.5 [2.3,32.7] 
 3 months after stroke Rodgers Motricity arm 54 85.0 (20.0) 51 78.0 (36.3) 7.0 [-4.3,18.3] 
  Subtotal – Motricity arm 83  85  10.7 [1.7,19.8] 
 18 weeks after start therapy Cooke Knee extend torque 19 56.4  (36.3) 18 37.9  (27.8) 18.5a [-2.3, 39.3] 
 18 weeks after start therapy Cooke Knee flexion torque 19 41.7  (28.8) 18 25.2  (22.9) 16.5a [-0.2, 33.2] 
 3 months after start therapy Lincoln Hand grip strength 84 9.0 (28.2) 84 19.0 (43.0) -10.0 [-19.5,1.8] 
Follow-up 2 
        
 6 months after start therapy Lincoln Hand grip strength 81 23.0 (40.7) 81 25.0 (45.2) -2.0 [-15.3,11.3] 
 6 months after stroke Rodgers Motricity arm 48 83.0 (28.2) 48 77.0 (25.9) 6.0 [-4.8,16.8] 
 6 months after start therapy GAPS Motricity arm + leg 30 124.0 (42.0) 34 121.0 (51.0) 3.0 [-19.8,25.8] 
a
 = fixed effect model used; b = random effect model used; FU = Follow-up; * =  < 0.05 
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Table 6  Motor impairment - movement control 
 




subjects Mean (SD) 
Number 
subjects Mean (SD) 
Effect 
size [95% CI] 
Outcome 
        
 6 weeks after start therapy Cooke Symmetry step time 19 18.8  (35.6) 15 28.6  (33.1) 9.7a [-32.9, 13.5] 
 6 weeks after start therapy Cooke Symmetry step length 19 13.5  (15.8) 15 25.0  (36.6) 11.5a [-31.3,  8.3] 
 6 weeks after start therapy Donaldson 9 Hole Peg Test 10 0.2    (0.2) 8 0.2    (0.1) 0.0a [-0.1,  0.1] 
 5 weeks after start therapy Lincoln 10 Hole Peg Test 87 0.0  (19.3) 90 0.0  (41.5) 0.0a [-9.5,9.5] 
Follow-up 1 
        
 18 weeks after start therapy Cooke Symmetry step time 19 19.4  (29.9) 14 23.0  (23.5) 3.6a [-21.9, 14.6] 
 18 weeks after start therapy Cooke Symmetry step length 19 23.7  (49.9) 14 12.3  (11.0) -11.4a [-11.8, 34.6] 
Follow-up 2 
        
 6 months after start therapy Lincoln 10 Hole Peg Test 81 0 (40.7) 81 0 (45.2) 0.0 [-13.3,13.3] 
 
a
 = fixed effect model used; b = random effect model used; FU = Follow-up; * = = < 0.05 
 
Note: symmetry values represent difference from total symmetry therefore a higher value indicates a worse outcome.
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Table 7  Effect sizes for functional activity 
Time-point 
 




subjects Mean (SD) 
No.  
subjects Mean (SD) 
Effect 
size [95% CI] 
Outcome 
        
 6 weeks after start therapy Donaldson ARAT 10 41.8 (17.8) 8 45.0 (14.0) 3.2 [-17.9,11.5] 
 20 weeks after start therapy Kwakkel  ARAT 29 9.0 (28.9) 34 0.0 (1.5) 9.0 [-1.5,19.5] 
 5 weeks after start therapy Lincoln ARAT 87 1.0 (25.9) 90 5.0 (28.2) -4.0 [-12.0,4.0] 
  Subtotal - ARAT  126  132  0.1 [-5.7,6.0] 
 5 weeks after start therapy Lincoln Rivermead arm 87 3.0 (5.9) 90 4.0 (5.2) -1.0 [-2.6,0.6] 
 6 weeks after start therapy Cooke Rivermead mobility 31 36.6 (10.4) 32 34.6 (10.8) 2.0 [-3.2,7.2] 
 6 weeks after start therapy Cooke Walk 0.8m/s or more  31 11 32 4 3.9c [1.1,13.9] 
 6 weeks after start therapy Cooke Comfort walk speed 32 0.6 (0.5) 31 0.3 (0.4) 0.3 [0.1,0.5] 
 20 weeks after start therapy Kwakkel Comfort walk speed 26 0.7 (0.5) 34 0.4 (0.4) 0.3 [0.1,0.5] 
  Subtotal – comfort walk speed 58  65  0.3 [0.1,0.5] 
 20 weeks after start therapy Kwakkel Max walk speed 26 0.9 (0.7) 34 0.5 (0.6) 0.4 [0.1,0.7] 
 20 weeks after start therapy Kwakkel FAC 29 4 (1.5) 34 3 (2.2) 1.0 [0.1,2.0] 
 6 weeks after start therapy Partridge 5 metre walk time 33 49.2 (32.0) 22 39.9 (29.9) 9.3 [-7.3,25.9] 
 5 weeks after start therapy Lincoln Rivermead Gross Function 87 3.0 (4.4) 87 5.0 (5.2) -2.0 [-3.4,-0.6] 
Follow-up 1 
        
 26 weeks after start therapy Kwakkel  ARAT 29 4.0 (28.2) 34 0.0 (1.85) 4.0 [-6.3,14.3] 
 3 months after stroke Rodgers ARAT 54 53.0 (27.4) 51 54.0 (41.5) -1.0 [-14.5,12.5] 
  Subtotal - ARAT 83  85  2.2 [-6.0, 10.4] 
 18 weeks after start therapy Cooke Rivermead mobility 28 36.6 (9.8) 23 39.7 (5.7) -3.1 [-7.4,1.2] 
 3 months after start therapy GAPS Rivermead mobility 32 9.7 (3.3) 34 8.1 (3.6) 1.6 [-0.1,3.3] 
  Subtotal – Rivermead mobility 60  57  1.0 [-0.6,2.5] 
 18 weeks after start therapy Cooke Comfort walk speed 27 0.6 (0.5) 23 0.4 (0.4) 0.2 [-0.1,0.5] 
 26 weeks after start therapy Kwakkel Comfort walk speed 26 0.6 (0.5) 34 0.4 (0.4) 0.2 [-0.0,0.4] 
  Subtotal – Comfort walk speed 59  61  0.2 [-0.1,0.4] 
 3 months after stroke Rodgers Frenchay Arm Test 54 4.0 (2.2) 51 4.0 (3.7) 0.0 [-1.2,1.2] 
 3 months after start therapy Lincoln Rivermead arm 84 3.0 (5.9) 84 5.0 (5.2) -2.0 [-3.7,-0.3] 
 6 months after start therapy Partridge 5 metre walk time 27 35.8 (16.5) 33 49.4 (32.1) -13.6 [-26.2,-1.0] 
 3 months after start therapy Lincoln Rivermead Gross Function 84 5.0 (5.2) 84 6.0 (5.9) -1.0 [-2.7,0.7] 
 26 weeks after start therapy Kwakkel FAC 26 5.0 (0.7) 34 4.0 (2.2) 1.0 [0.2,1.8] 
 18 weeks after start therapy Cooke Walk 0.8m/s or more 27 10 23 4 2.8 [0.8,10.6] 
 26 weeks after start therapy Kwakkel Max walk speed 26 0.9 (0.7) 34 0.6 (0.6) 0.3 [-0.0,0.6] 
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Follow-up 2 
        
 6 months after start therapy Lincoln ARAT 81 3.0 (28.9) 81 19.0 (33.3) -16.0 [-25.6,-6.4] 
 52 weeks after start therapy Kwakkel  ARAT 28 6.0 (31.3) 33 1.0 (21.1) 5.00 [-8.6,18.7] 
 6 months after stroke Rodgers ARAT 48 55.0 (31.9) 48 56.0 (23.7) -1.0 [-12.2,10.2] 
  Subtotal - ARAT 157  162  -6.4 [-12.8,0.0] 
 6 months after stroke Rodgers Frenchay Arm Test 48 5.0 (3.0) 48 4 (3.0) 1.0 [-0.2,2.2] 
 6 months after start therapy Lincoln Rivermead arm 81 4.0 (6.7) 81 6.0 (5.9) -2.0 [-4.0,-0.1] 
 6 months after start therapy Lincoln Rivermead Gross Function 81 6.0 (5.9) 81 7.0 (3.7) -1.0 [-2.5,0.5] 
 52 weeks after start therapy Kwakkel Max walk speed 25 0.9 (0.6) 33 0.7 (0.6) 0.2 [-0.1,0.5] 
 52 weeks after start therapy Kwakkel FAC 25 5 (0.7) 33 4 (1.48) 1.0 [0.4,1.6] 
 6 months after start therapy GAPS Rivermead mobility 30 10.2 (3.1) 34 9.1 (4.0) 1.1 [-0.6,2.8] 
 52 weeks after start therapy Kwakkel Comfort walk speed 25 0.6 (0.5) 33 0.5 (0.4) 0.1 [-0.1,0.3] 
a
 = fixed effect model used; b = random effect model used; c = odds ratio used; FU = Follow-up; * = = < 0.05;  ARAT = Action Research Arm Test; FAC 
= Functional Ambulation Category 
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Fig 1.   Flow Diagram for this systematic review (note: 3 full-text articles 
reported the same study) 
 
Records after duplicates removed 
(n = 940 ) 
Records screened 
(n = 940) 
Records excluded 
(n = 909 ) 
Full-text articles assessed 
for eligibility 
(n = 31 ) 
Full-text articles excluded, 
with reasons 
(n = 22  ) 
Studies included in 
qualitative synthesis 
(n =  7 ) 
Studies included in 
quantitative synthesis 
(meta-analysis) 































Appendix IV  
Data extraction form  

















Sex of participants 




Type of stroke  
 
 
Side of weakness  
 
 
Time since stroke  
 
 












Median (range) length of follow-up 
reported in this paper (state weeks, 
months or years or if not stated) 
 
  
Duration of treatment (State weeks / 
months, etc, if cross-over trial give 
length of time in each arm) 
 
 
Time-points when measurements were 
taken during the study  
 
 

























Intervention group Control group Details if outcome only described in text 
n Mean (SD) n Mean (SD) 
 
       
       
       
       
       







For Dichotomous data 
Outcomes (rename) Intervention group (n) 
n = number of participants, not number of events 
Control group (n) 
n = number of  participants, not number of events 
   
   
   
   
   





Risk of bias assessment form 
 Appendix 5: Risk of bias assessment form adapted from 
Cochrane Handbook version 5.1.0 (Higgins and Green, 
2011). 
 
Author (year): _____________________________ 
 
Reviewer:      _____________________________ 
Quality Criteria 
 



























   





















I am writing to tell you about research being carried out in Norfolk by Dr Jane 
Cross and a team of researchers at The University of East Anglia. 
Dr Cross and her team are seeing whether a new physiotherapy treatment 
is effective for people who have a stroke. They want to find out whether doing 
6 weeks of a new therapy called “Functional Strength Training” can help 
people to use their arm and leg better for daily activities such as walking 
and getting dressed.  
 
The Research team are asking people who have had a stroke within the 
last 5 years to take part. In all the researchers are looking for 58 people who 
have weakness in their arm and leg caused by their stroke. Your details 
were identified from your in-patient stay after having your stroke.  
 
What would I have to do? 
Taking part in the study would mean having physiotherapy for your arm or 
leg for 4 days a week for 6 weeks. Each training session will be an hour 
long. You might practise tasks for the arm such as reaching for objects, 
unscrewing lids and pouring water; or tasks for the leg such as climbing 
stairs, standing, and walking. We would need to assess your arm and leg 
before and after the 6 weeks of therapy.  
All the therapy and assessments would be in your home with a research 
physiotherapist. We may also ask questions about how you found the 
therapy and whether it was what you were hoping for.  
Recipients address 






Version 4: 30/06/2010 
Am I the right person for this research? 
Are you walking as well as you had done before the stroke? 
Are you able to use your arm as well as you had done before the stroke? 
If your answer is NO to both these questions then you may be able to be 
included in this research. 
 
Taking part in this research is entirely voluntary. You will not be out of 
pocket if you decide you would like to take part.   
 
Please return the reply slip in the stamped address envelope to show 
whether or not you would like to have more information about the study.  
If you would like to talk to somebody before deciding, please contact Kath 
Mares on 01603 593099 or 07827 840497.  
If the research team has not heard from you within 2 weeks we will send you 
one reminder by post.  
 
Thank you for taking the time to consider this invitation 
Yours sincerely 




Dr Phyo Myint 
Consultant in Elderly Medicine 
Norfolk and Norwich University 
Hospital  
Dr Kneale Metcalf 
Consultant in Elderly Medicine 






Expression of interest form 
FeST1vAlS (ISRCTN71632550) 




            
 
 
Functional Strength Training to improve walking and upper limb function in 
people later after stroke 
 
EXPRESSION OF INTEREST FORM 
 
Thank you for filling in this form and expressing an interest in being part of 
this research. Following receipt of this form we will contact you by telephone 
to arrange to come and visit you to discuss the research further. 
 







                                                                             Postcode: 
Tel:                                                          
 
 
Thank you for filling in this form.  Please do not hesitate to contact me if you 
have any questions about the study or filling in the form.   
 
 
Please return the form in the envelope provided to: Kath Mares, School of 
Allied Health Professions, Queen’s Building, University of East Anglia, 
Norwich NR4 7TJ 
 
 








Participant information sheet 
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Functional Strength Training to improve walking and upper limb 




You are invited to take part in a research study. Before you decide 
whether you would like to take part you need to understand why the 
research is being done and what would be involved. Please take time to 
read the following information carefully.  
 
Talk to others about the study if you wish. If you have any questions or 
would like further information there are some contact numbers on page 
10 and 11 of this information pack. 
 
 Part 1 describes the purpose of this study and what will happen if 
you decide to take part. 
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Part 1  
 
 
What is the purpose of this study? 
 
Weakness in the arm and leg is common after stroke and this can affect 
people’s ability to walk and carry out daily activities.   
Many people think that there is little chance of further improvement a year 
after stroke. Most people do not receive therapy at this time.  We want to 
find out whether a new therapy called Functional Strength Training 
(FST) is effective for people at least six months after their stroke. We also 
want to find out what people think about FST and whether it is suitable to 
be provided to people in their own homes 
 
What is Functional Strength Training (FST)? 
Functional Training involves practising activities that you do every day 
such as walking and reaching for objects. Adding ‘Strength’ Training 
means increasing the number of times the activity is practised or 














Activities could include: 
Standing up from chairs at different heights 
Climbing steps or stairs 
Exercises with weights sitting down 
 
Activities could include: 
Reaching for objects from cupboards 
Lifting objects of different weights.   
Tying shoelaces, undoing buttons 
 
 
FST for the leg FST for the arm 






Why have I been asked to take part? 
 
You have been chosen because you have had a stroke within the last 5 



























What will happen if I decide to take part? 
 
Once you are happy that you want to take part in the study, one of the 
research team will visit you at home.  
On your home visit a member of the research team will assess your arm 
and leg to see whether or not you are suitable to participate in the study. 
 
Do I have to take part? 
 
No. It is up to you to decide. Taking part in the research study is entirely 
voluntary. If you want to you can speak to a member of the research 
team before you decide.   
You are free to withdraw from the study at any time and you do not have 
to give a reason.  
 
 
We are looking for people who; 
 
 Have weakness in their arm and leg following a stroke; 
 Are not receiving physiotherapy for their arm and leg; 
 But who are able to participate in physiotherapy.  
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If you are not suitable to participate in the study, you will be told by the 
Research team and you will not be asked to take any further part in the 
study.  
 
If you are you will be asked to sign a consent form to show you agree to 
take part. We will leave the consent form with you for 1 week so that you 
can think about becoming part of the study. If you still wish to take part in the 
study a Researcher will come and visit you at home and will take some 
more measurements of your arm and leg. They will also help you complete 
a questionnaire about your health and use of health services  
      
This will take approximately 30-40 minutes.  
 
In order to do this we will: 
 
 Assess your ability to stand and walk 
 Assess your ability to use your stroke arm in every day activities. 
For example, lift different sized objects from the table onto a box in 
front of you   
 











Touch your head 9 Hole Peg Test 




With your consent the Research Team will tell your GP that you are taking 
part in the study and check that there are no medical reasons why you 
can’t take part. 
 
After the home visit 
 
 
 Group 1 will receive 6 weeks of FST training for their arm  
 
 






















You will be identified by a number. None of your personal details are given. 
The research therapist giving the FST training will tell you which group you 
are in.   
 
Can I choose which group I get allocated?  
 
No. Participants have to be randomly allocated to either of the groups to 
allow us to find out whether this treatment is effective or not. The 
researcher who does the assessments at the start and end of the study 
will not know which group you are in and therefore will not be able to 
influence the findings. This is called a ‘blind trial’. You must not tell the 
assessor which group you are in or anything about your FST training.  
 
If you are suitable for the study you will be allocated to group 1 or group 2 at random.  
 



















Weekly measures of arm and leg function 
Once a week (usually the first visit each week) the therapist who is 
visiting you to carry out the intervention will carry out a brief 
assessment of your arm and leg movement.  This information will be 
used to tell us whether 6 weeks of therapy is enough, too little or too much. 
This assessment should only take about 20 minutes and won’t impact on 
















A small number of participants (6 out of the 58) will be 
chosen to take part in two interviews as well as the 
FST therapy.  
 
There will be two interviews conducted by an Independent Researcher. 






Outcome and follow- up assessments  
After the 6 weeks of FST training the researcher will assess your arm 
and leg again, using the same assessments as before.   
This will also happen 6 weeks after the FST training has stopped so we 
can see if any improvements in your arm and leg have been maintained.  
You will also be asked to complete the same questionnaire about your 
health and use of health services.  
 












































The purpose of the interviews is to help us find out whether or not you find  
this level of training acceptable and whether it is suitable to be provided in 
people’s homes  
Interview 1  
Will take place before you start the FST Training 
You will be asked questions about what life was like before your stroke. 
We want to find out what difficulties you now have because of your 
stroke and what you are hoping to achieve by participating in the FST 
training.  
Interview 2   
Will take place after the 6 weeks of FST Training 
You will be asked for feedback about what you thought of the FST training. 
For example if it was too tiring and whether you saw any benefits.  
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You will be allocated to either the Arm group OR Leg group 
Arm group 
6 weeks of FST for your stroke arm 
(4 days a week, 60 minutes a day) 
Leg group 
6 weeks of FST for your stroke leg 
(4 days a week, 60 minutes a day) 
 
Interview 1 
Not all participants will be asked to take part in the interview. 
Telephone call from Research team (1 week after receiving information) 
Home visit  
You will be screened to see whether you can be included in the 





Not all participants will take part in interview 2  
 
Outcome Measures (Week 6) 
Same questions and assessment of your arm and leg as in first assessment 
Home visit 
You will sign a consent form and have an assessment of your arm and leg. 
You will be helped to complete a short questionnaire 
 
 









































    
           Expenses 
  
 The study will take place entirely within your own home and 
therefore there will be no travel expenses.  
 
    You will not be out of pocket if you take part in the study.  
 
     
£ 
               
    Are there any possible risks with this study? 
 
There is a small risk that you may experience some pain or 
discomfort if you overwork your arm or leg in therapy. This will 
be closely monitored and we will pace therapy to your level 
of ability. Therapy can be stopped at any time. If you want 
to stop being involved you simply tell us.  
 
If there are any questions during the study that you do not want to answer, 
you do not have to answer them.  
                            
                        What are the possible benefits of taking part in the study? 
     
 Previous studies have shown that functional strength training 
improved recovery of people early after stroke. However we 
do not know if the therapy is effective for people at least a 




      
    What happens when the study stops?  
 
This is the first study of FST at 1 year after stroke. The 
Follow-up measures (Week 12)  
Same questions and assessments of your arm and leg 
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This completes Part 1 of the information sheet. 
 
    What if there is a problem? 
 
If you have any complaints about the way you have been 
dealt with or any harm is caused during the study this will be 
addressed. Detailed information relating to this is outlined in 




     
     Will my taking part in the study be kept confidential? 
     
Yes, all the information about you and your participation 
in the study will be kept strictly confidential. We will follow 
ethical and legal practice and all information about you will 














Independent Contact Details: 
If you wish to discuss this study with someone who is not involved in the research 
then you can contact the 
Research and Development Office, Norfolk and Norwich University Hospital: 
 
                                                                            
 
http://www.nnuh.nhs.uk/Dept.asp?ID=60                                       01603 286611 
 
If this information interests you and you are considering taking part, please 
continue to read additional information in Part 2 before making any decision. 
If you have any queries you can contact the Research Physiotherapist, 
Kath Mares or Jane Cross the Principal Investigator.  
Contact details:  
 
 
                    
                               
                        
      
      
    
 
 
                    
       
 











Kath Mares   
Research  
Physiotherapist 
The Queens Building 
University of East Anglia    
Norwich                
NR4 7TJ            
    







               
 
 
Dr Jane Cross    
Principle 
Investigator  
The Queens Building 
University of East Anglia    
Norwich                
NR4 7TJ            
    
     
j.cross@uea.ac.uk 01603  
593636               
 
 












































     
What happens if new information about the research 
therapy comes along?   
 
Sometimes in research, new things are found out about 
new therapies.  Very few studies have been done about 
this therapy (FST) and this study is to find evidence to 
justify a larger study. If however, new information is 
published then you will be told.  
 
 
     
                 What happens if I no longer wish to continue with the       study? 
      study? 
  
You may withdraw from the study at any time without giving 
a reason. If you withdraw from the study, we will need to use 
the data collected up to when you withdrew.  
Withdrawing from the study will not affect your treatment now or at any time 




       Will anyone else know I am doing this? 
 With your consent the research team will contact your GP to 
inform them you are taking part in the study.  
 
If the Research Team are concerned at any time about your health during your 
participation in this study they will report these concerns to your GP or the 
appropriate health care professional.   
 
 













































    What if there is a problem or something goes wrong? 
 
If you have any concerns about this study, you should first 
contact Kath Mares or Jane Cross, who will do their best to           
answer your questions or resolve the problem.  (Contact 
details given at end of Part 1). 
 
If you are still unhappy or wish to make a formal complaint you may do this 
through the NHS Complaints Procedure. Details can be obtained from the 
hospital.   
                                  
In the event that something does go wrong and you are harmed during the 
research study there are no special compensation arrangements.   
If you are harmed due to someone’s negligence then you may have grounds 
for legal action for compensation against the University of East Anglia, but you 








The Stroke Association have awarded a grant to enable the trial to be funded. 
The Research Team at the University of East Anglia are responsible for 
organising and running the trial.  
 












































    Will my taking part in this study be kept confidential? 
The research team will only have access to information about 
you that is relevant to the study. All information will be kept 
strictly confidential.  
 
Information may include details such as your date of birth and the date and 
diagnosis of your stroke. Personal information such as your address will also 
be required to allow us to visit you at home.  
 
You will be given a trial number for the purpose of collecting and analysing 
data. This means you will remain anonymous 
 
 
The data will only be accessed by authorised persons within the Research 
Teams and the Research and Development Office of the NHS Trust, who 
ensure the quality of the research carried out.  
 
Data will be stored securely in the research office during the study and for 5 
years after the study.  Long term data is then stored in a secure room in the 
NHS Clinical trials Research Unit at UEA for 25 years. All procedures for 
handling, processing, storage and destruction of data are compliant with the 
Data Protection Act 1998. 
 
 
    How will my information be stored?  
 
Data will be stored securely in the research office during 
the study and for 5 years after the study.  Long term data is 
then stored in a secure room in the NHS Clinical trials 
Research Unit at UEA for 25 years.  
 
All procedures for handling, processing, storage and destruction of data are 










































End of Part 2 
Thank you for taking the time to read this information. If you choose to 
participate, you will keep a copy of this participant information sheet and 
the signed consent form. 
What will happen to the results of the research study? 
 
The results of the trial will be analysed and used to justify 
whether or not a larger scale study is required to prove 
effectiveness of this therapy.  
 
The results will be published in an academic journal but individual 
participants will not be identifiable. Participants can be sent trial report at the 






Who has reviewed the study?  
 
The Trial has been reviewed by The Stroke Association and Stroke 
Survivors at our Patient Forum.  All were positive about the proposed trial 
and feedback has been incorporated into this research plan.  
 
The Cambridgeshire 2 Research Ethics Committee has approved the study 


















Title of Project: Functional Strength Training to improve walking 

























Please initial the relevant box 
 
 














                                       
I confirm that I have read and understood the information 
sheet dated 15/3/2012, Version 6 for the above study. 
 
I have had the opportunity to consider the information, ask 




















































I understand that my participation is voluntary and that 
I am free to withdraw at any time, without giving any 





I understand I can stop at any time 
 
 
I understand that some information about my 
stroke may be held by individuals from the 
University of East Anglia. These may be 
people outside of the research team who may 




My information can be seen 
 





















































My GP can be told I am in the study  
 
                                       
I agree that my GP can be informed of my 
participation in the study. I agree for my GP to be 
asked whether or not I am fit to take part in this 
study. I agree that my GP can be informed if there 





I consent to the use of audio visual 
equipment for the purposes of 
recording my interviews if I am 
selected for that part of this 
project. 
 
I consent for my interviews to be recorded 
 































      




Researcher       Date          Signature 
(Person taking consent) 
 
When completed; 1 for patient; 1 for researcher site file; 1 (original)   



















            
 
Faculty of Medicine and Health Sciences 
School of Allied Health Professions 
University of East Anglia 







Dear Dr ………………………………….. 
 
I am writing to inform you that you patient ………………………………………  (DOB…………………………) has 
consented to take part in a trial that is currently underway at the University of East Anglia. This trial 
is called Functional Strength Training Later after Stroke (FeSTlvAlS) and has been funded by the 
Stroke Association. We are aiming to recruit 58 participants who have had a stroke between 6 
months and 5 years ago to take part in a functional strength training programme which will target 
either their upper or lower limb, depending on group allocation. 
Please find a one page copy of the protocol on the reverse of this letter. 
 
We would be grateful if you could let us know of any medical reason why this patient may not be 
included in this study. If we have not heard from you within 10 working days from the receipt of 
this letter, then we will go ahead and included the patient named above ion the study. 
 
If you require any further information about the study then please contact either myself (Kath 




Kath Mares      Dr Jane Cross 
k.mares@uea.ac.uk     j.cross@uea.ac.uk 
















Version 2: 03/06/2010 
Kath Mares 
Research Physiotherapist FeST1vAlS (ISRCTN71632550) 
Ethics reference: 09/H0308/147  
k.mares@uea.ac.uk 
01603 593099 
Functional Strength Training Later After Stroke (FeSTlvAlS) 
Description of Intervention: 
Functional Strength Training (FST) is a ‘hands-off’ progressive, resistive low intensity exercise during 
functional activity. FST is designed to increase ability to produce voluntary muscle force throughout joint 
range and increase ability to modulate force in muscles/muscle groups appropriate for the activity being 
trained and improve functional ability.  Activities are progressed by increasing the number of repetitions, 
increasing range of joint motion required and increasing the load to be moved.  The intervention will be 
carried out in people’s homes by a Research Physiotherapist four times a week for six weeks. Portable 
equipment (e.g. free weights and steppers) will be used as appropriate.  Participants will be encouraged 
to use the paretic limb (upper or lower as allocated) in everyday functional activity.   
 
Research study primary objective: 
 To estimate if there is sufficient efficacy to justify subsequent trials of Functional Strength Training 




 adults aged 18+ years, 6 months to 5 years after stroke in anterior circulation (infarct or 
haemorrhage)  
 be able to walk 4 steps with continuous support from one person and/or assistive devices, but unable 
to step on and off a block with either the affected or unaffected leg more than 14 times in 
15 seconds. 
 be able to take paretic hand from position on lap and place on table top in front, but unable to pick up 
four £1 coins individually from a tabletop and stack them evenly in a pile. 
 can follow a 1-stage command i.e. sufficient communication/orientation for interventions in this trial 
 
Exclusion criteria: 
 known pathology which excludes participation in the low intensity exercise training involved 























Adverse events are not expected in this intervention but there is a small possibility of an overuse 
syndrome resulting in limb pain.  This will be considered to have occurred if a participant reports or 
exhibits limb pain (behavioural signs) to the Research Physiotherapist on 4 consecutive treatment days. 
If pain occurs then participants will be withdrawn from their allocated treatment. 
Participant presents with stroke 6 months to 5 
years ago 










Lower limb treatment schedule 
 Appendix 12: Lower limb physiotherapy treatment record for patients in FST trial 
(Items in bold refer to components of Functional Strength Training) 
 
 4 
Date  …………….…..      Patient ID   ………………………………………….…    Therapist ID  ......…………………….. 
No. Physiotherapists used  ..…….       No. Rehabilitation Assistants used …..….   Estimated duration of session ……… 
Aims 
1.  To reduce pain  3.  To improve muscle activity/function  5.  To improve gross mobility  
      2.  To improve sensory awareness  4.  To improve postural control  6.  To improve endurance  
Gross position of patient during activities used – what about kneeling postures? 
1.  Supine lying  4. non-paretic side lying  7.  4 pt kneeling  10.   Standing   
        2.  Crook lying  5.  Sitting - 900  8.  2 pt kneeling  11.   Walking  
 3.  Paretic side lying  6.  Sitting – perch  9.  ½ kneeling  12.  Other  
Equipment used  
1.  High hold/surface  4.  Perching stool  7.   Walking aid  10.  Other  
        2.  Low hold/surface  5.  Rolled up towel  8.  Tilt table    
        3. Hip high hold/surface  6.  Gym ball  9.   Standing frame    
Specific Physical Therapy interventions 
Function – in lying towards sitting
1.   Soft tissue mobilisation 
1.1   Specific soft tissue mobilisation  
  1.2   Passive movement  
  1.3   Muscle stretching  
2.   Facilitation of activity in specific muscles 
2.1   Imagery of specific muscle activity  
  2.2   Specific muscle activation  
  2.3   Activation of muscle activity during function  
3.   Facilitation of isolated (selective) joint movement    
3.1   Imagery specific joint movement  
  3.2   Active assisted isolated joint movement  
  3.3   Facilitate specific joint movement during function   
4. Facilitation of co-ordinated (combined) movement  
4.1.   Imagery of co-ordinated patterns of movement  
  4.2   Active assisted co-ordinated patterns of movement  
  4.3   Facilitate co-ordinated movement during function  
  4.4   Facilitate leg/foot activity from another body part  
5. Resistive exercise  
5.1   Resistance from therapist  
  5.2   Resistance from patient’s bodyweight  
  5.3   Resistance from equipment  
6. Specific sensory (tactile & proprioceptive) input  
6.1   “Hands-on” techniques  
  6.2   Provision of environmental surface  
7. Splinting techniques  
7.1   Strapping  
  7.2   Splinting  
 
8. Function – in lying towards sitting 
8.1   PT “hands-on” techniques to re-ed posture  
  8.2   Re-ed of funct act through specific mvmnt patterns  
  8.3   Rolling – functional activity training  
  8.4.  Bridging - functional activity training  
  8.5   Lying to sitting – functional activity training  
  8.6   Sitting to lying  - functional activity training  
  8.7   Static sitting balance training  
9. Function – In sitting towards standing  
9.1   PT “hands-on” techniques to re-ed posture  
  9.2   Re-ed of funct act through specific mvmnt patterns  
  9.3   Dynamic sitting balance training  
  9.4   Transfers training  
  9.5   Sit to standing – functional activity training  
  9.6   Stand to sit – functional activity training  
10. Function – In standing towards walking  
10.1  PT “hands-on” techniques to re-ed posture  
  10.2  Re-ed of funct act through specific mvmnt patterns  
  10.3  Static standing balance training  
  10.4  Dynamic standing balance training  
  10.5  One leg stand activities – functional training  
11. Function – Walking and onwards 
11.1  PT “hands-on” techniques to re-ed posture  
  11.2  Re-ed of funct act through specific mvmnt patterns  
  11.3  Overground indoor walking training  
  11.4  Overground outdoor walking training  
  11.5  Treadmill walking/bicycle training  
  11.6  Obstacle negotiation training  
  11.7  Ascending/descending stair training  
  5 
Instructions for completion of recording form overleaf 
1. ONE FORM FOR EACH TREATMENT SESSION 
Please complete one form for each treatment session given to patients included as subjects in the 
Functional Strength Training lower limb clinical trial 
2. TO COMPLETE THE AIMS SECTION  
Please place a tick in the box which best describes the aims relevant to the particular treatment 
session being recorded 
3. TO COMPLETE THE GROSS POSITION SECTION 
Please place a tick in the box for every gross position used to deliver physiotherapy treatment during 
the treatment session being recorded 
4. TO COMPLETE THE EQUIPMENT SECTION 
Please place a tick in the boxes which best describes the equipment used during the particular 
treatment session being recorded 
5. TO COMPLETE THE SECTION “SPECIFIC PHYSICAL THERAPY INTERVENTIONS” 
Please place a tick in the boxes which best describe the treatment that was given to the patient 
during the particular treatment session being recorded. 
6. FOR FURTHER DESCRIPTION OF ITEMS ON RECORDING FORM OVERLEAF 
Please refer to the accompanying document “Description of Lower Limb Treatment for Patients in 
FST Trial” 
 
Abbreviations for and glossary of terms used in recording form overleaf 
Act Activity/activities 
Environmental surface A surface to enhance  sensory input during functional activity e.g. sitting on a 
block of foam, walking on an exercise mat, walking on uneven ground 
Facilitation The application of an appropriate mode and dose (frequency, duration and 
intensity) of sensory stimulus provided by the therapist to access a desired 
active response from the patient 
Funct Function/functional 
High hold/surface A surface level with at least the mid-thoracic point of the patient to provide a 
hold and/or security during physical therapy intervention  
Imagery Mental rehearsal of a motor act that occurs in the absence of overt motor 
output 
Low hold/surface A surface level between the hip and mid-thoracic point of the patient to 
provide a hold and/or security during  physical therapy intervention 
Mvmnt Movement 
Physiotherapist Person with professional Physiotherapy qualification 
PT Physical Therapy 
Re-ed Re-education 
Rehabilitation Assistant Person assisting the physiotherapist but who is not a qualified 






Upper limb treatment schedule 
Appendix 13: Upper Limb Treatment Recording Form (Items in bold refer to components of Functional 
Strength Training) 
 
Date:………………..   Patient ID:………………………… Therapist ID:…………………………. 
No. physiotherapists used: ………  No rehab assistants used………….  Est duration of upper limb Rx……….. 
 
Aims:  
1.  Postural Control          2.  Musculo-skeletal range of motion          3.  Oedema management  
      4.  Alignment          5.  Manipulative ability of the hand          6  Sensory ability  
      7.  Muscle activity Paretic limb          8.  Transport ability of the arm          9.  Prevent/ reduce pain  
      10.  Muscle activity Non paretic limb         11.  Incorporate arm into balance and 
               mobility activity 
         12.  Awareness of  2 complications  
Gross position of patient during activities used: 
1.   Supine        2.   Prone         3.   Sidelying on unaffected side  4. Side lying on affected side  
        5.   4-point kneeling        6.   2-point kneeling         7.   Unsupported sitting  8.  Supported sitting  
        9.   Asymmetrical sitting        10.  Perch Sitting         11. Standing  12. Prone standing  
 
Setting 
1.  Gym        2.  Ward         3.  Hydrotherapy pool  4.   Other  
            (please state)…………………….. 
Equipment Used:…………………………………………………………………………………………………..… 
 
Treatment Activities.  
1.    Soft tissue mobilisation          6.    Splinting techniques  
1.1  Stroking          6.1  Shoulder support  
    1.2  Effleurage          6.2  Elbow support  
    1.3  Lymph drainage techniques          6.3  Wrist/hand support  
    1.4  Petrissage (kneading/wringing/picking-up/rolling)  
                
               Splinting material used           ……………………………….. 
  1.5  Specific compression (trigger points)            
    1.6  Myofascial release          7.    Exercise to increase strength  
    1.7  Frictions          7.1  Resistance from the therapist  
              7.2  Resistance from body weight  
    2.    Joint mobilisation          7.3  Resistance from equipment  
1.1  Accessory Movements          7.4  Gravity neutral repetitive movement   
    1.2  Passive Movements   
    1.3  Active Movements          8.   Balance and mobility incorporating upper limb activity 
              8.1  In, or from, lying  
    3.   Facilitation of muscle activity/movement          8.2  In, or from, kneeling  
    3.1  Mental Imagery          8.3  In, or from, sitting  
    3.2  Patient Generated Cueing          8.4  In, or from, standing  
    3.3  Therapist Generated Cueing          8.5  In walking  
1.      3.4  ‘Hand on’ to induce a desired motor response            
    3.5  Active Assisted          9.   Upper limb functional tasks  
    3.6  Facilitated Arm/Hand Activity from another body part          9.1  Bilateral functional activities  
    3.7  Restricted use of non-paretic limb          9.2  Unilateral reaching activities that are object directed  
              9.3  Unilateral reaching activities that are spatially directed  
4.    Positioning          9.4  Dexterity exercises  
4.1  Side lying hemiplegic side    
    4.2  Side lying non-hemiplegic side          10.   Education for patient and/or carer  
    4.3  Supine lying          10.1  To encourage self monitoring of upper limb   
    4.4  Half lying          10.2  Transfers training  
    4.5  Sitting in armchair          10.3  Limb handling and positioning skills  
    4.6  Forwards lean sitting          10.4  Written/ visual/ photo exercise programme  
    4.7  Sitting in wheelchair    
    
5.    Specific sensory input          11.     Other interventions / techniques  
5.1  Tactile Stimulation          11.1  Acupuncture  
     5.2  Proprioceptive Stimulation          11.2  Ultrasound  
    5.3  Electrical stimulation          11.3  Compression  
Appendix 13 5 
  
Instructions for completion of recording form 
 
 
1. ONE FORM FOR EACH TREATMENT SESSION 
Please complete one form for each treatment session given to patients included as subjects in the Functional Strength Training 
upper limb clinical trial 
2. TO COMPLETE THE AIMS SECTION  
Please place a tick in the box that best describes the aims relevant to the particular treatment session being recorded. Unless stated 
otherwise, it is assumed that the aim is to ‘Improve/ Optimise’ in each case. 
3. TO COMPLETE THE GROSS POSITION SECTION 
Place a tick in the box for every gross position used to deliver physiotherapy treatment during treatment sessions being recorded 
4. TO COMPLETE THE EQUIPMENT SECTION 
Please write the name of any equipment used during the particular treatment session being recorded.  Please refer to the booklet for 
further details of equipment.   
5. TO COMPLETE THE SECTION “TREATMENT ACTIVITIES” 
Please place a tick in the boxes which best describe the treatment that was given to the patient during the particular treatment 
session being recorded. 
6. FOR FURTHER DESCRIPTION OF ITEMS ON RECORDING FORM OVERLEAF 
Please refer to the accompanying document “Upper Limb Treatment Schedule Booklet: to accompany the Upper Limb Treatment 
Recording Form” 
 
Abbreviations for and glossary of terms used in recording form overleaf 
Effleurage A gliding manipulation performed with light centripetal pressure that deforms subcutaneous tissue down 
to the investing layer of the deep fascia * 
Est duration of upper 
limb Rx 
Estimated duration of upper limb treatment session.  If the treatment session does not involve the upper 
limb the therapist should place a ‘0’ in this section. 
Facilitation The application of an appropriate mode and dose (frequency, duration and intensity) of sensory stimulus 
provided by the therapist to access a desired active response from the patient ** 
Friction A repetitive, specific, nongliding technique that produces movement between the fibres of connective 
tissue, increasing tissue extensibility, and promoting ordered alignment of collagen within the tissues. * 
Lymph drainage 
techniques 
A nongliding technique performed in the direction of lymphatic flow, using short, rhythmical strokes 
with minimal to light pressure, which deforms subcutaneous tissue without engaging muscle *  
Mental Imagery Mental rehearsal of a motor act that occurs in the absence of overt motor output 
Myofascial Release A technique that combines a nongliding fascial traction with varying amounts of orthopaedic stretch to 
produce a moderate, sustained tensional force on the muscle and its associated fascia, which results in 
palpable viscoelastic lengthening and plastic deformation of the fascia * 
Petrissage A group of related techniques that repetitively compress, shear, and release muscle tissue with varying 
amounts of drag, lift, and glide * 
Physiotherapist Person with professional Physiotherapy qualification 
Rx Treatment 
Specific compression A non-gliding technique that is applied with a specific contact surface to muscle, tendon, or connective 
tissue; the compression and release is applied in a direction that is perpendicular to the target tissue, and 
the compression is often sustained * 
Stroking Gliding over the patient’s skin (unidirectionally) with minimal deformation of subcutaneous tissues.* 
Rehabilitation Assistant Person assisting the physiotherapist but who is not a qualified physiotherapist  
References:  
* Andrade C-K, Clifford P. Outcome-Based Massage. Lippencott Williams and Wilkins, London 2001. 
**  Hunter S M, Crome P, Sim J, Pomeroy V M. Formulation of a schedule of ‘mobilization and tactile stimulation’ for the upper 






Field Notes  Page: 2.1 
   
Participant ID:  FSTXXX Group Allocation: LL 
Date: XXXXX  
Length of session: 45 minutes / 15 minutes rest  
   





















Toe tapping x10 (x3) 
Lifting left foot on and off step x 10  (x 3) 
Repeated with 1lb ankle weight x 10 (x 3) 
Kicking football to targets - 10 minutes 
 
Sit to stand and return x10 (x3) using hands 
Sit to stand in right step standing x 10 (x2) 
using hands 
Sit to stand and return x10 (x3) no hands 
Repeat in right step standing x10 (x3) no 
hands 
 
Dynamic balance activity throwing ball (10 
minutes) 
Dynamic balance activity kicking ball, holding 
on to stick (10 minutes) 
Dynamic balance activity kicking ball without 






Field Notes  Page: 2.2 
   
Participant ID:  FSTXXX Group Allocation: LL 
Date: XXXXX  
Length of session: 50 minutes / 10 minutes rest  
   




























Overground walking practice 
 
Lifting left foot on and off step x 10  (x 3) 
Repeated with 1lb ankle weight x 10 (x 3) 
Repeated with 2lb ankle weight x10 (x 1) 
 
Sit to stand and return x10 (x 3) no hands 
Sit to stand in right step standing x 10 (x 2) 
using hands 
Sit to stand and return x10 (x 2) right foot on 
step using hands 
Repeat in right step standing x10 (x 3) no 
hands 
 
Sit to stand and return x10 (x 2) 
Sit to stand and return x 10 (x 2) in right step 
stand 
 
Dynamic balance activity throwing ball (10 
minutes) 
Dynamic balance activity kicking ball with 
alternating legs (10 minutes) no stick 
 
Walking practice using bean bags to increase 
step length and hip, knee and dorsiflexion 




Field Notes  Page: 2.3 
   
Participant ID:  FSTXXX Group Allocation: LL 
Date: XXXXX  
Length of session: 30 minutes / 5 minutes rest  
   




No adverse events reported but had been out for the day yesterday and was 
complaining of feeling tired today.  
 
Notes: 













Lifting left foot on and off step with 2lb ankle 
weight x 10  (x 3) 
 
 
Sit to stand and return x10 (x3) using hands 
Sit to stand in right step standing x 10 (x2) 
using hands 
Sit to stand and return x10 (x3) no hands 
Repeat in right step standing x10 (x3) no 
hands 
 
Dynamic balance activity throwing ball (10 
minutes) 
 
Stopped treatment at participants request as 






Field Notes  Page: 2.4 
   
Participant ID:  FSTXXX Group Allocation: LL 
Date: XXXXX  
Length of session: 0 mins  
   







Participant telephoned to cancel appointment as was feeling too tired, 
expressed continued wish to participate in study, arranged appointments for 





























































































































































































































































































































































































































































































Intervention or procedure  1  2  3  4 
Recruitment  1 0 60 mins 2 letters and 1 phone call from RA1 
consent 1 0 15­30 mins RA1 in patients home
Baseline measures 1 0 60 mins Independent researcher in Patient's home
Semi­structured Interview  1 0 60 mins RA2 in patient's home











Intervention or procedure  1  2  3  4 
Baseline Measures 1 0 30­40 mins RA1 in Patient's home 
Outcome Measures  1 0 30­40 mins RA1 in Patient's home 
FST including Monitoring adverse effects  24 0 1hour  Research Physiotherapist 
Patient's home






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Intervention or procedure  1  2  3  4 
Recruitment  1 0 60 mins 2 letters and 1 phone call from RA1 
consent 1 0 15­30 mins RA1 in patients home
Baseline measures 1 0 60 mins Independent researcher in Patient's home
Semi­structured Interview  1 0 60 mins RA2 in patient's home











Intervention or procedure  1  2  3  4 
Baseline Measures 1 0 30­40 mins RA1 in Patient's home 
Outcome Measures  1 0 30­40 mins RA1 in Patient's home 
FST including Monitoring adverse effects  24 0 1hour  Research Physiotherapist 
Patient's home






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Intervention or procedure  1  2  3  4 
Recruitment  1 0 60 mins 2 letters and 1 phone call from RA1 
consent 1 0 15­30 mins RA1 in patients home
Baseline measures 1 0 60 mins Independent researcher in Patient's home
Semi­structured Interview  1 0 60 mins RA2 in patient's home











Intervention or procedure  1  2  3  4 
Baseline Measures 1 0 30­40 mins RA1 in Patient's home 
Outcome Measures  1 0 30­40 mins RA1 in Patient's home 
FST including Monitoring adverse effects  24 0 1hour  Research Physiotherapist 
Patient's home






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Intervention or procedure  1  2  3  4 
Recruitment  1 0 60 mins 2 letters and 1 phone call from RA1 
consent 1 0 15­30 mins RA1 in patients home
Baseline measures 1 0 60 mins Independent researcher in Patient's home
Semi­structured Interview  1 0 60 mins RA2 in patient's home











Intervention or procedure  1  2  3  4 
Baseline Measures 1 0 30­40 mins RA1 in Patient's home 
Outcome Measures  1 0 30­40 mins RA1 in Patient's home 
FST including Monitoring adverse effects  24 0 1hour  Research Physiotherapist 
Patient's home






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Intervention or procedure  1  2  3  4 
Recruitment  1 0 60 mins 2 letters and 1 phone call from RA1 
consent 1 0 15­30 mins RA1 in patients home
Baseline measures 1 0 60 mins Independent researcher in Patient's home
Semi­structured Interview  1 0 60 mins RA2 in patient's home











Intervention or procedure  1  2  3  4 
Baseline Measures 1 0 30­40 mins RA1 in Patient's home 
Outcome Measures  1 0 30­40 mins RA1 in Patient's home 
FST including Monitoring adverse effects  24 0 1hour  Research Physiotherapist 
Patient's home
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Intervention or procedure  1  2  3  4 
Recruitment  1 0 60 mins 2 letters and 1 phone call from RA1 
consent 1 0 15­30 mins RA1 in patients home
Baseline measures 1 0 60 mins Independent researcher in Patient's home
Semi­structured Interview  1 0 60 mins RA2 in patient's home











Intervention or procedure  1  2  3  4 
Baseline Measures 1 0 30­40 mins RA1 in Patient's home 
Outcome Measures  1 0 30­40 mins RA1 in Patient's home 
FST including Monitoring adverse effects  24 0 1hour  Research Physiotherapist 
Patient's home












































































































































































































































































































































































































































































































































































































































































































































NHS REC Form Ref rence:
09/H0308/147








































































































































































































































































































































































































































































Intervention or procedure  1  2  3  4 
Recruitment  1 0 60 mins 2 letters and 1 phone call from RA1 
consent 1 0 15­30 mins RA1 in patients home
Baseline measures 1 0 60 mins Independent researcher in Patient's home
Semi­structured Interview  1 0 60 mins RA2 in patient's home











Intervention or procedure  1  2  3  4 
Baseline Measures 1 0 30­40 mins RA1 in Patient's home 
Outcome Measures  1 0 30­40 mins RA1 in Patient's home 
FST including Monitoring adverse effects  24 0 1hour  Research Physiotherapist 
Patient's home























































































































































































































































































































































































































































































































































































































































































































































Study characteristics of the studies included in the systematic review. 
Study Base of support feedback in gait rehabilitation 
Aruin, A.S. et al (2003) 
Study Design Randomised controlled trial 
Participant 
Characteristics 
Experimental  Control 
Sample Unknown 
Inclusion criteria Participants with a narrow base of support due to recent 
single unilateral cardiovascular accident. 
Able to stand and walk up to 4.5-6m with assistance of a 
physical therapist. 
Sample size 8 8 
Male % 68% of whole sample 
Age: mean (SD) 65.34 (3.4) 
Time since stroke 
onset:  months (SD) 
0.59 (0.06) 
Intervention Auditory feedback during gait 
as an adjunct to conventional 
gait therapy 
10 days, twice daily for 25 
mins 
Conventional gait therapy 
10 days, twice daily for 25 
mins 
Primary Outcome Step width (metres) 
Measurement time 
points 
Pre intervention and post intervention 
Findings Step width increased from 
0.09(0.003) to 0.16(0.008) 
p<0.05. 
Step width increased from 
0.099(0.004) to 
0.13(0.003) p<0.05. 
 Statistically significant difference in step width between the 
two groups post intervention (p<0.05) 
Authors conclusion Authors conclude that auditory biofeedback may have been 
useful in light of greater improvement seen in the 
experimental group. 
Comments Lack of detail about blinding of assessors to treatment 
allocation increases the potential for bias. All patients 
included in the study completed the intervention but exact 
details about treatment fidelity are not possible to discern 
from the reported study. This is a small study with no 
power calculation therefore at risk of a type II error, 
however the intervention seems feasible. It was unclear 
whether participants in this study were inpatients or 
outpatients but the intervention appeared to be taking place 
in a clinical location. 
 
  
Study HandTutorTM Enhanced Hand Rehabilitation after 
Stroke 
Carmeli et al (2011) 




Experimental  Control 
Sample Inpatients in a rehabilitation department in one hospital 
Inclusion criteria Minimum of 10° extension of flexion at the wrist or 
fingers, an ability to extend the wrist joint five times 
continuously without losing active range of motion. 
Sample size (analysed) 16 15 
Male % 69 73 
Age: Mean (SD) 57.8 (8.9) 62.5 (5.0) 
Time since stroke onset: 
Months (SD) 
0.28 (0.25) 0.37(0.27) 
Intervention Traditional hand therapy 
with additional training 
using the HandTutorTM for 
extrinsic feedback for 20-
30 minutes on each 
intervention session. 
Intervention took place 
over 15 consecutive 
treatment sessions. 
Traditional hand therapy 
with extra traditional hand 
therapy for 20-30 
minutes. 
Intervention took place 
over 15 consecutive 
treatment sessions. 
Primary Outcome Brunnstrom Fugl Meyer  (BFM) and Box and Block Test 
Measurements taken at 4 time points: Baseline, 
Midway (after 10 days), end of study period (outcome) 
and 10 days post intervention (follow up). 
Findings 
BFM mean (SD) 
Outcome 
Follow up 


















Authors conclusion Statistically significant improvement in both primary 
outcome measures in favour of the experimental group.  
The authors suggest that the intervention could be a 
useful alternative for providing extra movement practice 
whilst the feedback mechanism offers control over the 
‘correct’ practice and may serve to motivate the patient. 
Lack of a statistically significant difference between the 
outcome and follow up scores lead the authors to 
conclude that the training effect was maintained for ten 
days after the intervention. 
Comments 34/134 (25%) patients screened were included based 
on the inclusion criteria. Two participants in the 
experimental group dropped out, one died and the 
other didn’t wish to continue taking part. One 
participant dropped out of the control group as they did 
not wish to take part. Reasons for this were not given 
but the authors’ assumption that the intervention might 
motivate the participant may not be appropriate in light 
of these drop outs. This assertion was also not based 
on any data obtained from the trial so seems to be 
speculative. There is no information about what if any 
intervention was received on completion of the trial 
therefore the assumption that the effects of the study 
are carried over may be confounded by other variables. 
The process for randomisation was not described 




Study Facilitation of Sensory and Motor Recovery by 
Thermal Intervention for the Hemiplegic Upper Limb in 
Acute Stroke Patients: A Single-Blind Randomized 
Clinical Trial 
Chen et al (2005) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental  Control 
Sample Inpatients on wards within rehabilitation medicine and 
neurology departments in one hospital. 
Inclusion Criteria Presenting with motor deficits of the upper limb under 
Brunnstrom stage IV. 
Sample size (analysed) 15 14 
Male % 40% 71% 
Age: Mean (SD) 58.5(12.9) 59.6(12.0) 
Time since stroke onset: 
Months (SD) 
0.47(0.22) 0.41(0.22) 
Intervention Standard treatment for 
the upper limb and 
thermal stimulation to the 
upper limb. Intervention 
given 5 times weekly over 
six weeks. 
Standard treatment for 
the upper limb.  
Primary Outcome Brunnstrom stage: Weekly assessments in order to 
derive temporal changes over the course of the study. 
Findings: mean (SD) Outcome - 0.4(0.2) Outcome - 0.2(0.1) 
p=0.0005 
Authors conclusion Thermal stimulation significantly increased the 
outcomes of the Brunnstrom stage compared to the 
control group. Acknowledged the high drop out rate 
and suggested that in future studies an intention to 
treat analysis would minimise the effects of this on the 
study outcomes. 
Comments Forty six people were initially recruited but 17 dropped 
out because of discharge from hospital, pulmonary 
infection or searching alternative Chinese medicine 
therapy. Suggestions were given to minimise the 
effects of this on the analysis but no proposal were 
discussed for preventing this from occurring again in 
the future. Reporting of the trial showed a low risk of 
bias for all categories suggesting that the results of 
this trial are reliable, although the small sample size 
may impact on its generalisability and increase the 
risk of a type II error. 
 
  
Study Facilitation of motor and balance recovery by thermal 
intervention for the paretic lower limb of acute stroke: 
a single-blind randomised clinical trial. 
Chen et al (2011) 
Study Design Single-blind randomised controlled trial 
Participant Characteristics Experimental  Control 
Sample Consecutive patients who were admitted to one 
rehabilitation hospital over a one year period  
Inclusion criteria Motor deficit of the paretic leg at or less than 
Brunnstrom stage III 
Sample size (analysed) 17 16 
Male % 76% 56% 
Age: Mean (SD) 58.0 (11.5) 62.3 (11.3) 
Time since stroke onset: 
Months (SD) 
0.36(9.5-12.0) 0.36(9.3-14.0) 
Intervention Standard therapy and 
thermal stimulation for 48 
minutes five times weekly 
for six weeks. 
Standard therapy and 
‘discussion of  20 minutes 
duration at least 3 times a 
week’ for six weeks 
Primary Outcome Fugl-Meyer Assessment, Medical Research Council 
scale for Lower extremity, Functional Ambulation 
Category (FAC). Measures were taken at baseline, 4 
weeks and 6 weeks (outcome). 
Findings 





















Authors conclusion Authors reported this to be a pilot study with a 
relatively small sample of people and suggested 
larger confirmatory trials were warranted. 
Comments Two people dropped out of the study because they 
were discharged from hospital. It was not possible to 
blind either the therapist or participant to group 
allocation therefore this may have been a source of 
bias. All other aspects of the risk of bias assessment 
were reported and seemed to be at low risk. Dose 
was reported but it is unclear whether this was the 
intended intensity for this intervention and therefore it 
is not possible to speculate on treatment fidelity. 
 
  
Study The effectiveness of EMG biofeedback in the 
treatment of arm function after stroke 
Crow et al (1989) 
Study Design Single blind randomised controlled trial 
Participant Characteristics Experimental  Control 
Sample All patients admitted to one District Hospital, 
participants were stratified according to severity of 
upper limb symptoms. 
Inclusion criteria At least a flicker of activity around the shoulder girdle 
and had not already spontaneously recovered or did 
not have near normal movement. 
Sample size (analysed) 20 20 
Male % 70% 55% 
Age: Mean (SD) 67.4(10.4) 68.1(9.5) 
Time since stroke onset: 
Months (SD) 
2-8 weeks post stroke 
Intervention EMG biofeedback 
Intervention was carried 
out over 6 weeks  
Placebo 
Intervention was carried 
out over six weeks 
Primary Outcome Action Research Arm Test (ARAT) and Brunnstrom 
Fugl-Meyer (BFM) taken at baseline, 6 weeks 
(outcome) and 12 weeks (follow up) 
Findings 
BFM mean (SD) 
Outcome 
Follow up 


















Authors conclusion EMG biofeedback facilitated the recovery of arm 
function during the period of time when the treatment 
was given but this did not persist once treatment 
stopped. The control group continued to improve 
during the follow up period although this was not 
statistically significant – the authors proposed that this 
was because the control group reached their plateau 
of recovery slower than the treatment group. The 
hiatus in improvement seen in the treatment group 
was reported to be because of a need for a period of 
consolidation of learning. 
Comments Three participants died during the trial and a further 
two died during the follow up period. Treatment bias 
was reported to be minimised by having each 
therapist treat both intervention and control group. 
Effort was made to standardise motivation and 
enthusiasm although therapists could not be blind to 
treatment allocation therefore the potential for 
treatment bias was high. Both groups received 
standard physiotherapy delivered by a therapist 
outside of the treatment group – this was not 
standardised or recorded and therefore could have 
had an impact on the study outcomes. Treatment 
records were recorded daily but it is unclear whether 
the intervention was given over working days or 
everyday therefore the exact dose for this intervention 
is not possible to define and therefore replicate. The 
authors reported that the treatment group only 
received 18 sessions and that this might be the cause 
for the lack of improvement at follow up. Reasons for 




Study Virtual reality based rehabilitation speeds up functional 
recovery of the upper extremities after stroke: A 
randomised controlled pilot study in the acute phase of 
stroke using the Rehabilitation gaming System 
Da Silva Cameirao et al (2011) 
Study Design Randomised controlled trial with two control groups 
Participant 
Characteristics 
Experimental  Control (IOT) Control (NSG) 
Sample Patients admitted to one rehabilitation unit 
Inclusion criteria Severe to moderate deficit of the affected upper limb 
Sample size 
(analysed) 
10 5 4 
Male % 50% 60% 25% 
Age: Mean (SD) 63.7(11.83) 59.4(10.62) 58.0(14.00) 
Time since stroke 
onset: Months (SD) 
0.38(0.17) 0.56(0.13) 0.43(0.14) 






sessions of 20 









3 weekly sessions 









sessions of 20 
mins over 12 
weeks 
Primary Outcome Barthel, Fugl-Meyer (FM), Motricity Index MI), Chedoke 
Arm and Hand Inventory (CAHI). Measurements were 
carried out at baseline, 5 weeks, 12 weeks (outcome and 
24 weeks (follow up). 
Findings 







































Authors conclusion Authors concluded that at outcome the experimental 
group proved better than the control groups on a number 
of the clinical scales although this only reached statistical 
significance for one of these. 
Study used a Likert scale to assess various factors about 
acceptability of the intervention, analysis of these findings 
suggested that the intervention was highly acceptable to 
the participants in this study. Authors acknowledged that 
scores at follow up did not show the same findings as at 
outcome and suggested that the intervention may not 
have been sufficiently intense or may have increased the 
speed of recovery to the point of plateau. 
Comments Twenty five patients were originally selected for the study 
but 5 people left before week 5 assessment, 4 moved to a 
different institution and 1 dropped all rehabilitation.  The 
study tried to control for difference aspects of the gaming 
experience i.e. the motivation that a participant might 
experience by taking part in a ‘game’ and also the 
potential effects of the movement therapy experienced as 
part of the intervention. The sample size increases the risk 
of a type II error but it appears from this study that the 
intervention was feasible and acceptable and did have the 
potential to show some effect. Methods for random 
sequence generation and allocation concealment were 
unclear in the reporting of this study therefore it is at risk 
of selection bias. 
 
Study Dynamic thigh muscle strength after auditory 
feedback training of body weight distribution in stroke 
patients 
Engardt and Knutsson (1994) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental  Control 
Sample Participants who had previously been part of an 
earlier study 
Inclusion criteria Included in previous study 
Sample size (analysed) 16 14 
Male % 75% 29% 
Age: Mean (SD) 67 (6.05) 65 (8.46) 
Time since stroke onset: 
Months (SD) 
33.2(6.6) 34.3(5.8) 
Intervention Auditory feedback from a 
force platform during sit to 
stand. Training lasted 15 
minutes a day, 3 times a 
day for 6 weeks. 
Sit to stand training 
without the addition of the 
auditory feedback. 
Training lasted 15 
minutes a day, 3 times a 
day for 6 weeks. 
Primary Outcome Body weight distribution (BWD) on the paretic leg in 
rising to stand and sitting down. This was a follow up 
study so measurements were taken after training 
(outcome) and then again approximately 33 months 
after training finished (follow up). 
Findings 

























Not statistically significant 
Authors conclusion The decrease in body weight distribution on the 
affected leg at follow up was due to decreased muscle 
strength in the hemiparetic limb which had led to 
dependence on the unaffected limb. They also 
postulated that the participants had become 
dependent on the auditory feedback in the original trial 
and therefore when it was removed had not built up 
any internal mechanisms to compensate for this. 
Comments There was a very long time between the outcome and 
follow up measures; it is unlikely that without ongoing 
intervention that participants would have maintained 
the training effect. Ten of the original participants had 
not taken part in this follow up study, 6 people were 
too unwell, 2 had moved away and 2 could not be 
contacted. It is difficult to draw any conclusions from 
this study as the time period between the 
measurements was so long and therefore 
confounding effects of other interventions and 
activities in  that time period cannot be controlled for. 
It could suggest however that this intervention would 
need to be repeated/have a longer intensity for any 
effects to be maintained or that a self-directed training 
post intervention may have been indicated. 
 
  
Study Action observation has a positive impact on 
rehabilitation of motor deficits after stroke. 
Ertelt et al (2007) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental  Control 
Sample Inpatients at a local rehabilitation centre 
Inclusion criteria Younger than 76 years with a moderate paresis 
Sample size (analyse) 8 8 
Male % 63% 75% 
Age: Mean (SD) 57.1(8.7) 55.4(10.8) 
Time since stroke onset: 
Months (SD) 
48.42(41.39) 23.83(11.87) 
Intervention Action observation of an 
upper limb task and 
physical practice of the 
same. 
Watching a video with 
geometric symbols and 
letters and physical 
practice. 
Primary Outcome Frenchay Arm Test (FAT) and Wolf Motor Function 
Test (WMFT). Measurements were taken 14 days 
before the onset of the therapy, day before the 
therapy and at the end of the treatment (outcome).  

















Authors conclusion Action observation and intensive repetitive practice of 
the observed actions provides a significant 
improvement in motor functions in chronic patients 
diagnosed with a stroke who had an established 
motor impairment. 
Comments This study demonstrates improvement in motor 
deficits in participants who were within the chronic 
phase of recovery – the experimental group were on 
average over two years more post stroke than the 
control group. There is no description of recruitment 
methods or fidelity to treatment protocol therefore little 
can be learned about these aspects from this trial. 
Despite claims of efficacy by the authors this was a 




Study Mental practice with motor imagery in stroke recovery: 
randomized controlled trial of efficacy  
Ietswaart et al (2011) 
Study Design Randomised controlled trial 
Participant 
Characteristics 
Experimental  Control 
Sample All stroke admissions to several acute hospitals were 
recorded and screened for inclusion. Participant 
information was given to patients if they were 
interested whilst they were inpatients in the hospital. 
Inclusion criteria Action Research Arm test score of between 3 and 
51/57 
Sample size (analyse) 39 Attention controlled: 31 
Normal care: 39 
Male % 56% Attention controlled: 71% 
Normal care: 64% 
Age: Mean (SD) 69.3(10.8) Attention controlled: 
68.6(16.3) 
Normal care: 64.4(15.9) 
Time since stroke onset: 
Months (SD) 
2.73(1.83) Attention controlled: 
3.03(2.11) 
Normal care: 2.68(2.09) 
Intervention Motor imagery 
intervention including 
mental practice and 
action observation on a 
one to one basis during 
45mins, 3 days a week 
and 2 x 30 mins working 
independently over 4 
weeks. 
Two control groups: 
Attention controlled 
placebo – visualisation 
programme matched for 
therapist time and self 
directed practice over the 
same time period. 
Normal care with no 
additional training. 
Primary Outcome Action Research Arm Test (ARAT) recorded before the 
intervention and at the end of the treatment phase 
(outcome). 
Findings 












Authors conclusion No evidence for the benefit of mental imagery 
intervention on movement recovery in the subacute 
period of recovery after stroke.  
Comments Analysis was based on an intention to treat, adherence 
to treatment protocol is not reported in terms of dose 
however there were a number of drop outs from the 
study. One person withdrew from the experimental 
intervention, and 10 withdrew from the control groups 
suggesting that the intervention may have been more 
acceptable to the participants than the control 
interventions. Reasons for withdrawing from the 
intervention other than through ill health are not 
reported. This study was at low risk of bias. 
 
  
Study Effects of Motor Imagery Training on Gait Ability of 
Patients with Chronic Stroke. 
Lee et al (2011) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental  Control 
Sample Patients already participating in a rehabilitation 
programme in a community centre. 
Inclusion criteria Able to walk 10m independently without an assistive 
device 
Sample size (analyse) 13 11 
Male % 46% 36% 
Age: Mean (SD) 60.7(7.53) 61.9(11.26) 
Time since stroke onset: 
Months (SD) 
Greater than 6 months 
Intervention Motor imagery (MI) and 
treadmill training. 30 mins 
of MI training and 30 mins 
of treadmill 3 x week for 6 
weeks. 
Treadmill training only. 30 
mins treadmill training 3 x 
week. 
Primary Outcome Walking speed taken before the intervention and after 
(outcome). 
Findings 









Authors conclusion The change between pre and post test scores was 
greater for the experimental group and there were 
also statistically significant changes in other gait 
parameters which led the authors to conclude a 
positive effect of MI. 
Comments This study was small and therefore should probably 
be interpreted as a pilot study. Participants were a 
convenience sample of individuals already attending a 
rehabilitation group and were arguably not left with a 
severe impairment, therefore may not be 
representative of all stroke survivors in the chronic 
stage of recovery from stroke. A total of 12 drop outs 
were reported but it is not clear from which group. 
This was a third of the original sample but without 
further details the impact of this for future studies 
cannot be extrapolated. Allocation concealment and 
blinding of outcome assessor were not reported so 
were at ‘unclear’ risk of bias therefore reliability of 
these findings needs to be made in light of this. 
  
Study Added Value of Mental Practice Combined with a 
Small Amount of Physical Practice on the Relearning 
of Rising and Sitting Post-Stroke: A Pilot Study 
Malouin et al (2009) 
Study Design Randomised controlled trial: pilot study 
Participant 
Characteristics 
Experimental  Control 
Sample Convenience sample of inpatients in one rehabilitation 
unit 
Inclusion criteria Residual limb loading asymmetry but able to sit to 
stand without using their hands. 
Sample size (analyse) 3 3 
Male % 100% Cognitive: 60% 
No training: 100% 
Age: Mean (SD) 57.1(8.7) Cognitive:55.4(10.8) 
No training: 61.8(9.5) 
Time since stroke onset: 
Months (SD) 
28.8(21.6) Cognitive:42(34.8) 
No training: 28.8(24.0) 
Intervention Mental practice and 
physical training. Three 
times a week for four 
weeks. Each session 
took approximately 1 
hour. 
Two control groups: 
No training – no training at 
all 
Cognitive task and 
physical training. The 
same physical practice but 
with mental activities 
equivalent in time to the 
metal rehearsal in the 
experimental group for the 
same duration. 
Primary Outcome Loading of the affected leg on rising and sitting, 
calculated as percent body weight. Measurements 
made at baseline, before training and after 
intervention (outcome). 
Findings  
% body weight on 
affected leg rising 
mean(SD) – outcome 
% body weight on 
affected leg sitting mean 

















Authors conclusion Only the experimental group had a statistically 
significant improvement in % body weight on the 
affected leg during both rising and sitting. 
Comments Allocation concealment was not reported therefore this 
was judged to be at ‘unclear’ risk of bias. This study 
may therefore be at risk of selection bias. Time spent 
in physical practice and either mental or cognitive 
practice was monitored during this study. Both groups 
received equivalent time on each of these activities 
therefore changes could not be attributed to dose. 
Over the period of the intervention participants in the 
experimental group received a mean of 19.2 minutes 
physical practice and 157.6 minutes of mental 
practice. Adherence to treatment cannot be 
ascertained as it was unclear what the proportion of 
time in each activity was intended. The intended dose 
was reportedly approximately 60 minutes for both 
aspects of the intervention totalling an intended dose 
of 720 minutes.  Only 24% of this was actually 
delivered however reasons for this were not 
suggested and therefore cannot inform the designs of 
future studies. 
  
Study Effects of virtual reality training on gait biomechanics 
of individuals post-stroke. 
Mirelman(2010) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental  Control 
Sample Sampling was not described but intervention took 
place in a gait analysis laboratory 
Inclusion criteria Partial anti-gravity dorsiflexion but able to walk 50 feet 
without assistance. 
Sample size (analyse) 9 9 
Male % 83% 
Age: Mean (range) 62 years (41-75) 
Time since stroke onset: 
Months (SD) 
Greater than 2 years 
Intervention Three times a week for 4 
weeks for approximately 
1 hour each time. Virtual 
reality to provide 
feedback on ankle 
movement. 
Three times a week for 4 
weeks for approximately 
1 hour each time. The 
same exercises as the 
experimental group but 
with therapist feedback 
and pacing supplied by a 
metronome. 
Primary Outcome Self-selected walking speed (m/s). Measurements 
occurred 1 week before the intervention and after 
(outcome) and then three months after the end of the 
intervention (follow up). 
Findings  











Authors conclusion Task based virtual reality training was more effective 
than task based training alone. 
Comments Risk of bias was ‘unclear’ for random sequence 
generation, allocation concealment and blinding of 
outcome assessment indicating that this study is 
possibly at risk of selection bias and detection bias.  
The recruitment process for participants was not 
described so cannot be used to inform future trials. All 
participants were reported to have taken part in all 
treatment sessions without adverse events – although 
these were not described so further information 
cannot be extrapolated. Feedback via virtual reality 
may be a useful adjunct to task specific training. 
 
  
Study Transcutaneous Electrical Nerve Stimulation (TENS) 
Combined With Task-Related Training Improves Lower 
Limb Functions in Subjects With Chronic Stroke. 
Ng and Hui-Chan (2007) 
Study Design Randomised controlled trial 
Sample Recruited from the community rehabilitation network 
Inclusion criteria Able to walk 10m unassisted with or without walking 
aids 
 TENS TENS+TRT PLBO+TRT CONTROL 
Sample size (analyse) 19 21 20 20 
Male % 89.5% 76% 85% 85% 
Age: Mean (SD) 56.4(9.1) 58.4(7.1) 57.1(7.8) 57.3(8.6) 
Time since stroke onset: 
Months (SD) 
> 12 months 
Intervention 60 mins of 
TENS 
60 mins of 
TENS 
followed by 



















Home programme 5 days a week for 4 weeks with 8 
sessions in the laboratory to check competence and 
compliance. 
Primary Outcome Gait velocity, measurements taken at baseline, after 2 
weeks, after 4 weeks (outcome) and 4 weeks after the 
end of the intervention (follow up) 
Findings  























Authors conclusion Combining TENS with physical treatment was more 
superior to other interventions in improving motor 
functions in participants with chronic stroke. 
Comments Although showing changes in gait speed, it is 
questionable whether these were clinically significant. 
The greatest gain in speed between the baseline and 
outcome was achieved by the intervention group but 
this was still only 17cm/s, therefore the impact of this 
intervention on the participant may not have been 
noticeable. Fidelity to treatment was measured by log 
books, the dose of each treatment session was not 
reported and therefore it is difficult to see if participants 
were compliant with the intervention and whether or 
not results were achieved because one group was 
more motivated and carried out more of the 
intervention than another.  The recruitment strategy 
was not described therefore cannot be used to inform 
future interventions. 
  
Study Does the use of TENS increase the effectiveness of 
exercise for improving walking after stroke?  A 
randomised controlled trial. 
Ng and Hui-Chan (2009) 
Study Design Randomised controlled trial 
Sample Recruited from the local rehabilitation network 
Inclusion criteria At least 10o of passive ankle dorsiflexion 
 TENS TENS+TRT PLBO+TRT CONTROL 
Sample size (analyse) 25 26 23 27 
Male % 81% 78% 80% 69% 
Age: Mean (SD) 56.5(8.2) 57.8(7.3) 56.9(8.6) 55.5(8.0) 
Time since stroke onset: 
Months (SD) 
> 12 months 
Intervention 60 mins of 
TENS 
60 mins of 
TENS 
followed by 













Home programme 20 sessions over 5 days a week for 
4 weeks. Over this period of time participants attended 
the laboratory 8 times to check for competence and 
compliance. 
Primary Outcome Gait velocity, measurements taken at baseline, after 2 
weeks, after 4 weeks (outcome) and 4 weeks after the 
end of the intervention (follow up) 
Findings  























Authors conclusion Combining TENS with exercise produces greater 
benefit than either exercise or stimulation alone. 
Comments Although showing changes in gait speed, it is 
questionable whether these were clinically significant. 
The greatest gain in speed between the baseline and 
outcome was achieved by the intervention group but 
this was still only 25.3cm/s, therefore the impact of this 
intervention on the participant may not have been 
noticeable. Fidelity to treatment was measured by log 
books, the dose of each treatment session was not 
reported and therefore it is difficult to see if participants 
were compliant with the intervention and whether or 
not results were achieved because one group was 
more motivated and carried out more of the 
intervention than another.  The recruitment strategy 
was not described therefore cannot be used to inform 
future interventions. Authors reported ‘difficulties in 
recruiting’ but did not describe what these were making 
it difficult to learn from this for future studies. 
  
Study Imagery Improves Upper Extremity Motor Function in 
Chronic Stroke Patients: A Pilot Study 
Page (2000) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental Control 
Sample Local advertisements in doctors’ offices, newspapers, 
newsletters and stroke support groups. 
Inclusion criteria Exclusion criteria were listed only. 
Sample size (analyse) 8 8 
Male % 100% 100% 
Age: Mean (SD) 63.2(4) 
Time since stroke onset: 
Months (SD) 
21.6 
Intervention Occupational therapy and 
imagery (OT+I). OT for 3 
times/week for 4 weeks 
for 30 mins followed by  a 
tape recorded imagery for 
20 mins 
Occupational therapy. 
OT for 3 times/week for 4 
weeks for 30 mins 
followed by  tape 
recorded instructions and 
information for 20 mins. 
Primary Outcome Upper extremity of the Fugl Meyer (FM). Tested 
before and after the intervention (outcome). 
Findings  








Authors conclusion Participants who received motor imagery showed 
statistically significant improvements compared to OT.  
Comments The authors reported that no volunteers were 
excluded from participating in the study but the 
success of the recruitment strategy is still relatively 
unknown as the length of time for these 
advertisements was not given nor the scope of the 
advertising programme. Randomisation was used to 
match for characteristics; however the sample size is 
so small that any confounders were un likely to be 
controlled for within this process. Inclusion criteria 
were not described therefore generalising these 
findings is not possible. The study was at ‘unclear’ risk 
of random sequence generation, allocation 
concealment and blinding of the outcome assessment 
su7gesting risk of selection and detection bias. 




Study A randomised efficacy and feasibility study of imagery 
in acute stroke. 
Page et al (2001) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental Control 
Sample Individuals who had responded to advertisements 
placed outside outpatient therapy department in four 
rehabilitation hospitals. 
Inclusion criteria Upper limb hemiparesis in their dominant limb 
Sample size (analyse) 8 5 
Male % 75% 80% 
Age: Mean (SD) 64.4(9.7) 65.0(7.0) 
Time since stroke onset: 
Months (SD) 
5.88(3.44) 7.6(3.21) 
Intervention Therapy plus imagery. 
Three times per week for 
one hour for six weeks. 
After therapy participants 
listened to a tape 
recorded imagery 
intervention lasting 
approximately 10 mins.  
Therapy only. 
Three times per week for 
one hour for six weeks. 
After therapy participants 
listened to a tape 
containing stroke 
information lasting 
approximately 10 mins. 
Primary Outcome Upper Extremity portion of the Fugl Meyer (FM) and 
the Action Research Arm Test (ARAT). Measures 
were administered twice before the intervention one 
week apart and then after the intervention (outcome). 
Findings  
FM mean(SD)  
 outcome 












Authors conclusion Imagery was a feasible intervention and the group 
that received imagery showed greater improvement 
between the baseline and outcome. 
Comments The results describe a home practice schedule but 
this was not described in the methods in the reporting 
of this trial. Interview assessing acceptability of the 
intervention was also carried out but the results of 
these have not been reported. The presence or not of 
blinding of the outcome assessor was not reported 
and therefore is at ‘unclear’ risk of bias. This trial was 
reported as a pilot study assessing feasibility and 
therefore little information can be derived about 
efficacy, poor reporting also makes it difficult to 
extrapolate any findings on acceptability and 
adherence to the treatment protocol. 
 
  
Study Modified Constraint-Induced Therapy Combined with 
mental Practice. Thinking Through Better Outcomes 
Page et al (2009) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental Control 
Sample Volunteers recruited by advertisements placed in local 
therapy clinics 
Inclusion criteria Ability to extend at least 100 at the 
metacarpophalangeal joints of each digit and extend 
200 at the wrist. Score of <2.5 of the amount of use 
scale of the Motor Activity Log. 
Sample size (analyse) 5 5 
Male % 80% 60% 
Age: Mean (SD) 58.4(9.8) 6.4(9.0) 
Time since stroke onset: 
Months (SD) 
26.4(13.6) 30.6(11.4) 
Intervention Mental practice and 
modified constraint 
induced therapy 
(mCIMT). Mental practice 
was administered after 
the mCIMT. 
30 minute therapy 
sessions 3times/week for 
10 weeks with 30 minutes 
of mental practice. 
Modified constraint 
induced therapy. 
Primary Outcome Fugl Meyer (FM) and Action research Arm Test 
(ARAT). 
Administered twice before the start of the intervention,  
5 weekdays apart and then after the end of the 
intervention (outcome) and then 3 months after the 
end of the intervention (follow up) 
Findings  
FM mean(SD)  
Outcome 
Follow up 



















Authors conclusion Both groups exhibited clinically relevant changes, the 
addition of MP facilitated more practice repetitions 
and therefore may explain the better outcomes seen 
in this group.  
Comments Thirty people were screened for the study and 20 
were excluded because they did not meet the 
recruitment criteria. There is no detail of the time 
period over which recruitment occurred. Compliance 
with the mental practice intervention was not 
measured and this aspect of the study was self-
administered, however the improved outcomes seen 
in this group would suggests some engagement with 
this therapy. Allocation concealment was ‘unclear’ and 
therefore the study may be at risk of selection bias. 
 
  
Study Single blind randomised controlled trial of visual 
feedback after stroke: effects on stance symmetry and 
function 
Sackley and Lincoln (1997) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental Control 
Sample Inpatients in one city hospital in the UK 
Inclusion criteria Able to stand for 1 minute and had an abnormal 
stance symmetry 
Sample size (analyse) 12 13 
Male % 83% 77% 
Age: Mean (SD) 60.8(12.3) 67.9(9.2) 
Time since stroke onset: 
Months (SD) 
4.64(3.65) 4.34(4.45) 
Intervention Symmetry training in 
standing using the 
Nottingham Balance 
Platform (NBP) enabling 
feedback. 
60 minutes 3 times/week 
for 4 weeks 
Symmetry training using 
the NRP but with no 
feedback 
60 minutes 3 times/week 
for 4 weeks 
Primary Outcome Balance coefficient (BC) 
Carried out before and after (outcome) the 
intervention 
Findings  








Authors conclusion Feedback delivered through the NBP led to a 
statistically significant improvement in stance 
symmetry compared to the group that received no 
feedback via the NBP. 
Comments Consort or patient flow not described therefore difficult 
to ascertain how many patients were screened 
relative to those that were recruited. Two participants 
dropped out of the study, one from each group due to 
issues unrelated to the trial. Treatment fidelity was not 
recorded although treatment sessions were only 
reportedly dependent on the patient’s tolerance and 
medical status; therefore it is unclear how much 
therapy each participant received. Allocation 
concealment was ‘unclear’ therefore the study may be 
at risk of selection bias.  
 
  
Study Musical Motor Feedback (MMF) in walking 
hemiparetic stroke patients: randomised trials of gait 
improvement 
Schauer and Mauritz (2003) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental Control 
Sample “All hemiparetic patients” 
Inclusion criteria Execute at least task 7 but failed at task 11 or higher 
of the Rivermead gross function score of the 
Rivermead Motor Assessment. Able to walk twenty 
minutes without any assistive device. 
Sample size (analyse) 11 12 
Male % No data given  
Age: Mean (SD) 50.0(12.0) 61.0(12.0) 
Time since stroke onset: 
Months (SD) 
1.74 2.2 
Intervention Walking practice with 
musical motor feedback 
(MMF) providing 
feedback. 5 days/week 20 
minutes each day for a 
total of 15 sessions. 
Walking practice with a 
therapist for 20 minutes 
each day for a total of 15 
sessions. 
Primary Outcome Gait velocity m/s 
Assessments taken before and after the intervention 
(outcome). 
Findings  











Authors conclusion The authors reflected that whilst the results in favour 
of the intervention were statistically significant that this 
was due to very sensitive responders and those that 
failed to show an effect.  
Comments Sampling strategy was non specific and therefore not 
able to inform future trials. 37 people could have been 
recruited but only 23 gave consent, reasons for this 
were unknown. The sample size was small and 
therefore generalisation would not be possible - if the 
study authors wished to evaluate which responders 
would be most sensitive to this type of intervention 
then a different trial methodology might be useful. 
Fidelity to treatment intervention was not possible to 
extrapolate because information relating to 
acceptability and dose were not provided. The study 
was 'unclear' in respect of random sequence 
generation and allocation concealment, presenting a 
risk of selection bias. It was also 'unclear' in respect of 
blinding of outcome assessment making the study 
potentially at risk of detection bias. 
 
Study Efficacy of an insole shoe wedge and augmented 
pressure sensor for gait training in individuals with 
stroke: a randomised controlled trial. 
Sungkarat et al (2011) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental Control 
Sample Participants were recruited from one rehabilitation unit 
and the physical therapy clinic. 
Inclusion criteria Able to walk at least 10m with or without assistance. 
Sample size (analyse) 17 18 
Male % 71% 67% 
Age: Mean (SD) 52.1(7.2) 53.8(11.2) 
Time since stroke onset: 
Months (SD) 
3.94(4.79) 4.7(5.8) 
Intervention Insole show wedge 
providing feedback 
60 minute sessions 5 
days a week for 3 weeks. 
30 minutes of each 
session involved gait 
training with the insole 
and 30 mins conventional 
therapy 
Conventional therapy and 
gait training. 
60 minute session for 5 
days a week for 3 weeks. 
30 mins of each session 
involved gait training and 
the other 30 mins of 
conventional therapy. 
Primary Outcome Gait speed (cm/s) 
Before and after the training (outcome) 
Findings  









Authors conclusion The experimental group demonstrated 3x greater 
improvement in gait speed compared to the control 
group leading the authors to conclude that augmented 
feedback is beneficial. 
Comments 5 people dropped out in total, 2 from the control group 
and 3 from the intervention group. None of these were 
for reasons related to the trial interventions. Authors 
did comment that although there was improvement 
the gait speed eventually achieved by the 
experimental group was still below that required for 
community ambulation. Treatment fidelity is not 
possible to extrapolate as this information has not 
been provided and this is a small sample size so the 
generalisability of these findings to other stroke 
survivors is limited. Inclusion criteria was not limited in 
respect of time since onset of stroke but the study 
design means that it is not possible to determine 
whether either of these populations responded in 
different ways to the experimental intervention.  
 
Study Effect of Thermal Stimulation on Upper Extremity 
Motor Recovery 3 Months After Stroke. 
Wu et al (2010) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental Control 
Sample Little detail but appears to be outpatients in one 
rehabilitation unit. 
Inclusion criteria Ability to sit on a chair for 30 minutes and move 
paretic hand away from thermal therapeutic pad 
independently, with and without the assistance of the 
nonparetic hand. 
Sample size (analyse) 12 11 
Male % 33% 45% 
Age: Mean (SD) 59.9(11.4) 54.3(10.3) 
Time since stroke onset: 
Months (SD) 
10.0(7.3) 7.2(5.4) 
Intervention 1 hour of physical therapy 
and 1 hour of 
occupational therapy. An 
additional upper extremity 
thermal stimulation 
protocol. 
30 minutes, 3 times per 
week for 8 weeks.  
1 hour of physical therapy 
and 1 hour of 
occupational therapy. An 
additional lower extremity 
thermal stimulation 
protocol. 
30 minutes, 3 times per 
week for 8 weeks. 
Primary Outcome UE subscale of the Stroke Rehabilitation Assessment 
of Movement and the Action Research Arm Test 
(STREAM) 
Before treatment, after treatment (outcome) and week 
12 of study (follow up) 
Findings  






10.0(5.3) p<0.001  





8.0(5.6) p=0.005  
Authors conclusion The thermal stimulation could lead to further 
improvement in upper extremity movement in stroke 
survivors who are more than 3 months after stroke. 
Comments No information about treatment fidelity or recruitment 
methods was given. There were no drop outs from the 
study therefore it could be assumed that the 
intervention was acceptable to the participants. Both 
groups showed improvement after the interventions 
although this was less for the control group but does 
indicate capacity for further improvement in this 
population of stroke survivors. The study was at 
‘unclear’ risk of bias for random sequence generation 
and allocation concealment indicating the potential for 
selection bias. 
  
Study Virtual reality-based training improves community 
ambulation in individuals with stroke: A randomised 
controlled trial 
Yang et al (2008) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental Control 
Sample Subjects were recruited from community groups 
Inclusion criteria Limited household walker, unlimited household 
walker, most-limited community walker by functional 
walking category. 
Sample size (analyse) 11 9 
Male % 45% 56% 
Age: Mean (SD) 55.4(12.1) 60.9(9.3) 
Time since stroke onset: 
Months (SD) 
71.16(50.04) 73.2(123.84) 
Intervention Walking on a treadmill in 
a virtual reality 
environment 
20 minute session, three 
sessions a week for three 
weeks. 
Walking on a treadmill 
and asked to carry out 
various tasks.  20 minute 
session, three sessions a 
week for three weeks. 
Primary Outcome Walking speed (m/s) 
Before training, at the end of training (outcome) and 1 
month after completion of the training (follow up) 
Findings  












Authors conclusion Virtual reality-based training improved walking speed 
compared to walking training alone. These results 
were maintained at follow up. 
Comments Four participants dropped out of the study, three from 
the control group and 1 from the experimental group. 
Reasons for these drop outs have not been given. 
Treatment fidelity has not been described and 
recruitment methods have not been described. This 
study does suggest that stroke survivors in the 
chronic phase of recovery can still show capacity for 
improvement. This study was at low risk of bias for all 
aspects of the risk of bias assessment suggesting that 





Study Mirror Therapy Improves Hand Function in Subacute 
Stroke: A Randomized Controlled Trial 
Yavuzer et al (2008) 
Study Design Randomised controlled trial 
Participant Characteristics Experimental Control 
Sample Referred for inpatient rehabilitation from all over 
Turkey 
Inclusion criteria Had a Brunnstrom score between stages I and IV for 
the upper extremity. 
Sample size (analyse) 20 20 
Male % 45% 50% 
Age: Mean (SD) 63.2(9.2) 63.3(9.5) 
Time since stroke onset: 
Months (SD) 
5.4(2.9) 5.5(2.5) 
Intervention Conventional stroke 
program and an 
additional 30 minutes of 
mirror therapy. 
5 days a week, 2-5 hours 
a day for 4 weeks. 
Conventional stroke 
program and an 
additional 30 minutes 
using non reflective side 
of mirror. 
5 days a week, 2-5 hours 
a day for 4 weeks. 
Primary Outcome Motor recovery Brunnstrom stages for hand and 
upper extremity (UE) 
Pre treatment , post treatment – after 4 weeks 























Authors conclusion Mirror therapy in conjunction with conventional 
therapy was more effective than conventional therapy 
alone. 
Comments Some follow up data was lost as participants were 
unable to travel to the rehabilitation centre for 
measurement (3 from the experimental group and 1 
from the control group). Treatment varied in dose from 
between 2 and 5 hours and no information was given 
regarding length of treatment for either group. It is 
possible that the experimental group received more 
therapy and the improvements observed were as a 
result of this. Recruitment was via a convenience 
sample of inpatients and therefore little can be gained 
regarding recruitment to a community trial. The study 
was however at low risk of bias and therefore results 








Follow up results for ARAT  















Histogram showing relationship between side of hemiplegia and change in the ARAT score at 





Histogram showing relationship between side of hemiplegia and change in the ARAT score at 
follow up for the lower limb group 
 
Histogram showing relationship between the gender of the participant and change in the 




Histogram showing relationship between the gender of the participant and change in the 






Scatterplot of the change in ARAT score at follow up and the time between stroke onset and 






Scatterplot to show the relationship between the change in ARAT at follow up and ARAT 






Scatterplot to show relationship between the change in ARAT at follow up and severity as 







Follow up results for FAC 
Secondary Analysis of Follow up Results for FAC  
 
 













Histogram showing relationship between side of hemiplegia and change in the FAC score at 
follow up for the upper limb group 
 
 
Histogram showing relationship between side of hemiplegia and change in the FAC score at 




Histogram showing relationship between the gender of the participant and change in the FAC 




Histogram showing relationship between the gender of the participant and change in the FAC 
score at follow up for the lower limb group 
 
Scatterplot of the change in FAC score at follow up and the time between stroke onset and 








Scatterplot to show relationship between the change in FAC at follow up and severity as 
categorised by the FAC. 
 
